data_2l1a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l1a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.411 -2.386 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 39.6 mtt -128.19 140.1 52.1 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -170.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 43.6 tttm -97.21 94.81 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -104.11 137.29 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.76 -171.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 41.6 mtm180 -71.82 130.7 41.7 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.386 0.613 . . . . 0.0 110.196 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' SER . 45.8 t -117.99 127.91 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.346 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.28 43.4 mt-10 -90.18 143.76 26.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 116.257 -2.177 . . . . 0.0 109.358 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.2 tm? -111.7 129.67 56.03 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.071 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.452 -0.914 0 N-CA-C 108.675 -1.317 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.7 p -135.87 153.1 51.58 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 -173.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -146.87 145.95 19.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 m -97.8 104.98 17.05 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 35.7 t60 -111.24 144.87 39.7 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 -169.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.76 113.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.45 143.84 42.91 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.1 164.51 37.11 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.397 1.079 . . . . 0.0 108.402 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.84 14.81 63.58 Favored Glycine 0 C--N 1.291 -1.967 0 O-C-N 124.239 0.962 . . . . 0.0 112.787 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -105.61 -28.34 10.81 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 121.994 0.902 . . . . 0.0 110.1 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 39.9 m -94.7 132.36 39.53 Favored 'General case' 0 N--CA 1.39 -3.466 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.362 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.94 149.55 14.97 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -54.9 -53.15 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.163 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 22.3 pttm -54.38 -30.72 52.91 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 124.468 1.105 . . . . 0.0 111.02 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.8 m-20 -78.1 -36.31 48.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.204 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.474 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 96.2 m-70 -64.04 -39.73 94.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 30.1 mt -66.87 -44.32 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.977 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 96.4 mttt -56.69 -34.4 67.38 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.64 0.654 . . . . 0.0 110.821 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.4 t -69.59 -54.27 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.652 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.51 -49.51 67.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.429 0.456 . . . . 0.0 111.159 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.1 mt -54.74 -50.13 69.13 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 123.622 0.576 . . . . 0.0 109.844 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.0 m -58.16 -39.87 79.96 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -71.53 -27.87 63.48 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.139 0.495 . . . . 0.0 111.712 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 46.1 m-85 -89.82 2.04 55.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.291 0.567 . . . . 0.0 111.609 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 67.77 35.47 3.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.318 1.447 . . . . 0.0 112.579 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.2 135.78 19.42 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.97 135.88 69.63 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.429 2.086 . . . . 0.0 111.156 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 32.4 m -64.37 -10.73 8.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.813 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.392 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.42 -15.99 63.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.77 0.795 . . . . 0.0 109.523 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.91 -7.53 58.11 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.964 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -46.45 -30.69 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.097 0 C-N-CA 127.226 2.211 . . . . 0.0 111.128 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.271 16.5 m -56.99 -45.09 83.21 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 126.018 1.727 . . . . 0.0 111.724 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' MET . 8.7 m -100.9 7.13 43.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.057 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 28.8 m-85 -109.91 143.56 39.66 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 122.154 -0.341 . . . . 0.0 110.92 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 147.65 28.42 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.325 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 89.0 mt -80.47 134.67 36.01 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.603 1.189 . . . . 0.0 107.944 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' NE2' HD21 ' A' ' 74' ' ' LEU . 6.0 tt0 -125.8 147.08 49.53 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.48 135.73 68.6 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.91 -16.14 29.38 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 115.076 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -105.83 -46.76 4.05 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.687 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -90.05 -18.09 26.58 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.639 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.415 HD21 ' NE2' ' A' ' 69' ' ' GLN . 10.6 mt 65.07 22.63 12.37 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.387 1.075 . . . . 0.0 110.918 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.05 135.87 35.89 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.374 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.61 149.85 20.83 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.644 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.86 106.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.62 10.86 29.0 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 123.107 1.432 . . . . 0.0 108.83 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.49 154.03 37.19 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.165 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.2 m -83.53 -35.46 24.79 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.702 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -129.8 149.55 51.49 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.263 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.37 153.04 22.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.212 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -108.35 158.84 32.76 Favored Pre-proline 0 N--CA 1.411 -2.415 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.1 -35.9 98.36 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.176 1.917 . . . . 0.0 109.16 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.75 -41.66 95.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.814 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -63.59 -43.08 97.99 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.514 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 69.8 mt -62.99 -48.08 80.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.377 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 30.4 t -61.1 -45.8 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.18 -27.96 68.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.66 -44.09 29.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.429 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 3.7 mm-40 -52.58 -22.18 4.7 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.84 -34.42 40.54 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.2 m -146.62 -83.84 0.12 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.63 177.91 10.87 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.52 1.128 . . . . 0.0 108.587 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.45 151.78 35.35 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 10.6 mt -114.9 140.81 34.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.34 107.01 12.85 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 63.8 mtp180 -129.0 159.48 35.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.39 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' SER . 52.3 mtp . . . . . 0 N--CA 1.411 -2.417 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 166.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.443 -0.812 0 CA-C-O 121.326 0.584 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.719 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 47.0 mtt -123.88 141.88 51.63 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.727 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.1 tttm -100.66 97.01 7.73 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -107.33 139.75 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.743 -172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 10.7 mtp180 -67.22 134.92 52.59 Favored 'General case' 0 CA--C 1.454 -2.72 0 CA-C-O 121.838 0.828 . . . . 0.0 111.828 170.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.3 t -120.81 122.9 69.06 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.501 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.308 0.7 OUTLIER -83.78 144.41 29.33 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 116.082 -2.247 . . . . 0.0 108.518 166.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.6 tm? -114.55 137.09 52.3 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.404 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.313 -1.007 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.093 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.782 0 N-CA-C 111.081 -0.392 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.8 m -140.37 159.89 41.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.149 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 8.5 p -150.36 149.45 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -98.77 104.69 16.76 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.0 t60 -109.67 147.9 32.3 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.315 -170.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 113.02 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.81 147.45 38.33 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.25 -170.37 3.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.34 18.25 8.33 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.86 -28.37 8.41 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 124.03 0.932 . . . . 0.0 110.596 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 40.7 m -95.5 131.84 41.24 Favored 'General case' 0 N--CA 1.386 -3.67 0 C-N-CA 124.513 1.125 . . . . 0.0 109.096 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 148.49 14.73 Favored 'General case' 0 C--O 1.254 1.332 0 O-C-N 123.795 0.684 . . . . 0.0 110.618 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.2 -53.15 31.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.111 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -54.54 -31.92 57.31 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.344 1.028 . . . . 0.0 111.419 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.6 m-20 -75.88 -38.75 57.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.443 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.484 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.0 m-70 -61.98 -39.24 91.5 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.5 mt -67.1 -43.31 88.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.1 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.98 -34.3 71.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.066 0.848 . . . . 0.0 111.141 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 47' ' ' ASP . 87.1 t -68.14 -52.62 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.239 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.79 -48.71 72.38 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.403 0.439 . . . . 0.0 111.089 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.66 -47.49 79.67 Favored 'General case' 0 C--O 1.2 -1.513 0 O-C-N 123.644 0.59 . . . . 0.0 109.796 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.2 m -59.42 -40.34 86.41 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -70.91 -34.04 71.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 50.3 m-85 -83.81 -2.37 56.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.37 0.605 . . . . 0.0 111.702 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 69.72 34.42 2.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.806 1.643 . . . . 0.0 111.999 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.27 137.24 19.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.68 132.47 50.41 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 121.926 1.751 . . . . 0.0 110.877 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.486 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.54 -10.14 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.166 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.99 -14.34 62.65 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.97 0.414 . . . . 0.0 111.187 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 60.8 mttm -86.33 -7.74 58.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.408 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -46.41 -32.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 C-N-CA 126.666 1.986 . . . . 0.0 110.833 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 p -54.17 -49.77 68.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 125.997 1.719 . . . . 0.0 111.219 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' MET . 27.2 t -96.0 9.21 41.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.865 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.447 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 16.4 m-85 -109.94 140.08 44.32 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.779 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.876 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 86.0 mt -85.53 125.85 33.4 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.394 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -113.82 148.62 36.3 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 120.78 0.324 . . . . 0.0 110.872 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -81.94 132.22 54.68 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.82 -18.59 52.94 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.627 2.218 . . . . 0.0 115.288 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.65 -44.44 4.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.014 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 p -89.5 -20.29 24.03 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.252 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 mt 68.48 16.53 9.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 111.654 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.69 139.37 38.5 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -98.95 147.36 25.06 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.728 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.11 106.01 14.03 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.469 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.1 10.15 41.72 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 123.983 0.913 . . . . 0.0 109.888 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.98 154.14 39.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.273 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.5 m -82.85 -38.48 22.94 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.052 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -130.67 148.74 52.5 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.351 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -80.65 157.71 25.87 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.771 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 56.5 p -110.78 153.92 43.48 Favored Pre-proline 0 N--CA 1.403 -2.816 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.63 -32.09 81.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.619 1.546 . . . . 0.0 110.119 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.66 -51.01 71.76 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.72 0.808 . . . . 0.0 110.783 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 23.9 mmm180 -60.95 -37.99 84.3 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 123.205 0.315 . . . . 0.0 110.688 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.719 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.8 mt -63.22 -49.21 75.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 123.973 0.796 . . . . 0.0 110.34 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.497 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 38.0 t -62.98 -44.2 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.63 -33.22 73.55 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.586 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.13 -42.48 46.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.649 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 25.0 mt-10 -52.34 -23.19 5.46 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -53.48 -35.59 60.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.896 0.879 . . . . 0.0 112.583 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 m -145.2 -84.82 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER -162.23 178.13 9.01 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.797 1.239 . . . . 0.0 108.612 -177.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 m-85 -111.63 146.88 36.65 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 94' ' ' TYR . 4.9 mt -112.66 100.41 10.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.765 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.34 102.71 8.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -123.87 160.08 28.23 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.664 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.447 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 52.3 mtp . . . . . 0 N--CA 1.4 -2.959 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 166.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.0 112.552 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.9 mtt -113.68 138.17 50.58 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.704 -1.589 . . . . 0.0 111.782 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 77.0 tttt -96.97 90.49 5.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -100.49 137.84 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.47 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 16.3 mtm180 -73.79 131.36 41.47 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.5 t -118.39 127.65 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.294 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.767 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 34.6 mt-10 -88.23 148.37 24.39 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 116.63 -2.028 . . . . 0.0 107.866 165.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -118.66 128.97 55.03 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.055 0.222 . . . . 0.0 110.542 177.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.317 -0.84 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.545 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 C--O 1.238 0.488 0 N-CA-C 110.36 -0.669 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.6 p -132.49 150.08 52.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.688 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 9.3 p -147.02 148.22 16.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 12.8 m -99.5 105.44 17.35 Favored 'General case' 1 N--CA 1.379 -4.021 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -110.05 146.32 35.56 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.922 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -83.52 111.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.25 145.1 40.54 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.07 172.05 13.62 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.45 17.64 54.98 Favored Glycine 0 C--N 1.307 -1.069 0 O-C-N 124.271 0.982 . . . . 0.0 112.606 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -113.67 -22.75 10.09 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 121.618 0.723 . . . . 0.0 111.987 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.513 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 59.8 m -101.28 137.17 39.98 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.137 0.975 . . . . 0.0 109.952 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.14 147.33 16.41 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 124.025 0.828 . . . . 0.0 110.767 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.3 t -54.98 -53.97 28.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.857 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -57.6 -28.93 64.07 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.267 0.98 . . . . 0.0 111.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 51' ' ' VAL . 1.5 m-20 -75.91 -37.29 58.94 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.228 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.513 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 93.9 m-70 -62.15 -38.3 88.48 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 171.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 43.5 mt -67.11 -43.58 88.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.172 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.17 -34.46 68.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.836 0.744 . . . . 0.0 111.034 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 47' ' ' ASP . 63.4 t -70.55 -52.86 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.595 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.65 -49.62 67.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.252 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 91.7 mt -56.36 -48.29 77.11 Favored 'General case' 0 C--O 1.206 -1.231 0 O-C-N 123.48 0.487 . . . . 0.0 109.801 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.8 m -58.94 -40.18 83.89 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -71.82 -29.81 64.82 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.959 0.409 . . . . 0.0 112.023 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 41.1 m-85 -86.94 -0.97 57.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.232 0.539 . . . . 0.0 112.159 175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HZ3' ' HB3' ' A' ' 57' ' ' LYS . 9.5 mtpm? 69.79 30.86 3.68 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.967 1.707 . . . . 0.0 112.579 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.23 135.51 20.29 Favored Pre-proline 0 N--CA 1.404 -2.74 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.26 134.68 60.62 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.952 1.768 . . . . 0.0 111.24 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.464 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.2 m -63.26 -9.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.655 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.6 -15.46 63.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.785 0.326 . . . . 0.0 110.534 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -86.91 -5.48 59.08 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.847 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 1.6 p -48.9 -32.71 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 125.095 1.358 . . . . 0.0 110.609 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -57.14 -42.22 80.55 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.89 1.276 . . . . 0.0 110.379 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.2 m -103.52 13.7 32.87 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.243 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.77 144.29 45.45 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.89 154.77 31.77 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.042 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.4 mt -83.58 130.14 34.98 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.76 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.34 150.7 35.88 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -81.09 131.99 57.9 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.84 -19.82 46.32 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.914 2.409 . . . . 0.0 115.537 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.52 -45.28 4.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.355 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -92.14 -18.29 23.72 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.267 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.93 20.36 10.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.476 1.11 . . . . 0.0 112.443 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.16 137.71 35.9 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -94.54 147.44 23.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.217 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.44 107.67 13.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -101.38 12.38 37.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.195 0.521 . . . . 0.0 111.09 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -76.44 155.77 33.65 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 122.299 1.047 . . . . 0.0 111.684 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -81.86 -38.31 25.61 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.627 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.34 151.02 51.3 Favored 'General case' 0 N--CA 1.417 -2.121 0 C-N-CA 123.901 0.881 . . . . 0.0 108.631 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.9 mt -83.33 154.53 24.03 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.352 0.596 . . . . 0.0 110.521 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -111.46 153.44 44.17 Favored Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.42 -36.38 79.09 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 0.0 109.674 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.45 -46.49 86.45 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.813 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.59 -37.12 86.46 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 75.8 mt -65.19 -49.12 70.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.922 0.763 . . . . 0.0 110.184 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.465 ' CG2' ' HE3' ' A' ' 8' ' ' MET . 39.6 t -60.51 -44.07 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -62.16 -32.2 72.79 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.17 -43.83 23.16 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.79 -25.25 7.24 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -54.35 -36.67 64.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.672 1.189 . . . . 0.0 112.529 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.6 m -140.67 -80.79 0.26 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.05 -178.92 3.9 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 124.864 1.265 . . . . 0.0 108.443 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 2.6 m-85 -117.43 148.15 42.05 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 170.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.65 101.57 12.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.019 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.28 103.72 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -125.97 164.3 21.11 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.514 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' SER . 58.4 mtp . . . . . 0 N--CA 1.405 -2.723 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.42 -1.934 0 CA-C-O 121.625 0.726 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 45.0 mtt -112.95 141.24 47.01 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.71 -169.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 22.5 ttmm -98.63 101.07 12.38 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -112.22 138.64 40.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 124.833 1.253 . . . . 0.0 109.834 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.33 134.99 47.14 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.555 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' SER . 58.5 t -118.88 127.69 75.75 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.79 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.019 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.77 149.46 24.84 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.52 -1.672 . . . . 0.0 107.765 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tm? -115.17 132.65 56.54 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.093 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.47 ' N ' HD21 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.306 -1.315 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.735 -0.91 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.6 p -139.37 157.25 46.19 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.011 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG13 ' CZ ' ' A' ' 56' ' ' PHE . 7.4 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -97.45 99.48 10.9 Favored 'General case' 0 N--CA 1.387 -3.594 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 59.9 t60 -106.12 144.99 32.04 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.814 -167.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 9' ' ' LYS 0.253 48.4 mm -83.65 114.06 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -115.35 151.5 34.52 Favored 'General case' 0 C--N 1.272 -2.78 0 C-N-CA 123.299 0.639 . . . . 0.0 109.513 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -146.71 -167.79 2.85 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.16 21.18 5.24 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -108.98 -25.46 10.71 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.469 0.652 . . . . 0.0 110.171 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.3 m -105.79 138.08 42.59 Favored 'General case' 0 N--CA 1.412 -2.342 0 C-N-CA 124.633 1.173 . . . . 0.0 109.391 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.64 145.86 22.44 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 121.444 0.64 . . . . 0.0 110.93 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 81.4 t -48.54 -52.05 9.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.701 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -56.57 -35.35 68.07 Favored 'General case' 0 C--O 1.198 -1.617 0 O-C-N 124.565 1.166 . . . . 0.0 111.204 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.61 -34.62 65.13 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.862 -0.524 . . . . 0.0 111.703 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -63.38 -36.98 85.51 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.62 -41.65 85.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.354 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -56.26 -38.78 71.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.856 0.753 . . . . 0.0 110.622 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.75 -53.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.902 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.3 mt -53.22 -50.56 64.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.133 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.99 -49.14 76.65 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 123.677 0.611 . . . . 0.0 110.047 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -59.13 -38.76 80.44 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -73.94 -31.47 63.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 14' ' ' LEU . 29.6 m-85 -81.58 -8.45 59.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.066 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt 74.57 37.23 0.56 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.638 1.575 . . . . 0.0 111.91 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.6 mt -109.63 131.53 21.85 Favored Pre-proline 0 N--CA 1.409 -2.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.72 136.11 57.89 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 C-N-CA 122.557 2.171 . . . . 0.0 111.932 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.7 m -64.29 -9.8 6.94 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.903 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.49 -15.93 63.35 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.674 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.9 mptp? -85.32 -4.36 59.13 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.5 p -49.37 -30.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.919 1.688 . . . . 0.0 110.481 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.2 p -56.05 -50.53 70.7 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.005 173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 99' ' ' MET . 19.6 m -98.44 13.16 32.69 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.256 -172.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 19.2 m-85 -114.25 142.43 46.29 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.942 -0.474 . . . . 0.0 111.748 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.08 146.65 24.1 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.671 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.92 138.26 38.79 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.059 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -122.14 144.97 48.62 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.89 130.32 76.24 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.42 -18.72 49.67 Favored 'Trans proline' 0 C--N 1.329 -0.453 0 C-N-CA 122.575 2.183 . . . . 0.0 114.957 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -110.52 -39.48 4.9 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.2 p -90.12 -18.07 26.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.146 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 68.86 15.56 8.92 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.0 111.943 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.72 137.72 37.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.38 156.91 17.9 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.289 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 79' ' ' ASP . 46.6 t -104.07 77.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 122.141 0.972 . . . . 0.0 111.845 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.4 2.94 2.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 125.234 1.414 . . . . 0.0 114.174 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 77' ' ' VAL . 6.4 m-20 -68.84 154.73 41.48 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.582 177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -82.96 -37.28 24.31 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.851 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.49 153.37 48.88 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.291 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.68 146.83 26.65 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.2 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -99.02 157.79 33.46 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.5 -34.81 98.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.071 1.848 . . . . 0.0 109.398 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.09 -45.67 93.77 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.401 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 8.7 mmt180 -61.14 -39.7 91.04 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.691 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 79.0 mt -64.86 -48.68 73.4 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 124.073 0.858 . . . . 0.0 109.778 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.504 ' CG2' ' HE1' ' A' ' 8' ' ' MET . 41.5 t -62.77 -45.3 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -63.83 -28.71 70.04 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.131 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.06 24.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.632 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 15.6 mt-10 -53.02 -22.71 6.13 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 119.059 0.845 . . . . 0.0 113.117 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.93 -42.93 65.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.706 0.803 . . . . 0.0 110.826 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.6 m -140.91 -80.41 0.26 Allowed 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.36 -179.26 4.39 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 124.133 0.973 . . . . 0.0 109.04 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.61 149.49 42.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.3 99.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.02 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 105.5 10.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.018 0.913 . . . . 0.0 108.589 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -124.07 166.15 16.26 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.427 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' SER . 57.4 mtp . . . . . 0 N--CA 1.4 -2.964 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.463 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.5 mmt -115.46 138.23 51.24 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.899 -172.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 45.3 tttm -99.04 91.98 5.27 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.61 137.27 31.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.939 -171.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 30.0 mtm105 -69.42 130.71 43.29 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 121.714 0.769 . . . . 0.0 110.225 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.0 t -117.07 122.58 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.385 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.487 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.275 33.0 mt-10 -82.38 149.36 27.73 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 116.566 -2.053 . . . . 0.0 107.037 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.52 123.09 36.97 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.314 -0.972 0 C-N-CA 119.242 -0.983 . . . . 0.0 109.019 171.375 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 C--O 1.242 0.696 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.6 m -145.86 157.59 43.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.193 0.52 . . . . 0.0 112.008 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -147.76 148.15 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.734 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.803 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.4 m -97.05 103.86 15.82 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 43.1 t60 -107.86 147.59 30.73 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.138 -169.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 38' ' ' ILE . 49.7 mm -83.83 111.18 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.0 146.02 38.62 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.47 -168.85 3.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.83 20.45 6.03 Favored Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.471 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.12 -26.86 9.0 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.641 0.734 . . . . 0.0 110.699 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.0 m -99.62 135.3 41.25 Favored 'General case' 0 N--CA 1.39 -3.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.942 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.31 146.12 12.76 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 123.931 0.769 . . . . 0.0 111.58 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' A' ' 82' ' ' LEU . 89.0 t -52.75 -54.0 18.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.643 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HB3' ' HZ1' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -56.82 -31.02 64.31 Favored 'General case' 0 C--O 1.204 -1.329 0 O-C-N 124.464 1.102 . . . . 0.0 111.977 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 -38.94 62.16 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.91 -37.6 85.24 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.542 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.5 mt -68.81 -42.35 82.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.127 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.7 mttt -58.58 -33.55 70.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.87 -54.82 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.6 mt -53.12 -49.34 66.74 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 123.268 0.355 . . . . 0.0 111.178 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 86.4 mt -56.65 -48.19 78.12 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 123.404 0.44 . . . . 0.0 110.224 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -59.7 -38.76 82.47 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.71 -30.32 64.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.856 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.43 1.09 55.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.362 0.601 . . . . 0.0 112.03 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 67.3 35.05 4.55 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.489 1.516 . . . . 0.0 112.497 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.54 136.76 19.13 Favored Pre-proline 0 N--CA 1.411 -2.407 0 C-N-CA 124.802 1.241 . . . . 0.0 107.8 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.13 133.0 50.24 Favored 'Trans proline' 0 CA--C 1.495 -1.445 0 C-N-CA 121.999 1.799 . . . . 0.0 110.861 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -62.05 -9.85 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.115 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.05 -19.2 64.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.277 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -82.21 -5.51 58.55 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.9 p -48.01 -29.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 125.759 1.623 . . . . 0.0 110.975 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -48.95 77.54 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.977 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.0 m -99.78 12.96 35.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.843 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.3 m-85 -115.78 140.28 49.37 Favored 'General case' 0 CA--C 1.473 -1.992 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.163 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.07 152.36 27.93 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.434 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.71 127.99 33.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.859 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.411 ' NE2' HD23 ' A' ' 74' ' ' LEU . 11.6 tt0 -111.04 144.53 40.01 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -73.87 125.18 90.52 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 -19.97 64.43 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.177 2.585 . . . . 0.0 114.84 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.79 -44.79 4.55 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.935 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.8 p -90.78 -15.18 30.59 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD23 ' NE2' ' A' ' 69' ' ' GLN . 9.1 mt 64.89 18.96 11.71 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.799 1.24 . . . . 0.0 111.262 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.47 136.38 38.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.734 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -92.77 147.76 22.6 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.385 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.9 105.99 17.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -107.07 13.87 26.96 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.799 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.23 163.97 27.04 Favored 'General case' 0 CA--C 1.461 -2.451 0 CA-C-O 122.719 1.247 . . . . 0.0 112.755 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.7 m -88.3 -38.92 14.79 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-N 112.6 -2.091 . . . . 0.0 109.129 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -131.85 149.21 52.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.857 0.863 . . . . 0.0 110.17 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.45 ' HG ' HG23 ' A' ' 45' ' ' VAL . 21.5 mt -86.15 152.61 22.7 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.796 0.838 . . . . 0.0 111.786 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 62.0 p -103.05 155.92 36.0 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.73 -31.49 91.99 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.017 1.812 . . . . 0.0 109.411 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.7 -44.6 96.63 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.475 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.3 mmp_? -60.25 -38.8 84.59 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 83' ' ' THR . 58.0 mt -67.31 -47.63 69.99 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.699 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.604 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 42.9 t -62.74 -47.65 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 176.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 45.9 mt-10 -62.69 -30.8 71.67 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 111.664 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.43 58.27 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.909 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 3.0 mm-40 -59.08 -22.88 61.5 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.604 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -54.69 -38.74 67.38 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.097 172.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.4 m -144.76 -78.89 0.19 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.37 -177.27 4.4 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.699 1.2 . . . . 0.0 108.568 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.46 151.1 39.79 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.3 102.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.555 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 107.41 10.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -126.42 159.2 33.95 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.901 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' SER . 62.9 mtp . . . . . 0 N--CA 1.4 -2.97 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 121.136 0.493 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 13.0 mmt -123.78 140.84 52.59 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.293 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 28.5 ttpt -98.95 95.68 7.32 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.232 1.015 . . . . 0.0 108.953 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -105.45 139.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.243 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.8 mmt180 -65.76 131.86 47.33 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-O 121.139 0.495 . . . . 0.0 110.04 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.5 t -117.01 126.16 74.28 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.734 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.265 33.6 mt-10 -86.02 150.1 24.7 Favored 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 116.642 -2.023 . . . . 0.0 107.185 167.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -121.94 130.84 53.65 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.071 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 CA--C 1.543 0.962 0 N-CA-C 110.047 -0.789 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 25.5 p -136.08 152.43 50.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -148.35 151.43 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 m -100.93 105.95 17.24 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 42.6 t60 -113.09 140.81 47.56 Favored 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.503 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.251 36.3 mm -76.84 111.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.74 145.96 39.61 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.521 ' OD2' ' HE1' ' A' ' 48' ' ' HIS . 4.2 p30 -148.42 -170.74 3.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.9 17.58 7.65 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -108.71 -28.94 8.95 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.689 0.757 . . . . 0.0 109.719 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -100.45 132.06 46.04 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.772 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.59 151.23 4.41 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.524 0.73 . . . . 0.0 111.875 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.55 -54.28 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.996 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.72 -30.46 65.55 Favored 'General case' 0 C--O 1.204 -1.301 0 O-C-N 124.221 0.951 . . . . 0.0 112.525 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' HG22 ' A' ' 51' ' ' VAL . 4.5 m-20 -73.66 -37.05 65.42 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.079 -0.388 . . . . 0.0 110.033 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.521 ' HE1' ' OD2' ' A' ' 40' ' ' ASP . 90.6 m-70 -62.77 -39.59 94.64 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 42.8 mt -68.52 -41.82 83.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.31 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.39 -34.66 70.98 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 119.047 0.84 . . . . 0.0 110.759 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 47' ' ' ASP . 84.7 t -68.7 -54.13 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.3 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.85 -47.33 74.31 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.215 0.322 . . . . 0.0 111.191 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.1 mt -57.59 -46.87 83.48 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 123.377 0.423 . . . . 0.0 109.977 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -59.35 -40.69 87.19 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.16 -32.78 67.18 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 47.2 m-85 -83.94 -5.75 59.28 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.387 0.613 . . . . 0.0 111.296 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp 69.28 45.99 0.82 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 126.287 1.835 . . . . 0.0 112.983 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.99 135.88 21.26 Favored Pre-proline 0 N--CA 1.404 -2.739 0 C-N-CA 125.782 1.633 . . . . 0.0 107.286 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.36 134.64 62.13 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.142 1.895 . . . . 0.0 111.373 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.3 m -63.77 -10.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.176 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CG ' ' HZ2' ' A' ' 62' ' ' LYS . 3.9 p-10 -69.94 -15.84 63.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.726 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' A' ' 61' ' ' ASP . 2.5 mptp? -85.0 -4.04 59.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.83 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.1 p -47.05 -31.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 126.08 1.752 . . . . 0.0 110.296 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.4 m -55.78 -47.02 77.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.744 1.618 . . . . 0.0 110.849 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -100.72 12.66 37.02 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.33 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.447 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.4 m-85 -113.28 143.24 44.75 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.906 -0.496 . . . . 0.0 111.654 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.35 147.54 28.43 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.838 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -83.54 125.64 31.98 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 124.26 0.975 . . . . 0.0 108.415 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -112.77 147.77 36.19 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.22 129.91 70.94 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.08 -20.63 67.75 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.82 2.347 . . . . 0.0 115.179 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -103.71 -44.89 4.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.984 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 p -89.5 -20.55 23.7 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.851 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt 67.24 17.27 10.26 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.599 1.159 . . . . 0.0 111.821 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.2 39.18 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.53 154.26 17.38 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.45 110.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -102.32 11.58 37.89 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.546 0.689 . . . . 0.0 110.424 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.17 156.85 36.89 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.934 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.6 m -81.73 -38.59 25.49 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.618 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.46 149.27 52.21 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 124.194 0.997 . . . . 0.0 108.657 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.66 155.07 28.22 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 73.0 p -109.35 153.32 42.8 Favored Pre-proline 0 N--CA 1.401 -2.899 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HG2' ' OE2' ' A' ' 85' ' ' GLU . 8.6 Cg_endo -53.94 -37.56 85.87 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.553 2.169 . . . . 0.0 110.386 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.501 ' OE2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 mp0 -60.09 -44.43 94.8 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 89' ' ' GLU . 4.0 mmp_? -61.7 -40.4 94.9 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 83' ' ' THR . 66.3 mt -66.29 -47.12 74.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.711 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.76 -46.3 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.585 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 86' ' ' ARG . 49.7 mt-10 -63.78 -31.8 73.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 111.451 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.82 61.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.622 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -57.33 -24.9 58.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.188 0.595 . . . . 0.0 111.934 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 67.0 mttm -56.17 -35.62 67.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.506 1.122 . . . . 0.0 112.534 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.1 m -146.79 -85.1 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.61 -178.82 7.38 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.297 1.039 . . . . 0.0 108.843 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.35 149.27 42.11 Favored 'General case' 0 C--O 1.209 -1.075 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 169.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -116.63 101.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 118.821 0.737 . . . . 0.0 110.325 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.39 102.99 9.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -119.99 161.05 21.57 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.447 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 46.8 mtp . . . . . 0 N--CA 1.413 -2.284 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.424 -1.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.431 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 12.0 mmt -127.96 142.07 51.35 Favored 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 71.8 tttt -99.13 97.57 8.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -109.4 138.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.17 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 87.9 mtt180 -69.3 130.79 43.57 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.364 0.602 . . . . 0.0 110.683 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.3 t -116.83 123.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.561 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.607 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.259 35.6 mt-10 -84.69 142.4 29.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.622 -2.031 . . . . 0.0 107.711 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.4 tm? -115.38 130.73 56.98 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.972 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.246 0.895 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.48 0.721 0 N-CA-C 109.422 -1.03 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.6 m -143.61 159.89 41.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.792 -0.567 . . . . 0.0 109.623 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.69 150.39 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -97.35 106.72 19.09 Favored 'General case' 0 N--CA 1.394 -3.261 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 173.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 38.3 t60 -110.2 145.42 37.32 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.132 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.254 50.2 mm -83.28 109.89 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.85 144.51 39.76 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -152.41 169.21 23.11 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 124.235 1.014 . . . . 0.0 108.534 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.65 17.98 53.93 Favored Glycine 0 C--N 1.282 -2.465 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -104.95 -30.03 10.08 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-O 121.715 0.769 . . . . 0.0 109.963 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.636 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 31.6 m -97.75 137.39 36.7 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 124.793 1.237 . . . . 0.0 108.564 175.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.04 149.34 12.1 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-O 121.517 0.675 . . . . 0.0 110.44 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.6 t -55.74 -53.92 31.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.096 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -57.4 -31.1 65.5 Favored 'General case' 0 C--O 1.208 -1.107 0 O-C-N 124.159 0.912 . . . . 0.0 111.818 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -74.16 -36.64 64.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 122.344 -0.223 . . . . 0.0 110.813 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.636 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 91.3 m-70 -62.76 -39.06 92.99 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.7 mt -68.67 -43.12 83.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.473 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.51 -31.88 68.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.733 0.697 . . . . 0.0 110.899 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 47' ' ' ASP . 91.1 t -68.61 -54.31 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.417 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.14 -48.76 67.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 122.502 0.321 . . . . 0.0 111.013 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.0 mt -57.73 -49.07 77.79 Favored 'General case' 0 C--O 1.195 -1.815 0 O-C-N 123.654 0.596 . . . . 0.0 109.811 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 m -59.72 -38.51 81.87 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -72.68 -31.91 65.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 47.6 m-85 -83.09 -7.09 59.69 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.188 0.518 . . . . 0.0 111.334 173.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 72.02 38.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.62 1.568 . . . . 0.0 112.237 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.426 ' CG2' ' HD2' ' A' ' 62' ' ' LYS . 75.1 mt -105.89 134.79 19.57 Favored Pre-proline 0 N--CA 1.409 -2.517 0 C-N-CA 125.345 1.458 . . . . 0.0 107.865 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.01 131.39 46.15 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.339 2.026 . . . . 0.0 111.325 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.6 m -62.42 -11.04 5.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.553 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.43 -14.65 62.22 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.426 ' HD2' ' CG2' ' A' ' 58' ' ' ILE . 66.9 mttm -81.62 -9.96 59.54 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.827 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.3 p -47.27 -31.33 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 127.257 2.223 . . . . 0.0 110.343 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 m -54.41 -46.24 73.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.564 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 99' ' ' MET . 14.8 t -94.41 -0.64 54.68 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.823 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -101.14 139.05 37.36 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.714 -1.194 . . . . 0.0 112.315 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 142.24 24.55 Favored 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.646 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.0 126.41 30.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.7 148.57 38.06 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.82 128.0 73.09 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.08 -17.64 40.55 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 122.553 2.169 . . . . 0.0 114.828 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.85 -43.28 5.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.209 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 p -91.25 -18.86 23.7 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.62 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 mt 69.45 17.62 8.02 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.382 1.073 . . . . 0.0 111.671 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.96 140.82 30.79 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.55 150.83 19.85 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 120.959 0.409 . . . . 0.0 110.692 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.7 t -87.9 106.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.08 16.69 23.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.403 1.097 . . . . 0.0 109.836 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.49 158.26 32.84 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.75 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.65 -38.13 20.2 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.29 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -131.58 144.82 51.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.272 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.96 152.74 30.87 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.777 0.798 . . . . 0.0 110.632 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.9 p -106.32 152.21 40.47 Favored Pre-proline 0 N--CA 1.398 -3.051 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.44 -31.69 92.01 Favored 'Trans proline' 0 C--O 1.208 -0.977 0 C-N-CA 122.287 1.992 . . . . 0.0 109.865 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.24 -47.81 82.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.458 0.703 . . . . 0.0 110.644 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HE ' ' HA ' ' A' ' 86' ' ' ARG . 3.7 mmp_? -62.54 -37.27 85.46 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.893 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 83' ' ' THR . 57.7 mt -66.92 -47.29 72.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.385 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.97 -46.06 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.126 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -64.27 -30.98 72.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.659 0.742 . . . . 0.0 111.209 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.09 -34.09 59.52 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.623 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.43 -24.39 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -53.67 -40.22 65.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.102 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m -143.05 -80.69 0.2 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.64 -179.29 6.77 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.788 1.235 . . . . 0.0 108.947 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -119.1 155.52 31.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.4 mt -115.83 134.59 58.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -107.78 99.8 9.23 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -176.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -121.5 162.3 20.77 Favored 'General case' 0 CA--C 1.46 -2.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.018 -172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' SER . 54.4 mtp . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 169.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.708 0.29 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mmt -118.26 139.72 50.89 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.569 ' HD3' ' CD1' ' A' ' 38' ' ' ILE . 36.5 tptt -100.55 100.19 10.89 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.32 136.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.287 -170.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 62.6 mtm180 -69.26 135.94 51.22 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-O 121.567 0.699 . . . . 0.0 110.754 171.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' SER . 62.3 t -121.11 124.54 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.571 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.272 29.8 mt-10 -85.9 138.82 31.75 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.907 -1.917 . . . . 0.0 108.228 168.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -115.99 129.61 56.45 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 178.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.6 mp . . . . . 0 C--O 1.248 1.001 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.718 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 111.662 -0.168 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 30.6 m -138.91 159.54 41.9 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.729 -0.607 . . . . 0.0 112.128 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 10.0 p -151.93 150.92 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -95.92 115.82 28.0 Favored 'General case' 1 N--CA 1.378 -4.055 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 171.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -115.23 142.57 46.49 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.399 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.569 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 31.1 mm -79.39 110.82 15.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.01 141.38 42.9 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' OD1' ' HE1' ' A' ' 48' ' ' HIS . 7.9 p-10 -145.99 160.34 42.0 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.274 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.4 20.34 51.1 Favored Glycine 0 C--N 1.281 -2.496 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.812 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -110.19 -24.97 10.41 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 121.701 0.763 . . . . 0.0 109.815 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 91.4 m -103.23 137.19 41.71 Favored 'General case' 0 N--CA 1.401 -2.875 0 C-N-CA 124.274 1.03 . . . . 0.0 109.436 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.18 152.6 13.36 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.692 0.758 . . . . 0.0 111.69 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.409 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.4 t -56.26 -54.83 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.129 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -57.07 -30.39 64.26 Favored 'General case' 0 C--O 1.207 -1.183 0 O-C-N 124.31 1.006 . . . . 0.0 111.387 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.1 m-20 -75.48 -37.4 60.26 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.519 ' HE1' ' OD1' ' A' ' 40' ' ' ASP . 88.9 m-70 -61.36 -39.28 90.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.2 mt -67.38 -43.35 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.072 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -57.28 -35.22 69.51 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.036 0.835 . . . . 0.0 110.936 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 47' ' ' ASP . 97.1 t -69.0 -53.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.322 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -53.14 -48.86 67.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 123.357 0.411 . . . . 0.0 110.982 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.7 mt -57.65 -47.75 81.39 Favored 'General case' 0 C--O 1.202 -1.428 0 O-C-N 123.408 0.443 . . . . 0.0 110.048 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 m -58.92 -40.97 86.18 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -71.21 -35.02 71.37 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.187 0.517 . . . . 0.0 112.19 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 46.1 m-85 -79.46 -2.17 40.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.241 0.543 . . . . 0.0 111.332 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 70.54 36.43 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.205 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -107.31 138.39 19.89 Favored Pre-proline 0 N--CA 1.415 -2.201 0 C-N-CA 125.277 1.431 . . . . 0.0 107.81 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.93 133.14 56.06 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 121.805 1.67 . . . . 0.0 110.638 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.554 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.8 m -62.77 -10.04 4.99 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.512 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.09 -19.6 65.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.0 110.125 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.4 mptp? -80.61 -8.06 59.48 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.765 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.2 p -47.97 -33.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 C-N-CA 125.548 1.539 . . . . 0.0 110.052 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.256 14.4 m -54.42 -48.17 71.95 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 126.184 1.794 . . . . 0.0 109.907 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' MET . 25.4 m -100.49 14.47 31.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.09 -1.413 . . . . 0.0 112.179 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.0 m-85 -112.26 139.06 48.11 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.376 0.608 . . . . 0.0 112.05 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.91 141.99 24.9 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.779 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 90.0 mt -76.06 159.13 31.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.38 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -143.25 150.5 39.37 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.16 128.96 71.6 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.18 -15.72 43.21 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.763 2.309 . . . . 0.0 115.226 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -109.37 -45.52 3.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.756 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -88.97 -17.62 29.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.465 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt 70.91 15.02 6.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.494 1.117 . . . . 0.0 112.683 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.96 137.46 38.33 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.048 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -85.1 174.21 9.87 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.045 0.45 . . . . 0.0 111.61 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.423 HG23 ' NH1' ' A' ' 86' ' ' ARG . 88.4 t -117.35 107.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.51 12.34 26.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.004 0.907 . . . . 0.0 110.293 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.38 157.58 33.99 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.73 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -84.33 -40.81 17.47 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.042 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.92 152.35 49.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 123.774 0.829 . . . . 0.0 109.409 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 45' ' ' VAL . 18.0 mt -88.34 148.59 24.2 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.517 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.1 p -99.49 152.9 37.96 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.35 -35.66 92.11 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.704 2.269 . . . . 0.0 110.125 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.39 -48.96 77.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.482 0.713 . . . . 0.0 110.511 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' NH1' HG23 ' A' ' 77' ' ' VAL . 7.2 mmm-85 -61.48 -37.27 83.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 123.304 0.377 . . . . 0.0 111.626 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 63.6 mt -64.85 -47.98 75.96 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.694 0.621 . . . . 0.0 110.578 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -63.99 -44.83 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -61.68 -27.68 68.86 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.798 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.43 -36.33 24.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -53.93 -24.56 16.73 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -50.29 -39.81 46.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.724 0.81 . . . . 0.0 111.021 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.6 m -147.74 -92.35 0.08 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.46 178.46 8.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.512 0.725 . . . . 0.0 109.424 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.65 154.41 30.59 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 14.3 mt -116.33 139.78 41.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 170.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.22 109.12 17.0 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -127.95 160.88 30.5 Favored 'General case' 0 CA--C 1.467 -2.248 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 54.8 mtp . . . . . 0 N--CA 1.397 -3.08 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.472 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.8 mmt -118.31 138.47 52.37 Favored 'General case' 0 CA--C 1.47 -2.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.909 -172.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 76.4 tttt -97.18 93.07 6.34 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.86 140.08 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.211 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 86.2 mtt180 -70.13 129.62 39.91 Favored 'General case' 0 CA--C 1.475 -1.932 0 O-C-N 123.516 0.51 . . . . 0.0 110.113 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.49 124.74 72.3 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.546 0 CA-C-O 117.675 -1.155 . . . . 0.0 108.092 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.268 47.0 mt-10 -85.54 145.39 27.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 116.829 -1.948 . . . . 0.0 107.764 168.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -116.14 131.66 56.88 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' N ' HD23 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.314 -0.971 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.447 -1.238 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 162.16 36.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.263 -171.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -151.37 149.45 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -98.23 107.36 19.82 Favored 'General case' 0 N--CA 1.386 -3.645 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 39.8 t60 -113.93 146.59 39.87 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.469 -170.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.73 112.02 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.96 146.04 39.73 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.3 173.95 14.93 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 123.535 0.734 . . . . 0.0 109.159 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.54 14.98 56.36 Favored Glycine 0 C--N 1.304 -1.228 0 O-C-N 124.413 1.071 . . . . 0.0 112.825 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -108.97 -32.11 7.38 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 121.209 0.528 . . . . 0.0 112.063 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.8 m -93.72 134.2 36.29 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.59 0.756 . . . . 0.0 109.317 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.77 149.1 6.53 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.041 0.936 . . . . 0.0 110.942 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.7 t -55.29 -53.14 38.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.523 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -59.36 -28.36 66.78 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.434 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 m-20 -73.35 -39.1 65.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -61.89 -38.48 88.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.3 mt -69.22 -43.99 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.13 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -56.91 -34.18 67.67 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 118.985 0.811 . . . . 0.0 110.603 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 47' ' ' ASP . 96.2 t -69.17 -55.51 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.445 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.1 -49.19 66.99 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 123.301 0.375 . . . . 0.0 111.55 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.46 -48.55 76.84 Favored 'General case' 0 C--O 1.201 -1.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.138 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.7 m -59.81 -36.79 77.49 Favored 'General case' 0 N--CA 1.397 -3.109 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -73.43 -32.13 64.22 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 43.9 m-85 -84.64 -3.95 58.76 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 122.883 0.473 . . . . 0.0 111.688 174.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 70.49 35.76 1.87 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.219 1.408 . . . . 0.0 112.718 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.3 mt -105.23 132.1 21.17 Favored Pre-proline 0 N--CA 1.409 -2.511 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.82 135.36 62.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.07 1.847 . . . . 0.0 111.267 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -62.32 -9.52 3.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.904 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -68.01 -16.39 64.02 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 120.874 0.368 . . . . 0.0 110.11 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.58 -5.11 58.39 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.619 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.3 p -47.6 -33.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 C-N-CA 125.933 1.693 . . . . 0.0 110.995 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.276 15.3 m -54.8 -48.56 72.58 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 126.061 1.745 . . . . 0.0 110.444 174.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.7 m -102.11 17.73 22.56 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.821 -172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.4 m-85 -116.76 142.65 46.64 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.73 146.44 25.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.222 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 85.9 mt -79.61 126.39 30.83 Favored 'General case' 0 N--CA 1.418 -2.057 0 O-C-N 124.71 1.256 . . . . 0.0 107.846 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' OE1' ' HD2' ' A' ' 98' ' ' ARG . 38.8 tt0 -114.21 147.8 38.37 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.05 125.7 84.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -8.34 22.61 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 122.655 2.237 . . . . 0.0 115.169 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.47 -40.75 3.56 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.298 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.2 p -90.44 -20.79 22.35 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.069 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt 70.59 18.91 6.33 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.797 1.239 . . . . 0.0 111.977 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.28 140.86 30.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.634 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.407 ' OH ' ' HD3' ' A' ' 98' ' ' ARG . 80.9 m-85 -98.14 144.53 27.51 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.822 0.344 . . . . 0.0 110.23 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.15 106.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -100.26 12.14 37.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.062 0.934 . . . . 0.0 110.362 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.15 152.21 34.98 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.371 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.9 m -79.12 -36.98 39.73 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.152 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.34 143.83 50.8 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.115 0.966 . . . . 0.0 108.806 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.9 mt -77.49 157.54 30.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.39 0.614 . . . . 0.0 111.257 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.0 p -111.71 153.64 44.27 Favored Pre-proline 0 N--CA 1.409 -2.477 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.28 -34.93 72.29 Favored 'Trans proline' 0 C--O 1.21 -0.91 0 C-N-CA 122.35 2.034 . . . . 0.0 110.349 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.86 -48.49 77.98 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HE ' ' HA ' ' A' ' 86' ' ' ARG . 4.1 mmp_? -61.11 -38.85 87.8 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.369 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 83' ' ' THR . 52.4 mt -67.69 -48.09 67.55 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.727 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.22 -47.56 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.26 -29.66 70.46 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.253 0.549 . . . . 0.0 111.784 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.45 -37.03 60.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.78 -24.23 48.89 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -53.0 -43.79 66.74 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -137.63 -82.46 0.34 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.22 178.55 6.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.16 1.384 . . . . 0.0 108.489 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 155.07 30.4 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 11.7 mt -115.39 138.51 45.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 99.26 7.06 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 69' ' ' GLN . 44.0 mtp180 -119.67 162.63 18.69 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 65' ' ' SER . 41.2 mtp . . . . . 0 N--CA 1.393 -3.288 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.683 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 44.6 mtt -114.13 139.41 49.35 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.566 -170.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -100.36 96.87 7.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.43 138.58 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.851 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 17.3 mtp180 -68.21 131.13 44.83 Favored 'General case' 0 CA--C 1.46 -2.503 0 CA-C-O 122.146 0.974 . . . . 0.0 111.947 170.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.15 123.51 71.73 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.361 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.155 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 11' ' ' ARG 0.272 0.5 OUTLIER -83.98 149.42 26.31 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.213 166.451 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -123.34 130.66 53.03 Favored 'General case' 0 C--N 1.265 -3.08 0 O-C-N 123.469 0.481 . . . . 0.0 111.084 176.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.245 0.848 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.29 169.394 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 CA--C 1.539 0.73 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -138.6 155.79 48.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 10.1 p -147.98 150.2 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.4 m -98.11 105.36 17.5 Favored 'General case' 0 N--CA 1.387 -3.616 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -109.59 147.79 32.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.402 -170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.9 113.84 23.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.31 146.0 40.13 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.36 -171.89 3.68 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.58 -11.44 11.6 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.559 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -83.07 -26.11 31.41 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 124.197 0.999 . . . . 0.0 111.996 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.536 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 36.7 m -96.2 131.7 42.4 Favored 'General case' 0 N--CA 1.388 -3.561 0 C-N-CA 123.793 0.837 . . . . 0.0 109.631 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 149.57 9.0 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.867 0.73 . . . . 0.0 110.844 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.6 t -55.66 -51.78 54.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.87 -31.0 64.37 Favored 'General case' 0 C--O 1.202 -1.427 0 O-C-N 124.381 1.05 . . . . 0.0 111.387 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.0 m-20 -75.42 -38.9 59.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.536 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -61.71 -40.23 94.29 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.514 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.8 mt -68.34 -42.46 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.13 -34.36 70.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.89 0.768 . . . . 0.0 110.977 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.0 t -68.97 -53.38 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.4 -48.28 68.8 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.22 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.8 mt -57.84 -48.39 79.9 Favored 'General case' 0 C--O 1.193 -1.91 0 O-C-N 123.538 0.523 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -60.14 -38.91 84.54 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -72.11 -30.4 65.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.1 -0.375 . . . . 0.0 111.52 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 41.2 m-85 -88.56 -0.24 57.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.377 0.608 . . . . 0.0 112.201 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 69.0 32.46 3.77 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.661 1.584 . . . . 0.0 112.28 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -103.16 135.6 19.37 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.86 133.02 53.32 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.96 1.773 . . . . 0.0 111.918 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.0 m -62.59 -9.27 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.795 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.98 -18.38 62.62 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.634 0.731 . . . . 0.0 109.585 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -82.4 -9.99 59.23 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.903 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.7 p -46.04 -31.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 126.902 2.081 . . . . 0.0 110.741 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 m -54.67 -45.97 73.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.903 1.681 . . . . 0.0 111.067 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.4 t -97.96 0.33 46.22 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.618 -173.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -103.59 137.23 41.94 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.405 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.25 145.45 31.28 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.567 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.54 123.93 29.65 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -111.07 148.48 32.54 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -82.37 126.71 73.38 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 18.6 Cg_endo -60.63 -23.62 76.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.419 2.746 . . . . 0.0 114.82 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -103.84 -46.17 4.57 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.47 -1.292 . . . . 0.0 112.855 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -88.01 -17.1 31.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.557 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt 66.42 18.21 10.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 111.285 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.95 138.24 35.0 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.145 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -96.16 143.99 26.79 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.3 102.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.1 13.98 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 123.037 1.398 . . . . 0.0 108.537 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.55 158.56 31.08 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.999 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.5 m -84.88 -37.82 20.17 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.824 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -129.58 155.4 45.87 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.965 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.76 147.15 23.42 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.174 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.0 p -98.99 151.06 37.23 Favored Pre-proline 0 N--CA 1.401 -2.913 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.51 -33.85 93.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.245 1.963 . . . . 0.0 109.975 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.56 -47.41 85.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -61.3 -36.01 78.9 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.683 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 68.2 mt -64.09 -50.15 69.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.697 0.623 . . . . 0.0 110.485 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.489 ' CG2' ' HE3' ' A' ' 8' ' ' MET . 40.5 t -62.24 -43.36 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.77 -32.99 69.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.76 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.11 -42.43 23.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 11.7 mt-10 -52.2 -25.28 8.76 Favored 'General case' 0 C--N 1.369 1.441 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.52 -36.81 62.18 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 124.367 1.067 . . . . 0.0 112.258 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -143.99 -83.14 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -165.92 -178.75 4.88 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.668 0.787 . . . . 0.0 109.263 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.12 148.29 43.22 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -114.95 100.69 11.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.621 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.79 103.24 8.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -126.34 162.48 25.41 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.685 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.433 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 45.5 mtp . . . . . 0 N--CA 1.405 -2.69 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.484 0.659 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 42.3 mtt -115.57 141.09 48.53 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.494 -172.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.2 tttm -99.63 95.07 6.72 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.86 138.69 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.849 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 54.9 mtm-85 -69.39 131.53 44.93 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-O 121.623 0.725 . . . . 0.0 110.841 172.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 34' ' ' SER . 46.7 t -119.19 124.07 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.578 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.216 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 12' ' ' VAL . 31.4 mm-40 -81.18 158.88 24.77 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -130.81 133.17 45.73 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 122.074 -0.391 . . . . 0.0 111.091 175.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.457 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--O 1.243 0.745 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.457 -0.646 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 5.5 p -140.52 161.04 38.68 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.46 149.07 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -97.69 105.28 17.4 Favored 'General case' 0 N--CA 1.389 -3.513 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.1 t60 -109.11 147.28 32.69 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.103 -170.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -83.26 110.67 18.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.06 149.02 34.01 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -149.48 -169.72 3.45 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.35 15.1 8.73 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -106.59 -34.19 7.43 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.677 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -93.97 134.35 36.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 C-N-CA 124.152 0.981 . . . . 0.0 108.376 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.56 151.72 7.63 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.563 0.697 . . . . 0.0 111.589 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.5 t -55.27 -54.58 23.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.734 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.89 -30.43 63.88 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.628 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 51' ' ' VAL . 8.7 m-20 -73.79 -37.44 64.95 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.962 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -62.43 -38.67 90.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.4 mt -67.81 -44.22 85.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.47 -34.16 68.73 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.843 0.747 . . . . 0.0 111.129 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 47' ' ' ASP . 85.7 t -69.05 -54.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.66 -49.19 68.48 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.657 0.383 . . . . 0.0 111.471 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.1 mt -57.25 -47.41 81.46 Favored 'General case' 0 C--O 1.195 -1.806 0 O-C-N 123.38 0.425 . . . . 0.0 110.05 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.68 -38.37 84.73 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -70.61 -37.83 73.9 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.975 0.417 . . . . 0.0 111.514 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 57.0 m-85 -78.81 -9.52 59.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.389 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm 74.42 39.74 0.45 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.87 1.268 . . . . 0.0 112.584 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.73 140.92 22.3 Favored Pre-proline 0 N--CA 1.411 -2.382 0 C-N-CA 125.74 1.616 . . . . 0.0 107.622 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.97 134.47 53.36 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 122.222 1.948 . . . . 0.0 111.087 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.524 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.4 m -63.28 -9.63 5.13 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.89 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.801 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.48 -14.83 62.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.0 110.221 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.458 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 65.1 mttm -88.98 -6.46 57.22 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.844 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.1 p -49.62 -29.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 126.287 1.835 . . . . 0.0 109.773 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 p -54.08 -51.14 65.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.237 1.815 . . . . 0.0 110.977 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' MET . 5.8 m -98.03 6.91 47.1 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.881 -171.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.458 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 16.8 m-85 -107.79 143.55 36.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.342 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.31 145.04 25.92 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.29 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 83.9 mt -80.97 128.13 33.34 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -118.09 149.8 40.41 Favored 'General case' 0 C--N 1.28 -2.452 0 O-C-N 122.161 -0.337 . . . . 0.0 110.101 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -81.77 132.72 53.74 Favored Pre-proline 0 C--N 1.313 -0.982 0 O-C-N 124.385 1.053 . . . . 0.0 108.276 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.48 -19.38 48.98 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.14 2.56 . . . . 0.0 115.105 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -105.01 -40.26 5.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.735 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -95.98 -19.51 19.44 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.328 0.585 . . . . 0.0 111.239 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.89 22.62 12.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.394 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.35 140.96 33.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.716 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.76 144.52 26.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.593 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.13 102.69 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.55 13.57 31.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.824 1.297 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.75 157.04 34.02 Favored 'General case' 0 N--CA 1.405 -2.696 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.647 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.0 m -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.875 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.33 147.91 52.09 Favored 'General case' 0 N--CA 1.418 -2.069 0 C-N-CA 124.041 0.936 . . . . 0.0 108.562 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -79.16 154.8 29.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.11 0.481 . . . . 0.0 110.208 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 p -104.71 151.59 39.33 Favored Pre-proline 0 N--CA 1.399 -2.983 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.94 -31.59 93.1 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.173 1.915 . . . . 0.0 109.727 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.66 -48.66 78.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.494 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.84 -36.39 83.06 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.482 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.4 mt -64.3 -48.79 74.29 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.496 0.498 . . . . 0.0 110.18 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.476 ' CG2' ' HE3' ' A' ' 8' ' ' MET . 50.1 t -61.62 -46.46 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -60.85 -32.87 72.26 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 112.209 171.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.82 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.48 -27.05 35.0 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 95.7 mttt -54.96 -31.38 60.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.284 1.034 . . . . 0.0 112.083 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.8 m -143.81 -86.76 0.13 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.457 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -167.38 178.79 5.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.003 1.321 . . . . 0.0 108.527 -176.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -114.89 159.71 20.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 HD11 ' CE2' ' A' ' 94' ' ' TYR . 2.9 mp -120.22 141.61 39.71 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.781 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 167.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 98.38 6.73 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 40.0 mtp180 -115.69 161.21 19.03 Favored 'General case' 0 CA--C 1.464 -2.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.071 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 65' ' ' SER . 51.3 mtp . . . . . 0 N--CA 1.391 -3.403 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 165.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.41 -2.466 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.462 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.6 mmt -110.08 141.43 42.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.394 -170.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 64.7 tttt -101.62 95.75 6.65 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.51 140.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.334 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -70.9 134.18 47.05 Favored 'General case' 0 CA--C 1.466 -2.283 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.867 173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.85 123.36 71.58 Favored 'Isoleucine or valine' 2 N--CA 1.37 -4.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.6 OUTLIER -84.49 148.49 26.51 Favored 'General case' 0 N--CA 1.407 -2.581 0 C-N-CA 116.25 -2.18 . . . . 0.0 107.843 167.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.509 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.5 tm? -115.0 134.38 55.24 Favored 'General case' 0 C--N 1.278 -2.517 0 O-C-N 123.28 0.362 . . . . 0.0 110.6 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--O 1.251 1.165 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.68 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--O 1.239 0.534 0 N-CA-C 109.614 -0.956 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -139.12 159.8 41.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 p -150.37 151.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 m -99.44 107.25 19.42 Favored 'General case' 0 N--CA 1.39 -3.445 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.0 t60 -112.56 146.57 38.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.916 -170.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.27 111.31 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -112.36 144.82 41.15 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 2.8 p30 -146.02 -168.52 3.01 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.13 -9.45 8.05 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.91 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' A' ' 40' ' ' ASP . 2.0 mp0 -82.46 -26.86 32.27 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.81 0.814 . . . . 0.0 110.683 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.555 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 26.5 m -95.98 129.53 43.22 Favored 'General case' 0 N--CA 1.383 -3.825 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.12 149.24 9.76 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.525 0.679 . . . . 0.0 110.99 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.442 HG22 ' HG ' ' A' ' 82' ' ' LEU . 99.0 t -53.05 -53.8 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.313 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -54.88 -32.16 60.55 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 124.612 1.195 . . . . 0.0 111.722 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' O ' HG21 ' A' ' 51' ' ' VAL . 22.8 m-20 -78.79 -34.32 45.59 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.906 -0.496 . . . . 0.0 111.635 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.555 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.7 m-70 -62.24 -39.36 92.59 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.576 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.1 mt -66.51 -42.91 90.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -56.02 -37.81 69.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.683 0.674 . . . . 0.0 110.672 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 47' ' ' ASP . 87.9 t -67.07 -53.22 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.093 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.31 -47.75 72.11 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 123.311 0.382 . . . . 0.0 110.902 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -56.92 -49.03 76.86 Favored 'General case' 0 C--O 1.194 -1.863 0 O-C-N 123.519 0.512 . . . . 0.0 109.816 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -60.28 -37.82 81.68 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -74.06 -29.3 61.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.172 0.51 . . . . 0.0 111.867 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.55 0.98 55.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.476 0.655 . . . . 0.0 111.947 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 57' ' ' LYS . 9.5 mtpm? 67.18 40.8 2.73 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.48 1.512 . . . . 0.0 113.124 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.87 136.93 20.72 Favored Pre-proline 0 N--CA 1.404 -2.766 0 C-N-CA 124.679 1.192 . . . . 0.0 108.385 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.05 134.61 63.3 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.606 2.204 . . . . 0.0 110.828 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.54 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 34.3 m -63.33 -9.85 5.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.487 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.627 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.63 -14.33 62.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.649 0.737 . . . . 0.0 110.692 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -87.26 -5.87 58.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.029 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -48.87 -31.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 126.787 2.035 . . . . 0.0 110.756 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 m -55.86 -46.11 78.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.094 1.358 . . . . 0.0 110.59 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 99' ' ' MET . 22.2 m -101.71 14.83 30.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.876 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.4 m-85 -115.49 144.05 44.41 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 121.789 -0.569 . . . . 0.0 111.627 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.29 156.14 31.93 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.93 133.38 33.94 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.05 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.76 149.05 42.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -81.04 131.65 58.98 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 Cg_endo -66.35 -25.73 48.96 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.611 2.207 . . . . 0.0 114.893 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.22 -44.05 5.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.402 -0.919 . . . . 0.0 113.167 -174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.03 -20.09 24.82 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.728 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 69.45 16.48 8.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.256 1.022 . . . . 0.0 111.797 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.92 37.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -92.75 152.08 19.69 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.61 103.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.86 10.62 32.46 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.144 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -76.79 159.17 30.33 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -82.92 -38.94 22.14 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.116 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.04 156.03 44.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.442 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -93.03 143.98 25.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.076 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 77.5 p -93.44 153.72 41.37 Favored Pre-proline 0 N--CA 1.409 -2.485 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.09 -32.0 94.49 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.896 1.731 . . . . 0.0 109.138 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -46.14 90.92 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.053 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 7.1 mmm180 -58.86 -39.35 81.06 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.569 0.223 . . . . 0.0 111.349 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 8' ' ' MET . 62.9 mt -64.39 -46.56 82.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 124.095 0.872 . . . . 0.0 110.359 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.2 -45.53 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.88 -37.14 30.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -54.33 -24.28 18.68 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -51.21 -43.98 61.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.14 0.576 . . . . 0.0 110.586 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 m -142.48 -86.75 0.15 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -157.3 -178.93 7.72 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.996 0.918 . . . . 0.0 109.427 -177.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.09 148.32 44.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -114.23 100.34 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.303 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.78 103.72 8.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -122.59 162.09 22.49 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.573 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.4 mtp . . . . . 0 N--CA 1.398 -3.048 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.434 -1.226 0 CA-C-O 121.786 0.803 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.472 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.2 mmt -115.55 140.43 49.17 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.143 -170.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -97.5 96.42 8.32 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.35 138.5 31.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.762 -172.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -69.74 133.69 47.77 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.293 0.568 . . . . 0.0 110.341 172.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -118.07 121.57 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.885 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.374 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 39.6 mt-10 -80.37 147.17 31.15 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.774 168.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -116.83 131.89 56.84 Favored 'General case' 0 C--N 1.272 -2.771 0 O-C-N 123.294 0.371 . . . . 0.0 110.612 175.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' N ' HD21 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.453 0 N-CA-C 110.012 -0.803 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.7 m -138.25 163.99 30.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.175 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.3 148.57 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 107.37 19.82 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -112.87 145.45 40.67 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.347 -170.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 38' ' ' ILE 0.26 49.8 mm -83.15 112.48 20.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -177.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -112.11 143.16 43.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -147.28 166.89 25.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 O-C-N 124.652 1.22 . . . . 0.0 108.693 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 18.03 56.74 Favored Glycine 0 C--N 1.279 -2.591 0 O-C-N 124.118 0.886 . . . . 0.0 112.012 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.31 -29.52 11.62 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-O 121.626 0.727 . . . . 0.0 111.278 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.482 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 83.6 m -99.67 137.74 37.73 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.897 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.38 18.97 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 123.527 0.517 . . . . 0.0 110.469 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.62 -54.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.01 -30.77 62.33 Favored 'General case' 0 C--O 1.203 -1.364 0 O-C-N 124.226 0.953 . . . . 0.0 111.501 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.97 -36.35 59.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.996 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.9 m-70 -63.1 -39.82 95.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.5 mt -66.33 -42.91 91.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.801 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.24 -34.72 68.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.619 0.645 . . . . 0.0 111.206 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.87 -54.73 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.51 -47.77 69.6 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.342 0.402 . . . . 0.0 111.024 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.3 mt -56.71 -48.04 78.61 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.548 0.53 . . . . 0.0 109.806 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.1 m -59.03 -39.68 82.73 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -71.52 -29.98 65.41 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.3 m-85 -89.54 3.29 52.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.311 0.577 . . . . 0.0 112.145 175.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 7.2 mmpt? 67.62 33.31 5.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.3 mt -105.28 138.29 19.5 Favored Pre-proline 0 N--CA 1.411 -2.399 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.09 136.23 63.83 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.223 1.948 . . . . 0.0 111.433 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -63.19 -9.41 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.018 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.31 -16.26 62.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.032 0.444 . . . . 0.0 110.481 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -88.5 -4.87 58.53 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -49.07 -29.21 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 127.116 2.166 . . . . 0.0 111.032 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -56.68 -47.62 79.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.533 1.533 . . . . 0.0 111.047 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' ' SD ' ' A' ' 99' ' ' MET . 7.3 m -98.07 1.21 47.43 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.227 -171.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.403 ' CE2' ' SD ' ' A' ' 99' ' ' MET . 17.5 m-85 -105.1 141.67 36.24 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.414 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.63 149.05 28.7 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.339 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.71 124.23 30.03 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.423 ' NE2' HD22 ' A' ' 74' ' ' LEU . 20.5 tt0 -111.61 147.98 34.31 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.47 134.35 66.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.0 Cg_endo -65.91 -18.72 58.01 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.877 2.385 . . . . 0.0 115.667 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 -42.79 3.89 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.0 p -90.72 -18.26 25.31 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.423 HD22 ' NE2' ' A' ' 69' ' ' GLN . 7.6 mt 62.62 22.23 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.645 1.178 . . . . 0.0 112.005 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.71 143.02 31.2 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.01 147.19 24.76 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.203 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -83.56 105.95 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -107.33 12.07 28.48 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.957 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.57 161.7 29.05 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.286 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.4 m -85.37 -39.69 17.33 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.322 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.96 152.77 50.9 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.367 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -84.58 159.64 20.61 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.885 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 38.8 p -115.47 156.54 45.8 Favored Pre-proline 0 C--N 1.276 -2.624 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.49 -35.34 92.06 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.684 2.256 . . . . 0.0 109.709 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -57.03 -49.55 75.45 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.714 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.49 -38.37 87.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 83' ' ' THR . 63.8 mt -65.75 -46.17 79.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.036 0.835 . . . . 0.0 110.54 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.98 -45.4 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -32.55 73.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.341 0.591 . . . . 0.0 112.167 172.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.43 -34.32 58.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.433 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.86 -27.51 63.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -56.05 -34.89 66.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.881 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.5 m -145.08 -78.44 0.19 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -170.73 -177.55 2.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.369 1.467 . . . . 0.0 108.743 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.51 152.23 37.29 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 168.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.81 101.78 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.066 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.9 104.88 9.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -127.66 165.08 20.68 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.185 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.439 ' SD ' ' HB2' ' A' ' 65' ' ' SER . 9.1 mmm . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.707 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.4 mtt -113.11 137.18 51.83 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.991 -169.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 72.1 tttt -98.08 97.49 8.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.5 mt -109.54 138.64 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.975 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 42.5 mtm180 -69.83 129.96 40.98 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 121.213 0.53 . . . . 0.0 109.858 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.2 t -116.33 126.13 73.67 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.388 0 CA-C-O 117.806 -1.092 . . . . 0.0 108.309 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.264 50.8 mt-10 -86.85 146.98 26.0 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.225 -1.79 . . . . 0.0 107.843 167.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -121.86 126.57 49.02 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 175.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 15' ' ' ILE . 1.4 mp . . . . . 0 N--CA 1.424 -1.755 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.831 171.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 C--O 1.236 0.397 0 N-CA-C 110.431 -0.642 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.4 p -134.02 156.85 47.46 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.253 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -152.72 149.91 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 15.4 m -97.9 107.23 19.67 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 52.4 t60 -110.38 145.23 37.9 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.344 -170.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.29 110.72 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.23 148.06 34.9 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.27 167.2 29.4 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 124.297 1.039 . . . . 0.0 108.351 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.43 19.71 51.53 Favored Glycine 0 C--N 1.29 -1.98 0 O-C-N 124.166 0.916 . . . . 0.0 112.64 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.64 -22.85 11.75 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.638 0.732 . . . . 0.0 110.626 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 m -105.9 139.9 39.74 Favored 'General case' 0 N--CA 1.403 -2.814 0 C-N-CA 124.59 1.156 . . . . 0.0 109.791 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 147.86 22.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.396 0.617 . . . . 0.0 110.541 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 82' ' ' LEU . 94.5 t -54.17 -50.1 57.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.996 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -57.29 -31.69 65.89 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.796 -176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 51' ' ' VAL . 5.7 m-20 -73.66 -40.56 63.62 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -61.24 -38.7 87.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.71 -43.7 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.222 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -56.86 -37.11 70.85 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 119.055 0.843 . . . . 0.0 111.092 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 47' ' ' ASP . 84.1 t -65.92 -53.97 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.983 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.7 -48.43 69.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.508 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -57.07 -48.51 78.41 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 123.374 0.421 . . . . 0.0 110.317 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -59.54 -39.38 83.76 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -71.82 -31.46 66.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 44.5 m-85 -84.35 -8.71 58.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.032 0.444 . . . . 0.0 111.303 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 mttp 71.29 46.17 0.44 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.16 1.384 . . . . 0.0 112.608 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 58' ' ' ILE . 76.8 mt -113.88 136.89 22.13 Favored Pre-proline 0 N--CA 1.408 -2.544 0 C-N-CA 125.815 1.646 . . . . 0.0 107.222 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.45 131.91 48.61 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.375 2.05 . . . . 0.0 111.49 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 31.1 m -62.93 -9.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.267 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.12 -22.12 64.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.395 0.617 . . . . 0.0 109.954 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 63.4 mttm -81.41 -5.46 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.233 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p -49.72 -29.3 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 126.435 1.894 . . . . 0.0 109.776 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 p -55.15 -47.2 75.45 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.429 1.492 . . . . 0.0 110.081 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -104.64 14.92 28.98 Favored 'General case' 0 N--CA 1.4 -2.929 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.7 -171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.426 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 23.7 m-85 -114.56 145.24 42.19 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.474 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.46 35.72 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.292 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.07 154.58 17.11 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.601 ' HB2' ' NH2' ' A' ' 98' ' ' ARG . 52.9 tt0 -143.18 152.78 42.16 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -87.32 131.2 44.95 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.25 -18.59 50.54 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.89 2.394 . . . . 0.0 115.3 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -105.01 -43.32 5.08 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.408 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -89.2 -21.92 23.03 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.756 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 70.27 16.44 7.28 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.766 1.226 . . . . 0.0 111.576 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.99 36.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -83.27 168.85 16.31 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.2 t -118.43 98.82 6.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.78 14.47 28.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.369 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.75 156.2 36.84 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 126.529 1.932 . . . . 0.0 109.876 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -83.59 -38.86 21.07 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.525 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.51 154.95 45.6 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.427 ' HG ' HG21 ' A' ' 45' ' ' VAL . 20.4 mt -88.53 154.48 20.31 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.195 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.3 p -112.8 156.59 42.35 Favored Pre-proline 0 C--N 1.282 -2.326 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -56.32 -35.24 95.7 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.533 2.156 . . . . 0.0 110.281 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.03 -42.97 99.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.268 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -64.07 -38.21 90.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 123.288 0.367 . . . . 0.0 111.398 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.707 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.3 mt -65.47 -49.08 70.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.139 0.9 . . . . 0.0 110.304 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.491 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 15.4 t -59.25 -41.17 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.35 -34.14 72.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.934 172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.9 17.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.646 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 8.2 mt-10 -53.98 -23.43 13.2 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.74 -37.88 60.01 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.121 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -142.43 -82.45 0.19 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.66 178.55 8.92 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.315 1.446 . . . . 0.0 108.488 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.65 150.12 38.65 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.4 mt -114.76 135.69 53.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.8 OUTLIER -117.4 107.34 14.23 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -176.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.601 ' NH2' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.11 171.27 12.05 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 43.4 mtp . . . . . 0 N--CA 1.411 -2.388 0 O-C-N 124.301 1.001 . . . . 0.0 110.179 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 40.2 mtt -122.19 140.38 52.65 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.983 -171.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 73.3 tttt -100.15 93.19 5.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -102.21 141.96 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.892 -171.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 62.3 mtm-85 -72.03 131.29 42.69 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 121.365 0.602 . . . . 0.0 110.047 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 34' ' ' SER . 49.9 t -117.32 125.91 74.27 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.208 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.277 41.8 mt-10 -84.84 150.58 24.91 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 116.681 -2.008 . . . . 0.0 106.091 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -125.4 125.04 42.76 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.039 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.306 -1.31 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.492 171.275 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 N-CA-C 111.02 -0.415 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.5 p -133.78 154.03 51.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 120.946 0.403 . . . . 0.0 110.91 -172.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 149.47 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 m -99.6 106.03 17.96 Favored 'General case' 0 N--CA 1.391 -3.387 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 51.5 t60 -112.07 144.6 41.16 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.045 -170.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.06 112.91 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.98 151.71 33.67 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -146.28 -170.23 3.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.18 18.19 8.96 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.94 -25.38 9.02 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 123.226 0.61 . . . . 0.0 112.008 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.503 ' HB ' ' NE2' ' A' ' 48' ' ' HIS . 59.9 m -98.63 136.89 38.05 Favored 'General case' 0 N--CA 1.395 -3.18 0 C-N-CA 124.553 1.141 . . . . 0.0 109.036 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 145.01 20.65 Favored 'General case' 0 C--O 1.249 1.03 0 O-C-N 123.695 0.622 . . . . 0.0 110.704 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' HG ' ' A' ' 82' ' ' LEU . 89.4 t -53.05 -53.41 22.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.879 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -58.08 -28.17 64.33 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.551 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -76.87 -37.85 54.77 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.076 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.503 ' NE2' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -62.36 -37.86 87.31 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.6 mt -68.24 -41.56 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.204 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.32 -34.41 66.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.639 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.13 -53.64 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.265 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -54.01 -46.99 71.95 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.217 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 85.5 mt -57.76 -48.71 78.87 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 123.478 0.486 . . . . 0.0 109.975 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -59.48 -37.47 78.32 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -73.32 -33.98 65.44 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.42 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 50.5 m-85 -85.4 0.24 52.79 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt 70.72 35.1 1.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 125.298 1.439 . . . . 0.0 112.665 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.7 mt -105.8 133.76 20.05 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.23 133.73 59.79 Favored 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.896 1.731 . . . . 0.0 110.821 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.6 m -61.71 -9.83 3.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.076 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.77 -20.48 65.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.558 0.218 . . . . 0.0 110.569 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.91 -4.81 58.61 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.61 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.6 p -48.91 -29.98 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 125.422 1.489 . . . . 0.0 110.622 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -55.34 -43.21 74.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.893 1.677 . . . . 0.0 110.733 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -109.4 13.59 24.06 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.66 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 16.0 m-85 -114.14 140.83 48.2 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.93 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.92 149.89 30.18 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.839 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.8 mt -82.59 122.69 28.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.234 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -109.31 149.4 29.52 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -78.6 129.61 73.66 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.86 -12.27 34.82 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.101 2.534 . . . . 0.0 115.795 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.31 -40.78 3.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.795 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.7 p -93.17 -17.55 23.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.993 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 66.27 20.08 11.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 111.748 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.42 137.28 33.98 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.559 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -95.17 137.06 34.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.73 104.58 8.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -106.2 12.85 29.65 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.979 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.53 158.24 36.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.73 -37.86 20.39 Favored 'General case' 0 N--CA 1.394 -3.252 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.077 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -128.5 147.82 50.71 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.607 0.763 . . . . 0.0 108.957 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 45' ' ' VAL . 19.4 mt -81.1 152.24 27.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.584 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.9 p -108.43 154.27 41.58 Favored Pre-proline 0 N--CA 1.401 -2.9 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.38 -36.22 78.2 Favored 'Trans proline' 0 C--O 1.219 -0.452 0 C-N-CA 122.463 2.109 . . . . 0.0 110.523 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -64.09 -41.56 97.25 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.4 mmp_? -63.0 -36.63 84.17 Favored 'General case' 0 CA--C 1.485 -1.528 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.629 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 61.8 mt -68.42 -48.65 64.06 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 124.217 0.948 . . . . 0.0 110.62 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.591 ' O ' ' HD3' ' A' ' 92' ' ' LYS 0.311 47.8 t -61.61 -49.34 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 2.3 mp0 -64.48 -27.26 68.86 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.21 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.43 -45.26 60.42 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -54.27 -23.75 16.21 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -52.15 -46.97 65.65 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.041 0.936 . . . . 0.0 110.276 173.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m -135.27 -79.71 0.43 Allowed 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.92 -175.67 2.43 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.149 1.379 . . . . 0.0 108.962 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -120.1 151.32 39.23 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -116.15 101.6 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.025 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.68 109.44 12.9 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.26 163.11 26.36 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.246 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.467 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.9 mtp . . . . . 0 N--CA 1.399 -2.995 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.415 -2.19 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.483 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.3 mmt -115.25 138.34 51.05 Favored 'General case' 0 CA--C 1.465 -2.291 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.092 -171.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 73.2 tttt -100.54 93.57 5.68 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.7 mt -103.52 140.75 20.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.732 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -73.14 134.71 44.54 Favored 'General case' 0 CA--C 1.459 -2.53 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.195 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.12 122.04 69.1 Favored 'Isoleucine or valine' 2 N--CA 1.363 -4.785 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -84.14 156.74 21.97 Favored 'General case' 0 N--CA 1.406 -2.657 0 C-N-CA 115.872 -2.331 . . . . 0.0 107.063 167.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -128.81 132.44 47.83 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 177.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' HD23 ' A' ' 14' ' ' LEU 0.266 1.6 mp . . . . . 0 C--N 1.316 -0.876 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 CA-C-O 120.943 0.31 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 p -142.21 158.69 43.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.346 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.22 149.97 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -98.14 108.29 20.96 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 43.4 t60 -110.86 145.97 37.31 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 -170.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.01 111.62 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.56 145.72 39.82 Favored 'General case' 0 C--N 1.259 -3.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.31 -174.88 4.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.45 -13.95 13.87 Favored Glycine 0 C--N 1.304 -1.217 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.678 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -82.17 -21.82 36.35 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.814 0.816 . . . . 0.0 111.351 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.47 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 38.5 m -95.88 127.4 41.86 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.44 175.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.53 149.51 10.47 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.354 0.597 . . . . 0.0 110.471 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 82' ' ' LEU . 97.8 t -54.13 -53.73 26.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.193 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 61.4 pttt -54.45 -31.86 56.42 Favored 'General case' 0 C--O 1.199 -1.578 0 O-C-N 124.522 1.138 . . . . 0.0 112.086 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 m-20 -77.39 -34.37 54.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.47 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.2 m-70 -64.2 -40.16 95.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.6 mt -66.22 -43.44 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.828 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.4 mttt -57.15 -35.34 69.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.678 0.672 . . . . 0.0 111.278 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 47' ' ' ASP . 76.8 t -69.55 -53.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.482 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -54.49 -47.65 72.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.129 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 84.9 mt -55.77 -50.57 70.06 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.0 m -58.5 -39.52 80.27 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.23 -27.96 62.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 52.6 m-85 -91.74 4.24 53.26 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.386 0.612 . . . . 0.0 111.529 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 66.76 37.49 4.18 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.506 1.522 . . . . 0.0 112.556 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.64 132.66 20.84 Favored Pre-proline 0 N--CA 1.414 -2.232 0 C-N-CA 124.863 1.265 . . . . 0.0 108.259 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 134.0 58.62 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.256 1.97 . . . . 0.0 110.836 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.2 m -62.46 -10.43 5.09 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.677 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.027 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.01 -20.97 65.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.048 0.451 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.468 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -82.63 -4.36 57.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.2 p -47.78 -29.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 125.984 1.713 . . . . 0.0 110.603 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p -54.86 -46.83 74.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.56 -1.654 . . . . 0.0 111.612 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 m -105.01 10.34 34.13 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 124.312 1.045 . . . . 0.0 112.702 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 26.6 m-85 -109.19 143.34 38.74 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 121.881 -0.512 . . . . 0.0 111.391 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.77 151.88 34.33 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.1 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.36 127.85 34.86 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.033 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -113.93 144.29 43.3 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.51 132.92 77.76 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 39.0 Cg_endo -66.99 -21.37 49.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.872 2.381 . . . . 0.0 115.416 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.73 -46.19 4.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.818 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -86.4 -20.19 28.58 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.122 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt 69.25 16.14 8.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 111.842 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.04 137.75 40.41 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.202 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -94.41 141.27 28.77 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.997 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.05 103.02 8.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -108.51 15.24 24.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.697 1.237 . . . . 0.0 109.103 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.47 155.4 38.04 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.338 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.6 m -81.27 -40.76 23.22 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.375 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.62 157.15 37.94 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.037 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -90.42 142.96 27.21 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.276 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.8 p -99.31 153.1 37.95 Favored Pre-proline 0 N--CA 1.4 -2.96 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.74 -32.58 91.72 Favored 'Trans proline' 0 C--O 1.204 -1.199 0 C-N-CA 121.882 1.721 . . . . 0.0 109.289 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.5 -46.58 88.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.191 0.596 . . . . 0.0 111.568 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -62.34 -39.44 93.09 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.692 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 83' ' ' THR . 55.9 mt -66.06 -48.63 70.39 Favored 'General case' 0 C--O 1.205 -1.273 0 O-C-N 123.677 0.611 . . . . 0.0 110.153 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.5 t -62.11 -46.26 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.29 -28.72 69.52 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.77 -35.54 51.5 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.939 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.35 -25.24 33.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.108 0.563 . . . . 0.0 111.124 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -55.39 -42.26 73.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.284 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.8 m -142.97 -82.28 0.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -160.51 -178.39 6.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.954 0.901 . . . . 0.0 109.273 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -119.49 148.41 43.3 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.37 102.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.408 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.87 107.25 11.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -131.14 162.72 29.27 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.825 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.5 mtp . . . . . 0 N--CA 1.4 -2.944 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 122.252 1.025 . . . . 0.0 112.843 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.657 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.8 mtt -117.26 140.07 50.01 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.956 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HE2' HD12 ' A' ' 38' ' ' ILE . 20.1 ttmm -96.68 98.61 10.31 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.22 137.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.4 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.55 129.11 38.95 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.125 0.488 . . . . 0.0 109.902 172.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.1 t -115.91 122.28 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.694 0 CA-C-O 117.696 -1.145 . . . . 0.0 108.272 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -83.65 153.88 24.0 Favored 'General case' 0 N--CA 1.413 -2.301 0 C-N-CA 116.456 -2.098 . . . . 0.0 108.027 167.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.75 127.96 45.89 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.197 0.31 . . . . 0.0 110.171 176.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.431 ' N ' HD23 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.31 -1.13 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 N-CA-C 110.272 -0.703 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 22.2 p -140.77 157.42 45.43 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.902 -172.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -144.98 147.59 18.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -97.37 98.8 10.27 Favored 'General case' 0 N--CA 1.386 -3.66 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -105.73 144.9 31.83 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.12 -167.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.421 HD12 ' HE2' ' A' ' 9' ' ' LYS . 35.1 mm -84.52 112.22 21.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -113.19 149.49 33.61 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.402 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -148.07 -170.4 3.58 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.81 15.67 8.39 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.5 -23.59 11.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.925 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.7 m -104.73 135.83 45.38 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 123.592 0.757 . . . . 0.0 109.444 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.71 148.88 9.15 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.805 0.842 . . . . 0.0 111.18 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG21 ' HG ' ' A' ' 82' ' ' LEU . 90.2 t -54.18 -51.33 48.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.778 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 40.5 mttm -54.73 -34.14 62.06 Favored 'General case' 0 C--O 1.196 -1.714 0 O-C-N 124.685 1.241 . . . . 0.0 110.663 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 51' ' ' VAL . 12.1 m-20 -73.95 -39.18 63.93 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -62.11 -38.91 90.69 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.7 mt -67.33 -44.61 87.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.913 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 97.4 mttt -57.59 -33.91 68.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 118.843 0.747 . . . . 0.0 110.978 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.4 t -68.77 -54.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.189 175.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.71 -48.66 69.36 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 123.329 0.393 . . . . 0.0 111.382 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.45 -48.27 77.4 Favored 'General case' 0 C--O 1.203 -1.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -59.77 -38.31 81.46 Favored 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -74.72 -29.76 61.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.846 0.355 . . . . 0.0 111.659 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.46 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 38.5 m-85 -89.64 4.57 49.06 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.298 0.571 . . . . 0.0 112.518 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 68.97 32.38 3.85 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.642 1.577 . . . . 0.0 112.284 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -107.31 128.23 26.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -50.86 133.01 38.96 Favored 'Trans proline' 0 CA--C 1.502 -1.099 0 C-N-CA 122.52 2.147 . . . . 0.0 111.073 172.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.502 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.6 m -62.87 -9.96 5.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.682 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.88 -18.49 65.4 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.392 0.615 . . . . 0.0 110.516 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 12.1 mptt -85.14 -5.27 59.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.225 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.9 p -47.45 -27.98 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 C-N-CA 126.196 1.798 . . . . 0.0 110.301 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -56.42 -49.44 74.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 126.42 1.888 . . . . 0.0 111.359 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -104.27 14.88 29.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.952 1.301 . . . . 0.0 112.257 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 30.2 m-85 -113.93 142.52 46.03 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.605 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.92 31.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.2 mt -83.79 124.19 30.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.171 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -113.36 152.99 29.25 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -85.56 137.63 36.28 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 52.7 Cg_endo -70.59 -13.23 32.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.072 2.515 . . . . 0.0 115.81 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.41 -44.42 3.1 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.855 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.5 p -87.46 -19.13 28.44 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.561 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 63.03 21.74 13.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 110.783 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 140.89 33.95 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.892 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -100.71 143.86 30.37 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.484 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -78.65 107.63 11.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -100.58 10.49 41.11 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.801 0.81 . . . . 0.0 109.949 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.48 152.72 41.76 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.483 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.6 m -83.59 -38.18 21.96 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.203 174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -128.61 149.51 50.61 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 45' ' ' VAL . 25.7 mt -84.41 161.64 20.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.502 0.668 . . . . 0.0 110.731 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.429 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 64.4 p -120.01 155.74 55.13 Favored Pre-proline 0 N--CA 1.401 -2.895 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.45 -32.11 95.63 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.889 1.726 . . . . 0.0 109.801 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.74 -42.48 99.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.379 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.54 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.6 mmp_? -64.76 -38.36 90.72 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.657 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 76.7 mt -65.77 -47.94 73.5 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.016 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.503 ' CG2' ' HE3' ' A' ' 8' ' ' MET 0.258 20.1 t -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.92 -26.95 66.23 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.534 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -43.97 52.22 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.627 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 19.0 mt-10 -54.73 -23.26 16.95 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.34 -35.19 37.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.179 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 m -144.52 -80.37 0.18 Allowed 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -163.77 -175.5 4.14 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 125.788 1.635 . . . . 0.0 108.384 -177.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 3.3 m-85 -120.96 148.59 43.89 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 169.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.6 101.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.568 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.44 ' CD1' HD22 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -78.86 106.45 10.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -127.23 161.42 28.59 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.469 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.421 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 42.7 mtp . . . . . 0 N--CA 1.404 -2.751 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 166.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.393 -3.277 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.762 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 58.2 mtt -106.69 139.75 40.63 Favored 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.047 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 61.8 tttt -99.97 98.36 9.13 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.59 138.3 37.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.611 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 85.4 mtt180 -68.12 133.14 48.45 Favored 'General case' 0 CA--C 1.478 -1.804 0 CA-C-O 121.029 0.442 . . . . 0.0 110.551 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.9 t -120.12 124.63 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-O 117.735 -1.126 . . . . 0.0 108.639 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.259 21.8 mm-40 -84.2 153.46 23.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 170.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -126.03 130.82 51.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 176.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 15' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.319 -0.734 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.444 -1.441 0 N-CA-C 108.974 -1.202 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 1.4 p -138.78 152.46 47.93 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.44 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -147.68 149.65 15.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.3 m -96.21 108.32 20.78 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.5 t60 -113.05 147.17 37.79 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 -171.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 48.4 mm -84.89 112.74 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -113.68 146.07 40.36 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 123.039 0.535 . . . . 0.0 109.589 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.92 169.55 22.02 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 123.782 0.833 . . . . 0.0 109.243 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 26.24 24.06 Favored Glycine 0 C--N 1.298 -1.563 0 O-C-N 124.203 0.939 . . . . 0.0 112.435 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.62 -32.44 5.19 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-O 121.499 0.666 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.496 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 35.1 m -94.01 134.43 36.43 Favored 'General case' 0 N--CA 1.389 -3.523 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 148.76 15.12 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.261 0.553 . . . . 0.0 110.731 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG21 ' HG ' ' A' ' 82' ' ' LEU . 95.9 t -53.82 -52.28 36.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.114 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -57.08 -33.77 67.63 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.019 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.61 -37.06 65.55 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 122.06 -0.4 . . . . 0.0 110.712 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.496 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.8 m-70 -62.83 -39.27 93.82 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 27.2 mt -65.31 -44.13 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.67 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.93 -34.22 67.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.728 0.694 . . . . 0.0 111.18 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.56 -53.88 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.98 -48.27 70.54 Favored 'General case' 0 C--O 1.211 -0.921 0 O-C-N 123.558 0.536 . . . . 0.0 111.039 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.2 mt -56.88 -50.75 71.53 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -59.28 -37.32 77.38 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -74.07 -31.0 62.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.872 0.368 . . . . 0.0 111.644 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.475 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 37.0 m-85 -87.06 2.44 49.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 4.4 mmmp? 73.81 29.23 1.49 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.107 1.363 . . . . 0.0 113.108 175.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -105.83 135.99 19.34 Favored Pre-proline 0 N--CA 1.411 -2.392 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -56.58 137.01 79.12 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 122.016 1.811 . . . . 0.0 110.953 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.84 -10.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.945 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.305 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.8 -14.45 63.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.358 0.599 . . . . 0.0 110.956 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.5 mptp? -87.83 -5.19 58.73 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -48.55 -31.06 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 126.269 1.828 . . . . 0.0 110.428 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.275 15.5 m -55.37 -46.39 76.48 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 126.47 1.908 . . . . 0.0 110.964 174.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -103.01 7.79 39.01 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.755 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 26.0 m-85 -106.68 142.19 36.73 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.331 0.586 . . . . 0.0 111.432 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.04 141.02 23.78 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.387 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 80.1 mt -72.63 156.49 38.91 Favored 'General case' 0 N--CA 1.418 -2.051 0 O-C-N 124.82 1.325 . . . . 0.0 108.306 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 38.4 tt0 -146.12 152.0 38.58 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -89.3 137.17 29.33 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.133 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 56.7 Cg_endo -71.7 -17.6 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.788 2.326 . . . . 0.0 115.278 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -107.75 -46.26 3.84 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.311 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.2 p -84.05 -24.09 30.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.02 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt 69.61 14.57 8.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.451 1.1 . . . . 0.0 111.152 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 145.75 27.15 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.515 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 8.9 m-30 -88.06 -174.57 4.74 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 122.388 1.09 . . . . 0.0 112.194 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.9 t -124.57 101.84 9.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.49 14.81 29.35 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.695 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.32 158.3 33.03 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 125.483 1.513 . . . . 0.0 110.579 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.7 m -84.24 -36.38 22.75 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.735 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.78 146.74 52.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 45' ' ' VAL . 27.5 mt -80.18 153.85 28.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.287 0.565 . . . . 0.0 110.999 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.7 p -108.37 154.28 41.52 Favored Pre-proline 0 N--CA 1.403 -2.795 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.79 -36.6 95.51 Favored 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 110.02 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.86 -43.35 94.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.265 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -66.32 -37.15 84.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.314 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.762 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.8 mt -63.29 -51.45 66.05 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.831 0.707 . . . . 0.0 110.568 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 44.8 t -60.95 -45.86 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.58 -24.67 67.14 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.24 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.7 -39.94 35.13 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.704 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.616 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 32.5 mt-10 -51.03 -27.37 7.76 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 118.36 0.527 . . . . 0.0 111.809 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -49.7 -37.89 30.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.664 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -147.2 -88.66 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -154.98 177.76 10.95 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.476 1.11 . . . . 0.0 109.051 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -116.74 151.95 35.36 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 20.5 mt -117.8 135.96 56.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 115.38 24.35 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -147.73 173.47 12.74 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.5 mtp . . . . . 0 N--CA 1.397 -3.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.012 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.441 -0.89 0 CA-C-O 121.664 0.745 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.68 ' SD ' ' HG3' ' A' ' 91' ' ' GLU . 46.4 mtt -117.86 138.45 52.1 Favored 'General case' 0 CA--C 1.467 -2.233 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.819 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 30.3 ttpt -97.82 99.86 11.2 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.74 140.85 24.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.015 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -69.19 129.15 39.03 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -115.2 123.18 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.736 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.016 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.04 148.43 26.86 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 117.561 -1.656 . . . . 0.0 107.396 168.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -126.11 129.22 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 176.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 15' ' ' ILE . 1.5 mp . . . . . 0 C--N 1.307 -1.277 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.117 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--O 1.239 0.557 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.3 p -138.98 156.31 47.32 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.268 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -149.29 148.75 15.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -95.61 105.47 17.46 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.1 t60 -112.28 144.37 41.8 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.609 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.262 40.2 mm -83.69 113.46 22.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.49 145.32 41.37 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.94 -174.15 4.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 124.265 1.026 . . . . 0.0 108.289 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.44 22.43 8.33 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -112.15 -25.91 9.08 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.179 0.592 . . . . 0.0 111.231 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.527 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.4 m -96.69 154.08 17.49 Favored 'General case' 0 N--CA 1.389 -3.492 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.67 156.26 27.66 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 82' ' ' LEU . 91.4 t -52.96 -52.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 123.7 0.625 . . . . 0.0 109.717 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -55.68 -36.5 67.2 Favored 'General case' 0 C--O 1.196 -1.726 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.31 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -74.48 -36.19 63.29 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.993 -0.442 . . . . 0.0 111.758 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.527 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.6 m-70 -61.25 -38.79 87.95 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 36.8 mt -66.16 -42.95 92.15 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.079 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.67 -37.98 71.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.647 0.658 . . . . 0.0 110.796 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.44 -53.69 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.057 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -53.36 -49.61 66.79 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.467 0.479 . . . . 0.0 110.777 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -56.91 -47.43 80.57 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.522 0.514 . . . . 0.0 110.103 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.93 -40.52 93.53 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -70.84 -31.01 67.58 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.04 0.448 . . . . 0.0 111.51 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -86.67 1.87 50.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.341 0.591 . . . . 0.0 111.49 174.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 64.86 38.82 6.37 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 124.808 1.243 . . . . 0.0 113.18 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.0 mt -108.15 140.48 21.72 Favored Pre-proline 0 N--CA 1.41 -2.467 0 C-N-CA 124.988 1.315 . . . . 0.0 107.631 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.93 132.67 48.88 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.089 1.859 . . . . 0.0 110.925 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.9 m -63.75 -9.65 5.85 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.972 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.651 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -14.16 62.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.211 0.529 . . . . 0.0 111.544 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 64.2 mttm -85.38 -9.16 57.93 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.982 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.6 p -49.76 -30.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.906 2.082 . . . . 0.0 109.849 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.255 12.8 m -54.73 -48.91 71.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.146 1.778 . . . . 0.0 109.841 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -101.45 7.06 42.68 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.214 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 15.6 m-85 -106.55 144.38 33.3 Favored 'General case' 0 CA--C 1.477 -1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 110.751 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.57 149.25 25.19 Favored 'General case' 0 N--CA 1.41 -2.439 0 O-C-N 124.233 0.958 . . . . 0.0 109.292 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.68 132.75 35.61 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.574 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -118.92 153.58 34.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.03 131.0 48.08 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 33.1 Cg_endo -66.22 -20.26 56.03 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.421 2.748 . . . . 0.0 115.836 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -107.27 -43.61 4.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 p -87.37 -24.37 24.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.052 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt 70.72 19.45 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 124.366 1.066 . . . . 0.0 111.8 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.85 138.89 33.76 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.508 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -91.72 168.89 11.15 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.711 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.4 t -111.93 79.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.032 0.92 . . . . 0.0 111.399 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.27 -1.56 6.47 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.726 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -64.06 151.26 43.54 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.282 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -79.91 -41.17 26.66 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.282 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -131.32 153.22 49.82 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 124.22 1.008 . . . . 0.0 108.553 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.4 mt -85.99 153.67 21.99 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -109.51 155.32 41.48 Favored Pre-proline 0 N--CA 1.402 -2.849 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.53 -33.87 93.75 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.126 1.884 . . . . 0.0 109.973 173.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.75 -45.91 90.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.919 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -64.48 -37.92 89.23 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.179 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.536 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.0 mt -64.03 -47.52 79.91 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.612 0.57 . . . . 0.0 109.934 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.507 ' CG2' ' HE3' ' A' ' 8' ' ' MET 0.259 35.6 t -62.13 -46.29 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -67.2 -25.53 66.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.36 -43.12 28.51 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.68 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 4.2 mt-10 -53.72 -19.27 3.94 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -53.08 -39.81 63.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.84 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 m -144.88 -82.14 0.16 Allowed 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -161.91 -178.73 6.65 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.513 1.125 . . . . 0.0 109.114 -178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.99 147.02 46.05 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 169.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -113.43 101.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.458 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.52 105.06 9.54 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -126.75 159.21 34.42 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.683 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.415 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 46.0 mtp . . . . . 0 N--CA 1.393 -3.309 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 167.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.415 -2.198 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.434 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.7 mmt -122.91 137.29 54.98 Favored 'General case' 0 CA--C 1.477 -1.865 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.838 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 27.3 ttpt -96.22 98.95 10.71 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.28 139.32 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.721 -172.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 92.0 mtt180 -71.35 131.54 43.56 Favored 'General case' 0 CA--C 1.471 -2.088 0 O-C-N 123.456 0.473 . . . . 0.0 110.429 173.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 34' ' ' SER . 40.5 t -117.95 124.8 73.6 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.484 0 CA-C-O 117.911 -1.043 . . . . 0.0 109.011 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -80.0 149.55 30.72 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 168.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -126.4 125.6 42.45 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 120.467 0.175 . . . . 0.0 111.08 175.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.424 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 N--CA 1.442 -0.869 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.032 167.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.467 -0.07 0 N-CA-C 110.558 -0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -134.1 156.31 48.51 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.05 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.3 p -149.22 148.41 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 m -97.41 106.96 19.38 Favored 'General case' 0 N--CA 1.391 -3.389 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t60 -114.68 146.21 41.15 Favored 'General case' 0 N--CA 1.416 -2.157 0 C-N-CA 123.791 0.836 . . . . 0.0 110.529 -169.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.25 44.8 mm -83.13 112.92 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.664 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -113.12 145.87 40.18 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.23 169.63 18.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.38 17.85 42.79 Favored Glycine 0 C--N 1.292 -1.871 0 O-C-N 124.299 0.999 . . . . 0.0 113.008 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -108.08 -25.16 11.26 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-O 122.131 0.967 . . . . 0.0 110.998 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.1 m -103.6 137.84 41.1 Favored 'General case' 0 N--CA 1.391 -3.403 0 C-N-CA 125.059 1.344 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.91 150.01 17.47 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 121.44 0.638 . . . . 0.0 111.237 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 82' ' ' LEU . 83.8 t -52.8 -51.18 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.227 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -53.37 -42.18 66.62 Favored 'General case' 0 C--O 1.198 -1.619 0 O-C-N 125.003 1.439 . . . . 0.0 110.61 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.29 -39.07 85.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -62.51 -37.83 87.56 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.626 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 mt -66.52 -43.82 90.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.015 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.22 -34.72 66.58 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.839 0.745 . . . . 0.0 111.143 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.12 -53.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.136 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.31 -47.89 68.86 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 123.274 0.359 . . . . 0.0 111.12 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 79.5 mt -57.26 -49.43 76.07 Favored 'General case' 0 C--O 1.199 -1.564 0 O-C-N 123.705 0.628 . . . . 0.0 109.613 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -58.63 -39.8 81.53 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -71.41 -32.36 68.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 44.8 m-85 -86.42 -2.71 58.67 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.1 0.476 . . . . 0.0 111.835 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 69.15 39.23 1.76 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.389 1.476 . . . . 0.0 112.665 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.4 mt -106.42 136.85 19.32 Favored Pre-proline 0 N--CA 1.408 -2.538 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.28 134.91 62.06 Favored 'Trans proline' 0 CA--C 1.501 -1.16 0 C-N-CA 121.738 1.625 . . . . 0.0 111.515 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.58 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.1 m -64.38 -11.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.63 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.843 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.6 -20.61 64.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.257 0.551 . . . . 0.0 109.66 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 65.9 mttm -83.17 -2.46 55.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.265 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -49.0 -30.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 126.942 2.097 . . . . 0.0 110.618 176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -54.99 -58.12 8.92 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.915 173.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.1 m -87.85 10.96 16.84 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.422 -174.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 25.1 m-85 -109.22 143.51 38.57 Favored 'General case' 0 C--N 1.277 -2.567 0 O-C-N 121.277 -0.89 . . . . 0.0 111.34 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 154.35 40.22 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.037 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.29 160.48 16.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 41.5 tt0 -150.0 150.53 31.93 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 122.521 0.328 . . . . 0.0 110.207 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.83 137.98 31.5 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 124.459 1.103 . . . . 0.0 108.642 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.58 -21.16 30.06 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.814 2.342 . . . . 0.0 115.38 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -105.76 -42.49 5.15 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.747 -0.781 . . . . 0.0 113.001 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.5 p -90.43 -20.77 22.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.474 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt 66.58 17.96 10.7 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.491 1.117 . . . . 0.0 111.375 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.92 140.0 33.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 5.8 m-30 -86.03 -174.75 5.25 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.977 0.894 . . . . 0.0 110.567 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.0 101.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.97 11.95 36.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.796 1.284 . . . . 0.0 109.455 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.16 159.63 32.31 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 112.581 -2.1 . . . . 0.0 111.019 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 m -84.43 -39.44 18.97 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.317 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.06 154.92 45.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.863 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.9 mt -89.19 147.7 24.03 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.141 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.436 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 70.6 p -99.28 153.08 37.96 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.91 -34.17 97.99 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.428 2.085 . . . . 0.0 109.815 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -59.07 -47.62 84.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.142 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -60.28 -37.82 81.67 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 83' ' ' THR . 69.3 mt -64.35 -48.9 73.76 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.822 0.701 . . . . 0.0 110.401 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 43.7 t -63.48 -43.76 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -61.57 -29.89 70.32 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.79 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.56 -34.06 25.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.978 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.13 -24.58 55.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.644 0.735 . . . . 0.0 112.381 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 36.4 mmtm -54.09 -40.36 67.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.154 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.9 m -144.2 -88.31 0.12 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE2' HD12 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -156.64 178.96 9.73 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 108.752 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.25 152.85 34.93 Favored 'General case' 0 C--O 1.203 -1.363 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.438 HD12 ' CE2' ' A' ' 94' ' ' TYR . 2.7 mp -114.09 133.86 58.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.435 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -117.59 115.93 26.09 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.449 HH11 ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -146.41 177.56 8.94 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' SER . 49.4 mtp . . . . . 0 N--CA 1.381 -3.885 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.13 34.12 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.36 84.01 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -130.16 154.14 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.163 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.62 -88.89 0.23 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.83 -70.45 1.0 Allowed Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 m -85.34 147.48 26.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 39.6 mtt -128.19 140.1 52.1 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -170.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 43.6 tttm -97.21 94.81 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -104.11 137.29 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.76 -171.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.558 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 41.6 mtm180 -71.82 130.7 41.7 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.386 0.613 . . . . 0.0 110.196 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 34' ' ' SER . 45.8 t -117.99 127.91 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.346 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.28 43.4 mt-10 -90.18 143.76 26.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 116.257 -2.177 . . . . 0.0 109.358 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.2 tm? -111.7 129.67 56.03 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.77 122.62 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -150.07 76.24 1.27 Allowed 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.483 1.135 . . . . 0.0 109.215 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.81 15.24 31.63 Favored Glycine 0 C--N 1.295 -1.727 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.299 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.04 -40.32 18.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.22 137.24 33.12 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 165.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -82.96 69.98 9.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -140.9 115.96 9.84 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' C ' ' H ' ' A' ' 24' ' ' SER . 12.7 p -137.5 -158.92 0.9 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -82.24 30.77 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 22' ' ' THR . 17.7 m 72.19 11.51 5.93 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.911 1.684 . . . . 0.0 109.747 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.5 p -99.2 173.57 3.71 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.68 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.9 -160.22 0.12 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.528 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 49.5 mt-30 -84.76 20.41 1.79 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -108.34 95.42 15.82 Favored Pre-proline 0 C--N 1.271 -2.829 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 36.7 Cg_endo -89.69 131.16 1.94 Allowed 'Trans proline' 0 N--CA 1.426 -2.494 0 C-N-CA 122.379 2.053 . . . . 0.0 111.176 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.23 -47.34 74.13 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -135.96 158.1 45.24 Favored 'General case' 0 N--CA 1.401 -2.882 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -92.86 160.45 33.96 Favored Pre-proline 0 C--N 1.274 -2.68 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -50.81 128.43 24.27 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.247 1.965 . . . . 0.0 108.675 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.7 p -135.87 153.1 51.58 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 -173.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -146.87 145.95 19.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 m -97.8 104.98 17.05 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 35.7 t60 -111.24 144.87 39.7 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 -169.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.76 113.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.45 143.84 42.91 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.1 164.51 37.11 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.397 1.079 . . . . 0.0 108.402 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.84 14.81 63.58 Favored Glycine 0 C--N 1.291 -1.967 0 O-C-N 124.239 0.962 . . . . 0.0 112.787 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -105.61 -28.34 10.81 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 121.994 0.902 . . . . 0.0 110.1 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.474 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 39.9 m -94.7 132.36 39.53 Favored 'General case' 0 N--CA 1.39 -3.466 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.362 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.94 149.55 14.97 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -54.9 -53.15 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.163 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 22.3 pttm -54.38 -30.72 52.91 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 124.468 1.105 . . . . 0.0 111.02 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.8 m-20 -78.1 -36.31 48.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.204 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.474 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 96.2 m-70 -64.04 -39.73 94.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 30.1 mt -66.87 -44.32 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.977 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 96.4 mttt -56.69 -34.4 67.38 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.64 0.654 . . . . 0.0 110.821 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.4 t -69.59 -54.27 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.652 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.51 -49.51 67.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.429 0.456 . . . . 0.0 111.159 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.1 mt -54.74 -50.13 69.13 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 123.622 0.576 . . . . 0.0 109.844 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.0 m -58.16 -39.87 79.96 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -71.53 -27.87 63.48 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.139 0.495 . . . . 0.0 111.712 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 46.1 m-85 -89.82 2.04 55.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.291 0.567 . . . . 0.0 111.609 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 67.77 35.47 3.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.318 1.447 . . . . 0.0 112.579 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.2 135.78 19.42 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.97 135.88 69.63 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.429 2.086 . . . . 0.0 111.156 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 32.4 m -64.37 -10.73 8.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.813 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.392 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.42 -15.99 63.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.77 0.795 . . . . 0.0 109.523 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.91 -7.53 58.11 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.964 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -46.45 -30.69 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.097 0 C-N-CA 127.226 2.211 . . . . 0.0 111.128 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.271 16.5 m -56.99 -45.09 83.21 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 126.018 1.727 . . . . 0.0 111.724 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' MET . 8.7 m -100.9 7.13 43.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.057 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 98' ' ' ARG . 28.8 m-85 -109.91 143.56 39.66 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 122.154 -0.341 . . . . 0.0 110.92 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 147.65 28.42 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.325 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 89.0 mt -80.47 134.67 36.01 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.603 1.189 . . . . 0.0 107.944 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' NE2' HD21 ' A' ' 74' ' ' LEU . 6.0 tt0 -125.8 147.08 49.53 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.48 135.73 68.6 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.91 -16.14 29.38 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 115.076 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -105.83 -46.76 4.05 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.687 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -90.05 -18.09 26.58 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.639 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.415 HD21 ' NE2' ' A' ' 69' ' ' GLN . 10.6 mt 65.07 22.63 12.37 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.387 1.075 . . . . 0.0 110.918 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.05 135.87 35.89 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.374 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.61 149.85 20.83 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.644 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.86 106.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.62 10.86 29.0 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 123.107 1.432 . . . . 0.0 108.83 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.49 154.03 37.19 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.165 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.2 m -83.53 -35.46 24.79 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.702 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -129.8 149.55 51.49 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.263 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.37 153.04 22.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.212 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -108.35 158.84 32.76 Favored Pre-proline 0 N--CA 1.411 -2.415 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.1 -35.9 98.36 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.176 1.917 . . . . 0.0 109.16 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.75 -41.66 95.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.814 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -63.59 -43.08 97.99 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.514 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 69.8 mt -62.99 -48.08 80.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.377 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 30.4 t -61.1 -45.8 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.18 -27.96 68.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.66 -44.09 29.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.429 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 3.7 mm-40 -52.58 -22.18 4.7 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.84 -34.42 40.54 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.2 m -146.62 -83.84 0.12 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.63 177.91 10.87 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.52 1.128 . . . . 0.0 108.587 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.45 151.78 35.35 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 170.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 10.6 mt -114.9 140.81 34.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.34 107.01 12.85 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 63.8 mtp180 -129.0 159.48 35.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.39 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' SER . 52.3 mtp -76.19 128.01 34.07 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 166.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -66.81 126.01 91.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 O-C-N 123.815 0.697 . . . . 0.0 111.528 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.84 101.4 1.18 Allowed 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 122.034 1.822 . . . . 0.0 108.863 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -170.29 150.68 3.64 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.2 45.5 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.65 118.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.092 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.52 145.46 24.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.79 78.32 8.53 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 . . . . . 0 C--N 1.276 -2.594 0 CA-C-N 113.318 -1.764 . . . . 0.0 111.455 -179.761 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.21 97.05 10.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.461 0.648 . . . . 0.0 110.838 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -129.37 91.98 3.28 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -86.02 155.64 20.76 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.763 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.26 -17.25 7.06 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.92 77.05 1.25 Allowed Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 m -71.23 140.05 50.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.326 0.584 . . . . 0.0 110.864 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.719 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 47.0 mtt -123.88 141.88 51.63 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.727 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.1 tttm -100.66 97.01 7.73 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -107.33 139.75 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.743 -172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.541 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 10.7 mtp180 -67.22 134.92 52.59 Favored 'General case' 0 CA--C 1.454 -2.72 0 CA-C-O 121.838 0.828 . . . . 0.0 111.828 170.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.3 t -120.81 122.9 69.06 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.501 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.308 0.7 OUTLIER -83.78 144.41 29.33 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 116.082 -2.247 . . . . 0.0 108.518 166.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.6 tm? -114.55 137.09 52.3 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.404 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -111.29 118.76 58.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.093 168.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.95 67.7 0.61 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.83 167.16 30.67 Favored Glycine 0 N--CA 1.428 -1.878 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.787 -174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -129.53 21.25 5.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.967 0.889 . . . . 0.0 109.054 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 2.0 mp0 -82.01 -162.07 0.51 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 113.941 -1.482 . . . . 0.0 110.543 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 52.7 m80 80.39 110.48 0.07 Allowed 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 125.801 1.641 . . . . 0.0 109.891 -178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -131.71 168.83 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.199 0.999 . . . . 0.0 112.931 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 p -132.85 -151.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.1 m -59.16 151.11 23.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.1 t -81.12 15.17 1.98 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.047 0.927 . . . . 0.0 111.703 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.9 p -83.58 159.57 60.9 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.502 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -87.43 22.44 0.91 Allowed 'Trans proline' 0 C--O 1.225 -0.136 0 C-N-CA 122.792 2.328 . . . . 0.0 111.296 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -97.23 21.22 10.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.602 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.95 9.82 Favored Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.19 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.24 111.26 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.686 2.257 . . . . 0.0 110.622 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -133.56 86.61 2.31 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -93.9 -176.12 3.93 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.4 155.3 93.78 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 118.343 0.519 . . . . 0.0 110.229 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.46 134.41 45.6 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 123.718 2.945 . . . . 0.0 111.081 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.8 m -140.37 159.89 41.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.149 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 8.5 p -150.36 149.45 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -98.77 104.69 16.76 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.0 t60 -109.67 147.9 32.3 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.315 -170.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 113.02 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.81 147.45 38.33 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.25 -170.37 3.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.34 18.25 8.33 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.86 -28.37 8.41 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 124.03 0.932 . . . . 0.0 110.596 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 40.7 m -95.5 131.84 41.24 Favored 'General case' 0 N--CA 1.386 -3.67 0 C-N-CA 124.513 1.125 . . . . 0.0 109.096 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 148.49 14.73 Favored 'General case' 0 C--O 1.254 1.332 0 O-C-N 123.795 0.684 . . . . 0.0 110.618 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.2 -53.15 31.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.111 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -54.54 -31.92 57.31 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.344 1.028 . . . . 0.0 111.419 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.6 m-20 -75.88 -38.75 57.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.443 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.484 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.0 m-70 -61.98 -39.24 91.5 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.5 mt -67.1 -43.31 88.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.1 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.98 -34.3 71.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.066 0.848 . . . . 0.0 111.141 175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 47' ' ' ASP . 87.1 t -68.14 -52.62 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.239 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.79 -48.71 72.38 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.403 0.439 . . . . 0.0 111.089 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.66 -47.49 79.67 Favored 'General case' 0 C--O 1.2 -1.513 0 O-C-N 123.644 0.59 . . . . 0.0 109.796 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.2 m -59.42 -40.34 86.41 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -70.91 -34.04 71.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 50.3 m-85 -83.81 -2.37 56.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.37 0.605 . . . . 0.0 111.702 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 69.72 34.42 2.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.806 1.643 . . . . 0.0 111.999 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.27 137.24 19.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.68 132.47 50.41 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 121.926 1.751 . . . . 0.0 110.877 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.486 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.54 -10.14 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.166 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.99 -14.34 62.65 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.97 0.414 . . . . 0.0 111.187 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 60.8 mttm -86.33 -7.74 58.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.408 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -46.41 -32.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 C-N-CA 126.666 1.986 . . . . 0.0 110.833 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 p -54.17 -49.77 68.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 125.997 1.719 . . . . 0.0 111.219 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' MET . 27.2 t -96.0 9.21 41.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.865 -175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.447 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 16.4 m-85 -109.94 140.08 44.32 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.779 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.876 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 86.0 mt -85.53 125.85 33.4 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.394 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -113.82 148.62 36.3 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 120.78 0.324 . . . . 0.0 110.872 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -81.94 132.22 54.68 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.82 -18.59 52.94 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.627 2.218 . . . . 0.0 115.288 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.65 -44.44 4.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.014 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 p -89.5 -20.29 24.03 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.252 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 mt 68.48 16.53 9.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 111.654 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.69 139.37 38.5 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -98.95 147.36 25.06 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.728 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.11 106.01 14.03 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.469 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.1 10.15 41.72 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 123.983 0.913 . . . . 0.0 109.888 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.98 154.14 39.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.273 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.5 m -82.85 -38.48 22.94 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.052 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -130.67 148.74 52.5 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.351 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -80.65 157.71 25.87 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.771 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 56.5 p -110.78 153.92 43.48 Favored Pre-proline 0 N--CA 1.403 -2.816 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.63 -32.09 81.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.619 1.546 . . . . 0.0 110.119 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.66 -51.01 71.76 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.72 0.808 . . . . 0.0 110.783 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 23.9 mmm180 -60.95 -37.99 84.3 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 123.205 0.315 . . . . 0.0 110.688 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.719 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.8 mt -63.22 -49.21 75.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 123.973 0.796 . . . . 0.0 110.34 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 38.0 t -62.98 -44.2 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.63 -33.22 73.55 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.586 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.13 -42.48 46.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.649 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 25.0 mt-10 -52.34 -23.19 5.46 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -53.48 -35.59 60.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.896 0.879 . . . . 0.0 112.583 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 m -145.2 -84.82 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER -162.23 178.13 9.01 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.797 1.239 . . . . 0.0 108.612 -177.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 m-85 -111.63 146.88 36.65 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 94' ' ' TYR . 4.9 mt -112.66 100.41 10.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.765 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.34 102.71 8.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -123.87 160.08 28.23 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.664 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.447 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 52.3 mtp -77.32 128.73 34.81 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 166.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -65.86 135.96 95.57 Favored Pre-proline 0 C--N 1.274 -2.704 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.0 109.99 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.639 2.226 . . . . 0.0 110.008 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -68.12 143.39 55.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.4 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.4 156.83 21.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.013 0.821 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -81.44 98.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.086 0 CA-C-O 121.422 0.63 . . . . 0.0 109.74 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.32 110.38 8.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -98.38 29.99 3.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.584 0.707 . . . . 0.0 111.679 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 4.4 mmp_? . . . . . 0 C--N 1.301 -1.52 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.548 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.06 -52.55 0.64 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -56.06 -32.34 64.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt 54.24 79.56 0.13 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.91 -23.2 8.78 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.76 51.79 54.74 Favored Glycine 0 CA--C 1.477 -2.286 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -69.88 127.58 33.39 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.0 112.552 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.9 mtt -113.68 138.17 50.58 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.704 -1.589 . . . . 0.0 111.782 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 77.0 tttt -96.97 90.49 5.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -100.49 137.84 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.47 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 16.3 mtm180 -73.79 131.36 41.47 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.5 t -118.39 127.65 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.294 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.767 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 34.6 mt-10 -88.23 148.37 24.39 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 116.63 -2.028 . . . . 0.0 107.866 165.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -118.66 128.97 55.03 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.055 0.222 . . . . 0.0 110.542 177.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -103.2 118.38 50.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.545 169.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -136.79 26.83 3.03 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.95 66.95 0.85 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.995 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -124.77 -9.71 7.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 124.597 1.159 . . . . 0.0 108.791 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.6 23.46 2.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.533 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.4 m80 56.84 69.08 0.78 Allowed 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.679 0.792 . . . . 0.0 111.806 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -131.67 80.22 1.91 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p 54.17 -160.29 0.15 Allowed 'General case' 0 C--O 1.256 1.436 0 C-N-CA 124.011 0.925 . . . . 0.0 110.385 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -77.14 145.41 37.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m -81.95 13.61 3.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.178 0.99 . . . . 0.0 111.124 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 p -89.5 133.57 34.3 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 28' ' ' GLN . 9.2 Cg_endo -92.28 56.92 0.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.039 2.493 . . . . 0.0 113.264 -172.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -84.13 26.32 0.76 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.022 0.915 . . . . 0.0 110.896 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.55 ' C ' ' H ' ' A' ' 30' ' ' GLN . 13.2 mm-40 -116.37 164.87 16.53 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.507 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.99 28.89 0.48 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.632 2.221 . . . . 0.0 110.238 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.55 ' H ' ' C ' ' A' ' 28' ' ' GLN . 79.1 mt-30 -148.29 103.44 3.44 Favored 'General case' 0 N--CA 1.407 -2.587 0 C-N-CA 127.445 2.298 . . . . 0.0 106.359 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.5 -166.0 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -71.82 154.34 92.84 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -41.09 126.1 2.51 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.37 2.713 . . . . 0.0 110.36 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.6 p -132.49 150.08 52.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.688 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 9.3 p -147.02 148.22 16.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 12.8 m -99.5 105.44 17.35 Favored 'General case' 1 N--CA 1.379 -4.021 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -110.05 146.32 35.56 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.922 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -83.52 111.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.25 145.1 40.54 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.07 172.05 13.62 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.45 17.64 54.98 Favored Glycine 0 C--N 1.307 -1.069 0 O-C-N 124.271 0.982 . . . . 0.0 112.606 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -113.67 -22.75 10.09 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 121.618 0.723 . . . . 0.0 111.987 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.513 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 59.8 m -101.28 137.17 39.98 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.137 0.975 . . . . 0.0 109.952 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.14 147.33 16.41 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 124.025 0.828 . . . . 0.0 110.767 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.3 t -54.98 -53.97 28.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.857 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -57.6 -28.93 64.07 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.267 0.98 . . . . 0.0 111.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 51' ' ' VAL . 1.5 m-20 -75.91 -37.29 58.94 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.228 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.513 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 93.9 m-70 -62.15 -38.3 88.48 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 171.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 43.5 mt -67.11 -43.58 88.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.172 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -57.17 -34.46 68.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.836 0.744 . . . . 0.0 111.034 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 47' ' ' ASP . 63.4 t -70.55 -52.86 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.595 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.65 -49.62 67.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.252 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 91.7 mt -56.36 -48.29 77.11 Favored 'General case' 0 C--O 1.206 -1.231 0 O-C-N 123.48 0.487 . . . . 0.0 109.801 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.8 m -58.94 -40.18 83.89 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -71.82 -29.81 64.82 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.959 0.409 . . . . 0.0 112.023 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 41.1 m-85 -86.94 -0.97 57.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.232 0.539 . . . . 0.0 112.159 175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HZ3' ' HB3' ' A' ' 57' ' ' LYS . 9.5 mtpm? 69.79 30.86 3.68 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.967 1.707 . . . . 0.0 112.579 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.23 135.51 20.29 Favored Pre-proline 0 N--CA 1.404 -2.74 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.26 134.68 60.62 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.952 1.768 . . . . 0.0 111.24 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.464 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.2 m -63.26 -9.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.655 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.6 -15.46 63.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.785 0.326 . . . . 0.0 110.534 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -86.91 -5.48 59.08 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.847 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 1.6 p -48.9 -32.71 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 125.095 1.358 . . . . 0.0 110.609 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -57.14 -42.22 80.55 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.89 1.276 . . . . 0.0 110.379 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.2 m -103.52 13.7 32.87 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.243 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -117.77 144.29 45.45 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.89 154.77 31.77 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.042 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.4 mt -83.58 130.14 34.98 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.76 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -115.34 150.7 35.88 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -81.09 131.99 57.9 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.84 -19.82 46.32 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.914 2.409 . . . . 0.0 115.537 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.52 -45.28 4.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.355 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -92.14 -18.29 23.72 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.267 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.93 20.36 10.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.476 1.11 . . . . 0.0 112.443 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.16 137.71 35.9 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -94.54 147.44 23.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.217 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.44 107.67 13.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -101.38 12.38 37.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.195 0.521 . . . . 0.0 111.09 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -76.44 155.77 33.65 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 122.299 1.047 . . . . 0.0 111.684 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -81.86 -38.31 25.61 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.627 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.34 151.02 51.3 Favored 'General case' 0 N--CA 1.417 -2.121 0 C-N-CA 123.901 0.881 . . . . 0.0 108.631 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.9 mt -83.33 154.53 24.03 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.352 0.596 . . . . 0.0 110.521 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -111.46 153.44 44.17 Favored Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.42 -36.38 79.09 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 0.0 109.674 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.45 -46.49 86.45 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.813 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.59 -37.12 86.46 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 75.8 mt -65.19 -49.12 70.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.922 0.763 . . . . 0.0 110.184 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.465 ' CG2' ' HE3' ' A' ' 8' ' ' MET . 39.6 t -60.51 -44.07 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -62.16 -32.2 72.79 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.17 -43.83 23.16 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.79 -25.25 7.24 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -54.35 -36.67 64.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.672 1.189 . . . . 0.0 112.529 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.6 m -140.67 -80.79 0.26 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.05 -178.92 3.9 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 124.864 1.265 . . . . 0.0 108.443 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 2.6 m-85 -117.43 148.15 42.05 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 170.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.8 mt -115.65 101.57 12.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.019 175.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.28 103.72 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -125.97 164.3 21.11 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.514 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' SER . 58.4 mtp -79.41 122.97 27.06 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -61.5 155.87 56.33 Favored Pre-proline 0 C--N 1.282 -2.337 0 C-N-CA 125.019 1.327 . . . . 0.0 112.68 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.72 103.58 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.157 1.905 . . . . 0.0 108.709 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -135.26 156.02 49.67 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 131.79 51.0 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.132 0.491 . . . . 0.0 111.053 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt -86.36 136.03 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.725 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.95 96.0 5.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.011 0.434 . . . . 0.0 110.452 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -127.86 82.48 2.09 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.064 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER . . . . . 0 N--CA 1.397 -3.099 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.15 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.018 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.52 -8.64 54.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.114 0.457 . . . . 0.0 112.078 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -125.28 62.11 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.028 0.918 . . . . 0.0 111.334 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.1 mtp -116.48 41.64 2.61 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.553 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.65 63.6 0.31 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.99 44.72 1.04 Allowed Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.529 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 m -84.39 130.78 34.75 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.625 0.726 . . . . 0.0 109.193 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 45.0 mtt -112.95 141.24 47.01 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.71 -169.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 22.5 ttmm -98.63 101.07 12.38 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -112.22 138.64 40.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 124.833 1.253 . . . . 0.0 109.834 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -71.33 134.99 47.14 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.555 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' SER . 58.5 t -118.88 127.69 75.75 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.79 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.019 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.77 149.46 24.84 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.52 -1.672 . . . . 0.0 107.765 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tm? -115.17 132.65 56.54 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.093 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.47 ' N ' HD21 ' A' ' 14' ' ' LEU . 1.5 mp -105.54 114.35 44.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -160.24 83.84 0.71 Allowed 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.18 48.15 0.97 Allowed Glycine 0 C--N 1.269 -3.142 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.989 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -86.84 -41.5 13.99 Favored 'General case' 0 CA--C 1.468 -2.177 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.92 96.88 8.95 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.799 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -89.94 92.85 9.18 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -106.73 167.44 9.87 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.04 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.7 p -92.33 134.5 34.85 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.867 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 p -126.76 97.12 4.87 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 120.874 0.369 . . . . 0.0 110.67 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 m -88.9 -13.09 39.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.936 0.874 . . . . 0.0 108.805 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 p -85.93 154.57 58.21 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.007 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.13 60.21 3.82 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.139 2.559 . . . . 0.0 112.264 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -117.25 45.07 1.97 Allowed 'General case' 0 N--CA 1.402 -2.831 0 C-N-CA 123.845 0.858 . . . . 0.0 109.593 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.407 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 22.8 mp0 -56.07 115.24 9.21 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.934 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.33 95.49 1.0 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.349 2.033 . . . . 0.0 109.099 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.407 ' NE2' ' HB3' ' A' ' 28' ' ' GLN . 26.8 mm-40 -93.69 -53.62 3.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.645 0.736 . . . . 0.0 110.233 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -111.32 168.24 9.68 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.957 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -81.84 143.95 51.01 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.277 -177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -49.17 132.49 28.26 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 124.123 3.216 . . . . 0.0 109.735 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.6 p -139.37 157.25 46.19 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.011 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG13 ' CZ ' ' A' ' 56' ' ' PHE . 7.4 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -97.45 99.48 10.9 Favored 'General case' 0 N--CA 1.387 -3.594 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 59.9 t60 -106.12 144.99 32.04 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.814 -167.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD12 ' HB2' ' A' ' 9' ' ' LYS 0.253 48.4 mm -83.65 114.06 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -115.35 151.5 34.52 Favored 'General case' 0 C--N 1.272 -2.78 0 C-N-CA 123.299 0.639 . . . . 0.0 109.513 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -146.71 -167.79 2.85 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.16 21.18 5.24 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -108.98 -25.46 10.71 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.469 0.652 . . . . 0.0 110.171 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.3 m -105.79 138.08 42.59 Favored 'General case' 0 N--CA 1.412 -2.342 0 C-N-CA 124.633 1.173 . . . . 0.0 109.391 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.64 145.86 22.44 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 121.444 0.64 . . . . 0.0 110.93 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 81.4 t -48.54 -52.05 9.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.701 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -56.57 -35.35 68.07 Favored 'General case' 0 C--O 1.198 -1.617 0 O-C-N 124.565 1.166 . . . . 0.0 111.204 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.61 -34.62 65.13 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.862 -0.524 . . . . 0.0 111.703 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -63.38 -36.98 85.51 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.62 -41.65 85.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.354 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -56.26 -38.78 71.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.856 0.753 . . . . 0.0 110.622 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.75 -53.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.902 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.3 mt -53.22 -50.56 64.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.133 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.99 -49.14 76.65 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 123.677 0.611 . . . . 0.0 110.047 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -59.13 -38.76 80.44 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -73.94 -31.47 63.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 14' ' ' LEU . 29.6 m-85 -81.58 -8.45 59.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.066 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt 74.57 37.23 0.56 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.638 1.575 . . . . 0.0 111.91 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.6 mt -109.63 131.53 21.85 Favored Pre-proline 0 N--CA 1.409 -2.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.72 136.11 57.89 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 C-N-CA 122.557 2.171 . . . . 0.0 111.932 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.7 m -64.29 -9.8 6.94 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.903 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.49 -15.93 63.35 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.674 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.9 mptp? -85.32 -4.36 59.13 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.5 p -49.37 -30.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.919 1.688 . . . . 0.0 110.481 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.2 p -56.05 -50.53 70.7 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.005 173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 99' ' ' MET . 19.6 m -98.44 13.16 32.69 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.256 -172.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 19.2 m-85 -114.25 142.43 46.29 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.942 -0.474 . . . . 0.0 111.748 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.08 146.65 24.1 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.671 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.92 138.26 38.79 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.059 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -122.14 144.97 48.62 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.89 130.32 76.24 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.42 -18.72 49.67 Favored 'Trans proline' 0 C--N 1.329 -0.453 0 C-N-CA 122.575 2.183 . . . . 0.0 114.957 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -110.52 -39.48 4.9 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.2 p -90.12 -18.07 26.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.146 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 68.86 15.56 8.92 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.0 111.943 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.72 137.72 37.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.38 156.91 17.9 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.289 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 79' ' ' ASP . 46.6 t -104.07 77.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 122.141 0.972 . . . . 0.0 111.845 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.4 2.94 2.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 125.234 1.414 . . . . 0.0 114.174 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 77' ' ' VAL . 6.4 m-20 -68.84 154.73 41.48 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.582 177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -82.96 -37.28 24.31 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.851 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.49 153.37 48.88 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.291 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.5 mt -85.68 146.83 26.65 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.2 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -99.02 157.79 33.46 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.5 -34.81 98.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.071 1.848 . . . . 0.0 109.398 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.09 -45.67 93.77 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.401 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 8.7 mmt180 -61.14 -39.7 91.04 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.691 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 79.0 mt -64.86 -48.68 73.4 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 124.073 0.858 . . . . 0.0 109.778 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.504 ' CG2' ' HE1' ' A' ' 8' ' ' MET . 41.5 t -62.77 -45.3 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -63.83 -28.71 70.04 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.131 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.06 24.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.632 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 15.6 mt-10 -53.02 -22.71 6.13 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 119.059 0.845 . . . . 0.0 113.117 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.93 -42.93 65.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.706 0.803 . . . . 0.0 110.826 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.6 m -140.91 -80.41 0.26 Allowed 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -167.36 -179.26 4.39 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 124.133 0.973 . . . . 0.0 109.04 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.61 149.49 42.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.3 99.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.02 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 105.5 10.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.018 0.913 . . . . 0.0 108.589 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -124.07 166.15 16.26 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.427 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' SER . 57.4 mtp -81.11 132.79 35.38 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -61.71 147.68 88.48 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 124.402 1.081 . . . . 0.0 110.006 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.23 117.2 2.11 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.434 2.756 . . . . 0.0 111.146 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -93.45 149.89 20.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.712 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.36 -158.42 0.45 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.23 130.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.187 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 132.48 48.92 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.419 0.628 . . . . 0.0 111.25 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.55 16.33 5.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.193 0.997 . . . . 0.0 110.618 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 . . . . . 0 C--N 1.282 -2.343 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.606 177.046 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.56 -171.37 0.17 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.209 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -114.55 140.73 48.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.918 -0.489 . . . . 0.0 110.383 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.6 mtp -102.35 155.52 18.19 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.23 63.12 0.19 Allowed Glycine 0 C--N 1.289 -2.077 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.9 53.68 0.63 Allowed Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.119 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 m -78.72 140.22 38.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.463 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.5 mmt -115.46 138.23 51.24 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.899 -172.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 45.3 tttm -99.04 91.98 5.27 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.61 137.27 31.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.939 -171.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 30.0 mtm105 -69.42 130.71 43.29 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 121.714 0.769 . . . . 0.0 110.225 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.0 t -117.07 122.58 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.385 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.487 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.275 33.0 mt-10 -82.38 149.36 27.73 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 116.566 -2.053 . . . . 0.0 107.037 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.52 123.09 36.97 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -98.62 109.77 24.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 119.242 -0.983 . . . . 0.0 109.019 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -126.35 11.43 7.48 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.647 0.737 . . . . 0.0 109.058 172.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.54 63.78 0.45 Allowed Glycine 0 C--N 1.289 -2.053 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.659 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.3 -37.28 38.12 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.82 99.18 8.79 Favored 'General case' 0 N--CA 1.388 -3.559 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -65.43 108.83 2.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.886 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -115.35 142.78 46.23 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p 54.84 -165.76 0.1 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.686 1.194 . . . . 0.0 111.46 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 p -64.17 104.31 0.72 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -149.15 110.11 4.33 Favored 'General case' 0 N--CA 1.406 -2.643 0 C-N-CA 123.75 0.82 . . . . 0.0 108.787 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 p -68.2 170.66 7.17 Favored Pre-proline 0 C--N 1.275 -2.63 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.541 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -68.39 178.75 3.46 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.763 2.309 . . . . 0.0 112.373 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -80.99 30.62 0.32 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 125.318 1.447 . . . . 0.0 113.999 -174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HB2' ' HG3' ' A' ' 31' ' ' GLN . 89.2 mt-30 -70.49 170.48 10.53 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 30' ' ' GLN . 5.6 Cg_exo -82.57 158.07 16.6 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-N 120.874 1.348 . . . . 0.0 110.749 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 28.1 mt-30 60.22 27.98 17.53 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 125.25 1.42 . . . . 0.0 111.412 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HG3' ' HB2' ' A' ' 28' ' ' GLN . 83.4 mm-40 -109.33 -52.35 2.78 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 123.65 1.69 . . . . 0.0 114.022 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -63.38 155.73 73.36 Favored Pre-proline 1 C--N 1.2 -5.911 0 CA-C-N 110.148 -3.206 . . . . 0.0 112.152 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.26 135.52 11.52 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.928 3.085 . . . . 0.0 110.044 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.6 m -145.86 157.59 43.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.193 0.52 . . . . 0.0 112.008 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -147.76 148.15 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.734 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.803 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.4 m -97.05 103.86 15.82 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 43.1 t60 -107.86 147.59 30.73 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.138 -169.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 38' ' ' ILE . 49.7 mm -83.83 111.18 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.0 146.02 38.62 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.47 -168.85 3.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.83 20.45 6.03 Favored Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.471 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.12 -26.86 9.0 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.641 0.734 . . . . 0.0 110.699 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.0 m -99.62 135.3 41.25 Favored 'General case' 0 N--CA 1.39 -3.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.942 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.31 146.12 12.76 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 123.931 0.769 . . . . 0.0 111.58 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG23 ' HG ' ' A' ' 82' ' ' LEU . 89.0 t -52.75 -54.0 18.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.643 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -56.82 -31.02 64.31 Favored 'General case' 0 C--O 1.204 -1.329 0 O-C-N 124.464 1.102 . . . . 0.0 111.977 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 -38.94 62.16 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.91 -37.6 85.24 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.542 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.5 mt -68.81 -42.35 82.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.127 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.7 mttt -58.58 -33.55 70.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.87 -54.82 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.6 mt -53.12 -49.34 66.74 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 123.268 0.355 . . . . 0.0 111.178 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 86.4 mt -56.65 -48.19 78.12 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 123.404 0.44 . . . . 0.0 110.224 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -59.7 -38.76 82.47 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.71 -30.32 64.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.856 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.43 1.09 55.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.362 0.601 . . . . 0.0 112.03 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 67.3 35.05 4.55 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.489 1.516 . . . . 0.0 112.497 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.54 136.76 19.13 Favored Pre-proline 0 N--CA 1.411 -2.407 0 C-N-CA 124.802 1.241 . . . . 0.0 107.8 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.13 133.0 50.24 Favored 'Trans proline' 0 CA--C 1.495 -1.445 0 C-N-CA 121.999 1.799 . . . . 0.0 110.861 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -62.05 -9.85 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.115 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.05 -19.2 64.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.277 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -82.21 -5.51 58.55 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.9 p -48.01 -29.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 125.759 1.623 . . . . 0.0 110.975 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -48.95 77.54 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.977 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.0 m -99.78 12.96 35.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.843 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.3 m-85 -115.78 140.28 49.37 Favored 'General case' 0 CA--C 1.473 -1.992 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.163 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.07 152.36 27.93 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.434 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.71 127.99 33.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.859 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.411 ' NE2' HD23 ' A' ' 74' ' ' LEU . 11.6 tt0 -111.04 144.53 40.01 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -73.87 125.18 90.52 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 -19.97 64.43 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.177 2.585 . . . . 0.0 114.84 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.79 -44.79 4.55 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.935 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.8 p -90.78 -15.18 30.59 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD23 ' NE2' ' A' ' 69' ' ' GLN . 9.1 mt 64.89 18.96 11.71 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.799 1.24 . . . . 0.0 111.262 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.47 136.38 38.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.734 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -92.77 147.76 22.6 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.385 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.9 105.99 17.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -107.07 13.87 26.96 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.799 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.23 163.97 27.04 Favored 'General case' 0 CA--C 1.461 -2.451 0 CA-C-O 122.719 1.247 . . . . 0.0 112.755 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.7 m -88.3 -38.92 14.79 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-N 112.6 -2.091 . . . . 0.0 109.129 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -131.85 149.21 52.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.857 0.863 . . . . 0.0 110.17 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.45 ' HG ' HG23 ' A' ' 45' ' ' VAL . 21.5 mt -86.15 152.61 22.7 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.796 0.838 . . . . 0.0 111.786 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 62.0 p -103.05 155.92 36.0 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.73 -31.49 91.99 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.017 1.812 . . . . 0.0 109.411 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.7 -44.6 96.63 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.475 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.3 mmp_? -60.25 -38.8 84.59 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 83' ' ' THR . 58.0 mt -67.31 -47.63 69.99 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.699 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.604 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 42.9 t -62.74 -47.65 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 176.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 45.9 mt-10 -62.69 -30.8 71.67 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 111.664 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.43 58.27 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.909 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 3.0 mm-40 -59.08 -22.88 61.5 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.604 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -54.69 -38.74 67.38 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.097 172.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.4 m -144.76 -78.89 0.19 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.37 -177.27 4.4 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.699 1.2 . . . . 0.0 108.568 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.46 151.1 39.79 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.3 102.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.555 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 107.41 10.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -126.42 159.2 33.95 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.901 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 65' ' ' SER . 62.9 mtp -78.97 127.2 31.69 Favored 'General case' 0 N--CA 1.4 -2.97 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -58.31 141.9 82.15 Favored Pre-proline 0 N--CA 1.428 -1.544 0 O-C-N 124.576 1.173 . . . . 0.0 109.341 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -39.5 107.14 0.06 OUTLIER 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 124.102 3.201 . . . . 0.0 115.291 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -134.05 154.5 51.12 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.044 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.6 177.17 3.51 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.4 mt -73.48 97.93 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-O 121.541 0.686 . . . . 0.0 109.599 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.89 97.55 0.94 Allowed 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.93 68.75 8.47 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 121.625 0.726 . . . . 0.0 112.442 -174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 . . . . . 0 C--N 1.28 -2.45 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.592 174.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.21 -17.4 54.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.516 0.674 . . . . 0.0 109.847 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -105.52 -176.39 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.321 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 mmt -105.29 175.78 5.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.145 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.23 -96.74 2.38 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.29 75.08 0.71 Allowed Glycine 0 CA--C 1.483 -1.965 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 m -68.92 141.23 55.06 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.136 0.493 . . . . 0.0 110.728 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 13.0 mmt -123.78 140.84 52.59 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.293 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 28.5 ttpt -98.95 95.68 7.32 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.232 1.015 . . . . 0.0 108.953 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -105.45 139.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.243 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.8 mmt180 -65.76 131.86 47.33 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-O 121.139 0.495 . . . . 0.0 110.04 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.5 t -117.01 126.16 74.28 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.734 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.265 33.6 mt-10 -86.02 150.1 24.7 Favored 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 116.642 -2.023 . . . . 0.0 107.185 167.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -121.94 130.84 53.65 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 112.34 35.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.8 20.9 1.01 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.33 -166.79 24.5 Favored Glycine 0 N--CA 1.417 -2.603 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.089 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.79 48.48 1.97 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -57.99 143.31 43.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.307 -2.224 . . . . 0.0 113.184 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -114.92 119.27 35.97 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.97 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.46 ' NH1' ' HB2' ' A' ' 57' ' ' LYS . 70.6 mtt180 -110.33 -163.49 0.86 Allowed 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -60.55 102.97 0.21 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.355 0.598 . . . . 0.0 112.375 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.9 t -151.43 103.45 2.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -86.93 -5.06 59.21 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.564 0.697 . . . . 0.0 109.289 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.4 p -85.11 178.33 2.43 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.55 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 28' ' ' GLN . 5.2 Cg_exo -38.93 158.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 124.58 3.52 . . . . 0.0 113.788 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.54 19.21 0.27 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.648 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 26' ' ' PRO . 48.0 mt-30 65.35 163.54 0.12 Allowed Pre-proline 0 C--N 1.309 -1.18 0 C-N-CA 125.902 1.681 . . . . 0.0 111.349 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.79 136.55 71.02 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.291 -1.465 . . . . 0.0 108.291 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.404 ' H ' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER -82.6 60.32 5.15 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.866 1.317 . . . . 0.0 112.274 -174.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -136.64 -169.12 2.39 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 127.639 2.376 . . . . 0.0 106.216 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.444 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 94.1 m-20 -83.55 151.28 61.66 Favored Pre-proline 0 C--N 1.282 -2.326 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.07 133.07 18.46 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.989 3.126 . . . . 0.0 110.047 171.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 25.5 p -136.08 152.43 50.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -148.35 151.43 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 m -100.93 105.95 17.24 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 42.6 t60 -113.09 140.81 47.56 Favored 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.503 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.251 36.3 mm -76.84 111.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.74 145.96 39.61 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.521 ' OD2' ' HE1' ' A' ' 48' ' ' HIS . 4.2 p30 -148.42 -170.74 3.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.9 17.58 7.65 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -108.71 -28.94 8.95 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.689 0.757 . . . . 0.0 109.719 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -100.45 132.06 46.04 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.772 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.59 151.23 4.41 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.524 0.73 . . . . 0.0 111.875 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.55 -54.28 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.996 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.72 -30.46 65.55 Favored 'General case' 0 C--O 1.204 -1.301 0 O-C-N 124.221 0.951 . . . . 0.0 112.525 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.5 ' O ' HG22 ' A' ' 51' ' ' VAL . 4.5 m-20 -73.66 -37.05 65.42 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.079 -0.388 . . . . 0.0 110.033 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.521 ' HE1' ' OD2' ' A' ' 40' ' ' ASP . 90.6 m-70 -62.77 -39.59 94.64 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 42.8 mt -68.52 -41.82 83.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.31 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.39 -34.66 70.98 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 119.047 0.84 . . . . 0.0 110.759 174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 47' ' ' ASP . 84.7 t -68.7 -54.13 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.3 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.85 -47.33 74.31 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.215 0.322 . . . . 0.0 111.191 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.1 mt -57.59 -46.87 83.48 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 123.377 0.423 . . . . 0.0 109.977 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -59.35 -40.69 87.19 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.16 -32.78 67.18 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 47.2 m-85 -83.94 -5.75 59.28 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.387 0.613 . . . . 0.0 111.296 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.46 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 26.1 mtpp 69.28 45.99 0.82 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 126.287 1.835 . . . . 0.0 112.983 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.99 135.88 21.26 Favored Pre-proline 0 N--CA 1.404 -2.739 0 C-N-CA 125.782 1.633 . . . . 0.0 107.286 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.36 134.64 62.13 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.142 1.895 . . . . 0.0 111.373 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.3 m -63.77 -10.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.176 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CG ' ' HZ2' ' A' ' 62' ' ' LYS . 3.9 p-10 -69.94 -15.84 63.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.726 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.491 ' HZ2' ' CG ' ' A' ' 61' ' ' ASP . 2.5 mptp? -85.0 -4.04 59.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.83 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.1 p -47.05 -31.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 126.08 1.752 . . . . 0.0 110.296 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.4 m -55.78 -47.02 77.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.744 1.618 . . . . 0.0 110.849 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -100.72 12.66 37.02 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.33 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.447 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.4 m-85 -113.28 143.24 44.75 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.906 -0.496 . . . . 0.0 111.654 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.35 147.54 28.43 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.838 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -83.54 125.64 31.98 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 124.26 0.975 . . . . 0.0 108.415 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -112.77 147.77 36.19 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.22 129.91 70.94 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.08 -20.63 67.75 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.82 2.347 . . . . 0.0 115.179 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -103.71 -44.89 4.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.984 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 p -89.5 -20.55 23.7 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.851 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt 67.24 17.27 10.26 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.599 1.159 . . . . 0.0 111.821 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.2 39.18 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.53 154.26 17.38 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.45 110.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -102.32 11.58 37.89 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.546 0.689 . . . . 0.0 110.424 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.17 156.85 36.89 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.934 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.6 m -81.73 -38.59 25.49 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.618 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.46 149.27 52.21 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 124.194 0.997 . . . . 0.0 108.657 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.66 155.07 28.22 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 73.0 p -109.35 153.32 42.8 Favored Pre-proline 0 N--CA 1.401 -2.899 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HG2' ' OE2' ' A' ' 85' ' ' GLU . 8.6 Cg_endo -53.94 -37.56 85.87 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.553 2.169 . . . . 0.0 110.386 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.501 ' OE2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 mp0 -60.09 -44.43 94.8 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 89' ' ' GLU . 4.0 mmp_? -61.7 -40.4 94.9 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 83' ' ' THR . 66.3 mt -66.29 -47.12 74.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.711 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.76 -46.3 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.585 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 86' ' ' ARG . 49.7 mt-10 -63.78 -31.8 73.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 111.451 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.82 61.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.622 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -57.33 -24.9 58.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.188 0.595 . . . . 0.0 111.934 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 67.0 mttm -56.17 -35.62 67.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.506 1.122 . . . . 0.0 112.534 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.1 m -146.79 -85.1 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.61 -178.82 7.38 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.297 1.039 . . . . 0.0 108.843 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.35 149.27 42.11 Favored 'General case' 0 C--O 1.209 -1.075 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 169.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.7 mt -116.63 101.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 118.821 0.737 . . . . 0.0 110.325 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.39 102.99 9.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -119.99 161.05 21.57 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.447 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 46.8 mtp -78.82 125.3 29.19 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -59.73 130.22 88.1 Favored Pre-proline 0 C--N 1.288 -2.107 0 O-C-N 124.169 0.918 . . . . 0.0 112.311 -175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -60.24 110.08 0.73 Allowed 'Trans proline' 0 CA--C 1.506 -0.901 0 C-N-CA 123.027 2.484 . . . . 0.0 110.791 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 63.98 100.95 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.103 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.88 -166.89 1.28 Allowed 'General case' 0 C--N 1.251 -3.712 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.211 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.66 102.01 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.99 29.9 6.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.23 17.75 4.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.703 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 . . . . . 0 N--CA 1.436 -1.132 0 C-N-CA 127.392 2.277 . . . . 0.0 114.279 173.429 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.27 111.33 17.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -136.8 141.22 42.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtm 62.42 24.62 14.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.817 0.847 . . . . 0.0 110.806 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.33 -58.86 0.64 Allowed Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.38 66.2 1.82 Allowed Glycine 0 N--CA 1.423 -2.225 0 CA-C-N 115.128 -0.536 . . . . 0.0 113.649 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 m -80.77 150.83 29.09 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.431 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 12.0 mmt -127.96 142.07 51.35 Favored 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 71.8 tttt -99.13 97.57 8.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -109.4 138.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.17 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 87.9 mtt180 -69.3 130.79 43.57 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.364 0.602 . . . . 0.0 110.683 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.3 t -116.83 123.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.561 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.607 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.259 35.6 mt-10 -84.69 142.4 29.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.622 -2.031 . . . . 0.0 107.711 169.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.4 tm? -115.38 130.73 56.98 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.972 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.5 mp -115.44 123.79 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -122.88 3.06 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.976 1.37 . . . . 0.0 111.032 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.03 25.2 74.47 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.103 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -140.12 27.48 2.15 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.05 65.75 1.14 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.627 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.57 20.41 4.29 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 122.144 0.973 . . . . 0.0 110.598 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.48 23.68 6.83 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.435 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -80.31 80.4 6.75 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.402 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -121.86 16.39 10.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.865 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -91.28 -6.12 53.7 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.064 0.935 . . . . 0.0 109.165 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 p -82.1 162.03 58.27 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.106 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 28' ' ' GLN . 10.6 Cg_exo -76.31 -155.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.285 2.656 . . . . 0.0 109.278 172.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -81.19 13.47 2.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 122.57 1.176 . . . . 0.0 111.383 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 26' ' ' PRO . 86.9 mm-40 -89.15 159.99 43.88 Favored Pre-proline 0 C--N 1.278 -2.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.684 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.25 136.31 8.24 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 123.5 2.8 . . . . 0.0 112.118 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -82.0 71.41 9.03 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 122.317 1.056 . . . . 0.0 110.426 -175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.33 175.87 3.1 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 113.056 -1.884 . . . . 0.0 112.552 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 87.7 m-20 -57.74 144.86 72.57 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -172.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.74 137.84 79.59 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.556 3.504 . . . . 0.0 109.422 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.6 m -143.61 159.89 41.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.792 -0.567 . . . . 0.0 109.623 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.69 150.39 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -97.35 106.72 19.09 Favored 'General case' 0 N--CA 1.394 -3.261 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 173.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 38.3 t60 -110.2 145.42 37.32 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.132 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.254 50.2 mm -83.28 109.89 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.85 144.51 39.76 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -152.41 169.21 23.11 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 124.235 1.014 . . . . 0.0 108.534 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.65 17.98 53.93 Favored Glycine 0 C--N 1.282 -2.465 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -104.95 -30.03 10.08 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-O 121.715 0.769 . . . . 0.0 109.963 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.636 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 31.6 m -97.75 137.39 36.7 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 124.793 1.237 . . . . 0.0 108.564 175.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.04 149.34 12.1 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-O 121.517 0.675 . . . . 0.0 110.44 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.6 t -55.74 -53.92 31.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.096 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -57.4 -31.1 65.5 Favored 'General case' 0 C--O 1.208 -1.107 0 O-C-N 124.159 0.912 . . . . 0.0 111.818 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -74.16 -36.64 64.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 122.344 -0.223 . . . . 0.0 110.813 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.636 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 91.3 m-70 -62.76 -39.06 92.99 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.7 mt -68.67 -43.12 83.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.473 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.51 -31.88 68.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.733 0.697 . . . . 0.0 110.899 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 47' ' ' ASP . 91.1 t -68.61 -54.31 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.417 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.14 -48.76 67.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 122.502 0.321 . . . . 0.0 111.013 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.0 mt -57.73 -49.07 77.79 Favored 'General case' 0 C--O 1.195 -1.815 0 O-C-N 123.654 0.596 . . . . 0.0 109.811 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 m -59.72 -38.51 81.87 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -72.68 -31.91 65.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CZ ' HG11 ' A' ' 35' ' ' VAL . 47.6 m-85 -83.09 -7.09 59.69 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.188 0.518 . . . . 0.0 111.334 173.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 72.02 38.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.62 1.568 . . . . 0.0 112.237 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.426 ' CG2' ' HD2' ' A' ' 62' ' ' LYS . 75.1 mt -105.89 134.79 19.57 Favored Pre-proline 0 N--CA 1.409 -2.517 0 C-N-CA 125.345 1.458 . . . . 0.0 107.865 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.01 131.39 46.15 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.339 2.026 . . . . 0.0 111.325 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.6 m -62.42 -11.04 5.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.553 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.43 -14.65 62.22 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.426 ' HD2' ' CG2' ' A' ' 58' ' ' ILE . 66.9 mttm -81.62 -9.96 59.54 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.827 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.3 p -47.27 -31.33 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 127.257 2.223 . . . . 0.0 110.343 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 m -54.41 -46.24 73.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.564 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 99' ' ' MET . 14.8 t -94.41 -0.64 54.68 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.823 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -101.14 139.05 37.36 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.714 -1.194 . . . . 0.0 112.315 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.401 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . . . -149.56 142.24 24.55 Favored 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.646 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -79.0 126.41 30.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.7 148.57 38.06 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.82 128.0 73.09 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.08 -17.64 40.55 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 122.553 2.169 . . . . 0.0 114.828 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.85 -43.28 5.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.209 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 p -91.25 -18.86 23.7 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.62 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 mt 69.45 17.62 8.02 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.382 1.073 . . . . 0.0 111.671 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.96 140.82 30.79 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.55 150.83 19.85 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 120.959 0.409 . . . . 0.0 110.692 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.7 t -87.9 106.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.08 16.69 23.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.403 1.097 . . . . 0.0 109.836 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.49 158.26 32.84 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.75 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.65 -38.13 20.2 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.29 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -131.58 144.82 51.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.272 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.8 mt -78.96 152.74 30.87 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.777 0.798 . . . . 0.0 110.632 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.9 p -106.32 152.21 40.47 Favored Pre-proline 0 N--CA 1.398 -3.051 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.44 -31.69 92.01 Favored 'Trans proline' 0 C--O 1.208 -0.977 0 C-N-CA 122.287 1.992 . . . . 0.0 109.865 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.24 -47.81 82.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.458 0.703 . . . . 0.0 110.644 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 3.7 mmp_? -62.54 -37.27 85.46 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.893 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 83' ' ' THR . 57.7 mt -66.92 -47.29 72.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.385 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.97 -46.06 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.126 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -64.27 -30.98 72.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.659 0.742 . . . . 0.0 111.209 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.09 -34.09 59.52 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.623 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.43 -24.39 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -53.67 -40.22 65.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.102 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m -143.05 -80.69 0.2 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.64 -179.29 6.77 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.788 1.235 . . . . 0.0 108.947 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -119.1 155.52 31.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 12.4 mt -115.83 134.59 58.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.452 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -107.78 99.8 9.23 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -176.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -121.5 162.3 20.77 Favored 'General case' 0 CA--C 1.46 -2.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.018 -172.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 65' ' ' SER . 54.4 mtp -82.92 137.82 34.08 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 169.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 67' ' ' ALA . 87.8 mttt -74.27 164.48 60.98 Favored Pre-proline 0 C--N 1.271 -2.812 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.24 83.17 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.036 1.824 . . . . 0.0 111.521 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 59.76 120.46 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 127.674 2.39 . . . . 0.0 112.99 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.26 170.64 11.29 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.604 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.07 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-O 122.115 0.959 . . . . 0.0 109.573 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.38 103.36 1.78 Allowed 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.1 t70 64.49 26.42 13.4 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.171 1.462 . . . . 0.0 110.122 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 . . . . . 0 N--CA 1.404 -2.731 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.617 -179.18 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.86 73.89 0.35 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.206 1.003 . . . . 0.0 112.088 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -170.1 137.47 1.56 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.407 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.2 mtt -128.56 172.16 11.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.46 1.21 Allowed Glycine 0 C--O 1.243 0.684 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.84 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.86 68.41 1.48 Allowed Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.475 -0.393 . . . . 0.0 112.68 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 m -82.57 142.21 31.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.708 0.29 . . . . 0.0 110.889 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mmt -118.26 139.72 50.89 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.569 ' HD3' ' CD1' ' A' ' 38' ' ' ILE . 36.5 tptt -100.55 100.19 10.89 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.32 136.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.287 -170.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 62.6 mtm180 -69.26 135.94 51.22 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-O 121.567 0.699 . . . . 0.0 110.754 171.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' SER . 62.3 t -121.11 124.54 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.571 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.272 29.8 mt-10 -85.9 138.82 31.75 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.907 -1.917 . . . . 0.0 108.228 168.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -115.99 129.61 56.45 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 178.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 15' ' ' ILE . 1.6 mp -108.43 113.33 43.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.718 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.41 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 28.3 p-10 -112.31 17.89 19.03 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.528 1.156 . . . . 0.0 110.491 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.5 150.2 5.32 Favored Glycine 0 N--CA 1.407 -3.268 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.055 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -105.94 14.03 28.53 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.93 90.89 5.36 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -77.22 98.3 5.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.857 0.837 . . . . 0.0 112.552 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -94.34 90.23 6.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.181 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 p -77.13 111.96 13.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.5 p -173.25 176.63 2.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.7 m -89.71 75.59 7.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.878 1.323 . . . . 0.0 110.471 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.475 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 12.8 p -122.03 -175.7 0.38 Allowed Pre-proline 0 C--N 1.257 -3.414 0 CA-C-N 112.773 -2.012 . . . . 0.0 107.689 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' CD ' ' HB ' ' A' ' 25' ' ' THR . 5.0 Cg_exo -77.27 25.65 0.47 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.143 1.895 . . . . 0.0 112.043 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 25' ' ' THR . 45.8 mt-30 -121.47 35.39 4.9 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.669 1.588 . . . . 0.0 108.757 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -49.18 117.51 6.71 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.575 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.25 40.23 0.81 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 123.391 2.727 . . . . 0.0 113.811 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -93.8 -67.54 0.85 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -125.64 -170.07 2.11 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 35.5 m-80 -90.41 146.71 35.06 Favored Pre-proline 0 N--CA 1.402 -2.83 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -37.27 132.8 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 124.683 3.589 . . . . 0.0 111.662 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 30.6 m -138.91 159.54 41.9 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.729 -0.607 . . . . 0.0 112.128 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 10.0 p -151.93 150.92 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -95.92 115.82 28.0 Favored 'General case' 1 N--CA 1.378 -4.055 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 171.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -115.23 142.57 46.49 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.399 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.569 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 31.1 mm -79.39 110.82 15.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.01 141.38 42.9 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' OD1' ' HE1' ' A' ' 48' ' ' HIS . 7.9 p-10 -145.99 160.34 42.0 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.274 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.4 20.34 51.1 Favored Glycine 0 C--N 1.281 -2.496 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.812 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -110.19 -24.97 10.41 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 121.701 0.763 . . . . 0.0 109.815 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 91.4 m -103.23 137.19 41.71 Favored 'General case' 0 N--CA 1.401 -2.875 0 C-N-CA 124.274 1.03 . . . . 0.0 109.436 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.18 152.6 13.36 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.692 0.758 . . . . 0.0 111.69 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.409 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.4 t -56.26 -54.83 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.129 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -57.07 -30.39 64.26 Favored 'General case' 0 C--O 1.207 -1.183 0 O-C-N 124.31 1.006 . . . . 0.0 111.387 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 51' ' ' VAL . 3.1 m-20 -75.48 -37.4 60.26 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.519 ' HE1' ' OD1' ' A' ' 40' ' ' ASP . 88.9 m-70 -61.36 -39.28 90.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.2 mt -67.38 -43.35 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.072 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -57.28 -35.22 69.51 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.036 0.835 . . . . 0.0 110.936 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 47' ' ' ASP . 97.1 t -69.0 -53.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.322 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -53.14 -48.86 67.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 123.357 0.411 . . . . 0.0 110.982 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.7 mt -57.65 -47.75 81.39 Favored 'General case' 0 C--O 1.202 -1.428 0 O-C-N 123.408 0.443 . . . . 0.0 110.048 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 m -58.92 -40.97 86.18 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -71.21 -35.02 71.37 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.187 0.517 . . . . 0.0 112.19 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 46.1 m-85 -79.46 -2.17 40.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.241 0.543 . . . . 0.0 111.332 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 70.54 36.43 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.205 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -107.31 138.39 19.89 Favored Pre-proline 0 N--CA 1.415 -2.201 0 C-N-CA 125.277 1.431 . . . . 0.0 107.81 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.93 133.14 56.06 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 121.805 1.67 . . . . 0.0 110.638 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.554 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.8 m -62.77 -10.04 4.99 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.512 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.09 -19.6 65.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.0 110.125 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.4 mptp? -80.61 -8.06 59.48 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.765 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.2 p -47.97 -33.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 C-N-CA 125.548 1.539 . . . . 0.0 110.052 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.256 14.4 m -54.42 -48.17 71.95 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 126.184 1.794 . . . . 0.0 109.907 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 99' ' ' MET . 25.4 m -100.49 14.47 31.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.09 -1.413 . . . . 0.0 112.179 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.0 m-85 -112.26 139.06 48.11 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.376 0.608 . . . . 0.0 112.05 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.91 141.99 24.9 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.779 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 90.0 mt -76.06 159.13 31.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.38 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -143.25 150.5 39.37 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.16 128.96 71.6 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.18 -15.72 43.21 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.763 2.309 . . . . 0.0 115.226 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -109.37 -45.52 3.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.756 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -88.97 -17.62 29.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.465 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt 70.91 15.02 6.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.494 1.117 . . . . 0.0 112.683 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.96 137.46 38.33 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.048 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -85.1 174.21 9.87 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.045 0.45 . . . . 0.0 111.61 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.423 HG23 ' NH1' ' A' ' 86' ' ' ARG . 88.4 t -117.35 107.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.51 12.34 26.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.004 0.907 . . . . 0.0 110.293 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.38 157.58 33.99 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.73 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -84.33 -40.81 17.47 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.042 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.92 152.35 49.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 123.774 0.829 . . . . 0.0 109.409 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' HG ' HG22 ' A' ' 45' ' ' VAL . 18.0 mt -88.34 148.59 24.2 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.517 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.1 p -99.49 152.9 37.96 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.35 -35.66 92.11 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.704 2.269 . . . . 0.0 110.125 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.39 -48.96 77.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.482 0.713 . . . . 0.0 110.511 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' NH1' HG23 ' A' ' 77' ' ' VAL . 7.2 mmm-85 -61.48 -37.27 83.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 123.304 0.377 . . . . 0.0 111.626 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.44 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 63.6 mt -64.85 -47.98 75.96 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.694 0.621 . . . . 0.0 110.578 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -63.99 -44.83 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -61.68 -27.68 68.86 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.798 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.43 -36.33 24.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -53.93 -24.56 16.73 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -50.29 -39.81 46.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.724 0.81 . . . . 0.0 111.021 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.6 m -147.74 -92.35 0.08 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.46 178.46 8.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.512 0.725 . . . . 0.0 109.424 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.65 154.41 30.59 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 14.3 mt -116.33 139.78 41.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 170.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.22 109.12 17.0 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -127.95 160.88 30.5 Favored 'General case' 0 CA--C 1.467 -2.248 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 54.8 mtp -80.44 136.36 36.32 Favored 'General case' 0 N--CA 1.397 -3.08 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -60.96 116.5 19.03 Favored Pre-proline 0 C--N 1.286 -2.183 0 O-C-N 124.358 1.036 . . . . 0.0 109.63 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.17 102.48 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.755 2.303 . . . . 0.0 111.774 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -89.01 99.95 12.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.441 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.51 -176.93 6.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.817 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.2 mt -95.93 133.19 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.68 82.81 0.87 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 122.093 0.949 . . . . 0.0 109.948 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -138.95 89.87 2.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.352 -178.505 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.98 -176.83 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 110.868 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -93.12 107.77 19.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.001 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.64 126.64 34.08 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.506 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.88 56.68 0.08 OUTLIER Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.05 57.31 0.67 Allowed Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 p -84.76 142.6 29.7 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.472 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.8 mmt -118.31 138.47 52.37 Favored 'General case' 0 CA--C 1.47 -2.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.909 -172.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 76.4 tttt -97.18 93.07 6.34 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.86 140.08 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.211 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 86.2 mtt180 -70.13 129.62 39.91 Favored 'General case' 0 CA--C 1.475 -1.932 0 O-C-N 123.516 0.51 . . . . 0.0 110.113 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.49 124.74 72.3 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.546 0 CA-C-O 117.675 -1.155 . . . . 0.0 108.092 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.268 47.0 mt-10 -85.54 145.39 27.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 116.829 -1.948 . . . . 0.0 107.764 168.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -116.14 131.66 56.88 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.078 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' N ' HD23 ' A' ' 14' ' ' LEU . 1.5 mp -108.36 119.61 58.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -129.18 19.74 5.87 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.52 174.87 50.17 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 112.613 -2.085 . . . . 0.0 111.095 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -96.32 4.0 52.58 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.943 0.878 . . . . 0.0 109.914 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 42.3 mt-10 -96.42 -179.53 4.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.276 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 45.2 m80 74.13 83.26 0.11 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.329 1.051 . . . . 0.0 108.432 -172.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.42 144.2 46.43 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.837 -174.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p 55.61 31.91 18.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.256 1.022 . . . . 0.0 111.036 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.6 m -150.83 -40.95 0.12 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.354 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -146.49 100.22 3.32 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 122.06 0.933 . . . . 0.0 111.966 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 p -143.25 166.1 22.02 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.38 88.17 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.807 1.672 . . . . 0.0 109.739 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -90.31 21.08 4.01 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -138.78 117.6 9.3 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.912 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.74 46.34 1.66 Allowed 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 123.091 2.527 . . . . 0.0 110.627 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -141.78 -56.31 0.47 Allowed 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 124.592 1.157 . . . . 0.0 108.791 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -140.8 -158.82 0.89 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 4.4 m-20 -72.38 -179.02 0.72 Allowed Pre-proline 0 C--O 1.257 1.458 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 32' ' ' ASN . 5.2 Cg_endo -52.38 129.44 31.67 Favored 'Trans proline' 0 C--N 1.384 2.436 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 169.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 p -140.56 162.16 36.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.263 -171.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -151.37 149.45 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 m -98.23 107.36 19.82 Favored 'General case' 0 N--CA 1.386 -3.645 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 39.8 t60 -113.93 146.59 39.87 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.469 -170.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.73 112.02 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.96 146.04 39.73 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.3 173.95 14.93 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 123.535 0.734 . . . . 0.0 109.159 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.54 14.98 56.36 Favored Glycine 0 C--N 1.304 -1.228 0 O-C-N 124.413 1.071 . . . . 0.0 112.825 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -108.97 -32.11 7.38 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 121.209 0.528 . . . . 0.0 112.063 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.8 m -93.72 134.2 36.29 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.59 0.756 . . . . 0.0 109.317 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.77 149.1 6.53 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.041 0.936 . . . . 0.0 110.942 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.7 t -55.29 -53.14 38.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.523 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -59.36 -28.36 66.78 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.434 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.521 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 m-20 -73.35 -39.1 65.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -61.89 -38.48 88.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.3 mt -69.22 -43.99 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.13 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -56.91 -34.18 67.67 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 118.985 0.811 . . . . 0.0 110.603 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 47' ' ' ASP . 96.2 t -69.17 -55.51 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.445 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.1 -49.19 66.99 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 123.301 0.375 . . . . 0.0 111.55 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.46 -48.55 76.84 Favored 'General case' 0 C--O 1.201 -1.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.138 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.7 m -59.81 -36.79 77.49 Favored 'General case' 0 N--CA 1.397 -3.109 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -73.43 -32.13 64.22 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 43.9 m-85 -84.64 -3.95 58.76 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 122.883 0.473 . . . . 0.0 111.688 174.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 70.49 35.76 1.87 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.219 1.408 . . . . 0.0 112.718 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.3 mt -105.23 132.1 21.17 Favored Pre-proline 0 N--CA 1.409 -2.511 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.82 135.36 62.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.07 1.847 . . . . 0.0 111.267 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -62.32 -9.52 3.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.904 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -68.01 -16.39 64.02 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 120.874 0.368 . . . . 0.0 110.11 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.58 -5.11 58.39 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.619 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.3 p -47.6 -33.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 C-N-CA 125.933 1.693 . . . . 0.0 110.995 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.276 15.3 m -54.8 -48.56 72.58 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 126.061 1.745 . . . . 0.0 110.444 174.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.7 m -102.11 17.73 22.56 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.821 -172.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.424 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.4 m-85 -116.76 142.65 46.64 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.73 146.44 25.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.222 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 85.9 mt -79.61 126.39 30.83 Favored 'General case' 0 N--CA 1.418 -2.057 0 O-C-N 124.71 1.256 . . . . 0.0 107.846 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' OE1' ' HD2' ' A' ' 98' ' ' ARG . 38.8 tt0 -114.21 147.8 38.37 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.05 125.7 84.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -8.34 22.61 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 122.655 2.237 . . . . 0.0 115.169 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.47 -40.75 3.56 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.298 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.2 p -90.44 -20.79 22.35 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.069 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt 70.59 18.91 6.33 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.797 1.239 . . . . 0.0 111.977 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.28 140.86 30.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.634 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.407 ' OH ' ' HD3' ' A' ' 98' ' ' ARG . 80.9 m-85 -98.14 144.53 27.51 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.822 0.344 . . . . 0.0 110.23 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.15 106.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.444 ' CD ' ' HZ1' ' A' ' 100' ' ' LYS . 78.7 mm-40 -100.26 12.14 37.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.062 0.934 . . . . 0.0 110.362 -178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.15 152.21 34.98 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.371 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.9 m -79.12 -36.98 39.73 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.152 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.34 143.83 50.8 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.115 0.966 . . . . 0.0 108.806 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.9 mt -77.49 157.54 30.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.39 0.614 . . . . 0.0 111.257 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.0 p -111.71 153.64 44.27 Favored Pre-proline 0 N--CA 1.409 -2.477 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.28 -34.93 72.29 Favored 'Trans proline' 0 C--O 1.21 -0.91 0 C-N-CA 122.35 2.034 . . . . 0.0 110.349 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.86 -48.49 77.98 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 4.1 mmp_? -61.11 -38.85 87.8 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.369 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 83' ' ' THR . 52.4 mt -67.69 -48.09 67.55 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.727 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.22 -47.56 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.26 -29.66 70.46 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.253 0.549 . . . . 0.0 111.784 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.45 -37.03 60.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.78 -24.23 48.89 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -53.0 -43.79 66.74 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -137.63 -82.46 0.34 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.22 178.55 6.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.16 1.384 . . . . 0.0 108.489 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 155.07 30.4 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 11.7 mt -115.39 138.51 45.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 99.26 7.06 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.492 ' HD2' ' OE1' ' A' ' 69' ' ' GLN . 44.0 mtp180 -119.67 162.63 18.69 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 65' ' ' SER . 41.2 mtp -78.6 125.92 30.02 Favored 'General case' 0 N--CA 1.393 -3.288 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HZ1' ' CD ' ' A' ' 78' ' ' GLU . 47.0 mtpt -59.01 150.8 59.46 Favored Pre-proline 0 C--N 1.288 -2.103 0 O-C-N 124.454 1.096 . . . . 0.0 109.867 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -51.25 99.29 0.04 OUTLIER 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.609 2.873 . . . . 0.0 114.903 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -135.1 115.81 13.85 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 113.09 -1.868 . . . . 0.0 106.547 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.84 -165.13 0.78 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.89 113.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.17 98.68 9.06 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.44 77.65 1.53 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 172.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.236 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.577 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.178 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.16 -172.48 0.17 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.331 1.053 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -91.79 110.93 22.28 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.645 0.259 . . . . 0.0 111.191 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.45 105.49 17.64 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.21 -40.05 5.56 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.27 -44.62 1.2 Allowed Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m -82.79 133.67 35.14 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.683 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 44.6 mtt -114.13 139.41 49.35 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.566 -170.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -100.36 96.87 7.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.43 138.58 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.851 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 17.3 mtp180 -68.21 131.13 44.83 Favored 'General case' 0 CA--C 1.46 -2.503 0 CA-C-O 122.146 0.974 . . . . 0.0 111.947 170.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.15 123.51 71.73 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.361 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.155 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 11' ' ' ARG 0.272 0.5 OUTLIER -83.98 149.42 26.31 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.213 166.451 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -123.34 130.66 53.03 Favored 'General case' 0 C--N 1.265 -3.08 0 O-C-N 123.469 0.481 . . . . 0.0 111.084 176.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.82 119.4 58.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.29 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -129.36 45.08 2.86 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 31.97 0.83 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 115.729 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -87.85 -14.25 39.96 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.5 6.71 16.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.422 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -137.47 92.17 2.67 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.85 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -128.55 -170.1 2.19 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p 55.08 -153.06 0.33 Allowed 'General case' 0 C--O 1.249 1.059 0 C-N-CA 122.869 0.468 . . . . 0.0 110.107 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -56.44 -32.93 65.37 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.711 0.404 . . . . 0.0 111.302 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 80.62 126.09 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.586 ' HB ' ' NE2' ' A' ' 27' ' ' GLN . 10.4 p -64.05 160.62 46.32 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.238 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.86 32.1 0.51 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.223 2.616 . . . . 0.0 114.082 -176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.586 ' NE2' ' HB ' ' A' ' 25' ' ' THR . 2.4 mp0 -94.23 42.25 1.09 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.395 1.078 . . . . 0.0 109.995 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -39.69 113.66 0.89 Allowed Pre-proline 0 C--O 1.249 1.03 0 O-C-N 125.543 1.777 . . . . 0.0 112.073 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.47 89.53 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.489 2.126 . . . . 0.0 110.799 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -71.57 -42.39 67.88 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -121.85 158.67 28.41 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -105.12 152.57 39.74 Favored Pre-proline 0 C--N 1.27 -2.867 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.74 130.4 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.378 2.719 . . . . 0.0 110.533 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -138.6 155.79 48.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 10.1 p -147.98 150.2 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.4 m -98.11 105.36 17.5 Favored 'General case' 0 N--CA 1.387 -3.616 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -109.59 147.79 32.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.402 -170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.9 113.84 23.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.31 146.0 40.13 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.36 -171.89 3.68 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.58 -11.44 11.6 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.559 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -83.07 -26.11 31.41 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 124.197 0.999 . . . . 0.0 111.996 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.536 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 36.7 m -96.2 131.7 42.4 Favored 'General case' 0 N--CA 1.388 -3.561 0 C-N-CA 123.793 0.837 . . . . 0.0 109.631 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 149.57 9.0 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.867 0.73 . . . . 0.0 110.844 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.6 t -55.66 -51.78 54.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.87 -31.0 64.37 Favored 'General case' 0 C--O 1.202 -1.427 0 O-C-N 124.381 1.05 . . . . 0.0 111.387 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.0 m-20 -75.42 -38.9 59.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.536 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -61.71 -40.23 94.29 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.514 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.8 mt -68.34 -42.46 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.13 -34.36 70.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.89 0.768 . . . . 0.0 110.977 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.0 t -68.97 -53.38 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.4 -48.28 68.8 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.22 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.8 mt -57.84 -48.39 79.9 Favored 'General case' 0 C--O 1.193 -1.91 0 O-C-N 123.538 0.523 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -60.14 -38.91 84.54 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -72.11 -30.4 65.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.1 -0.375 . . . . 0.0 111.52 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.467 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 41.2 m-85 -88.56 -0.24 57.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.377 0.608 . . . . 0.0 112.201 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 69.0 32.46 3.77 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.661 1.584 . . . . 0.0 112.28 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -103.16 135.6 19.37 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.86 133.02 53.32 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.96 1.773 . . . . 0.0 111.918 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.0 m -62.59 -9.27 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.795 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.98 -18.38 62.62 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.634 0.731 . . . . 0.0 109.585 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -82.4 -9.99 59.23 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.903 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.7 p -46.04 -31.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 126.902 2.081 . . . . 0.0 110.741 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 m -54.67 -45.97 73.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.903 1.681 . . . . 0.0 111.067 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.4 t -97.96 0.33 46.22 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.618 -173.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -103.59 137.23 41.94 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.405 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.25 145.45 31.28 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.567 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.54 123.93 29.65 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -111.07 148.48 32.54 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -82.37 126.71 73.38 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 18.6 Cg_endo -60.63 -23.62 76.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.419 2.746 . . . . 0.0 114.82 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -103.84 -46.17 4.57 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.47 -1.292 . . . . 0.0 112.855 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -88.01 -17.1 31.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.557 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt 66.42 18.21 10.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 111.285 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.95 138.24 35.0 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.145 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -96.16 143.99 26.79 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.3 102.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.1 13.98 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 123.037 1.398 . . . . 0.0 108.537 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.55 158.56 31.08 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.999 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.5 m -84.88 -37.82 20.17 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.824 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -129.58 155.4 45.87 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.965 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.76 147.15 23.42 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.174 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.0 p -98.99 151.06 37.23 Favored Pre-proline 0 N--CA 1.401 -2.913 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.51 -33.85 93.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.245 1.963 . . . . 0.0 109.975 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.56 -47.41 85.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -61.3 -36.01 78.9 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.683 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 68.2 mt -64.09 -50.15 69.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.697 0.623 . . . . 0.0 110.485 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.489 ' CG2' ' HE3' ' A' ' 8' ' ' MET . 40.5 t -62.24 -43.36 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.77 -32.99 69.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.76 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.11 -42.43 23.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 11.7 mt-10 -52.2 -25.28 8.76 Favored 'General case' 0 C--N 1.369 1.441 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.52 -36.81 62.18 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 124.367 1.067 . . . . 0.0 112.258 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -143.99 -83.14 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -165.92 -178.75 4.88 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.668 0.787 . . . . 0.0 109.263 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.12 148.29 43.22 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -114.95 100.69 11.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.621 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.79 103.24 8.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -126.34 162.48 25.41 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.685 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.433 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 45.5 mtp -78.33 133.28 37.63 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 167.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.9 153.36 88.64 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -54.25 111.68 0.78 Allowed 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.298 2.665 . . . . 0.0 112.822 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -135.05 148.63 49.94 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.249 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.86 -176.04 2.24 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.24 141.56 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 69.31 70.12 0.26 Allowed 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.196 1.398 . . . . 0.0 109.075 -171.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -101.61 80.28 2.03 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.11 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.415 ' HD3' ' H ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.285 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.696 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.55 -164.84 1.23 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.263 34.6 p-80 52.95 66.38 1.25 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.387 1.075 . . . . 0.0 112.499 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.469 ' N ' ' HE1' ' A' ' 4' ' ' MET . 0.0 OUTLIER 71.75 76.38 0.17 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.594 -176.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.36 79.81 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.187 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.41 72.76 1.18 Allowed Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m -73.58 131.96 42.28 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.484 0.659 . . . . 0.0 110.968 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 42.3 mtt -115.57 141.09 48.53 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.494 -172.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.2 tttm -99.63 95.07 6.72 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.86 138.69 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.849 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 54.9 mtm-85 -69.39 131.53 44.93 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-O 121.623 0.725 . . . . 0.0 110.841 172.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 34' ' ' SER . 46.7 t -119.19 124.07 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.578 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.216 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 12' ' ' VAL . 31.4 mm-40 -81.18 158.88 24.77 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -130.81 133.17 45.73 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 122.074 -0.391 . . . . 0.0 111.091 175.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.457 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -110.15 113.4 44.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -111.31 12.07 21.65 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 122.529 1.157 . . . . 0.0 109.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 146.43 -171.81 27.17 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -125.36 -2.22 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 118.594 1.197 . . . . 0.0 109.989 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -87.69 147.92 25.01 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.424 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.2 m80 71.5 19.55 5.12 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtm-85 -127.69 66.46 1.33 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -94.98 88.37 5.24 Favored 'General case' 0 N--CA 1.409 -2.475 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.753 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.4 m -75.37 94.67 3.1 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -93.02 -2.95 55.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.044 0.926 . . . . 0.0 109.525 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.93 172.68 9.19 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.513 178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.69 51.34 1.17 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.041 2.494 . . . . 0.0 111.378 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.16 84.05 1.64 Allowed 'General case' 0 N--CA 1.383 -3.799 0 C-N-CA 128.042 2.537 . . . . 0.0 105.073 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' C ' ' H ' ' A' ' 30' ' ' GLN . 13.3 mm100 -42.08 134.2 2.44 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.539 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.26 25.18 0.31 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 123.944 3.096 . . . . 0.0 113.879 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 28' ' ' GLN . 92.8 mt-30 -89.81 -13.53 36.4 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.937 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.34 140.1 29.94 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -127.58 178.29 1.67 Allowed Pre-proline 0 C--N 1.253 -3.599 0 C-N-CA 124.969 1.307 . . . . 0.0 108.693 -170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -55.04 132.08 50.2 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.623 1.549 . . . . 0.0 108.139 166.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 5.5 p -140.52 161.04 38.68 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.46 149.07 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -97.69 105.28 17.4 Favored 'General case' 0 N--CA 1.389 -3.513 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.1 t60 -109.11 147.28 32.69 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.103 -170.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -83.26 110.67 18.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.06 149.02 34.01 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -149.48 -169.72 3.45 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.35 15.1 8.73 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -106.59 -34.19 7.43 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.677 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -93.97 134.35 36.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 C-N-CA 124.152 0.981 . . . . 0.0 108.376 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.56 151.72 7.63 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.563 0.697 . . . . 0.0 111.589 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.5 t -55.27 -54.58 23.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.734 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.89 -30.43 63.88 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.628 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 51' ' ' VAL . 8.7 m-20 -73.79 -37.44 64.95 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.962 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -62.43 -38.67 90.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.4 mt -67.81 -44.22 85.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.47 -34.16 68.73 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.843 0.747 . . . . 0.0 111.129 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 47' ' ' ASP . 85.7 t -69.05 -54.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.66 -49.19 68.48 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.657 0.383 . . . . 0.0 111.471 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.1 mt -57.25 -47.41 81.46 Favored 'General case' 0 C--O 1.195 -1.806 0 O-C-N 123.38 0.425 . . . . 0.0 110.05 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.68 -38.37 84.73 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -70.61 -37.83 73.9 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.975 0.417 . . . . 0.0 111.514 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 57.0 m-85 -78.81 -9.52 59.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.389 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm 74.42 39.74 0.45 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.87 1.268 . . . . 0.0 112.584 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.73 140.92 22.3 Favored Pre-proline 0 N--CA 1.411 -2.382 0 C-N-CA 125.74 1.616 . . . . 0.0 107.622 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.97 134.47 53.36 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 122.222 1.948 . . . . 0.0 111.087 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.524 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.4 m -63.28 -9.63 5.13 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.89 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.801 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.48 -14.83 62.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.0 110.221 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 65.1 mttm -88.98 -6.46 57.22 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.844 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.1 p -49.62 -29.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 126.287 1.835 . . . . 0.0 109.773 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 p -54.08 -51.14 65.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.237 1.815 . . . . 0.0 110.977 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' MET . 5.8 m -98.03 6.91 47.1 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.881 -171.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.458 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 16.8 m-85 -107.79 143.55 36.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.342 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.31 145.04 25.92 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.29 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 83.9 mt -80.97 128.13 33.34 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -118.09 149.8 40.41 Favored 'General case' 0 C--N 1.28 -2.452 0 O-C-N 122.161 -0.337 . . . . 0.0 110.101 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -81.77 132.72 53.74 Favored Pre-proline 0 C--N 1.313 -0.982 0 O-C-N 124.385 1.053 . . . . 0.0 108.276 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.48 -19.38 48.98 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.14 2.56 . . . . 0.0 115.105 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -105.01 -40.26 5.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.735 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -95.98 -19.51 19.44 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.328 0.585 . . . . 0.0 111.239 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.89 22.62 12.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.394 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.35 140.96 33.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.716 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.76 144.52 26.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.593 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.13 102.69 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.55 13.57 31.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.824 1.297 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.75 157.04 34.02 Favored 'General case' 0 N--CA 1.405 -2.696 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.647 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.0 m -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.875 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.33 147.91 52.09 Favored 'General case' 0 N--CA 1.418 -2.069 0 C-N-CA 124.041 0.936 . . . . 0.0 108.562 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -79.16 154.8 29.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.11 0.481 . . . . 0.0 110.208 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 p -104.71 151.59 39.33 Favored Pre-proline 0 N--CA 1.399 -2.983 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.94 -31.59 93.1 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.173 1.915 . . . . 0.0 109.727 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.66 -48.66 78.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.494 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.84 -36.39 83.06 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.482 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.4 mt -64.3 -48.79 74.29 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.496 0.498 . . . . 0.0 110.18 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.476 ' CG2' ' HE3' ' A' ' 8' ' ' MET . 50.1 t -61.62 -46.46 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -60.85 -32.87 72.26 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 112.209 171.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.82 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.48 -27.05 35.0 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 95.7 mttt -54.96 -31.38 60.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.284 1.034 . . . . 0.0 112.083 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.8 m -143.81 -86.76 0.13 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.457 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -167.38 178.79 5.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.003 1.321 . . . . 0.0 108.527 -176.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -114.89 159.71 20.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 HD11 ' CE2' ' A' ' 94' ' ' TYR . 2.9 mp -120.22 141.61 39.71 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.781 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 167.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 98.38 6.73 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 40.0 mtp180 -115.69 161.21 19.03 Favored 'General case' 0 CA--C 1.464 -2.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.071 -173.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 65' ' ' SER . 51.3 mtp -78.01 134.25 37.83 Favored 'General case' 0 N--CA 1.391 -3.403 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 165.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HZ2' ' HB3' ' A' ' 100' ' ' LYS . 8.3 mtpm? -69.23 134.06 89.37 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -53.92 118.2 4.71 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.52 2.813 . . . . 0.0 113.516 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -134.96 165.36 25.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.228 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 64.14 167.3 0.16 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 113.183 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.6 mt -83.62 115.0 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.04 156.22 25.97 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -80.66 66.24 6.1 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.514 1.149 . . . . 0.0 111.282 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.133 177.381 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.416 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.87 81.83 0.2 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.472 1.509 . . . . 0.0 113.933 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.74 166.24 25.28 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.4 mmm 60.83 29.68 19.17 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.383 1.087 . . . . 0.0 109.893 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.21 83.02 0.65 Allowed Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.58 -33.47 42.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m -86.1 134.3 33.83 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.462 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.6 mmt -110.08 141.43 42.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.394 -170.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 64.7 tttt -101.62 95.75 6.65 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.2 mt -105.51 140.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.334 -172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -70.9 134.18 47.05 Favored 'General case' 0 CA--C 1.466 -2.283 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.867 173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.85 123.36 71.58 Favored 'Isoleucine or valine' 2 N--CA 1.37 -4.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.6 OUTLIER -84.49 148.49 26.51 Favored 'General case' 0 N--CA 1.407 -2.581 0 C-N-CA 116.25 -2.18 . . . . 0.0 107.843 167.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.509 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.5 tm? -115.0 134.38 55.24 Favored 'General case' 0 C--N 1.278 -2.517 0 O-C-N 123.28 0.362 . . . . 0.0 110.6 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.13 118.11 54.26 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -169.25 85.96 0.15 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.45 61.32 0.13 Allowed Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.684 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -79.69 -34.17 40.46 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -75.01 81.48 2.21 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 113.522 -1.672 . . . . 0.0 107.785 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.8 m80 65.57 107.75 0.04 OUTLIER 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.415 1.086 . . . . 0.0 113.394 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -75.96 136.6 40.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p 62.46 -163.12 0.27 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 124.991 1.316 . . . . 0.0 110.507 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.8 t -113.26 19.31 17.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.4 m 66.43 80.12 0.23 Allowed 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.272 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 27' ' ' GLN . 12.5 p -116.87 167.34 10.86 Favored Pre-proline 0 C--N 1.271 -2.826 0 CA-C-N 112.975 -1.921 . . . . 0.0 108.393 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.35 33.26 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.563 2.175 . . . . 0.0 112.378 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 25' ' ' THR . 15.3 mm100 -99.82 -0.81 39.02 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.105 0.955 . . . . 0.0 110.162 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.417 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER 45.65 99.93 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 112.204 -2.271 . . . . 0.0 114.391 -176.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.37 42.79 1.39 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 123.28 2.653 . . . . 0.0 112.801 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.417 ' HG2' ' HB3' ' A' ' 28' ' ' GLN . 10.2 mm100 -68.29 -35.76 78.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.751 -177.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -108.81 -173.01 2.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.041 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.12 158.3 33.53 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 170.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.37 131.06 40.65 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.989 1.793 . . . . 0.0 109.614 171.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -139.12 159.8 41.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 p -150.37 151.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 m -99.44 107.25 19.42 Favored 'General case' 0 N--CA 1.39 -3.445 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.0 t60 -112.56 146.57 38.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.916 -170.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.27 111.31 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -112.36 144.82 41.15 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.404 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 2.8 p30 -146.02 -168.52 3.01 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.13 -9.45 8.05 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.91 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' OE2' ' HB2' ' A' ' 40' ' ' ASP . 2.0 mp0 -82.46 -26.86 32.27 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.81 0.814 . . . . 0.0 110.683 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.555 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 26.5 m -95.98 129.53 43.22 Favored 'General case' 0 N--CA 1.383 -3.825 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.12 149.24 9.76 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.525 0.679 . . . . 0.0 110.99 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.442 HG22 ' HG ' ' A' ' 82' ' ' LEU . 99.0 t -53.05 -53.8 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.313 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -54.88 -32.16 60.55 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 124.612 1.195 . . . . 0.0 111.722 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' O ' HG21 ' A' ' 51' ' ' VAL . 22.8 m-20 -78.79 -34.32 45.59 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.906 -0.496 . . . . 0.0 111.635 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.555 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.7 m-70 -62.24 -39.36 92.59 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.576 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.1 mt -66.51 -42.91 90.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -56.02 -37.81 69.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.683 0.674 . . . . 0.0 110.672 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 47' ' ' ASP . 87.9 t -67.07 -53.22 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.093 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.31 -47.75 72.11 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 123.311 0.382 . . . . 0.0 110.902 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -56.92 -49.03 76.86 Favored 'General case' 0 C--O 1.194 -1.863 0 O-C-N 123.519 0.512 . . . . 0.0 109.816 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -60.28 -37.82 81.68 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -74.06 -29.3 61.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.172 0.51 . . . . 0.0 111.867 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.55 0.98 55.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.476 0.655 . . . . 0.0 111.947 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HZ3' ' HB3' ' A' ' 57' ' ' LYS . 9.5 mtpm? 67.18 40.8 2.73 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.48 1.512 . . . . 0.0 113.124 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.87 136.93 20.72 Favored Pre-proline 0 N--CA 1.404 -2.766 0 C-N-CA 124.679 1.192 . . . . 0.0 108.385 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.05 134.61 63.3 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.606 2.204 . . . . 0.0 110.828 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.54 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 34.3 m -63.33 -9.85 5.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.487 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.627 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.63 -14.33 62.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.649 0.737 . . . . 0.0 110.692 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -87.26 -5.87 58.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.029 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -48.87 -31.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 126.787 2.035 . . . . 0.0 110.756 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 m -55.86 -46.11 78.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.094 1.358 . . . . 0.0 110.59 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 99' ' ' MET . 22.2 m -101.71 14.83 30.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.876 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.451 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.4 m-85 -115.49 144.05 44.41 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 121.789 -0.569 . . . . 0.0 111.627 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.29 156.14 31.93 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.93 133.38 33.94 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.05 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.76 149.05 42.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -81.04 131.65 58.98 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 Cg_endo -66.35 -25.73 48.96 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.611 2.207 . . . . 0.0 114.893 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.22 -44.05 5.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.402 -0.919 . . . . 0.0 113.167 -174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.03 -20.09 24.82 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.728 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 69.45 16.48 8.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.256 1.022 . . . . 0.0 111.797 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.92 37.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -92.75 152.08 19.69 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.61 103.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.86 10.62 32.46 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.144 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -76.79 159.17 30.33 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -82.92 -38.94 22.14 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.116 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.04 156.03 44.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.442 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -93.03 143.98 25.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.076 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 77.5 p -93.44 153.72 41.37 Favored Pre-proline 0 N--CA 1.409 -2.485 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.09 -32.0 94.49 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.896 1.731 . . . . 0.0 109.138 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -46.14 90.92 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.053 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 7.1 mmm180 -58.86 -39.35 81.06 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.569 0.223 . . . . 0.0 111.349 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.462 ' HB3' ' CG ' ' A' ' 8' ' ' MET . 62.9 mt -64.39 -46.56 82.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 124.095 0.872 . . . . 0.0 110.359 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.2 -45.53 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.88 -37.14 30.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -54.33 -24.28 18.68 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -51.21 -43.98 61.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.14 0.576 . . . . 0.0 110.586 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 m -142.48 -86.75 0.15 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -157.3 -178.93 7.72 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.996 0.918 . . . . 0.0 109.427 -177.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.09 148.32 44.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -114.23 100.34 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.303 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.78 103.72 8.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -122.59 162.09 22.49 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.573 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.4 mtp -79.6 129.05 34.13 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -69.34 135.64 88.85 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.064 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.91 108.06 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.218 2.612 . . . . 0.0 110.456 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -115.78 131.42 56.94 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.689 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.07 158.77 27.77 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.595 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.3 mt -72.25 117.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.13 125.5 30.95 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.9 75.2 10.39 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.396 1.093 . . . . 0.0 110.345 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 . . . . . 0 C--N 1.29 -2.001 0 CA-C-N 111.924 -2.398 . . . . 0.0 110.143 178.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.874 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.55 64.24 1.82 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.087 0.955 . . . . 0.0 111.37 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -81.54 100.87 9.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.804 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.4 mmm -93.37 105.2 17.3 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.24 -110.79 0.81 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.44 85.86 1.3 Allowed Glycine 0 N--CA 1.408 -3.21 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.1 m -68.57 133.56 48.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.786 0.803 . . . . 0.0 110.26 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.472 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.2 mmt -115.55 140.43 49.17 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.143 -170.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -97.5 96.42 8.32 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.35 138.5 31.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.762 -172.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -69.74 133.69 47.77 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.293 0.568 . . . . 0.0 110.341 172.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -118.07 121.57 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.885 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.374 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 39.6 mt-10 -80.37 147.17 31.15 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.774 168.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -116.83 131.89 56.84 Favored 'General case' 0 C--N 1.272 -2.771 0 O-C-N 123.294 0.371 . . . . 0.0 110.612 175.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' N ' HD21 ' A' ' 14' ' ' LEU . 1.7 mp -110.96 122.77 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -133.28 66.95 1.54 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.546 1.165 . . . . 0.0 109.296 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.81 69.36 1.13 Allowed Glycine 0 C--N 1.292 -1.909 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.365 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.49 -14.93 39.05 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 121.696 0.76 . . . . 0.0 110.158 -176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.43 -15.19 60.92 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.399 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.421 ' C ' ' H ' ' A' ' 22' ' ' THR . 65.3 m170 -118.03 -19.0 9.29 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.631 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 76.14 -22.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.74 1.616 . . . . 0.0 112.433 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' H ' ' C ' ' A' ' 20' ' ' HIS . 40.9 p 55.52 69.91 0.69 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.135 1.374 . . . . 0.0 113.433 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 m 67.4 178.1 0.24 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.154 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -102.85 20.65 17.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.912 0.863 . . . . 0.0 109.148 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -63.68 149.34 92.8 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.027 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -75.67 93.41 1.0 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.275 1.983 . . . . 0.0 114.037 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.98 6.3 49.18 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.124 0.964 . . . . 0.0 110.178 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 67.85 99.04 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 C-N-CA 127.763 2.425 . . . . 0.0 112.791 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.86 87.74 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.743 2.296 . . . . 0.0 112.64 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -137.24 -58.76 0.7 Allowed 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -130.66 -165.22 1.52 Allowed 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -76.61 166.85 41.67 Favored Pre-proline 0 C--N 1.29 -1.993 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -47.03 133.32 18.26 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.213 1.942 . . . . 0.0 110.012 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.7 m -138.25 163.99 30.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.175 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.3 148.57 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 m -96.72 107.37 19.82 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -112.87 145.45 40.67 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.347 -170.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 38' ' ' ILE 0.26 49.8 mm -83.15 112.48 20.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -177.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -112.11 143.16 43.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -147.28 166.89 25.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 O-C-N 124.652 1.22 . . . . 0.0 108.693 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 18.03 56.74 Favored Glycine 0 C--N 1.279 -2.591 0 O-C-N 124.118 0.886 . . . . 0.0 112.012 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.31 -29.52 11.62 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-O 121.626 0.727 . . . . 0.0 111.278 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.482 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 83.6 m -99.67 137.74 37.73 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.897 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.38 18.97 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 123.527 0.517 . . . . 0.0 110.469 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.62 -54.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.01 -30.77 62.33 Favored 'General case' 0 C--O 1.203 -1.364 0 O-C-N 124.226 0.953 . . . . 0.0 111.501 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.97 -36.35 59.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.996 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.9 m-70 -63.1 -39.82 95.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.5 mt -66.33 -42.91 91.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.801 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.24 -34.72 68.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.619 0.645 . . . . 0.0 111.206 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.87 -54.73 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.51 -47.77 69.6 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.342 0.402 . . . . 0.0 111.024 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.3 mt -56.71 -48.04 78.61 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.548 0.53 . . . . 0.0 109.806 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.1 m -59.03 -39.68 82.73 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -71.52 -29.98 65.41 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.3 m-85 -89.54 3.29 52.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.311 0.577 . . . . 0.0 112.145 175.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.497 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 7.2 mmpt? 67.62 33.31 5.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.3 mt -105.28 138.29 19.5 Favored Pre-proline 0 N--CA 1.411 -2.399 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.09 136.23 63.83 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.223 1.948 . . . . 0.0 111.433 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.446 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -63.19 -9.41 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.018 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.31 -16.26 62.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.032 0.444 . . . . 0.0 110.481 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -88.5 -4.87 58.53 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -49.07 -29.21 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 127.116 2.166 . . . . 0.0 111.032 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -56.68 -47.62 79.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.533 1.533 . . . . 0.0 111.047 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.439 ' HB2' ' SD ' ' A' ' 99' ' ' MET . 7.3 m -98.07 1.21 47.43 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.227 -171.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.403 ' CE2' ' SD ' ' A' ' 99' ' ' MET . 17.5 m-85 -105.1 141.67 36.24 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.414 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.63 149.05 28.7 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.339 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.71 124.23 30.03 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' NE2' HD22 ' A' ' 74' ' ' LEU . 20.5 tt0 -111.61 147.98 34.31 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.47 134.35 66.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.0 Cg_endo -65.91 -18.72 58.01 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.877 2.385 . . . . 0.0 115.667 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 -42.79 3.89 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.0 p -90.72 -18.26 25.31 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.423 HD22 ' NE2' ' A' ' 69' ' ' GLN . 7.6 mt 62.62 22.23 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.645 1.178 . . . . 0.0 112.005 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.71 143.02 31.2 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' HH ' ' HD3' ' A' ' 101' ' ' PRO . 77.8 m-85 -98.01 147.19 24.76 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.203 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -83.56 105.95 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -107.33 12.07 28.48 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.957 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.57 161.7 29.05 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.286 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.4 m -85.37 -39.69 17.33 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.322 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.96 152.77 50.9 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.367 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -84.58 159.64 20.61 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.885 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.516 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 38.8 p -115.47 156.54 45.8 Favored Pre-proline 0 C--N 1.276 -2.624 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.49 -35.34 92.06 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.684 2.256 . . . . 0.0 109.709 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -57.03 -49.55 75.45 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.714 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.49 -38.37 87.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 83' ' ' THR . 63.8 mt -65.75 -46.17 79.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.036 0.835 . . . . 0.0 110.54 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.98 -45.4 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -32.55 73.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.341 0.591 . . . . 0.0 112.167 172.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.43 -34.32 58.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.433 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.86 -27.51 63.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -56.05 -34.89 66.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.881 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.5 m -145.08 -78.44 0.19 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -170.73 -177.55 2.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.369 1.467 . . . . 0.0 108.743 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.51 152.23 37.29 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 168.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.81 101.78 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.066 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.9 104.88 9.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -127.66 165.08 20.68 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.185 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.439 ' SD ' ' HB2' ' A' ' 65' ' ' SER . 9.1 mmm -80.88 133.01 35.5 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 167.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HZ2' ' HB3' ' A' ' 100' ' ' LYS . 8.0 mtpm? -63.31 119.44 52.98 Favored Pre-proline 0 C--N 1.267 -3.003 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.44 ' HD3' ' HH ' ' A' ' 76' ' ' TYR . 18.1 Cg_endo -51.67 123.27 11.9 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 124.559 3.506 . . . . 0.0 113.387 -170.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.3 6.6 p-80 40.96 74.92 0.09 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.298 1.439 . . . . 0.0 113.32 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.54 142.34 46.69 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.82 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.06 124.74 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.42 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.629 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -127.18 83.95 2.21 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.683 0.754 . . . . 0.0 112.203 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -114.48 -1.49 13.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.866 1.317 . . . . 0.0 108.651 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 . . . . . 0 C--N 1.267 -2.995 0 CA-C-N 112.631 -2.077 . . . . 0.0 107.82 -177.271 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.723 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.36 -21.65 33.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -139.3 99.33 3.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.9 mtm -90.36 107.3 19.06 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.35 -102.06 0.53 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 50.21 2.89 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.402 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m -74.63 134.4 42.05 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.707 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.4 mtt -113.11 137.18 51.83 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.991 -169.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 72.1 tttt -98.08 97.49 8.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.5 mt -109.54 138.64 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.975 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 42.5 mtm180 -69.83 129.96 40.98 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 121.213 0.53 . . . . 0.0 109.858 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.2 t -116.33 126.13 73.67 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.388 0 CA-C-O 117.806 -1.092 . . . . 0.0 108.309 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.264 50.8 mt-10 -86.85 146.98 26.0 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.225 -1.79 . . . . 0.0 107.843 167.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -121.86 126.57 49.02 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 175.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 15' ' ' ILE . 1.4 mp -102.68 107.28 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.831 171.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -152.94 77.21 1.15 Allowed 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 169.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.93 41.33 0.25 Allowed Glycine 0 C--N 1.276 -2.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.382 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.17 -26.73 20.0 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.43 120.54 7.85 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.25 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -80.54 81.68 6.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -70.67 144.87 50.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.724 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -86.48 75.91 9.68 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.16 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.5 t -101.19 -20.34 15.33 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.853 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 m 63.16 18.68 11.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.069 . . . . 0.0 111.433 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -148.02 155.91 43.83 Favored Pre-proline 0 N--CA 1.407 -2.621 0 C-N-CA 125.847 1.659 . . . . 0.0 107.816 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.32 48.46 1.81 Allowed 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 122.907 2.405 . . . . 0.0 111.518 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -90.37 24.43 2.58 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.091 0.948 . . . . 0.0 113.214 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -83.17 160.17 60.7 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.77 111.85 0.64 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.3 2.0 . . . . 0.0 111.834 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -67.02 -49.57 64.87 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -122.63 167.02 13.94 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -74.64 138.2 73.97 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.677 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -45.79 132.24 13.54 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 124.519 3.479 . . . . 0.0 110.431 174.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.4 p -134.02 156.85 47.46 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.253 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -152.72 149.91 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.407 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 15.4 m -97.9 107.23 19.67 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 52.4 t60 -110.38 145.23 37.9 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.344 -170.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.29 110.72 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.23 148.06 34.9 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.27 167.2 29.4 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 124.297 1.039 . . . . 0.0 108.351 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.43 19.71 51.53 Favored Glycine 0 C--N 1.29 -1.98 0 O-C-N 124.166 0.916 . . . . 0.0 112.64 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.64 -22.85 11.75 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.638 0.732 . . . . 0.0 110.626 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.4 m -105.9 139.9 39.74 Favored 'General case' 0 N--CA 1.403 -2.814 0 C-N-CA 124.59 1.156 . . . . 0.0 109.791 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 147.86 22.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.396 0.617 . . . . 0.0 110.541 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.427 HG21 ' HG ' ' A' ' 82' ' ' LEU . 94.5 t -54.17 -50.1 57.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.996 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -57.29 -31.69 65.89 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.796 -176.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 51' ' ' VAL . 5.7 m-20 -73.66 -40.56 63.62 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -61.24 -38.7 87.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.71 -43.7 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.222 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -56.86 -37.11 70.85 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 119.055 0.843 . . . . 0.0 111.092 174.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 47' ' ' ASP . 84.1 t -65.92 -53.97 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.983 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.7 -48.43 69.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.508 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -57.07 -48.51 78.41 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 123.374 0.421 . . . . 0.0 110.317 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -59.54 -39.38 83.76 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -71.82 -31.46 66.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 44.5 m-85 -84.35 -8.71 58.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.032 0.444 . . . . 0.0 111.303 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 mttp 71.29 46.17 0.44 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.16 1.384 . . . . 0.0 112.608 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 58' ' ' ILE . 76.8 mt -113.88 136.89 22.13 Favored Pre-proline 0 N--CA 1.408 -2.544 0 C-N-CA 125.815 1.646 . . . . 0.0 107.222 174.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.45 131.91 48.61 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.375 2.05 . . . . 0.0 111.49 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.56 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 31.1 m -62.93 -9.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.267 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.12 -22.12 64.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.395 0.617 . . . . 0.0 109.954 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.426 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 63.4 mttm -81.41 -5.46 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.233 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p -49.72 -29.3 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 126.435 1.894 . . . . 0.0 109.776 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 p -55.15 -47.2 75.45 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.429 1.492 . . . . 0.0 110.081 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -104.64 14.92 28.98 Favored 'General case' 0 N--CA 1.4 -2.929 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.7 -171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.426 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 23.7 m-85 -114.56 145.24 42.19 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.474 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.46 35.72 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.292 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.07 154.58 17.11 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.601 ' HB2' ' NH2' ' A' ' 98' ' ' ARG . 52.9 tt0 -143.18 152.78 42.16 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -87.32 131.2 44.95 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.25 -18.59 50.54 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.89 2.394 . . . . 0.0 115.3 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -105.01 -43.32 5.08 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.408 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -89.2 -21.92 23.03 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.756 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 70.27 16.44 7.28 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.766 1.226 . . . . 0.0 111.576 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.99 36.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.402 ' HE2' ' HG2' ' A' ' 100' ' ' LYS . 3.0 m-85 -83.27 168.85 16.31 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.2 t -118.43 98.82 6.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.78 14.47 28.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.369 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.75 156.2 36.84 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 126.529 1.932 . . . . 0.0 109.876 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -83.59 -38.86 21.07 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.525 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.51 154.95 45.6 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.427 ' HG ' HG21 ' A' ' 45' ' ' VAL . 20.4 mt -88.53 154.48 20.31 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.195 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.3 p -112.8 156.59 42.35 Favored Pre-proline 0 C--N 1.282 -2.326 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -56.32 -35.24 95.7 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.533 2.156 . . . . 0.0 110.281 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.03 -42.97 99.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.268 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -64.07 -38.21 90.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 123.288 0.367 . . . . 0.0 111.398 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.707 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.3 mt -65.47 -49.08 70.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.139 0.9 . . . . 0.0 110.304 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.491 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 15.4 t -59.25 -41.17 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.35 -34.14 72.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.934 172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.9 17.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.646 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 8.2 mt-10 -53.98 -23.43 13.2 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.74 -37.88 60.01 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.121 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -142.43 -82.45 0.19 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.66 178.55 8.92 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.315 1.446 . . . . 0.0 108.488 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.65 150.12 38.65 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.4 mt -114.76 135.69 53.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.8 OUTLIER -117.4 107.34 14.23 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -176.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.601 ' NH2' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.11 171.27 12.05 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 43.4 mtp -82.22 129.16 34.77 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 124.301 1.001 . . . . 0.0 110.179 171.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.402 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 37.7 mtmt -78.59 159.94 73.35 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 125.367 1.467 . . . . 0.0 110.999 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.72 100.18 0.58 Allowed 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.171 1.914 . . . . 0.0 109.664 168.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -149.25 144.29 26.42 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.21 -145.47 0.61 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 124.378 1.049 . . . . 0.0 108.356 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.16 91.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.71 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.58 22.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.38 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.47 80.58 8.05 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.117 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 . . . . . 0 C--N 1.28 -2.448 0 CA-C-N 112.812 -1.995 . . . . 0.0 110.115 175.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.764 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.4 100.14 9.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.355 0.577 . . . . 0.0 110.202 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -177.25 149.34 0.66 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -64.59 94.39 0.12 Allowed 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.722 0.639 . . . . 0.0 110.326 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 -26.08 21.0 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.0 -59.27 0.29 Allowed Glycine 0 CA--C 1.478 -2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -88.58 139.92 29.99 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 40.2 mtt -122.19 140.38 52.65 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.983 -171.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 73.3 tttt -100.15 93.19 5.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -102.21 141.96 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.892 -171.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 62.3 mtm-85 -72.03 131.29 42.69 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 121.365 0.602 . . . . 0.0 110.047 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 34' ' ' SER . 49.9 t -117.32 125.91 74.27 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.208 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.277 41.8 mt-10 -84.84 150.58 24.91 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 116.681 -2.008 . . . . 0.0 106.091 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -125.4 125.04 42.76 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.039 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.13 114.3 36.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.492 171.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.91 70.57 1.24 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.18 66.28 0.35 Allowed Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -94.38 -30.79 14.31 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.51 -155.47 0.55 Allowed 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 m170 80.03 167.23 0.17 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.373 1.469 . . . . 0.0 110.351 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 -137.81 177.02 8.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -89.47 95.68 10.38 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 123.818 0.699 . . . . 0.0 109.664 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m 69.07 171.53 0.3 Allowed 'General case' 0 C--O 1.253 1.25 0 C-N-CA 124.197 0.999 . . . . 0.0 111.87 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 65.39 17.47 10.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.578 1.18 . . . . 0.0 109.867 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -93.26 170.89 7.98 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.889 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.23 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.038 1.826 . . . . 0.0 113.041 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -90.59 44.42 1.2 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 125.013 1.325 . . . . 0.0 109.594 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.88 153.02 4.74 Favored Pre-proline 0 C--O 1.249 1.041 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.953 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.37 153.98 25.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.623 2.216 . . . . 0.0 111.599 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.67 -41.83 74.97 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.588 0.755 . . . . 0.0 109.016 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -92.14 -166.95 1.65 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -78.59 156.98 77.74 Favored Pre-proline 0 N--CA 1.422 -1.871 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -41.57 131.52 3.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.573 2.849 . . . . 0.0 111.02 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.5 p -133.78 154.03 51.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 120.946 0.403 . . . . 0.0 110.91 -172.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -149.53 149.47 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 m -99.6 106.03 17.96 Favored 'General case' 0 N--CA 1.391 -3.387 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 51.5 t60 -112.07 144.6 41.16 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.045 -170.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.06 112.91 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.98 151.71 33.67 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -146.28 -170.23 3.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.18 18.19 8.96 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.94 -25.38 9.02 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 123.226 0.61 . . . . 0.0 112.008 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.503 ' HB ' ' NE2' ' A' ' 48' ' ' HIS . 59.9 m -98.63 136.89 38.05 Favored 'General case' 0 N--CA 1.395 -3.18 0 C-N-CA 124.553 1.141 . . . . 0.0 109.036 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 145.01 20.65 Favored 'General case' 0 C--O 1.249 1.03 0 O-C-N 123.695 0.622 . . . . 0.0 110.704 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.505 HG23 ' HG ' ' A' ' 82' ' ' LEU . 89.4 t -53.05 -53.41 22.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.879 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -58.08 -28.17 64.33 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.551 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -76.87 -37.85 54.77 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.076 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.503 ' NE2' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -62.36 -37.86 87.31 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.544 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.6 mt -68.24 -41.56 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.204 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.32 -34.41 66.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.639 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.13 -53.64 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.265 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -54.01 -46.99 71.95 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.217 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 85.5 mt -57.76 -48.71 78.87 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 123.478 0.486 . . . . 0.0 109.975 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -59.48 -37.47 78.32 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -73.32 -33.98 65.44 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.42 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 50.5 m-85 -85.4 0.24 52.79 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt 70.72 35.1 1.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 125.298 1.439 . . . . 0.0 112.665 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.7 mt -105.8 133.76 20.05 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.23 133.73 59.79 Favored 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.896 1.731 . . . . 0.0 110.821 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.507 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.6 m -61.71 -9.83 3.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.076 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.77 -20.48 65.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.558 0.218 . . . . 0.0 110.569 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.91 -4.81 58.61 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.61 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.6 p -48.91 -29.98 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 125.422 1.489 . . . . 0.0 110.622 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -55.34 -43.21 74.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.893 1.677 . . . . 0.0 110.733 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -109.4 13.59 24.06 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.66 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 16.0 m-85 -114.14 140.83 48.2 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.93 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.92 149.89 30.18 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.839 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.8 mt -82.59 122.69 28.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.234 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -109.31 149.4 29.52 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -78.6 129.61 73.66 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.86 -12.27 34.82 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.101 2.534 . . . . 0.0 115.795 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.31 -40.78 3.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.795 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.7 p -93.17 -17.55 23.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.993 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 66.27 20.08 11.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 111.748 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.42 137.28 33.98 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.559 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -95.17 137.06 34.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.73 104.58 8.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -106.2 12.85 29.65 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.979 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.53 158.24 36.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.73 -37.86 20.39 Favored 'General case' 0 N--CA 1.394 -3.252 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.077 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -128.5 147.82 50.71 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.607 0.763 . . . . 0.0 108.957 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HG ' HG23 ' A' ' 45' ' ' VAL . 19.4 mt -81.1 152.24 27.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.584 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.9 p -108.43 154.27 41.58 Favored Pre-proline 0 N--CA 1.401 -2.9 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.38 -36.22 78.2 Favored 'Trans proline' 0 C--O 1.219 -0.452 0 C-N-CA 122.463 2.109 . . . . 0.0 110.523 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -64.09 -41.56 97.25 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.569 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.4 mmp_? -63.0 -36.63 84.17 Favored 'General case' 0 CA--C 1.485 -1.528 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.629 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 61.8 mt -68.42 -48.65 64.06 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 124.217 0.948 . . . . 0.0 110.62 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.591 ' O ' ' HD3' ' A' ' 92' ' ' LYS 0.311 47.8 t -61.61 -49.34 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 2.3 mp0 -64.48 -27.26 68.86 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.21 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.43 -45.26 60.42 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -54.27 -23.75 16.21 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -52.15 -46.97 65.65 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.041 0.936 . . . . 0.0 110.276 173.057 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m -135.27 -79.71 0.43 Allowed 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.92 -175.67 2.43 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.149 1.379 . . . . 0.0 108.962 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -120.1 151.32 39.23 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -116.15 101.6 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.025 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.68 109.44 12.9 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.26 163.11 26.36 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.246 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.467 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.9 mtp -79.94 131.74 35.9 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -72.52 152.8 91.83 Favored Pre-proline 0 C--N 1.277 -2.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 146.83 73.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.789 2.326 . . . . 0.0 111.261 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -139.32 -171.35 3.1 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.429 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -4.74 41.24 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 123.011 1.386 . . . . 0.0 111.809 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.03 134.77 27.21 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 CA-C-N 111.906 -2.406 . . . . 0.0 108.927 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.85 146.52 25.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 0.0 110.341 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -132.26 91.89 3.01 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 C--N 1.292 -1.904 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.51 -177.356 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.466 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.58 118.68 26.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -98.86 8.4 45.02 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.099 0.952 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 173.45 6.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.27 -53.07 4.27 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.19 -51.73 0.68 Allowed Glycine 0 CA--C 1.485 -1.839 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 m -95.86 139.83 31.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.483 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.3 mmt -115.25 138.34 51.05 Favored 'General case' 0 CA--C 1.465 -2.291 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.092 -171.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 73.2 tttt -100.54 93.57 5.68 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 91.7 mt -103.52 140.75 20.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.732 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -73.14 134.71 44.54 Favored 'General case' 0 CA--C 1.459 -2.53 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.195 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.12 122.04 69.1 Favored 'Isoleucine or valine' 2 N--CA 1.363 -4.785 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -84.14 156.74 21.97 Favored 'General case' 0 N--CA 1.406 -2.657 0 C-N-CA 115.872 -2.331 . . . . 0.0 107.063 167.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.464 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -128.81 132.44 47.83 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 177.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' HD23 ' A' ' 14' ' ' LEU 0.266 1.6 mp -116.53 114.37 45.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 166.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -124.13 11.82 8.87 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.0 -163.73 24.79 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 -173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -104.72 16.45 25.99 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 118.336 1.068 . . . . 0.0 108.901 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 44.5 mt-10 -65.98 137.55 57.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.963 -178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.466 ' C ' ' H ' ' A' ' 22' ' ' THR . 31.5 m170 76.37 103.82 0.07 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.42 1.488 . . . . 0.0 111.556 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -87.35 33.14 0.69 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.063 0.935 . . . . 0.0 111.429 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.612 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 39.1 p 52.74 25.03 3.52 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.894 2.078 . . . . 0.0 114.972 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -137.31 100.66 4.31 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.562 0.696 . . . . 0.0 111.29 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 166.45 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 127.296 2.238 . . . . 0.0 105.921 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.5 p -142.74 152.68 60.0 Favored Pre-proline 0 N--CA 1.396 -3.129 0 CA-C-N 112.392 -2.186 . . . . 0.0 106.53 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -67.91 95.31 0.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.825 1.683 . . . . 0.0 110.852 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -117.89 16.22 14.3 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 67.61 88.67 0.1 Allowed Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 113.017 -1.902 . . . . 0.0 111.443 -172.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 93.8 Cg_endo -77.53 53.23 4.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 124.209 3.273 . . . . 0.0 112.602 -174.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.88 -54.65 2.02 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.767 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -128.63 -157.43 0.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.658 1.183 . . . . 0.0 108.758 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -56.34 161.39 4.08 Favored Pre-proline 0 C--O 1.251 1.173 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -47.79 127.68 14.71 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.872 1.715 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 p -142.21 158.69 43.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.346 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.22 149.97 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -98.14 108.29 20.96 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 43.4 t60 -110.86 145.97 37.31 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 -170.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.01 111.62 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.56 145.72 39.82 Favored 'General case' 0 C--N 1.259 -3.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.31 -174.88 4.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.45 -13.95 13.87 Favored Glycine 0 C--N 1.304 -1.217 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.678 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -82.17 -21.82 36.35 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.814 0.816 . . . . 0.0 111.351 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.47 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 38.5 m -95.88 127.4 41.86 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.44 175.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.53 149.51 10.47 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.354 0.597 . . . . 0.0 110.471 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 82' ' ' LEU . 97.8 t -54.13 -53.73 26.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.193 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 61.4 pttt -54.45 -31.86 56.42 Favored 'General case' 0 C--O 1.199 -1.578 0 O-C-N 124.522 1.138 . . . . 0.0 112.086 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 m-20 -77.39 -34.37 54.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.47 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.2 m-70 -64.2 -40.16 95.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.545 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.6 mt -66.22 -43.44 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.828 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.4 mttt -57.15 -35.34 69.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.678 0.672 . . . . 0.0 111.278 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 47' ' ' ASP . 76.8 t -69.55 -53.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.482 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -54.49 -47.65 72.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.129 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 84.9 mt -55.77 -50.57 70.06 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.0 m -58.5 -39.52 80.27 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.23 -27.96 62.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 52.6 m-85 -91.74 4.24 53.26 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.386 0.612 . . . . 0.0 111.529 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 66.76 37.49 4.18 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.506 1.522 . . . . 0.0 112.556 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.64 132.66 20.84 Favored Pre-proline 0 N--CA 1.414 -2.232 0 C-N-CA 124.863 1.265 . . . . 0.0 108.259 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 134.0 58.62 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.256 1.97 . . . . 0.0 110.836 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.2 m -62.46 -10.43 5.09 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.677 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.027 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.01 -20.97 65.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.048 0.451 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.468 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -82.63 -4.36 57.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.2 p -47.78 -29.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 125.984 1.713 . . . . 0.0 110.603 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p -54.86 -46.83 74.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.56 -1.654 . . . . 0.0 111.612 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 m -105.01 10.34 34.13 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 124.312 1.045 . . . . 0.0 112.702 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 26.6 m-85 -109.19 143.34 38.74 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 121.881 -0.512 . . . . 0.0 111.391 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.77 151.88 34.33 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.1 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.36 127.85 34.86 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.033 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -113.93 144.29 43.3 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.51 132.92 77.76 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 39.0 Cg_endo -66.99 -21.37 49.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.872 2.381 . . . . 0.0 115.416 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.73 -46.19 4.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.818 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -86.4 -20.19 28.58 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.122 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt 69.25 16.14 8.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 111.842 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.04 137.75 40.41 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.202 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -94.41 141.27 28.77 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.997 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.05 103.02 8.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -108.51 15.24 24.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.697 1.237 . . . . 0.0 109.103 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.47 155.4 38.04 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.338 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.6 m -81.27 -40.76 23.22 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.375 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.62 157.15 37.94 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.037 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -90.42 142.96 27.21 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.276 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.8 p -99.31 153.1 37.95 Favored Pre-proline 0 N--CA 1.4 -2.96 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.74 -32.58 91.72 Favored 'Trans proline' 0 C--O 1.204 -1.199 0 C-N-CA 121.882 1.721 . . . . 0.0 109.289 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.5 -46.58 88.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.191 0.596 . . . . 0.0 111.568 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -62.34 -39.44 93.09 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.692 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 83' ' ' THR . 55.9 mt -66.06 -48.63 70.39 Favored 'General case' 0 C--O 1.205 -1.273 0 O-C-N 123.677 0.611 . . . . 0.0 110.153 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.5 t -62.11 -46.26 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.29 -28.72 69.52 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.77 -35.54 51.5 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.939 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.35 -25.24 33.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.108 0.563 . . . . 0.0 111.124 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -55.39 -42.26 73.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.284 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.8 m -142.97 -82.28 0.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -160.51 -178.39 6.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.954 0.901 . . . . 0.0 109.273 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -119.49 148.41 43.3 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.7 mt -114.37 102.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.408 175.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.87 107.25 11.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -131.14 162.72 29.27 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.825 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.414 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.5 mtp -77.03 131.58 38.5 Favored 'General case' 0 N--CA 1.4 -2.944 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -60.6 152.9 64.76 Favored Pre-proline 0 C--N 1.288 -2.105 0 O-C-N 123.491 0.495 . . . . 0.0 110.647 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.38 130.17 38.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.337 2.025 . . . . 0.0 109.294 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -68.23 129.97 41.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.619 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 146.6 27.96 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.43 91.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.393 -3.302 0 CA-C-O 122.055 0.931 . . . . 0.0 110.199 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.58 137.48 32.46 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.455 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.89 79.28 9.54 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 . . . . . 0 C--N 1.287 -2.143 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.653 176.633 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.464 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.29 107.63 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 C-N-CA 125.289 1.436 . . . . 0.0 111.682 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -81.44 75.67 8.39 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -123.5 69.26 1.02 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 165.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.26 -43.34 2.24 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.87 69.47 1.39 Allowed Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 m -68.63 130.2 42.15 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.252 1.025 . . . . 0.0 112.843 -167.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.657 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.8 mtt -117.26 140.07 50.01 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.956 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HE2' HD12 ' A' ' 38' ' ' ILE . 20.1 ttmm -96.68 98.61 10.31 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.22 137.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.4 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.55 129.11 38.95 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.125 0.488 . . . . 0.0 109.902 172.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.1 t -115.91 122.28 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.694 0 CA-C-O 117.696 -1.145 . . . . 0.0 108.272 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -83.65 153.88 24.0 Favored 'General case' 0 N--CA 1.413 -2.301 0 C-N-CA 116.456 -2.098 . . . . 0.0 108.027 167.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.46 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.75 127.96 45.89 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.197 0.31 . . . . 0.0 110.171 176.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.431 ' N ' HD23 ' A' ' 14' ' ' LEU . 1.7 mp -100.98 115.01 41.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -159.06 85.68 0.81 Allowed 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -49.29 141.75 11.34 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.642 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -74.53 -14.81 60.86 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.07 0.938 . . . . 0.0 110.102 -173.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -59.21 138.17 57.69 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.706 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -92.74 67.64 4.53 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 49.08 73.21 0.24 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 p -125.41 -151.76 0.49 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -72.96 72.23 1.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -100.34 75.06 1.77 Allowed 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 122.582 1.182 . . . . 0.0 109.44 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 p -80.0 161.05 67.22 Favored Pre-proline 0 C--N 1.254 -3.548 0 CA-C-N 113.362 -1.745 . . . . 0.0 111.158 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.19 88.89 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.394 2.063 . . . . 0.0 111.624 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -120.69 23.04 10.96 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.703 1.24 . . . . 0.0 108.861 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.13 152.78 68.7 Favored Pre-proline 0 C--N 1.286 -2.166 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.844 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.0 173.7 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.096 2.53 . . . . 0.0 113.204 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -63.9 -40.97 97.73 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.623 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -97.28 147.36 24.21 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -124.31 170.87 8.01 Favored Pre-proline 0 C--N 1.254 -3.568 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.66 133.07 10.21 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.661 2.241 . . . . 0.0 110.272 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 22.2 p -140.77 157.42 45.43 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.902 -172.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -144.98 147.59 18.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.4 m -97.37 98.8 10.27 Favored 'General case' 0 N--CA 1.386 -3.66 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -105.73 144.9 31.83 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.12 -167.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.421 HD12 ' HE2' ' A' ' 9' ' ' LYS . 35.1 mm -84.52 112.22 21.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -113.19 149.49 33.61 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.402 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -148.07 -170.4 3.58 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.81 15.67 8.39 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.5 -23.59 11.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.925 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.7 m -104.73 135.83 45.38 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 123.592 0.757 . . . . 0.0 109.444 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.71 148.88 9.15 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.805 0.842 . . . . 0.0 111.18 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG21 ' HG ' ' A' ' 82' ' ' LEU . 90.2 t -54.18 -51.33 48.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.778 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 40.5 mttm -54.73 -34.14 62.06 Favored 'General case' 0 C--O 1.196 -1.714 0 O-C-N 124.685 1.241 . . . . 0.0 110.663 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 51' ' ' VAL . 12.1 m-20 -73.95 -39.18 63.93 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -62.11 -38.91 90.69 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.533 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.7 mt -67.33 -44.61 87.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.913 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 97.4 mttt -57.59 -33.91 68.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 118.843 0.747 . . . . 0.0 110.978 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.4 t -68.77 -54.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.189 175.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.71 -48.66 69.36 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 123.329 0.393 . . . . 0.0 111.382 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.45 -48.27 77.4 Favored 'General case' 0 C--O 1.203 -1.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -59.77 -38.31 81.46 Favored 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -74.72 -29.76 61.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.846 0.355 . . . . 0.0 111.659 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.46 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 38.5 m-85 -89.64 4.57 49.06 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.298 0.571 . . . . 0.0 112.518 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 68.97 32.38 3.85 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.642 1.577 . . . . 0.0 112.284 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -107.31 128.23 26.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -50.86 133.01 38.96 Favored 'Trans proline' 0 CA--C 1.502 -1.099 0 C-N-CA 122.52 2.147 . . . . 0.0 111.073 172.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.502 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.6 m -62.87 -9.96 5.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.682 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.88 -18.49 65.4 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.392 0.615 . . . . 0.0 110.516 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 12.1 mptt -85.14 -5.27 59.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.225 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.9 p -47.45 -27.98 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 C-N-CA 126.196 1.798 . . . . 0.0 110.301 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -56.42 -49.44 74.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 126.42 1.888 . . . . 0.0 111.359 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -104.27 14.88 29.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.952 1.301 . . . . 0.0 112.257 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.437 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 30.2 m-85 -113.93 142.52 46.03 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.605 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.92 31.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.2 mt -83.79 124.19 30.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.171 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -113.36 152.99 29.25 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -85.56 137.63 36.28 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 52.7 Cg_endo -70.59 -13.23 32.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.072 2.515 . . . . 0.0 115.81 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.41 -44.42 3.1 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.855 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.5 p -87.46 -19.13 28.44 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.561 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 63.03 21.74 13.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 110.783 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 140.89 33.95 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.892 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -100.71 143.86 30.37 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.484 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -78.65 107.63 11.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -100.58 10.49 41.11 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.801 0.81 . . . . 0.0 109.949 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.48 152.72 41.76 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.483 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.6 m -83.59 -38.18 21.96 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.203 174.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -128.61 149.51 50.61 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 45' ' ' VAL . 25.7 mt -84.41 161.64 20.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.502 0.668 . . . . 0.0 110.731 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.429 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 64.4 p -120.01 155.74 55.13 Favored Pre-proline 0 N--CA 1.401 -2.895 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.45 -32.11 95.63 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.889 1.726 . . . . 0.0 109.801 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.74 -42.48 99.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.379 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.54 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.6 mmp_? -64.76 -38.36 90.72 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.657 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 76.7 mt -65.77 -47.94 73.5 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.016 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' CG2' ' HE3' ' A' ' 8' ' ' MET 0.258 20.1 t -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.92 -26.95 66.23 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.534 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -43.97 52.22 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.627 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 19.0 mt-10 -54.73 -23.26 16.95 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.34 -35.19 37.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.179 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 m -144.52 -80.37 0.18 Allowed 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -163.77 -175.5 4.14 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 125.788 1.635 . . . . 0.0 108.384 -177.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 3.3 m-85 -120.96 148.59 43.89 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 169.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.6 101.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.568 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.44 ' CD1' HD22 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -78.86 106.45 10.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -127.23 161.42 28.59 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.469 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.421 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 42.7 mtp -76.05 124.95 28.22 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 166.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -60.17 145.39 85.59 Favored Pre-proline 0 C--N 1.286 -2.192 0 C-N-CA 123.875 0.87 . . . . 0.0 111.306 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 148.74 86.86 Favored 'Trans proline' 0 C--O 1.256 1.406 0 C-N-CA 122.574 2.183 . . . . 0.0 110.896 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -61.44 131.09 49.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.879 0.847 . . . . 0.0 111.228 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -142.51 176.15 9.24 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.16 102.35 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.803 0 CA-C-O 121.617 0.723 . . . . 0.0 109.839 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.39 108.42 19.82 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -135.65 88.01 2.37 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.882 0.848 . . . . 0.0 110.687 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 C--N 1.284 -2.24 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.481 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.832 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.56 147.39 48.72 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -65.21 128.13 34.54 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.3 mtp -76.32 93.87 3.51 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.735 0.779 . . . . 0.0 109.622 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.5 72.8 0.47 Allowed Glycine 0 N--CA 1.412 -2.955 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.35 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.13 -45.75 7.39 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.5 m -109.85 123.96 50.49 Favored 'General case' 0 N--CA 1.393 -3.277 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 168.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.762 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 58.2 mtt -106.69 139.75 40.63 Favored 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.047 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 61.8 tttt -99.97 98.36 9.13 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.59 138.3 37.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.611 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 85.4 mtt180 -68.12 133.14 48.45 Favored 'General case' 0 CA--C 1.478 -1.804 0 CA-C-O 121.029 0.442 . . . . 0.0 110.551 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.9 t -120.12 124.63 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-O 117.735 -1.126 . . . . 0.0 108.639 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.481 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.259 21.8 mm-40 -84.2 153.46 23.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 170.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -126.03 130.82 51.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 176.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 15' ' ' ILE . 1.6 mp -117.92 119.72 62.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.418 ' HB3' HD11 ' A' ' 14' ' ' LEU . 29.0 p-10 -110.64 13.91 22.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.341 1.067 . . . . 0.0 111.506 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.9 -161.34 23.45 Favored Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.908 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -97.36 35.78 1.57 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.07 35.99 0.11 Allowed 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 125.849 1.66 . . . . 0.0 112.603 -170.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -99.51 106.7 18.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -91.21 165.85 13.25 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.609 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -78.09 84.71 4.32 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.78 0.8 . . . . 0.0 111.491 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -86.04 -49.53 7.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m 64.48 10.66 5.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.677 1.191 . . . . 0.0 112.755 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.9 p -93.97 171.72 6.64 Favored Pre-proline 0 C--N 1.28 -2.42 0 C-N-CA 124.968 1.307 . . . . 0.0 109.736 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.44 84.0 2.13 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.021 1.147 . . . . 0.0 114.511 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -86.15 2.03 48.36 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 121.538 0.685 . . . . 0.0 111.314 171.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 59.46 -179.03 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.63 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.8 105.39 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.331 1.354 . . . . 0.0 110.568 172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -145.45 113.28 6.41 Favored 'General case' 0 N--CA 1.397 -3.098 0 C-N-CA 124.524 1.129 . . . . 0.0 108.98 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.99 -171.04 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.459 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 83.1 m-20 -68.29 156.4 90.25 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.318 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.46 124.19 10.35 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 122.554 2.169 . . . . 0.0 108.974 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 1.4 p -138.78 152.46 47.93 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.44 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -147.68 149.65 15.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.3 m -96.21 108.32 20.78 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.5 t60 -113.05 147.17 37.79 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 -171.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 48.4 mm -84.89 112.74 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -113.68 146.07 40.36 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 123.039 0.535 . . . . 0.0 109.589 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.92 169.55 22.02 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 123.782 0.833 . . . . 0.0 109.243 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 26.24 24.06 Favored Glycine 0 C--N 1.298 -1.563 0 O-C-N 124.203 0.939 . . . . 0.0 112.435 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.62 -32.44 5.19 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-O 121.499 0.666 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.496 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 35.1 m -94.01 134.43 36.43 Favored 'General case' 0 N--CA 1.389 -3.523 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 148.76 15.12 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.261 0.553 . . . . 0.0 110.731 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG21 ' HG ' ' A' ' 82' ' ' LEU . 95.9 t -53.82 -52.28 36.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.114 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -57.08 -33.77 67.63 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.019 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.61 -37.06 65.55 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 122.06 -0.4 . . . . 0.0 110.712 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.496 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.8 m-70 -62.83 -39.27 93.82 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 27.2 mt -65.31 -44.13 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.67 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.93 -34.22 67.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.728 0.694 . . . . 0.0 111.18 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.56 -53.88 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.98 -48.27 70.54 Favored 'General case' 0 C--O 1.211 -0.921 0 O-C-N 123.558 0.536 . . . . 0.0 111.039 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.2 mt -56.88 -50.75 71.53 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -59.28 -37.32 77.38 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -74.07 -31.0 62.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.872 0.368 . . . . 0.0 111.644 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.475 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 37.0 m-85 -87.06 2.44 49.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 4.4 mmmp? 73.81 29.23 1.49 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.107 1.363 . . . . 0.0 113.108 175.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -105.83 135.99 19.34 Favored Pre-proline 0 N--CA 1.411 -2.392 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -56.58 137.01 79.12 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 122.016 1.811 . . . . 0.0 110.953 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.571 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.84 -10.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.945 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.305 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.8 -14.45 63.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.358 0.599 . . . . 0.0 110.956 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.5 mptp? -87.83 -5.19 58.73 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -48.55 -31.06 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 126.269 1.828 . . . . 0.0 110.428 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.275 15.5 m -55.37 -46.39 76.48 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 126.47 1.908 . . . . 0.0 110.964 174.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -103.01 7.79 39.01 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.755 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 26.0 m-85 -106.68 142.19 36.73 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.331 0.586 . . . . 0.0 111.432 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.04 141.02 23.78 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.387 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 80.1 mt -72.63 156.49 38.91 Favored 'General case' 0 N--CA 1.418 -2.051 0 O-C-N 124.82 1.325 . . . . 0.0 108.306 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 38.4 tt0 -146.12 152.0 38.58 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -89.3 137.17 29.33 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.133 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 56.7 Cg_endo -71.7 -17.6 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.788 2.326 . . . . 0.0 115.278 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -107.75 -46.26 3.84 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.311 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.2 p -84.05 -24.09 30.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.02 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.2 mt 69.61 14.57 8.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.451 1.1 . . . . 0.0 111.152 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 145.75 27.15 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.515 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 8.9 m-30 -88.06 -174.57 4.74 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 122.388 1.09 . . . . 0.0 112.194 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.9 t -124.57 101.84 9.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 167.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.49 14.81 29.35 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.695 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.32 158.3 33.03 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 125.483 1.513 . . . . 0.0 110.579 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.7 m -84.24 -36.38 22.75 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.735 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.78 146.74 52.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 45' ' ' VAL . 27.5 mt -80.18 153.85 28.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.287 0.565 . . . . 0.0 110.999 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.7 p -108.37 154.28 41.52 Favored Pre-proline 0 N--CA 1.403 -2.795 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.79 -36.6 95.51 Favored 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 110.02 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.86 -43.35 94.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.265 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -66.32 -37.15 84.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.314 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.762 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.8 mt -63.29 -51.45 66.05 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.831 0.707 . . . . 0.0 110.568 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG2' ' HE2' ' A' ' 8' ' ' MET . 44.8 t -60.95 -45.86 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.58 -24.67 67.14 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.24 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.7 -39.94 35.13 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.704 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.616 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 32.5 mt-10 -51.03 -27.37 7.76 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 118.36 0.527 . . . . 0.0 111.809 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -49.7 -37.89 30.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.664 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -147.2 -88.66 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -154.98 177.76 10.95 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.476 1.11 . . . . 0.0 109.051 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -116.74 151.95 35.36 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 20.5 mt -117.8 135.96 56.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 115.38 24.35 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -176.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -147.73 173.47 12.74 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.5 mtp -82.12 137.64 34.94 Favored 'General case' 0 N--CA 1.397 -3.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.012 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -73.1 145.35 85.94 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.26 128.98 29.45 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.927 2.418 . . . . 0.0 111.549 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -151.66 165.9 32.92 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.29 141.53 54.31 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.7 mm -64.54 122.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-O 121.387 0.613 . . . . 0.0 112.397 -176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.41 105.6 17.77 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.62 97.41 2.73 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.336 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 . . . . . 0 C--N 1.288 -2.074 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.923 177.093 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.265 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.65 -168.17 2.48 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -132.65 36.63 3.53 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 81.6 mtp 73.86 110.33 0.07 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.974 1.31 . . . . 0.0 112.546 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.66 -109.24 2.39 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.64 95.25 1.42 Allowed Glycine 0 N--CA 1.398 -3.889 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 m -68.07 134.8 51.21 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.664 0.745 . . . . 0.0 109.422 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.68 ' SD ' ' HG3' ' A' ' 91' ' ' GLU . 46.4 mtt -117.86 138.45 52.1 Favored 'General case' 0 CA--C 1.467 -2.233 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.819 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 30.3 ttpt -97.82 99.86 11.2 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.74 140.85 24.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.015 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -69.19 129.15 39.03 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -115.2 123.18 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.736 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.016 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.04 148.43 26.86 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 117.561 -1.656 . . . . 0.0 107.396 168.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -126.11 129.22 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 176.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 15' ' ' ILE . 1.5 mp -114.5 113.9 45.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.117 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -115.34 28.18 8.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.402 0.681 . . . . 0.0 110.854 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.08 48.34 2.39 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.787 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -133.49 -9.47 2.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.964 1.305 . . . . 0.0 110.712 174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 37.3 mt-10 -79.1 63.45 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 30.4 m80 69.89 130.98 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 124.773 1.229 . . . . 0.0 110.816 -171.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 74.3 96.95 0.07 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 112.547 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -91.39 12.33 20.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 123.28 1.514 . . . . 0.0 110.041 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -148.98 119.92 7.65 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m 66.17 92.4 0.08 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 124.549 1.156 . . . . 0.0 109.378 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 p -70.49 169.04 15.28 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 113.465 -1.698 . . . . 0.0 113.343 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 28' ' ' GLN . 32.2 Cg_exo -64.16 -149.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.077 3.185 . . . . 0.0 114.126 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -75.61 26.79 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.932 1.293 . . . . 0.0 112.066 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 26' ' ' PRO . 32.0 mm-40 -83.81 154.0 64.45 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.619 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.02 176.19 2.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.0 2.467 . . . . 0.0 112.577 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.85 -50.61 19.51 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.12 149.68 37.34 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 90.0 m-20 -60.56 132.55 91.12 Favored Pre-proline 0 N--CA 1.427 -1.619 0 O-C-N 123.632 0.582 . . . . 0.0 110.699 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 10.0 Cg_endo -48.44 130.65 21.95 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.873 3.048 . . . . 0.0 110.103 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.3 p -138.98 156.31 47.32 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.268 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -149.29 148.75 15.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -95.61 105.47 17.46 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.1 t60 -112.28 144.37 41.8 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.609 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.262 40.2 mm -83.69 113.46 22.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.49 145.32 41.37 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.94 -174.15 4.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 124.265 1.026 . . . . 0.0 108.289 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.44 22.43 8.33 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -112.15 -25.91 9.08 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.179 0.592 . . . . 0.0 111.231 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.527 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.4 m -96.69 154.08 17.49 Favored 'General case' 0 N--CA 1.389 -3.492 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.67 156.26 27.66 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 82' ' ' LEU . 91.4 t -52.96 -52.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 123.7 0.625 . . . . 0.0 109.717 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -55.68 -36.5 67.2 Favored 'General case' 0 C--O 1.196 -1.726 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.31 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -74.48 -36.19 63.29 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.993 -0.442 . . . . 0.0 111.758 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.527 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.6 m-70 -61.25 -38.79 87.95 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 36.8 mt -66.16 -42.95 92.15 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.079 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.67 -37.98 71.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.647 0.658 . . . . 0.0 110.796 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.44 -53.69 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.057 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -53.36 -49.61 66.79 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.467 0.479 . . . . 0.0 110.777 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -56.91 -47.43 80.57 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.522 0.514 . . . . 0.0 110.103 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.93 -40.52 93.53 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -70.84 -31.01 67.58 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.04 0.448 . . . . 0.0 111.51 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -86.67 1.87 50.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.341 0.591 . . . . 0.0 111.49 174.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 64.86 38.82 6.37 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 124.808 1.243 . . . . 0.0 113.18 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.0 mt -108.15 140.48 21.72 Favored Pre-proline 0 N--CA 1.41 -2.467 0 C-N-CA 124.988 1.315 . . . . 0.0 107.631 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.93 132.67 48.88 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.089 1.859 . . . . 0.0 110.925 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.9 m -63.75 -9.65 5.85 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.972 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.651 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -14.16 62.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.211 0.529 . . . . 0.0 111.544 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 64.2 mttm -85.38 -9.16 57.93 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.982 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.6 p -49.76 -30.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.906 2.082 . . . . 0.0 109.849 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.255 12.8 m -54.73 -48.91 71.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.146 1.778 . . . . 0.0 109.841 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -101.45 7.06 42.68 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.214 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 15.6 m-85 -106.55 144.38 33.3 Favored 'General case' 0 CA--C 1.477 -1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 110.751 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.57 149.25 25.19 Favored 'General case' 0 N--CA 1.41 -2.439 0 O-C-N 124.233 0.958 . . . . 0.0 109.292 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.68 132.75 35.61 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.574 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -118.92 153.58 34.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -86.03 131.0 48.08 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 33.1 Cg_endo -66.22 -20.26 56.03 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.421 2.748 . . . . 0.0 115.836 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -107.27 -43.61 4.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 p -87.37 -24.37 24.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.052 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt 70.72 19.45 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 124.366 1.066 . . . . 0.0 111.8 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.85 138.89 33.76 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.508 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -91.72 168.89 11.15 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.711 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.4 t -111.93 79.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.032 0.92 . . . . 0.0 111.399 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.27 -1.56 6.47 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.726 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -64.06 151.26 43.54 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.282 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -79.91 -41.17 26.66 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.282 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -131.32 153.22 49.82 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 124.22 1.008 . . . . 0.0 108.553 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.4 mt -85.99 153.67 21.99 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.7 p -109.51 155.32 41.48 Favored Pre-proline 0 N--CA 1.402 -2.849 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.53 -33.87 93.75 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.126 1.884 . . . . 0.0 109.973 173.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.75 -45.91 90.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.919 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -64.48 -37.92 89.23 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.179 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.536 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.0 mt -64.03 -47.52 79.91 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.612 0.57 . . . . 0.0 109.934 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.507 ' CG2' ' HE3' ' A' ' 8' ' ' MET 0.259 35.6 t -62.13 -46.29 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -67.2 -25.53 66.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.36 -43.12 28.51 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.68 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 4.2 mt-10 -53.72 -19.27 3.94 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -53.08 -39.81 63.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.84 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 m -144.88 -82.14 0.16 Allowed 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -161.91 -178.73 6.65 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.513 1.125 . . . . 0.0 109.114 -178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.99 147.02 46.05 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 169.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -113.43 101.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.458 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.52 105.06 9.54 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -126.75 159.21 34.42 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.683 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.415 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 46.0 mtp -77.98 132.38 37.81 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 167.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.59 135.38 96.25 Favored Pre-proline 0 C--N 1.283 -2.3 0 O-C-N 123.905 0.753 . . . . 0.0 109.333 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -29.0 113.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.596 1 C-N-CA 125.874 4.382 . . . . 0.0 115.105 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -70.07 134.59 48.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.739 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -112.04 -160.76 0.73 Allowed 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.04 138.98 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 C-N-CA 123.242 0.617 . . . . 0.0 109.691 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.92 108.15 0.33 Allowed 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.688 0.618 . . . . 0.0 112.331 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.55 23.41 13.6 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.177 1.791 . . . . 0.0 112.275 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--N 1.3 -1.581 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.973 178.092 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.382 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.2 163.77 36.68 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -85.4 -9.65 57.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.884 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.0 mtt -64.59 109.52 2.02 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.58 38.18 6.29 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.34 20.51 30.24 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.003 -0.598 . . . . 0.0 111.97 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 146.46 23.8 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.434 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.7 mmt -122.91 137.29 54.98 Favored 'General case' 0 CA--C 1.477 -1.865 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.838 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 27.3 ttpt -96.22 98.95 10.71 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.28 139.32 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.721 -172.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 92.0 mtt180 -71.35 131.54 43.56 Favored 'General case' 0 CA--C 1.471 -2.088 0 O-C-N 123.456 0.473 . . . . 0.0 110.429 173.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 34' ' ' SER . 40.5 t -117.95 124.8 73.6 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.484 0 CA-C-O 117.911 -1.043 . . . . 0.0 109.011 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 31' ' ' GLN . 16.8 mt-10 -80.0 149.55 30.72 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 168.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 15' ' ' ILE . 1.0 OUTLIER -126.4 125.6 42.45 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 120.467 0.175 . . . . 0.0 111.08 175.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.424 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -110.44 106.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.032 167.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -114.48 7.97 16.36 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 123.955 1.836 . . . . 0.0 106.99 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.04 170.31 15.92 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 112.163 -2.289 . . . . 0.0 108.189 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.48 29.75 7.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -58.79 102.88 0.13 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.239 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.27 102.82 7.83 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.399 0.619 . . . . 0.0 110.932 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.32 130.13 42.12 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.493 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -87.47 37.47 0.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.348 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.2 m -64.53 122.43 16.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.343 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.2 m -80.14 1.62 27.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.787 0.803 . . . . 0.0 110.749 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 p -90.91 163.2 30.64 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.171 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 104.78 1.84 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.262 1.975 . . . . 0.0 109.183 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.54 -10.16 59.2 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 64.96 150.23 0.11 Allowed Pre-proline 0 C--N 1.263 -3.179 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.953 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.17 37.37 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.586 2.191 . . . . 0.0 112.192 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -85.6 42.55 0.97 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.623 0.769 . . . . 0.0 112.492 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.465 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 27.9 mt-30 48.82 -150.83 0.15 Allowed 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 125.107 1.363 . . . . 0.0 112.638 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -61.71 164.13 10.56 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -41.55 125.59 2.82 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.944 2.429 . . . . 0.0 110.558 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -134.1 156.31 48.51 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.05 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.3 p -149.22 148.41 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 m -97.41 106.96 19.38 Favored 'General case' 0 N--CA 1.391 -3.389 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t60 -114.68 146.21 41.15 Favored 'General case' 0 N--CA 1.416 -2.157 0 C-N-CA 123.791 0.836 . . . . 0.0 110.529 -169.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.25 44.8 mm -83.13 112.92 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.664 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -113.12 145.87 40.18 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.23 169.63 18.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.38 17.85 42.79 Favored Glycine 0 C--N 1.292 -1.871 0 O-C-N 124.299 0.999 . . . . 0.0 113.008 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -108.08 -25.16 11.26 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-O 122.131 0.967 . . . . 0.0 110.998 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.1 m -103.6 137.84 41.1 Favored 'General case' 0 N--CA 1.391 -3.403 0 C-N-CA 125.059 1.344 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.91 150.01 17.47 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 121.44 0.638 . . . . 0.0 111.237 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 82' ' ' LEU . 83.8 t -52.8 -51.18 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.227 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -53.37 -42.18 66.62 Favored 'General case' 0 C--O 1.198 -1.619 0 O-C-N 125.003 1.439 . . . . 0.0 110.61 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.29 -39.07 85.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -62.51 -37.83 87.56 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.626 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 mt -66.52 -43.82 90.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.015 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -56.22 -34.72 66.58 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.839 0.745 . . . . 0.0 111.143 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.12 -53.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.136 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.31 -47.89 68.86 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 123.274 0.359 . . . . 0.0 111.12 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 79.5 mt -57.26 -49.43 76.07 Favored 'General case' 0 C--O 1.199 -1.564 0 O-C-N 123.705 0.628 . . . . 0.0 109.613 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -58.63 -39.8 81.53 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -71.41 -32.36 68.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.415 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 44.8 m-85 -86.42 -2.71 58.67 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.1 0.476 . . . . 0.0 111.835 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 69.15 39.23 1.76 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.389 1.476 . . . . 0.0 112.665 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.4 mt -106.42 136.85 19.32 Favored Pre-proline 0 N--CA 1.408 -2.538 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.28 134.91 62.06 Favored 'Trans proline' 0 CA--C 1.501 -1.16 0 C-N-CA 121.738 1.625 . . . . 0.0 111.515 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.58 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.1 m -64.38 -11.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.63 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.843 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.6 -20.61 64.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.257 0.551 . . . . 0.0 109.66 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 65.9 mttm -83.17 -2.46 55.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.265 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.58 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -49.0 -30.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 126.942 2.097 . . . . 0.0 110.618 176.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -54.99 -58.12 8.92 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.915 173.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.1 m -87.85 10.96 16.84 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.422 -174.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 25.1 m-85 -109.22 143.51 38.57 Favored 'General case' 0 C--N 1.277 -2.567 0 O-C-N 121.277 -0.89 . . . . 0.0 111.34 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.96 154.35 40.22 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.037 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.29 160.48 16.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 41.5 tt0 -150.0 150.53 31.93 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 122.521 0.328 . . . . 0.0 110.207 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.83 137.98 31.5 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 124.459 1.103 . . . . 0.0 108.642 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.58 -21.16 30.06 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.814 2.342 . . . . 0.0 115.38 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -105.76 -42.49 5.15 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.747 -0.781 . . . . 0.0 113.001 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.5 p -90.43 -20.77 22.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.474 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt 66.58 17.96 10.7 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.491 1.117 . . . . 0.0 111.375 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.92 140.0 33.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 5.8 m-30 -86.03 -174.75 5.25 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.977 0.894 . . . . 0.0 110.567 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.0 101.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.97 11.95 36.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.796 1.284 . . . . 0.0 109.455 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.16 159.63 32.31 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 112.581 -2.1 . . . . 0.0 111.019 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 m -84.43 -39.44 18.97 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.317 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.06 154.92 45.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.863 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.9 mt -89.19 147.7 24.03 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.141 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.436 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 70.6 p -99.28 153.08 37.96 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.91 -34.17 97.99 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.428 2.085 . . . . 0.0 109.815 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -59.07 -47.62 84.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.142 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -60.28 -37.82 81.67 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 83' ' ' THR . 69.3 mt -64.35 -48.9 73.76 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.822 0.701 . . . . 0.0 110.401 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 43.7 t -63.48 -43.76 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -61.57 -29.89 70.32 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.79 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.56 -34.06 25.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.978 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.13 -24.58 55.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.644 0.735 . . . . 0.0 112.381 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 36.4 mmtm -54.09 -40.36 67.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.154 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.9 m -144.2 -88.31 0.12 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE2' HD12 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -156.64 178.96 9.73 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 108.752 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.25 152.85 34.93 Favored 'General case' 0 C--O 1.203 -1.363 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.438 HD12 ' CE2' ' A' ' 94' ' ' TYR . 2.7 mp -114.09 133.86 58.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.435 ' HB2' ' CG1' ' A' ' 12' ' ' VAL . 0.7 OUTLIER -117.59 115.93 26.09 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.449 HH11 ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -146.41 177.56 8.94 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' SER . 49.4 mtp -80.94 138.75 36.11 Favored 'General case' 0 N--CA 1.381 -3.885 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 176.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -65.37 137.62 96.76 Favored Pre-proline 0 N--CA 1.415 -2.212 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.83 105.85 0.58 Allowed 'Trans proline' 0 CA--C 1.502 -1.093 0 C-N-CA 122.576 2.184 . . . . 0.0 111.333 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -81.98 113.63 20.01 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.59 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.9 178.19 7.99 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.37 113.8 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 CA-C-O 120.911 0.386 . . . . 0.0 110.427 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.38 93.7 0.77 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.067 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.44 77.57 1.28 Allowed 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 . . . . . 0 C--N 1.301 -1.526 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.201 -175.957 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.411 -2.386 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 39.6 mtt -128.19 140.1 52.1 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -170.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -97.21 94.81 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -104.11 137.29 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.76 -171.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 41.6 mtm180 -71.82 130.7 41.7 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.386 0.613 . . . . 0.0 110.196 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' SER . 45.8 t -117.99 127.91 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.346 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.28 43.4 mt-10 -90.18 143.76 26.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 116.257 -2.177 . . . . 0.0 109.358 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.2 tm? -111.7 129.67 56.03 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.071 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.452 -0.914 0 N-CA-C 108.675 -1.317 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.7 p -135.87 153.1 51.58 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 -173.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -146.87 145.95 19.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 m -97.8 104.98 17.05 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -111.24 144.87 39.7 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.76 113.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.45 143.84 42.91 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.1 164.51 37.11 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.397 1.079 . . . . 0.0 108.402 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.84 14.81 63.58 Favored Glycine 0 C--N 1.291 -1.967 0 O-C-N 124.239 0.962 . . . . 0.0 112.787 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -105.61 -28.34 10.81 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 121.994 0.902 . . . . 0.0 110.1 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 39.9 m -94.7 132.36 39.53 Favored 'General case' 0 N--CA 1.39 -3.466 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.362 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.94 149.55 14.97 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' A' ' 82' ' ' LEU . 88.2 t -54.9 -53.15 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.163 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 22.3 pttm -54.38 -30.72 52.91 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 124.468 1.105 . . . . 0.0 111.02 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.8 m-20 -78.1 -36.31 48.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.204 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 96.2 m-70 -64.04 -39.73 94.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 30.1 mt -66.87 -44.32 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.977 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 96.4 mttt -56.69 -34.4 67.38 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.64 0.654 . . . . 0.0 110.821 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.4 t -69.59 -54.27 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.652 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.51 -49.51 67.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.429 0.456 . . . . 0.0 111.159 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.1 mt -54.74 -50.13 69.13 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 123.622 0.576 . . . . 0.0 109.844 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.0 m -58.16 -39.87 79.96 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -71.53 -27.87 63.48 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.139 0.495 . . . . 0.0 111.712 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 46.1 m-85 -89.82 2.04 55.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.291 0.567 . . . . 0.0 111.609 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 67.77 35.47 3.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.318 1.447 . . . . 0.0 112.579 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.2 135.78 19.42 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.97 135.88 69.63 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.429 2.086 . . . . 0.0 111.156 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 32.4 m -64.37 -10.73 8.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.813 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.392 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.42 -15.99 63.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.77 0.795 . . . . 0.0 109.523 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.91 -7.53 58.11 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.964 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -46.45 -30.69 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.097 0 C-N-CA 127.226 2.211 . . . . 0.0 111.128 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.271 16.5 m -56.99 -45.09 83.21 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 126.018 1.727 . . . . 0.0 111.724 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' MET . 8.7 m -100.9 7.13 43.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.057 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 28.8 m-85 -109.91 143.56 39.66 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 122.154 -0.341 . . . . 0.0 110.92 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 147.65 28.42 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.325 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 89.0 mt -80.47 134.67 36.01 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.603 1.189 . . . . 0.0 107.944 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -125.8 147.08 49.53 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.48 135.73 68.6 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.91 -16.14 29.38 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 115.076 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -105.83 -46.76 4.05 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.687 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -90.05 -18.09 26.58 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.639 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt 65.07 22.63 12.37 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.387 1.075 . . . . 0.0 110.918 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.05 135.87 35.89 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.374 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.61 149.85 20.83 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.644 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.86 106.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.62 10.86 29.0 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 123.107 1.432 . . . . 0.0 108.83 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.49 154.03 37.19 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.165 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.2 m -83.53 -35.46 24.79 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.702 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -129.8 149.55 51.49 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.263 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 82' ' ' LEU . 18.7 mt -85.37 153.04 22.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -108.35 158.84 32.76 Favored Pre-proline 0 N--CA 1.411 -2.415 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.1 -35.9 98.36 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.176 1.917 . . . . 0.0 109.16 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.75 -41.66 95.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.814 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -63.59 -43.08 97.99 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.524 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 69.8 mt -62.99 -48.08 80.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.377 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.1 -45.8 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.18 -27.96 68.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.66 -44.09 29.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.46 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 3.7 mm-40 -52.58 -22.18 4.7 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.84 -34.42 40.54 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.2 m -146.62 -83.84 0.12 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.63 177.91 10.87 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.52 1.128 . . . . 0.0 108.587 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m-85 -116.45 151.78 35.35 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 170.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 10.6 mt -114.9 140.81 34.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -119.34 107.01 12.85 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -129.0 159.48 35.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.39 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 65' ' ' SER . 52.3 mtp . . . . . 0 N--CA 1.411 -2.417 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 166.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.443 -0.812 0 CA-C-O 121.326 0.584 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.727 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 47.0 mtt -123.88 141.88 51.63 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.727 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.1 tttm -100.66 97.01 7.73 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -107.33 139.75 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.743 -172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 10.7 mtp180 -67.22 134.92 52.59 Favored 'General case' 0 CA--C 1.454 -2.72 0 CA-C-O 121.838 0.828 . . . . 0.0 111.828 170.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.3 t -120.81 122.9 69.06 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.501 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.308 0.7 OUTLIER -83.78 144.41 29.33 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 116.082 -2.247 . . . . 0.0 108.518 166.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.6 tm? -114.55 137.09 52.3 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.313 -1.007 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.093 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.782 0 N-CA-C 111.081 -0.392 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.8 m -140.37 159.89 41.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.149 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 8.5 p -150.36 149.45 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -98.77 104.69 16.76 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 36.5 t-80 -109.67 147.9 32.3 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.315 -170.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 113.02 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.81 147.45 38.33 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.25 -170.37 3.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.34 18.25 8.33 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.86 -28.37 8.41 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 124.03 0.932 . . . . 0.0 110.596 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.648 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 40.7 m -95.5 131.84 41.24 Favored 'General case' 0 N--CA 1.386 -3.67 0 C-N-CA 124.513 1.125 . . . . 0.0 109.096 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 148.49 14.73 Favored 'General case' 0 C--O 1.254 1.332 0 O-C-N 123.795 0.684 . . . . 0.0 110.618 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.2 -53.15 31.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.111 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -54.54 -31.92 57.31 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.344 1.028 . . . . 0.0 111.419 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 m-20 -75.88 -38.75 57.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.443 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.648 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 40.1 m80 -61.98 -39.24 91.5 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.5 mt -67.1 -43.31 88.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.1 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HG3' HG21 ' A' ' 63' ' ' VAL . 98.2 mttt -58.98 -34.3 71.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.066 0.848 . . . . 0.0 111.141 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.1 t -68.14 -52.62 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.239 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.79 -48.71 72.38 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.403 0.439 . . . . 0.0 111.089 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.66 -47.49 79.67 Favored 'General case' 0 C--O 1.2 -1.513 0 O-C-N 123.644 0.59 . . . . 0.0 109.796 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.2 m -59.42 -40.34 86.41 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -70.91 -34.04 71.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.522 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 50.3 m-85 -83.81 -2.37 56.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.37 0.605 . . . . 0.0 111.702 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 69.72 34.42 2.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.806 1.643 . . . . 0.0 111.999 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.27 137.24 19.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.68 132.47 50.41 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 121.926 1.751 . . . . 0.0 110.877 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.54 -10.14 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.166 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.99 -14.34 62.65 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.97 0.414 . . . . 0.0 111.187 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 60.8 mttm -86.33 -7.74 58.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.408 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -46.41 -32.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 C-N-CA 126.666 1.986 . . . . 0.0 110.833 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 p -54.17 -49.77 68.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 125.997 1.719 . . . . 0.0 111.219 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.0 9.21 41.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.865 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 16.4 m-85 -109.94 140.08 44.32 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.779 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.876 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 86.0 mt -85.53 125.85 33.4 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.394 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -113.82 148.62 36.3 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 120.78 0.324 . . . . 0.0 110.872 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -81.94 132.22 54.68 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.82 -18.59 52.94 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.627 2.218 . . . . 0.0 115.288 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.65 -44.44 4.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.014 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 p -89.5 -20.29 24.03 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.252 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 mt 68.48 16.53 9.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 111.654 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.69 139.37 38.5 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -98.95 147.36 25.06 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.728 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.11 106.01 14.03 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.469 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.1 10.15 41.72 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 123.983 0.913 . . . . 0.0 109.888 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.98 154.14 39.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.273 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.5 m -82.85 -38.48 22.94 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.052 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -130.67 148.74 52.5 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.351 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -80.65 157.71 25.87 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.771 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 56.5 p -110.78 153.92 43.48 Favored Pre-proline 0 N--CA 1.403 -2.816 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.63 -32.09 81.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.619 1.546 . . . . 0.0 110.119 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.66 -51.01 71.76 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.72 0.808 . . . . 0.0 110.783 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.504 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 23.9 mmm180 -60.95 -37.99 84.3 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 123.205 0.315 . . . . 0.0 110.688 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.8 mt -63.22 -49.21 75.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 123.973 0.796 . . . . 0.0 110.34 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.98 -44.2 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.63 -33.22 73.55 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.586 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.13 -42.48 46.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.65 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 25.0 mt-10 -52.34 -23.19 5.46 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -53.48 -35.59 60.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.896 0.879 . . . . 0.0 112.583 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 m -145.2 -84.82 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER -162.23 178.13 9.01 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.797 1.239 . . . . 0.0 108.612 -177.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 m-85 -111.63 146.88 36.65 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 ' CE2' ' A' ' 94' ' ' TYR . 4.9 mt -112.66 100.41 10.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.765 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.34 102.71 8.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -123.87 160.08 28.23 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.664 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 52.3 mtp . . . . . 0 N--CA 1.4 -2.959 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 166.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m . . . . . 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.0 112.552 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.9 mtt -113.68 138.17 50.58 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.704 -1.589 . . . . 0.0 111.782 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 77.0 tttt -96.97 90.49 5.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -100.49 137.84 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.47 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 16.3 mtm180 -73.79 131.36 41.47 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.5 t -118.39 127.65 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.294 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.767 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 34.6 mt-10 -88.23 148.37 24.39 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 116.63 -2.028 . . . . 0.0 107.866 165.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -118.66 128.97 55.03 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.055 0.222 . . . . 0.0 110.542 177.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.416 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.317 -0.84 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.545 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 C--O 1.238 0.488 0 N-CA-C 110.36 -0.669 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.6 p -132.49 150.08 52.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.688 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 9.3 p -147.02 148.22 16.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 12.8 m -99.5 105.44 17.35 Favored 'General case' 1 N--CA 1.379 -4.021 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -110.05 146.32 35.56 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.922 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -83.52 111.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 7' ' ' SER . 87.8 m-85 -112.25 145.1 40.54 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.07 172.05 13.62 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.45 17.64 54.98 Favored Glycine 0 C--N 1.307 -1.069 0 O-C-N 124.271 0.982 . . . . 0.0 112.606 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -113.67 -22.75 10.09 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 121.618 0.723 . . . . 0.0 111.987 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 59.8 m -101.28 137.17 39.98 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.137 0.975 . . . . 0.0 109.952 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.14 147.33 16.41 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 124.025 0.828 . . . . 0.0 110.767 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.3 t -54.98 -53.97 28.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.857 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -57.6 -28.93 64.07 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.267 0.98 . . . . 0.0 111.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 m-20 -75.91 -37.29 58.94 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.228 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.483 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 39.4 m80 -62.15 -38.3 88.48 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 171.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 43.5 mt -67.11 -43.58 88.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.172 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -57.17 -34.46 68.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.836 0.744 . . . . 0.0 111.034 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' ASP . 63.4 t -70.55 -52.86 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.595 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.65 -49.62 67.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.252 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 91.7 mt -56.36 -48.29 77.11 Favored 'General case' 0 C--O 1.206 -1.231 0 O-C-N 123.48 0.487 . . . . 0.0 109.801 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.8 m -58.94 -40.18 83.89 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -71.82 -29.81 64.82 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.959 0.409 . . . . 0.0 112.023 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 41.1 m-85 -86.94 -0.97 57.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.232 0.539 . . . . 0.0 112.159 175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 69.79 30.86 3.68 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.967 1.707 . . . . 0.0 112.579 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.23 135.51 20.29 Favored Pre-proline 0 N--CA 1.404 -2.74 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.26 134.68 60.62 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.952 1.768 . . . . 0.0 111.24 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.2 m -63.26 -9.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.655 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.6 -15.46 63.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.785 0.326 . . . . 0.0 110.534 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -86.91 -5.48 59.08 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.847 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 1.6 p -48.9 -32.71 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 125.095 1.358 . . . . 0.0 110.609 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -57.14 -42.22 80.55 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.89 1.276 . . . . 0.0 110.379 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.2 m -103.52 13.7 32.87 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.243 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 15.8 m-85 -117.77 144.29 45.45 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.89 154.77 31.77 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.042 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.4 mt -83.58 130.14 34.98 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.76 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 38.5 tt0 -115.34 150.7 35.88 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -81.09 131.99 57.9 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.84 -19.82 46.32 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.914 2.409 . . . . 0.0 115.537 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.52 -45.28 4.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.355 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -92.14 -18.29 23.72 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.267 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.93 20.36 10.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.476 1.11 . . . . 0.0 112.443 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.16 137.71 35.9 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 37.5 m-85 -94.54 147.44 23.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.217 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.44 107.67 13.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -101.38 12.38 37.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.195 0.521 . . . . 0.0 111.09 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -76.44 155.77 33.65 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 122.299 1.047 . . . . 0.0 111.684 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -81.86 -38.31 25.61 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.627 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.34 151.02 51.3 Favored 'General case' 0 N--CA 1.417 -2.121 0 C-N-CA 123.901 0.881 . . . . 0.0 108.631 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.9 mt -83.33 154.53 24.03 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.352 0.596 . . . . 0.0 110.521 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -111.46 153.44 44.17 Favored Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.42 -36.38 79.09 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 0.0 109.674 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.45 -46.49 86.45 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.813 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.59 -37.12 86.46 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 75.8 mt -65.19 -49.12 70.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.922 0.763 . . . . 0.0 110.184 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.51 -44.07 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -62.16 -32.2 72.79 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.17 -43.83 23.16 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.79 -25.25 7.24 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -54.35 -36.67 64.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.672 1.189 . . . . 0.0 112.529 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.6 m -140.67 -80.79 0.26 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.05 -178.92 3.9 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 124.864 1.265 . . . . 0.0 108.443 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 2.6 m-85 -117.43 148.15 42.05 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 170.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.8 mt -115.65 101.57 12.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.019 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -78.28 103.72 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -125.97 164.3 21.11 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.514 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 65' ' ' SER . 58.4 mtp . . . . . 0 N--CA 1.405 -2.723 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.42 -1.934 0 CA-C-O 121.625 0.726 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 45.0 mtt -112.95 141.24 47.01 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.71 -169.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HE2' HD11 ' A' ' 38' ' ' ILE . 22.5 ttmm -98.63 101.07 12.38 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -112.22 138.64 40.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 124.833 1.253 . . . . 0.0 109.834 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 43.4 mtt180 -71.33 134.99 47.14 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.555 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 34' ' ' SER . 58.5 t -118.88 127.69 75.75 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.79 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.019 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.77 149.46 24.84 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.52 -1.672 . . . . 0.0 107.765 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tm? -115.17 132.65 56.54 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.093 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.306 -1.315 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.735 -0.91 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.6 p -139.37 157.25 46.19 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.011 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.4 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -97.45 99.48 10.9 Favored 'General case' 0 N--CA 1.387 -3.594 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 45.5 t-80 -106.12 144.99 32.04 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.814 -167.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.529 HD11 ' HE2' ' A' ' 9' ' ' LYS 0.253 48.4 mm -83.65 114.06 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -115.35 151.5 34.52 Favored 'General case' 0 C--N 1.272 -2.78 0 C-N-CA 123.299 0.639 . . . . 0.0 109.513 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -146.71 -167.79 2.85 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.16 21.18 5.24 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -108.98 -25.46 10.71 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.469 0.652 . . . . 0.0 110.171 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.3 m -105.79 138.08 42.59 Favored 'General case' 0 N--CA 1.412 -2.342 0 C-N-CA 124.633 1.173 . . . . 0.0 109.391 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.64 145.86 22.44 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 121.444 0.64 . . . . 0.0 110.93 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 81.4 t -48.54 -52.05 9.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.701 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -56.57 -35.35 68.07 Favored 'General case' 0 C--O 1.198 -1.617 0 O-C-N 124.565 1.166 . . . . 0.0 111.204 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.61 -34.62 65.13 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.862 -0.524 . . . . 0.0 111.703 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -63.38 -36.98 85.51 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.62 -41.65 85.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.354 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -56.26 -38.78 71.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.856 0.753 . . . . 0.0 110.622 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.75 -53.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.902 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.3 mt -53.22 -50.56 64.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.133 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.99 -49.14 76.65 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 123.677 0.611 . . . . 0.0 110.047 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -59.13 -38.76 80.44 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -73.94 -31.47 63.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 14' ' ' LEU . 29.6 m-85 -81.58 -8.45 59.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.066 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt 74.57 37.23 0.56 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.638 1.575 . . . . 0.0 111.91 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.6 mt -109.63 131.53 21.85 Favored Pre-proline 0 N--CA 1.409 -2.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.72 136.11 57.89 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 C-N-CA 122.557 2.171 . . . . 0.0 111.932 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.7 m -64.29 -9.8 6.94 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.903 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.49 -15.93 63.35 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.674 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.9 mptp? -85.32 -4.36 59.13 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.5 p -49.37 -30.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.919 1.688 . . . . 0.0 110.481 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.2 p -56.05 -50.53 70.7 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.005 173.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 19.6 m -98.44 13.16 32.69 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.256 -172.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.2 m-85 -114.25 142.43 46.29 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.942 -0.474 . . . . 0.0 111.748 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.08 146.65 24.1 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.671 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.92 138.26 38.79 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.059 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -122.14 144.97 48.62 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 24.8 t-20 -76.89 130.32 76.24 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 17.3 Cg_exo -67.42 -18.72 49.67 Favored 'Trans proline' 0 C--N 1.329 -0.453 0 C-N-CA 122.575 2.183 . . . . 0.0 114.957 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -110.52 -39.48 4.9 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.2 p -90.12 -18.07 26.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.146 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 68.86 15.56 8.92 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.0 111.943 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.72 137.72 37.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.38 156.91 17.9 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.289 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.07 77.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 122.141 0.972 . . . . 0.0 111.845 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.4 2.94 2.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 125.234 1.414 . . . . 0.0 114.174 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.84 154.73 41.48 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.582 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -82.96 -37.28 24.31 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.851 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.49 153.37 48.88 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.291 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 82' ' ' LEU . 19.5 mt -85.68 146.83 26.65 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.2 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -99.02 157.79 33.46 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.5 -34.81 98.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.071 1.848 . . . . 0.0 109.398 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.09 -45.67 93.77 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.401 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 8.7 mmt180 -61.14 -39.7 91.04 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.699 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 79.0 mt -64.86 -48.68 73.4 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 124.073 0.858 . . . . 0.0 109.778 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.77 -45.3 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -63.83 -28.71 70.04 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.131 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.06 24.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.636 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 15.6 mt-10 -53.02 -22.71 6.13 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 119.059 0.845 . . . . 0.0 113.117 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.93 -42.93 65.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.706 0.803 . . . . 0.0 110.826 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.6 m -140.91 -80.41 0.26 Allowed 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -167.36 -179.26 4.39 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 124.133 0.973 . . . . 0.0 109.04 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.61 149.49 42.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.3 99.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.02 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -78.8 105.5 10.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.018 0.913 . . . . 0.0 108.589 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -124.07 166.15 16.26 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.427 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.4 mtp . . . . . 0 N--CA 1.4 -2.964 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.5 mmt -115.46 138.23 51.24 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.899 -172.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -99.04 91.98 5.27 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.61 137.27 31.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.939 -171.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 30.0 mtm105 -69.42 130.71 43.29 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 121.714 0.769 . . . . 0.0 110.225 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.0 t -117.07 122.58 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.385 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.487 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.275 33.0 mt-10 -82.38 149.36 27.73 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 116.566 -2.053 . . . . 0.0 107.037 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.52 123.09 36.97 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp . . . . . 0 C--N 1.314 -0.972 0 C-N-CA 119.242 -0.983 . . . . 0.0 109.019 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 C--O 1.242 0.696 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.6 m -145.86 157.59 43.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.193 0.52 . . . . 0.0 112.008 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -147.76 148.15 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.734 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.803 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.4 m -97.05 103.86 15.82 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -107.86 147.59 30.73 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.138 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.83 111.18 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.0 146.02 38.62 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.47 -168.85 3.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.83 20.45 6.03 Favored Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.471 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.12 -26.86 9.0 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.641 0.734 . . . . 0.0 110.699 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.0 m -99.62 135.3 41.25 Favored 'General case' 0 N--CA 1.39 -3.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.942 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.31 146.12 12.76 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 123.931 0.769 . . . . 0.0 111.58 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.469 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.0 t -52.75 -54.0 18.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.643 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -56.82 -31.02 64.31 Favored 'General case' 0 C--O 1.204 -1.329 0 O-C-N 124.464 1.102 . . . . 0.0 111.977 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 -38.94 62.16 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -61.91 -37.6 85.24 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.5 mt -68.81 -42.35 82.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.127 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.7 mttt -58.58 -33.55 70.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.87 -54.82 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.6 mt -53.12 -49.34 66.74 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 123.268 0.355 . . . . 0.0 111.178 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 86.4 mt -56.65 -48.19 78.12 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 123.404 0.44 . . . . 0.0 110.224 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -59.7 -38.76 82.47 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.71 -30.32 64.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.856 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.43 1.09 55.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.362 0.601 . . . . 0.0 112.03 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 67.3 35.05 4.55 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.489 1.516 . . . . 0.0 112.497 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.54 136.76 19.13 Favored Pre-proline 0 N--CA 1.411 -2.407 0 C-N-CA 124.802 1.241 . . . . 0.0 107.8 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.13 133.0 50.24 Favored 'Trans proline' 0 CA--C 1.495 -1.445 0 C-N-CA 121.999 1.799 . . . . 0.0 110.861 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -62.05 -9.85 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.115 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.05 -19.2 64.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.277 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -82.21 -5.51 58.55 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.9 p -48.01 -29.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 125.759 1.623 . . . . 0.0 110.975 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -48.95 77.54 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.977 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.0 m -99.78 12.96 35.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.843 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.3 m-85 -115.78 140.28 49.37 Favored 'General case' 0 CA--C 1.473 -1.992 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.163 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -156.07 152.36 27.93 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.434 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.71 127.99 33.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.859 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.609 HE21 ' HE1' ' A' ' 76' ' ' TYR . 21.5 tt0 -111.04 144.53 40.01 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -73.87 125.18 90.52 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 -19.97 64.43 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.177 2.585 . . . . 0.0 114.84 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.79 -44.79 4.55 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.935 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.8 p -90.78 -15.18 30.59 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.89 18.96 11.71 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.799 1.24 . . . . 0.0 111.262 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.47 136.38 38.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.734 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.609 ' HE1' HE21 ' A' ' 69' ' ' GLN . 8.6 m-85 -92.77 147.76 22.6 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.385 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.9 105.99 17.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -107.07 13.87 26.96 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.799 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.23 163.97 27.04 Favored 'General case' 0 CA--C 1.461 -2.451 0 CA-C-O 122.719 1.247 . . . . 0.0 112.755 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.7 m -88.3 -38.92 14.79 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-N 112.6 -2.091 . . . . 0.0 109.129 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -131.85 149.21 52.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.857 0.863 . . . . 0.0 110.17 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 45' ' ' VAL . 21.5 mt -86.15 152.61 22.7 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.796 0.838 . . . . 0.0 111.786 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 62.0 p -103.05 155.92 36.0 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.73 -31.49 91.99 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.017 1.812 . . . . 0.0 109.411 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.7 -44.6 96.63 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.475 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 2.3 mmp_? -60.25 -38.8 84.59 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 58.0 mt -67.31 -47.63 69.99 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.699 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.607 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 42.9 t -62.74 -47.65 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 176.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 45.9 mt-10 -62.69 -30.8 71.67 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 111.664 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.43 58.27 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.909 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 3.0 mm-40 -59.08 -22.88 61.5 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -54.69 -38.74 67.38 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.097 172.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.4 m -144.76 -78.89 0.19 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.37 -177.27 4.4 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.699 1.2 . . . . 0.0 108.568 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.46 151.1 39.79 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.3 102.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.555 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.02 107.41 10.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -126.42 159.2 33.95 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.901 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 62.9 mtp . . . . . 0 N--CA 1.4 -2.97 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 121.136 0.493 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 13.0 mmt -123.78 140.84 52.59 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.293 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' HD13 ' A' ' 38' ' ' ILE . 28.5 ttpt -98.95 95.68 7.32 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.232 1.015 . . . . 0.0 108.953 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -105.45 139.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.243 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.8 mmt180 -65.76 131.86 47.33 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-O 121.139 0.495 . . . . 0.0 110.04 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.5 t -117.01 126.16 74.28 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.734 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.265 33.6 mt-10 -86.02 150.1 24.7 Favored 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 116.642 -2.023 . . . . 0.0 107.185 167.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -121.94 130.84 53.65 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.071 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 CA--C 1.543 0.962 0 N-CA-C 110.047 -0.789 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 25.5 p -136.08 152.43 50.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.506 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -148.35 151.43 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 m -100.93 105.95 17.24 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -113.09 140.81 47.56 Favored 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.503 -171.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.251 36.3 mm -76.84 111.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 179.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.74 145.96 39.61 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -148.42 -170.74 3.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.9 17.58 7.65 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -108.71 -28.94 8.95 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.689 0.757 . . . . 0.0 109.719 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -100.45 132.06 46.04 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.772 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.59 151.23 4.41 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.524 0.73 . . . . 0.0 111.875 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.55 -54.28 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.996 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.72 -30.46 65.55 Favored 'General case' 0 C--O 1.204 -1.301 0 O-C-N 124.221 0.951 . . . . 0.0 112.525 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -73.66 -37.05 65.42 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.079 -0.388 . . . . 0.0 110.033 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -62.77 -39.59 94.64 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 42.8 mt -68.52 -41.82 83.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.31 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -58.39 -34.66 70.98 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 119.047 0.84 . . . . 0.0 110.759 174.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.7 t -68.7 -54.13 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.3 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.85 -47.33 74.31 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.215 0.322 . . . . 0.0 111.191 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.1 mt -57.59 -46.87 83.48 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 123.377 0.423 . . . . 0.0 109.977 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -59.35 -40.69 87.19 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.16 -32.78 67.18 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 47.2 m-85 -83.94 -5.75 59.28 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.387 0.613 . . . . 0.0 111.296 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp 69.28 45.99 0.82 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 126.287 1.835 . . . . 0.0 112.983 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.99 135.88 21.26 Favored Pre-proline 0 N--CA 1.404 -2.739 0 C-N-CA 125.782 1.633 . . . . 0.0 107.286 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.36 134.64 62.13 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.142 1.895 . . . . 0.0 111.373 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.3 m -63.77 -10.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.176 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.94 -15.84 63.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.726 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.5 mptp? -85.0 -4.04 59.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.83 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.1 p -47.05 -31.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 126.08 1.752 . . . . 0.0 110.296 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.4 m -55.78 -47.02 77.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.744 1.618 . . . . 0.0 110.849 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -100.72 12.66 37.02 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.33 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.4 m-85 -113.28 143.24 44.75 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.906 -0.496 . . . . 0.0 111.654 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.35 147.54 28.43 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.838 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -83.54 125.64 31.98 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 124.26 0.975 . . . . 0.0 108.415 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -112.77 147.77 36.19 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.22 129.91 70.94 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.08 -20.63 67.75 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.82 2.347 . . . . 0.0 115.179 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -103.71 -44.89 4.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.984 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 p -89.5 -20.55 23.7 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.851 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt 67.24 17.27 10.26 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.599 1.159 . . . . 0.0 111.821 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.2 39.18 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.53 154.26 17.38 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.45 110.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -102.32 11.58 37.89 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.546 0.689 . . . . 0.0 110.424 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.17 156.85 36.89 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.934 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.6 m -81.73 -38.59 25.49 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.618 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.46 149.27 52.21 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 124.194 0.997 . . . . 0.0 108.657 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.66 155.07 28.22 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.554 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 73.0 p -109.35 153.32 42.8 Favored Pre-proline 0 N--CA 1.401 -2.899 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HG2' ' OE2' ' A' ' 85' ' ' GLU . 8.6 Cg_endo -53.94 -37.56 85.87 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.553 2.169 . . . . 0.0 110.386 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 mp0 -60.09 -44.43 94.8 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 4.0 mmp_? -61.7 -40.4 94.9 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 83' ' ' THR . 66.3 mt -66.29 -47.12 74.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.711 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.76 -46.3 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.585 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 86' ' ' ARG . 49.7 mt-10 -63.78 -31.8 73.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 111.451 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.82 61.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.622 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -57.33 -24.9 58.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.188 0.595 . . . . 0.0 111.934 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 67.0 mttm -56.17 -35.62 67.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.506 1.122 . . . . 0.0 112.534 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.1 m -146.79 -85.1 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.61 -178.82 7.38 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.297 1.039 . . . . 0.0 108.843 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.35 149.27 42.11 Favored 'General case' 0 C--O 1.209 -1.075 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 169.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 98' ' ' ARG . 9.7 mt -116.63 101.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 118.821 0.737 . . . . 0.0 110.325 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -79.39 102.99 9.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 96' ' ' ILE . 25.0 mtp180 -119.99 161.05 21.57 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 46.8 mtp . . . . . 0 N--CA 1.413 -2.284 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.424 -1.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 12.0 mmt -127.96 142.07 51.35 Favored 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -99.13 97.57 8.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -109.4 138.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.17 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 87.9 mtt180 -69.3 130.79 43.57 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.364 0.602 . . . . 0.0 110.683 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 48.3 t -116.83 123.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.561 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.607 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.259 35.6 mt-10 -84.69 142.4 29.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.622 -2.031 . . . . 0.0 107.711 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.4 tm? -115.38 130.73 56.98 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.972 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--O 1.246 0.895 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.48 0.721 0 N-CA-C 109.422 -1.03 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.6 m -143.61 159.89 41.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.792 -0.567 . . . . 0.0 109.623 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -151.69 150.39 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -97.35 106.72 19.09 Favored 'General case' 0 N--CA 1.394 -3.261 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 173.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -110.2 145.42 37.32 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.132 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.254 50.2 mm -83.28 109.89 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.85 144.51 39.76 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -152.41 169.21 23.11 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 124.235 1.014 . . . . 0.0 108.534 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.65 17.98 53.93 Favored Glycine 0 C--N 1.282 -2.465 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -104.95 -30.03 10.08 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-O 121.715 0.769 . . . . 0.0 109.963 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.681 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 31.6 m -97.75 137.39 36.7 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 124.793 1.237 . . . . 0.0 108.564 175.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.04 149.34 12.1 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-O 121.517 0.675 . . . . 0.0 110.44 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.6 t -55.74 -53.92 31.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.096 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -57.4 -31.1 65.5 Favored 'General case' 0 C--O 1.208 -1.107 0 O-C-N 124.159 0.912 . . . . 0.0 111.818 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -74.16 -36.64 64.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 122.344 -0.223 . . . . 0.0 110.813 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.681 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 91.3 m-70 -62.76 -39.06 92.99 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.7 mt -68.67 -43.12 83.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.473 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.7 mttt -58.51 -31.88 68.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.733 0.697 . . . . 0.0 110.899 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 47' ' ' ASP . 91.1 t -68.61 -54.31 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.417 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -53.14 -48.76 67.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 122.502 0.321 . . . . 0.0 111.013 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.0 mt -57.73 -49.07 77.79 Favored 'General case' 0 C--O 1.195 -1.815 0 O-C-N 123.654 0.596 . . . . 0.0 109.811 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 m -59.72 -38.51 81.87 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -72.68 -31.91 65.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 47.6 m-85 -83.09 -7.09 59.69 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.188 0.518 . . . . 0.0 111.334 173.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 72.02 38.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.62 1.568 . . . . 0.0 112.237 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' CG2' ' HD2' ' A' ' 62' ' ' LYS . 75.1 mt -105.89 134.79 19.57 Favored Pre-proline 0 N--CA 1.409 -2.517 0 C-N-CA 125.345 1.458 . . . . 0.0 107.865 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.01 131.39 46.15 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.339 2.026 . . . . 0.0 111.325 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.6 m -62.42 -11.04 5.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.553 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.43 -14.65 62.22 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HD2' ' CG2' ' A' ' 58' ' ' ILE . 66.9 mttm -81.62 -9.96 59.54 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.827 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.3 p -47.27 -31.33 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 127.257 2.223 . . . . 0.0 110.343 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 m -54.41 -46.24 73.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.564 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' MET . 14.8 t -94.41 -0.64 54.68 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.823 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 20.0 m-85 -101.14 139.05 37.36 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.714 -1.194 . . . . 0.0 112.315 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 142.24 24.55 Favored 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.646 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 97' ' ' LEU . 79.2 mt -79.0 126.41 30.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.7 148.57 38.06 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.82 128.0 73.09 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.08 -17.64 40.55 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 122.553 2.169 . . . . 0.0 114.828 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.85 -43.28 5.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.209 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 p -91.25 -18.86 23.7 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.62 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 mt 69.45 17.62 8.02 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.382 1.073 . . . . 0.0 111.671 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.96 140.82 30.79 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.55 150.83 19.85 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 120.959 0.409 . . . . 0.0 110.692 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.7 t -87.9 106.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.08 16.69 23.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.403 1.097 . . . . 0.0 109.836 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.49 158.26 32.84 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.75 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.65 -38.13 20.2 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.29 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -131.58 144.82 51.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.272 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.8 mt -78.96 152.74 30.87 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.777 0.798 . . . . 0.0 110.632 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.9 p -106.32 152.21 40.47 Favored Pre-proline 0 N--CA 1.398 -3.051 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.44 -31.69 92.01 Favored 'Trans proline' 0 C--O 1.208 -0.977 0 C-N-CA 122.287 1.992 . . . . 0.0 109.865 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.24 -47.81 82.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.458 0.703 . . . . 0.0 110.644 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 3.7 mmp_? -62.54 -37.27 85.46 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.893 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 83' ' ' THR . 57.7 mt -66.92 -47.29 72.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.385 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.97 -46.06 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.126 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -64.27 -30.98 72.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.659 0.742 . . . . 0.0 111.209 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.09 -34.09 59.52 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.623 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.43 -24.39 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -53.67 -40.22 65.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.102 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m -143.05 -80.69 0.2 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.64 -179.29 6.77 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.788 1.235 . . . . 0.0 108.947 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -119.1 155.52 31.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 12.4 mt -115.83 134.59 58.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -107.78 99.8 9.23 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -176.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -121.5 162.3 20.77 Favored 'General case' 0 CA--C 1.46 -2.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.018 -172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' SER . 54.4 mtp . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 169.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.708 0.29 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mmt -118.26 139.72 50.89 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.583 ' HD3' ' CD1' ' A' ' 38' ' ' ILE . 36.5 tptt -100.55 100.19 10.89 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.32 136.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.287 -170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 62.6 mtm180 -69.26 135.94 51.22 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-O 121.567 0.699 . . . . 0.0 110.754 171.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' SER . 62.3 t -121.11 124.54 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.571 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.272 29.8 mt-10 -85.9 138.82 31.75 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.907 -1.917 . . . . 0.0 108.228 168.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -115.99 129.61 56.45 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 178.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.411 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp . . . . . 0 C--O 1.248 1.001 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.718 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 111.662 -0.168 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 30.6 m -138.91 159.54 41.9 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.729 -0.607 . . . . 0.0 112.128 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.0 p -151.93 150.92 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -95.92 115.82 28.0 Favored 'General case' 1 N--CA 1.378 -4.055 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 171.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -115.23 142.57 46.49 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.399 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 31.1 mm -79.39 110.82 15.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.01 141.38 42.9 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' O ' ' HE1' ' A' ' 48' ' ' HIS . 7.9 p-10 -145.99 160.34 42.0 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.274 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.4 20.34 51.1 Favored Glycine 0 C--N 1.281 -2.496 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.812 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -110.19 -24.97 10.41 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 121.701 0.763 . . . . 0.0 109.815 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.4 m -103.23 137.19 41.71 Favored 'General case' 0 N--CA 1.401 -2.875 0 C-N-CA 124.274 1.03 . . . . 0.0 109.436 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.18 152.6 13.36 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.692 0.758 . . . . 0.0 111.69 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.4 t -56.26 -54.83 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.129 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -57.07 -30.39 64.26 Favored 'General case' 0 C--O 1.207 -1.183 0 O-C-N 124.31 1.006 . . . . 0.0 111.387 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 m-20 -75.48 -37.4 60.26 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.593 ' HE1' ' O ' ' A' ' 40' ' ' ASP . 37.6 m80 -61.36 -39.28 90.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.2 mt -67.38 -43.35 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.072 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 63' ' ' VAL . 93.1 mttt -57.28 -35.22 69.51 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.036 0.835 . . . . 0.0 110.936 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 97.1 t -69.0 -53.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.322 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -53.14 -48.86 67.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 123.357 0.411 . . . . 0.0 110.982 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.7 mt -57.65 -47.75 81.39 Favored 'General case' 0 C--O 1.202 -1.428 0 O-C-N 123.408 0.443 . . . . 0.0 110.048 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 m -58.92 -40.97 86.18 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -71.21 -35.02 71.37 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.187 0.517 . . . . 0.0 112.19 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.552 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 46.1 m-85 -79.46 -2.17 40.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.241 0.543 . . . . 0.0 111.332 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 70.54 36.43 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.205 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -107.31 138.39 19.89 Favored Pre-proline 0 N--CA 1.415 -2.201 0 C-N-CA 125.277 1.431 . . . . 0.0 107.81 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.93 133.14 56.06 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 121.805 1.67 . . . . 0.0 110.638 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.8 m -62.77 -10.04 4.99 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.512 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.09 -19.6 65.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.0 110.125 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.4 mptp? -80.61 -8.06 59.48 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.765 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.2 p -47.97 -33.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 C-N-CA 125.548 1.539 . . . . 0.0 110.052 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.256 14.4 m -54.42 -48.17 71.95 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 126.184 1.794 . . . . 0.0 109.907 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 99' ' ' MET . 25.4 m -100.49 14.47 31.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.09 -1.413 . . . . 0.0 112.179 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.0 m-85 -112.26 139.06 48.11 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.376 0.608 . . . . 0.0 112.05 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.91 141.99 24.9 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.779 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 90.0 mt -76.06 159.13 31.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.38 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 45.5 tt0 -143.25 150.5 39.37 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.16 128.96 71.6 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.18 -15.72 43.21 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.763 2.309 . . . . 0.0 115.226 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -109.37 -45.52 3.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.756 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -88.97 -17.62 29.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.465 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt 70.91 15.02 6.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.494 1.117 . . . . 0.0 112.683 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.96 137.46 38.33 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.048 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 3.9 m-85 -85.1 174.21 9.87 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.045 0.45 . . . . 0.0 111.61 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.35 107.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.51 12.34 26.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.004 0.907 . . . . 0.0 110.293 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.38 157.58 33.99 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.73 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -84.33 -40.81 17.47 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.042 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.92 152.35 49.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 123.774 0.829 . . . . 0.0 109.409 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 45' ' ' VAL . 18.0 mt -88.34 148.59 24.2 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.517 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.1 p -99.49 152.9 37.96 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.35 -35.66 92.11 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.704 2.269 . . . . 0.0 110.125 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.39 -48.96 77.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.482 0.713 . . . . 0.0 110.511 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -61.48 -37.27 83.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 123.304 0.377 . . . . 0.0 111.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 63.6 mt -64.85 -47.98 75.96 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.694 0.621 . . . . 0.0 110.578 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -63.99 -44.83 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -61.68 -27.68 68.86 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.798 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.43 -36.33 24.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -53.93 -24.56 16.73 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -50.29 -39.81 46.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.724 0.81 . . . . 0.0 111.021 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.6 m -147.74 -92.35 0.08 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.46 178.46 8.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.512 0.725 . . . . 0.0 109.424 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.65 154.41 30.59 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 14.3 mt -116.33 139.78 41.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 170.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -116.22 109.12 17.0 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -127.95 160.88 30.5 Favored 'General case' 0 CA--C 1.467 -2.248 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 54.8 mtp . . . . . 0 N--CA 1.397 -3.08 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.8 mmt -118.31 138.47 52.37 Favored 'General case' 0 CA--C 1.47 -2.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.909 -172.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 76.4 tttt -97.18 93.07 6.34 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.86 140.08 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.211 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 86.2 mtt180 -70.13 129.62 39.91 Favored 'General case' 0 CA--C 1.475 -1.932 0 O-C-N 123.516 0.51 . . . . 0.0 110.113 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' SER . 41.2 t -115.49 124.74 72.3 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.546 0 CA-C-O 117.675 -1.155 . . . . 0.0 108.092 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.268 47.0 mt-10 -85.54 145.39 27.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 116.829 -1.948 . . . . 0.0 107.764 168.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -116.14 131.66 56.88 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.078 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.314 -0.971 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.447 -1.238 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.1 p -140.56 162.16 36.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.263 -171.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -151.37 149.45 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.0 m -98.23 107.36 19.82 Favored 'General case' 0 N--CA 1.386 -3.645 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -113.93 146.59 39.87 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.469 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.73 112.02 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.96 146.04 39.73 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.3 173.95 14.93 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 123.535 0.734 . . . . 0.0 109.159 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.54 14.98 56.36 Favored Glycine 0 C--N 1.304 -1.228 0 O-C-N 124.413 1.071 . . . . 0.0 112.825 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -108.97 -32.11 7.38 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 121.209 0.528 . . . . 0.0 112.063 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.8 m -93.72 134.2 36.29 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.59 0.756 . . . . 0.0 109.317 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.77 149.1 6.53 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.041 0.936 . . . . 0.0 110.942 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.7 t -55.29 -53.14 38.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.523 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -59.36 -28.36 66.78 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.434 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 m-20 -73.35 -39.1 65.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -61.89 -38.48 88.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.3 mt -69.22 -43.99 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.13 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.2 mttt -56.91 -34.18 67.67 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 118.985 0.811 . . . . 0.0 110.603 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 47' ' ' ASP . 96.2 t -69.17 -55.51 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.445 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.1 -49.19 66.99 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 123.301 0.375 . . . . 0.0 111.55 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.46 -48.55 76.84 Favored 'General case' 0 C--O 1.201 -1.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.138 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.7 m -59.81 -36.79 77.49 Favored 'General case' 0 N--CA 1.397 -3.109 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -73.43 -32.13 64.22 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 43.9 m-85 -84.64 -3.95 58.76 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 122.883 0.473 . . . . 0.0 111.688 174.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 70.49 35.76 1.87 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.219 1.408 . . . . 0.0 112.718 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.3 mt -105.23 132.1 21.17 Favored Pre-proline 0 N--CA 1.409 -2.511 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.82 135.36 62.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.07 1.847 . . . . 0.0 111.267 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -62.32 -9.52 3.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.904 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -68.01 -16.39 64.02 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 120.874 0.368 . . . . 0.0 110.11 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.58 -5.11 58.39 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.619 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.3 p -47.6 -33.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 C-N-CA 125.933 1.693 . . . . 0.0 110.995 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.276 15.3 m -54.8 -48.56 72.58 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 126.061 1.745 . . . . 0.0 110.444 174.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.7 m -102.11 17.73 22.56 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.821 -172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.4 m-85 -116.76 142.65 46.64 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.73 146.44 25.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.222 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 85.9 mt -79.61 126.39 30.83 Favored 'General case' 0 N--CA 1.418 -2.057 0 O-C-N 124.71 1.256 . . . . 0.0 107.846 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 98' ' ' ARG . 38.8 tt0 -114.21 147.8 38.37 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.05 125.7 84.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -8.34 22.61 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 122.655 2.237 . . . . 0.0 115.169 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.47 -40.75 3.56 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.298 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.2 p -90.44 -20.79 22.35 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.069 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt 70.59 18.91 6.33 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.797 1.239 . . . . 0.0 111.977 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.28 140.86 30.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.634 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' OH ' ' HD3' ' A' ' 98' ' ' ARG . 80.9 m-85 -98.14 144.53 27.51 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.822 0.344 . . . . 0.0 110.23 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.15 106.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -100.26 12.14 37.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.062 0.934 . . . . 0.0 110.362 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.15 152.21 34.98 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.371 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.9 m -79.12 -36.98 39.73 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.152 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.34 143.83 50.8 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.115 0.966 . . . . 0.0 108.806 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.9 mt -77.49 157.54 30.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.39 0.614 . . . . 0.0 111.257 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.0 p -111.71 153.64 44.27 Favored Pre-proline 0 N--CA 1.409 -2.477 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.28 -34.93 72.29 Favored 'Trans proline' 0 C--O 1.21 -0.91 0 C-N-CA 122.35 2.034 . . . . 0.0 110.349 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.86 -48.49 77.98 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 4.1 mmp_? -61.11 -38.85 87.8 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.369 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 52.4 mt -67.69 -48.09 67.55 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.727 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.22 -47.56 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.26 -29.66 70.46 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.253 0.549 . . . . 0.0 111.784 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.45 -37.03 60.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.78 -24.23 48.89 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -53.0 -43.79 66.74 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -137.63 -82.46 0.34 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.22 178.55 6.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.16 1.384 . . . . 0.0 108.489 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 155.07 30.4 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 11.7 mt -115.39 138.51 45.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 99.26 7.06 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 69' ' ' GLN . 44.0 mtp180 -119.67 162.63 18.69 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 41.2 mtp . . . . . 0 N--CA 1.393 -3.288 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 44.6 mtt -114.13 139.41 49.35 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.566 -170.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -100.36 96.87 7.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.43 138.58 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.851 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 17.3 mtp180 -68.21 131.13 44.83 Favored 'General case' 0 CA--C 1.46 -2.503 0 CA-C-O 122.146 0.974 . . . . 0.0 111.947 170.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.5 t -118.15 123.51 71.73 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.361 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.155 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 11' ' ' ARG 0.272 0.5 OUTLIER -83.98 149.42 26.31 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.213 166.451 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -123.34 130.66 53.03 Favored 'General case' 0 C--N 1.265 -3.08 0 O-C-N 123.469 0.481 . . . . 0.0 111.084 176.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp . . . . . 0 C--O 1.245 0.848 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.29 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 CA--C 1.539 0.73 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.2 m -138.6 155.79 48.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.1 p -147.98 150.2 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.4 m -98.11 105.36 17.5 Favored 'General case' 0 N--CA 1.387 -3.616 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -109.59 147.79 32.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.402 -170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.9 113.84 23.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.31 146.0 40.13 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.36 -171.89 3.68 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.58 -11.44 11.6 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.559 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -83.07 -26.11 31.41 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 124.197 0.999 . . . . 0.0 111.996 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.444 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 36.7 m -96.2 131.7 42.4 Favored 'General case' 0 N--CA 1.388 -3.561 0 C-N-CA 123.793 0.837 . . . . 0.0 109.631 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 149.57 9.0 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.867 0.73 . . . . 0.0 110.844 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.6 t -55.66 -51.78 54.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.87 -31.0 64.37 Favored 'General case' 0 C--O 1.202 -1.427 0 O-C-N 124.381 1.05 . . . . 0.0 111.387 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.0 m-20 -75.42 -38.9 59.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.444 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 39.3 m80 -61.71 -40.23 94.29 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.8 mt -68.34 -42.46 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.13 -34.36 70.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.89 0.768 . . . . 0.0 110.977 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.0 t -68.97 -53.38 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.4 -48.28 68.8 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.22 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.8 mt -57.84 -48.39 79.9 Favored 'General case' 0 C--O 1.193 -1.91 0 O-C-N 123.538 0.523 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -60.14 -38.91 84.54 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -72.11 -30.4 65.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.1 -0.375 . . . . 0.0 111.52 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 41.2 m-85 -88.56 -0.24 57.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.377 0.608 . . . . 0.0 112.201 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 69.0 32.46 3.77 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.661 1.584 . . . . 0.0 112.28 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -103.16 135.6 19.37 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.86 133.02 53.32 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.96 1.773 . . . . 0.0 111.918 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.0 m -62.59 -9.27 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.795 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.98 -18.38 62.62 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.634 0.731 . . . . 0.0 109.585 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -82.4 -9.99 59.23 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.903 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.7 p -46.04 -31.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 126.902 2.081 . . . . 0.0 110.741 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 m -54.67 -45.97 73.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.903 1.681 . . . . 0.0 111.067 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.4 t -97.96 0.33 46.22 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.618 -173.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -103.59 137.23 41.94 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.405 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.25 145.45 31.28 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.567 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.54 123.93 29.65 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -111.07 148.48 32.54 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -82.37 126.71 73.38 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 18.6 Cg_endo -60.63 -23.62 76.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.419 2.746 . . . . 0.0 114.82 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -103.84 -46.17 4.57 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.47 -1.292 . . . . 0.0 112.855 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -88.01 -17.1 31.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.557 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt 66.42 18.21 10.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 111.285 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.95 138.24 35.0 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.145 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -96.16 143.99 26.79 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.3 102.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.1 13.98 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 123.037 1.398 . . . . 0.0 108.537 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.55 158.56 31.08 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.999 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.5 m -84.88 -37.82 20.17 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.824 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -129.58 155.4 45.87 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.965 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.76 147.15 23.42 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.174 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.0 p -98.99 151.06 37.23 Favored Pre-proline 0 N--CA 1.401 -2.913 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.51 -33.85 93.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.245 1.963 . . . . 0.0 109.975 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.56 -47.41 85.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -61.3 -36.01 78.9 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.689 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 68.2 mt -64.09 -50.15 69.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.697 0.623 . . . . 0.0 110.485 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.24 -43.36 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.77 -32.99 69.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.76 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.11 -42.43 23.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.681 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 11.7 mt-10 -52.2 -25.28 8.76 Favored 'General case' 0 C--N 1.369 1.441 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.52 -36.81 62.18 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 124.367 1.067 . . . . 0.0 112.258 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -143.99 -83.14 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -165.92 -178.75 4.88 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.668 0.787 . . . . 0.0 109.263 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.12 148.29 43.22 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.404 HG22 ' HG2' ' A' ' 98' ' ' ARG . 10.9 mt -114.95 100.69 11.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.621 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.79 103.24 8.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' HG2' HG22 ' A' ' 96' ' ' ILE . 30.0 mtp180 -126.34 162.48 25.41 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.685 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 45.5 mtp . . . . . 0 N--CA 1.405 -2.69 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.484 0.659 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 42.3 mtt -115.57 141.09 48.53 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.494 -172.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -99.63 95.07 6.72 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.86 138.69 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.849 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 54.9 mtm-85 -69.39 131.53 44.93 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-O 121.623 0.725 . . . . 0.0 110.841 172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' SER . 46.7 t -119.19 124.07 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.578 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.216 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 12' ' ' VAL . 31.4 mm-40 -81.18 158.88 24.77 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -130.81 133.17 45.73 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 122.074 -0.391 . . . . 0.0 111.091 175.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--O 1.243 0.745 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.457 -0.646 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 5.5 p -140.52 161.04 38.68 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.46 149.07 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -97.69 105.28 17.4 Favored 'General case' 0 N--CA 1.389 -3.513 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -109.11 147.28 32.69 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.103 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -83.26 110.67 18.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.06 149.02 34.01 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -149.48 -169.72 3.45 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.35 15.1 8.73 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -106.59 -34.19 7.43 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.677 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -93.97 134.35 36.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 C-N-CA 124.152 0.981 . . . . 0.0 108.376 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.56 151.72 7.63 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.563 0.697 . . . . 0.0 111.589 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 82' ' ' LEU . 98.5 t -55.27 -54.58 23.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.734 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -56.89 -30.43 63.88 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.628 -177.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.7 m-20 -73.79 -37.44 64.95 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.962 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -62.43 -38.67 90.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.4 mt -67.81 -44.22 85.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 63' ' ' VAL . 95.9 mttt -57.47 -34.16 68.73 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.843 0.747 . . . . 0.0 111.129 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 47' ' ' ASP . 85.7 t -69.05 -54.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.66 -49.19 68.48 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.657 0.383 . . . . 0.0 111.471 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.1 mt -57.25 -47.41 81.46 Favored 'General case' 0 C--O 1.195 -1.806 0 O-C-N 123.38 0.425 . . . . 0.0 110.05 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.68 -38.37 84.73 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -70.61 -37.83 73.9 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.975 0.417 . . . . 0.0 111.514 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 57.0 m-85 -78.81 -9.52 59.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.389 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm 74.42 39.74 0.45 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.87 1.268 . . . . 0.0 112.584 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.73 140.92 22.3 Favored Pre-proline 0 N--CA 1.411 -2.382 0 C-N-CA 125.74 1.616 . . . . 0.0 107.622 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.97 134.47 53.36 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 122.222 1.948 . . . . 0.0 111.087 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.4 m -63.28 -9.63 5.13 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.89 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.801 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.48 -14.83 62.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.0 110.221 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 65.1 mttm -88.98 -6.46 57.22 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.844 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.1 p -49.62 -29.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 126.287 1.835 . . . . 0.0 109.773 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 p -54.08 -51.14 65.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.237 1.815 . . . . 0.0 110.977 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' MET . 5.8 m -98.03 6.91 47.1 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.881 -171.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 16.8 m-85 -107.79 143.55 36.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.342 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.31 145.04 25.92 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.29 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 83.9 mt -80.97 128.13 33.34 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -118.09 149.8 40.41 Favored 'General case' 0 C--N 1.28 -2.452 0 O-C-N 122.161 -0.337 . . . . 0.0 110.101 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -81.77 132.72 53.74 Favored Pre-proline 0 C--N 1.313 -0.982 0 O-C-N 124.385 1.053 . . . . 0.0 108.276 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.48 -19.38 48.98 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.14 2.56 . . . . 0.0 115.105 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -105.01 -40.26 5.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.735 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -95.98 -19.51 19.44 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.328 0.585 . . . . 0.0 111.239 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.89 22.62 12.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.394 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.35 140.96 33.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.716 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.76 144.52 26.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.593 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.13 102.69 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.55 13.57 31.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.824 1.297 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.75 157.04 34.02 Favored 'General case' 0 N--CA 1.405 -2.696 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.647 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.0 m -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.875 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.33 147.91 52.09 Favored 'General case' 0 N--CA 1.418 -2.069 0 C-N-CA 124.041 0.936 . . . . 0.0 108.562 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.0 mt -79.16 154.8 29.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.11 0.481 . . . . 0.0 110.208 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 p -104.71 151.59 39.33 Favored Pre-proline 0 N--CA 1.399 -2.983 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.94 -31.59 93.1 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.173 1.915 . . . . 0.0 109.727 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.66 -48.66 78.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.494 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.84 -36.39 83.06 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.4 mt -64.3 -48.79 74.29 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.496 0.498 . . . . 0.0 110.18 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.62 -46.46 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -60.85 -32.87 72.26 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 112.209 171.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.82 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.48 -27.05 35.0 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 89' ' ' GLU . 95.7 mttt -54.96 -31.38 60.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.284 1.034 . . . . 0.0 112.083 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.8 m -143.81 -86.76 0.13 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -167.38 178.79 5.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.003 1.321 . . . . 0.0 108.527 -176.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -114.89 159.71 20.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 2.9 mp -120.22 141.61 39.71 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.781 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 167.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 98.38 6.73 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -115.69 161.21 19.03 Favored 'General case' 0 CA--C 1.464 -2.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.071 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.3 mtp . . . . . 0 N--CA 1.391 -3.403 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 165.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.41 -2.466 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.495 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.6 mmt -110.08 141.43 42.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.394 -170.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 64.7 tttt -101.62 95.75 6.65 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 90' ' ' ALA . 86.2 mt -105.51 140.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.334 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -70.9 134.18 47.05 Favored 'General case' 0 CA--C 1.466 -2.283 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.867 173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.85 123.36 71.58 Favored 'Isoleucine or valine' 2 N--CA 1.37 -4.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.6 OUTLIER -84.49 148.49 26.51 Favored 'General case' 0 N--CA 1.407 -2.581 0 C-N-CA 116.25 -2.18 . . . . 0.0 107.843 167.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -115.0 134.38 55.24 Favored 'General case' 0 C--N 1.278 -2.517 0 O-C-N 123.28 0.362 . . . . 0.0 110.6 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.4 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--O 1.251 1.165 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--O 1.239 0.534 0 N-CA-C 109.614 -0.956 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -139.12 159.8 41.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.5 p -150.37 151.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 m -99.44 107.25 19.42 Favored 'General case' 0 N--CA 1.39 -3.445 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 41.1 t-80 -112.56 146.57 38.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.916 -170.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.27 111.31 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -112.36 144.82 41.15 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 2.8 p30 -146.02 -168.52 3.01 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.13 -9.45 8.05 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.91 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 40' ' ' ASP . 2.0 mp0 -82.46 -26.86 32.27 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.81 0.814 . . . . 0.0 110.683 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 26.5 m -95.98 129.53 43.22 Favored 'General case' 0 N--CA 1.383 -3.825 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.12 149.24 9.76 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.525 0.679 . . . . 0.0 110.99 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 82' ' ' LEU . 99.0 t -53.05 -53.8 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.313 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -54.88 -32.16 60.55 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 124.612 1.195 . . . . 0.0 111.722 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 22.8 m-20 -78.79 -34.32 45.59 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.906 -0.496 . . . . 0.0 111.635 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 38.6 m80 -62.24 -39.36 92.59 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.1 mt -66.51 -42.91 90.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -56.02 -37.81 69.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.683 0.674 . . . . 0.0 110.672 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.9 t -67.07 -53.22 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.093 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -54.31 -47.75 72.11 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 123.311 0.382 . . . . 0.0 110.902 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -56.92 -49.03 76.86 Favored 'General case' 0 C--O 1.194 -1.863 0 O-C-N 123.519 0.512 . . . . 0.0 109.816 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -60.28 -37.82 81.68 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -74.06 -29.3 61.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.172 0.51 . . . . 0.0 111.867 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.55 0.98 55.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.476 0.655 . . . . 0.0 111.947 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 67.18 40.8 2.73 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.48 1.512 . . . . 0.0 113.124 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.87 136.93 20.72 Favored Pre-proline 0 N--CA 1.404 -2.766 0 C-N-CA 124.679 1.192 . . . . 0.0 108.385 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.05 134.61 63.3 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.606 2.204 . . . . 0.0 110.828 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 34.3 m -63.33 -9.85 5.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.487 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.627 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.63 -14.33 62.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.649 0.737 . . . . 0.0 110.692 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -87.26 -5.87 58.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.029 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -48.87 -31.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 126.787 2.035 . . . . 0.0 110.756 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 m -55.86 -46.11 78.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.094 1.358 . . . . 0.0 110.59 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' MET . 22.2 m -101.71 14.83 30.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.876 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.4 m-85 -115.49 144.05 44.41 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 121.789 -0.569 . . . . 0.0 111.627 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.29 156.14 31.93 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.93 133.38 33.94 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.05 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.76 149.05 42.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -81.04 131.65 58.98 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 Cg_endo -66.35 -25.73 48.96 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.611 2.207 . . . . 0.0 114.893 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.22 -44.05 5.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.402 -0.919 . . . . 0.0 113.167 -174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.03 -20.09 24.82 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.728 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 69.45 16.48 8.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.256 1.022 . . . . 0.0 111.797 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.92 37.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -92.75 152.08 19.69 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.61 103.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.86 10.62 32.46 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.144 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -76.79 159.17 30.33 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -82.92 -38.94 22.14 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.116 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.04 156.03 44.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -93.03 143.98 25.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.076 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 77.5 p -93.44 153.72 41.37 Favored Pre-proline 0 N--CA 1.409 -2.485 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.09 -32.0 94.49 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.896 1.731 . . . . 0.0 109.138 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -46.14 90.92 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.053 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.489 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 7.1 mmm180 -58.86 -39.35 81.06 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.569 0.223 . . . . 0.0 111.349 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 8' ' ' MET . 62.9 mt -64.39 -46.56 82.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 124.095 0.872 . . . . 0.0 110.359 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.2 -45.53 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -80.88 -37.14 30.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -54.33 -24.28 18.68 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -51.21 -43.98 61.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.14 0.576 . . . . 0.0 110.586 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 m -142.48 -86.75 0.15 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -157.3 -178.93 7.72 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.996 0.918 . . . . 0.0 109.427 -177.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.09 148.32 44.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -114.23 100.34 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.303 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.78 103.72 8.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -122.59 162.09 22.49 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.573 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.4 mtp . . . . . 0 N--CA 1.398 -3.048 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.434 -1.226 0 CA-C-O 121.786 0.803 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.521 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.2 mmt -115.55 140.43 49.17 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.143 -170.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 76.1 tttt -97.5 96.42 8.32 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.35 138.5 31.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.762 -172.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -69.74 133.69 47.77 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.293 0.568 . . . . 0.0 110.341 172.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -118.07 121.57 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.885 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.374 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 39.6 mt-10 -80.37 147.17 31.15 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.774 168.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -116.83 131.89 56.84 Favored 'General case' 0 C--N 1.272 -2.771 0 O-C-N 123.294 0.371 . . . . 0.0 110.612 175.063 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.453 0 N-CA-C 110.012 -0.803 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.7 m -138.25 163.99 30.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.175 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -150.3 148.57 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 5.1 m -96.72 107.37 19.82 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -112.87 145.45 40.67 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.347 -170.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 49.8 mm -83.15 112.48 20.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -112.11 143.16 43.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -147.28 166.89 25.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 O-C-N 124.652 1.22 . . . . 0.0 108.693 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 18.03 56.74 Favored Glycine 0 C--N 1.279 -2.591 0 O-C-N 124.118 0.886 . . . . 0.0 112.012 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.31 -29.52 11.62 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-O 121.626 0.727 . . . . 0.0 111.278 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.533 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 83.6 m -99.67 137.74 37.73 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.897 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.38 18.97 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 123.527 0.517 . . . . 0.0 110.469 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.62 -54.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.01 -30.77 62.33 Favored 'General case' 0 C--O 1.203 -1.364 0 O-C-N 124.226 0.953 . . . . 0.0 111.501 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.97 -36.35 59.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.996 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.533 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.9 m-70 -63.1 -39.82 95.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.5 mt -66.33 -42.91 91.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.801 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.24 -34.72 68.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.619 0.645 . . . . 0.0 111.206 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.87 -54.73 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.1 mt -53.51 -47.77 69.6 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.342 0.402 . . . . 0.0 111.024 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.3 mt -56.71 -48.04 78.61 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.548 0.53 . . . . 0.0 109.806 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.1 m -59.03 -39.68 82.73 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -71.52 -29.98 65.41 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.3 m-85 -89.54 3.29 52.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.311 0.577 . . . . 0.0 112.145 175.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 7.2 mmpt? 67.62 33.31 5.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.3 mt -105.28 138.29 19.5 Favored Pre-proline 0 N--CA 1.411 -2.399 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.09 136.23 63.83 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.223 1.948 . . . . 0.0 111.433 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -63.19 -9.41 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.018 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.31 -16.26 62.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.032 0.444 . . . . 0.0 110.481 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -88.5 -4.87 58.53 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -49.07 -29.21 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 127.116 2.166 . . . . 0.0 111.032 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -56.68 -47.62 79.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.533 1.533 . . . . 0.0 111.047 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB2' ' SD ' ' A' ' 99' ' ' MET . 7.3 m -98.07 1.21 47.43 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.227 -171.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -105.1 141.67 36.24 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.414 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.63 149.05 28.7 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.339 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.71 124.23 30.03 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -111.61 147.98 34.31 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.47 134.35 66.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.0 Cg_endo -65.91 -18.72 58.01 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.877 2.385 . . . . 0.0 115.667 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 -42.79 3.89 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.0 p -90.72 -18.26 25.31 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mt 62.62 22.23 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.645 1.178 . . . . 0.0 112.005 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.71 143.02 31.2 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.01 147.19 24.76 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.203 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -83.56 105.95 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -107.33 12.07 28.48 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.957 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.57 161.7 29.05 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.286 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.4 m -85.37 -39.69 17.33 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.322 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.96 152.77 50.9 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.367 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -84.58 159.64 20.61 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.885 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 38.8 p -115.47 156.54 45.8 Favored Pre-proline 0 C--N 1.276 -2.624 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.49 -35.34 92.06 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.684 2.256 . . . . 0.0 109.709 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -57.03 -49.55 75.45 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.714 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.49 -38.37 87.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 83' ' ' THR . 63.8 mt -65.75 -46.17 79.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.036 0.835 . . . . 0.0 110.54 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.98 -45.4 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -32.55 73.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.341 0.591 . . . . 0.0 112.167 172.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.43 -34.32 58.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.433 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.86 -27.51 63.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -56.05 -34.89 66.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.881 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.5 m -145.08 -78.44 0.19 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -170.73 -177.55 2.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.369 1.467 . . . . 0.0 108.743 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.51 152.23 37.29 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 168.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 98' ' ' ARG . 11.9 mt -118.81 101.78 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.066 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -78.9 104.88 9.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 96' ' ' ILE . 21.5 mtp180 -127.66 165.08 20.68 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.185 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' A' ' 65' ' ' SER . 9.1 mmm . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.4 mtt -113.11 137.18 51.83 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.991 -169.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 72.1 tttt -98.08 97.49 8.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.5 mt -109.54 138.64 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.975 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 42.5 mtm180 -69.83 129.96 40.98 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 121.213 0.53 . . . . 0.0 109.858 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.2 t -116.33 126.13 73.67 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.388 0 CA-C-O 117.806 -1.092 . . . . 0.0 108.309 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.264 50.8 mt-10 -86.85 146.98 26.0 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.225 -1.79 . . . . 0.0 107.843 167.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -121.86 126.57 49.02 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 175.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.444 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.424 -1.755 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.831 171.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 C--O 1.236 0.397 0 N-CA-C 110.431 -0.642 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.4 p -134.02 156.85 47.46 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.253 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -152.72 149.91 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 15.4 m -97.9 107.23 19.67 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -110.38 145.23 37.9 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.344 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.29 110.72 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.23 148.06 34.9 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.27 167.2 29.4 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 124.297 1.039 . . . . 0.0 108.351 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.43 19.71 51.53 Favored Glycine 0 C--N 1.29 -1.98 0 O-C-N 124.166 0.916 . . . . 0.0 112.64 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.64 -22.85 11.75 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.638 0.732 . . . . 0.0 110.626 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.432 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 69.4 m -105.9 139.9 39.74 Favored 'General case' 0 N--CA 1.403 -2.814 0 C-N-CA 124.59 1.156 . . . . 0.0 109.791 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 147.86 22.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.396 0.617 . . . . 0.0 110.541 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.5 t -54.17 -50.1 57.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.996 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -57.29 -31.69 65.89 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.796 -176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 m-20 -73.66 -40.56 63.62 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 97.2 m-70 -61.24 -38.7 87.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.71 -43.7 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.222 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HG3' HG21 ' A' ' 63' ' ' VAL . 65.1 mttm -56.86 -37.11 70.85 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 119.055 0.843 . . . . 0.0 111.092 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.1 t -65.92 -53.97 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.983 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.7 -48.43 69.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.508 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -57.07 -48.51 78.41 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 123.374 0.421 . . . . 0.0 110.317 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -59.54 -39.38 83.76 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -71.82 -31.46 66.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.5 m-85 -84.35 -8.71 58.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.032 0.444 . . . . 0.0 111.303 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 mttp 71.29 46.17 0.44 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.16 1.384 . . . . 0.0 112.608 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.8 mt -113.88 136.89 22.13 Favored Pre-proline 0 N--CA 1.408 -2.544 0 C-N-CA 125.815 1.646 . . . . 0.0 107.222 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.45 131.91 48.61 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.375 2.05 . . . . 0.0 111.49 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 31.1 m -62.93 -9.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.267 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.12 -22.12 64.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.395 0.617 . . . . 0.0 109.954 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 63.4 mttm -81.41 -5.46 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.233 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p -49.72 -29.3 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 126.435 1.894 . . . . 0.0 109.776 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 p -55.15 -47.2 75.45 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.429 1.492 . . . . 0.0 110.081 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -104.64 14.92 28.98 Favored 'General case' 0 N--CA 1.4 -2.929 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.7 -171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.453 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 23.7 m-85 -114.56 145.24 42.19 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.474 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.46 35.72 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.292 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.07 154.58 17.11 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HB2' ' NH2' ' A' ' 98' ' ' ARG . 52.9 tt0 -143.18 152.78 42.16 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -87.32 131.2 44.95 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.25 -18.59 50.54 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.89 2.394 . . . . 0.0 115.3 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -105.01 -43.32 5.08 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.408 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -89.2 -21.92 23.03 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.756 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 70.27 16.44 7.28 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.766 1.226 . . . . 0.0 111.576 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.99 36.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -83.27 168.85 16.31 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.2 t -118.43 98.82 6.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.78 14.47 28.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.369 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.75 156.2 36.84 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 126.529 1.932 . . . . 0.0 109.876 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -83.59 -38.86 21.07 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.525 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.51 154.95 45.6 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.4 mt -88.53 154.48 20.31 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.195 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.3 p -112.8 156.59 42.35 Favored Pre-proline 0 C--N 1.282 -2.326 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -56.32 -35.24 95.7 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.533 2.156 . . . . 0.0 110.281 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.03 -42.97 99.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.268 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -64.07 -38.21 90.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 123.288 0.367 . . . . 0.0 111.398 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.716 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.3 mt -65.47 -49.08 70.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.139 0.9 . . . . 0.0 110.304 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.25 -41.17 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.35 -34.14 72.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.934 172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.9 17.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.638 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 8.2 mt-10 -53.98 -23.43 13.2 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.74 -37.88 60.01 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.121 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -142.43 -82.45 0.19 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.66 178.55 8.92 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.315 1.446 . . . . 0.0 108.488 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.65 150.12 38.65 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 35.4 mt -114.76 135.69 53.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.491 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.8 OUTLIER -117.4 107.34 14.23 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -176.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.617 ' NH2' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.11 171.27 12.05 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 43.4 mtp . . . . . 0 N--CA 1.411 -2.388 0 O-C-N 124.301 1.001 . . . . 0.0 110.179 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 40.2 mtt -122.19 140.38 52.65 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.983 -171.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.3 tttt -100.15 93.19 5.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -102.21 141.96 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.892 -171.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 62.3 mtm-85 -72.03 131.29 42.69 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 121.365 0.602 . . . . 0.0 110.047 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 34' ' ' SER . 49.9 t -117.32 125.91 74.27 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.208 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.277 41.8 mt-10 -84.84 150.58 24.91 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 116.681 -2.008 . . . . 0.0 106.091 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -125.4 125.04 42.76 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.039 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.306 -1.31 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.492 171.275 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 N-CA-C 111.02 -0.415 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.5 p -133.78 154.03 51.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 120.946 0.403 . . . . 0.0 110.91 -172.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -149.53 149.47 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 7.4 m -99.6 106.03 17.96 Favored 'General case' 0 N--CA 1.391 -3.387 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -112.07 144.6 41.16 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.045 -170.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.06 112.91 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.98 151.71 33.67 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -146.28 -170.23 3.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.18 18.19 8.96 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.94 -25.38 9.02 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 123.226 0.61 . . . . 0.0 112.008 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 48' ' ' HIS . 59.9 m -98.63 136.89 38.05 Favored 'General case' 0 N--CA 1.395 -3.18 0 C-N-CA 124.553 1.141 . . . . 0.0 109.036 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 145.01 20.65 Favored 'General case' 0 C--O 1.249 1.03 0 O-C-N 123.695 0.622 . . . . 0.0 110.704 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.519 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.4 t -53.05 -53.41 22.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.879 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -58.08 -28.17 64.33 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.551 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -76.87 -37.85 54.77 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.076 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.523 ' NE2' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -62.36 -37.86 87.31 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.6 mt -68.24 -41.56 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.204 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.32 -34.41 66.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.639 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.13 -53.64 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.265 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' ILE . 17.9 mt -54.01 -46.99 71.95 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.217 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 85.5 mt -57.76 -48.71 78.87 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 123.478 0.486 . . . . 0.0 109.975 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -59.48 -37.47 78.32 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -73.32 -33.98 65.44 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 50.5 m-85 -85.4 0.24 52.79 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt 70.72 35.1 1.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 125.298 1.439 . . . . 0.0 112.665 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.7 mt -105.8 133.76 20.05 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.23 133.73 59.79 Favored 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.896 1.731 . . . . 0.0 110.821 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.6 m -61.71 -9.83 3.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.076 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.77 -20.48 65.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.558 0.218 . . . . 0.0 110.569 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.91 -4.81 58.61 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.61 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.6 p -48.91 -29.98 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 125.422 1.489 . . . . 0.0 110.622 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -55.34 -43.21 74.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.893 1.677 . . . . 0.0 110.733 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -109.4 13.59 24.06 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.66 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 16.0 m-85 -114.14 140.83 48.2 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.93 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.92 149.89 30.18 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.839 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.8 mt -82.59 122.69 28.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.234 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -109.31 149.4 29.52 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -78.6 129.61 73.66 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.86 -12.27 34.82 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.101 2.534 . . . . 0.0 115.795 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.31 -40.78 3.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.795 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.7 p -93.17 -17.55 23.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.993 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 66.27 20.08 11.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 111.748 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.42 137.28 33.98 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.559 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -95.17 137.06 34.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.73 104.58 8.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -106.2 12.85 29.65 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.979 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.53 158.24 36.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.73 -37.86 20.39 Favored 'General case' 0 N--CA 1.394 -3.252 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.077 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -128.5 147.82 50.71 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.607 0.763 . . . . 0.0 108.957 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.4 mt -81.1 152.24 27.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.584 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.9 p -108.43 154.27 41.58 Favored Pre-proline 0 N--CA 1.401 -2.9 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.38 -36.22 78.2 Favored 'Trans proline' 0 C--O 1.219 -0.452 0 C-N-CA 122.463 2.109 . . . . 0.0 110.523 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -64.09 -41.56 97.25 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.644 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.4 mmp_? -63.0 -36.63 84.17 Favored 'General case' 0 CA--C 1.485 -1.528 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.629 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 61.8 mt -68.42 -48.65 64.06 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 124.217 0.948 . . . . 0.0 110.62 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.591 ' O ' ' HD3' ' A' ' 92' ' ' LYS 0.311 47.8 t -61.61 -49.34 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 2.3 mp0 -64.48 -27.26 68.86 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.21 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.43 -45.26 60.42 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -54.27 -23.75 16.21 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -52.15 -46.97 65.65 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.041 0.936 . . . . 0.0 110.276 173.057 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m -135.27 -79.71 0.43 Allowed 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.92 -175.67 2.43 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.149 1.379 . . . . 0.0 108.962 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -120.1 151.32 39.23 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -116.15 101.6 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.025 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.68 109.44 12.9 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.26 163.11 26.36 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.246 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.9 mtp . . . . . 0 N--CA 1.399 -2.995 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.415 -2.19 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.3 mmt -115.25 138.34 51.05 Favored 'General case' 0 CA--C 1.465 -2.291 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.092 -171.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.2 tttt -100.54 93.57 5.68 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 90' ' ' ALA . 91.7 mt -103.52 140.75 20.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.732 -172.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -73.14 134.71 44.54 Favored 'General case' 0 CA--C 1.459 -2.53 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.195 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.12 122.04 69.1 Favored 'Isoleucine or valine' 2 N--CA 1.363 -4.785 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -84.14 156.74 21.97 Favored 'General case' 0 N--CA 1.406 -2.657 0 C-N-CA 115.872 -2.331 . . . . 0.0 107.063 167.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.472 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -128.81 132.44 47.83 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 177.233 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' N ' HD22 ' A' ' 14' ' ' LEU 0.266 1.6 mp . . . . . 0 C--N 1.316 -0.876 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 CA-C-O 120.943 0.31 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 p -142.21 158.69 43.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.346 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -151.22 149.97 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.3 m -98.14 108.29 20.96 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 47.7 t-80 -110.86 145.97 37.31 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 -170.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.01 111.62 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.56 145.72 39.82 Favored 'General case' 0 C--N 1.259 -3.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.31 -174.88 4.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.45 -13.95 13.87 Favored Glycine 0 C--N 1.304 -1.217 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.678 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -82.17 -21.82 36.35 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.814 0.816 . . . . 0.0 111.351 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 38.5 m -95.88 127.4 41.86 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.44 175.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.53 149.51 10.47 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.354 0.597 . . . . 0.0 110.471 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 ' HG ' ' A' ' 82' ' ' LEU . 97.8 t -54.13 -53.73 26.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.193 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 61.4 pttt -54.45 -31.86 56.42 Favored 'General case' 0 C--O 1.199 -1.578 0 O-C-N 124.522 1.138 . . . . 0.0 112.086 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 m-20 -77.39 -34.37 54.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.584 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 40.5 m80 -64.2 -40.16 95.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.6 mt -66.22 -43.44 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.828 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.4 mttt -57.15 -35.34 69.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.678 0.672 . . . . 0.0 111.278 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 47' ' ' ASP . 76.8 t -69.55 -53.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.482 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -54.49 -47.65 72.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.129 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 84.9 mt -55.77 -50.57 70.06 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.0 m -58.5 -39.52 80.27 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.23 -27.96 62.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 52.6 m-85 -91.74 4.24 53.26 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.386 0.612 . . . . 0.0 111.529 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 66.76 37.49 4.18 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.506 1.522 . . . . 0.0 112.556 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.64 132.66 20.84 Favored Pre-proline 0 N--CA 1.414 -2.232 0 C-N-CA 124.863 1.265 . . . . 0.0 108.259 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 134.0 58.62 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.256 1.97 . . . . 0.0 110.836 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.2 m -62.46 -10.43 5.09 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.677 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.027 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.01 -20.97 65.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.048 0.451 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -82.63 -4.36 57.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.2 p -47.78 -29.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 125.984 1.713 . . . . 0.0 110.603 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p -54.86 -46.83 74.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.56 -1.654 . . . . 0.0 111.612 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 m -105.01 10.34 34.13 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 124.312 1.045 . . . . 0.0 112.702 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 26.6 m-85 -109.19 143.34 38.74 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 121.881 -0.512 . . . . 0.0 111.391 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.77 151.88 34.33 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.1 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.36 127.85 34.86 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.033 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 45.5 tt0 -113.93 144.29 43.3 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.51 132.92 77.76 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 39.0 Cg_endo -66.99 -21.37 49.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.872 2.381 . . . . 0.0 115.416 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.73 -46.19 4.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.818 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -86.4 -20.19 28.58 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.122 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt 69.25 16.14 8.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 111.842 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.04 137.75 40.41 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.202 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -94.41 141.27 28.77 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.997 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.05 103.02 8.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -108.51 15.24 24.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.697 1.237 . . . . 0.0 109.103 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.47 155.4 38.04 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.338 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.6 m -81.27 -40.76 23.22 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.375 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.62 157.15 37.94 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.037 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -90.42 142.96 27.21 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.276 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.8 p -99.31 153.1 37.95 Favored Pre-proline 0 N--CA 1.4 -2.96 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.74 -32.58 91.72 Favored 'Trans proline' 0 C--O 1.204 -1.199 0 C-N-CA 121.882 1.721 . . . . 0.0 109.289 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.5 -46.58 88.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.191 0.596 . . . . 0.0 111.568 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -62.34 -39.44 93.09 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.692 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 55.9 mt -66.06 -48.63 70.39 Favored 'General case' 0 C--O 1.205 -1.273 0 O-C-N 123.677 0.611 . . . . 0.0 110.153 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.5 t -62.11 -46.26 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.29 -28.72 69.52 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -77.77 -35.54 51.5 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.939 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.35 -25.24 33.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.108 0.563 . . . . 0.0 111.124 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -55.39 -42.26 73.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.284 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.8 m -142.97 -82.28 0.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -160.51 -178.39 6.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.954 0.901 . . . . 0.0 109.273 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -119.49 148.41 43.3 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.7 mt -114.37 102.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.408 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -78.87 107.25 11.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -131.14 162.72 29.27 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.825 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.5 mtp . . . . . 0 N--CA 1.4 -2.944 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 122.252 1.025 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.8 mtt -117.26 140.07 50.01 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.956 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 38' ' ' ILE . 20.1 ttmm -96.68 98.61 10.31 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.22 137.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.4 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.55 129.11 38.95 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.125 0.488 . . . . 0.0 109.902 172.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.1 t -115.91 122.28 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.694 0 CA-C-O 117.696 -1.145 . . . . 0.0 108.272 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -83.65 153.88 24.0 Favored 'General case' 0 N--CA 1.413 -2.301 0 C-N-CA 116.456 -2.098 . . . . 0.0 108.027 167.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.75 127.96 45.89 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.197 0.31 . . . . 0.0 110.171 176.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.31 -1.13 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 N-CA-C 110.272 -0.703 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 22.2 p -140.77 157.42 45.43 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.902 -172.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -144.98 147.59 18.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.4 m -97.37 98.8 10.27 Favored 'General case' 0 N--CA 1.386 -3.66 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -105.73 144.9 31.83 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.12 -167.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 9' ' ' LYS . 35.1 mm -84.52 112.22 21.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' SER . 83.7 m-85 -113.19 149.49 33.61 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.402 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -148.07 -170.4 3.58 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.81 15.67 8.39 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.5 -23.59 11.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.925 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.7 m -104.73 135.83 45.38 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 123.592 0.757 . . . . 0.0 109.444 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.71 148.88 9.15 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.805 0.842 . . . . 0.0 111.18 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 82' ' ' LEU . 90.2 t -54.18 -51.33 48.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.778 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 40.5 mttm -54.73 -34.14 62.06 Favored 'General case' 0 C--O 1.196 -1.714 0 O-C-N 124.685 1.241 . . . . 0.0 110.663 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 51' ' ' VAL . 12.1 m-20 -73.95 -39.18 63.93 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.11 -38.91 90.69 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.7 mt -67.33 -44.61 87.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.913 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.4 mttt -57.59 -33.91 68.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 118.843 0.747 . . . . 0.0 110.978 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.4 t -68.77 -54.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.189 175.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.71 -48.66 69.36 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 123.329 0.393 . . . . 0.0 111.382 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.45 -48.27 77.4 Favored 'General case' 0 C--O 1.203 -1.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -59.77 -38.31 81.46 Favored 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -74.72 -29.76 61.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.846 0.355 . . . . 0.0 111.659 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 38.5 m-85 -89.64 4.57 49.06 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.298 0.571 . . . . 0.0 112.518 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 68.97 32.38 3.85 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.642 1.577 . . . . 0.0 112.284 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -107.31 128.23 26.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -50.86 133.01 38.96 Favored 'Trans proline' 0 CA--C 1.502 -1.099 0 C-N-CA 122.52 2.147 . . . . 0.0 111.073 172.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.6 m -62.87 -9.96 5.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.682 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.88 -18.49 65.4 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.392 0.615 . . . . 0.0 110.516 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 12.1 mptt -85.14 -5.27 59.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.225 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.9 p -47.45 -27.98 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 C-N-CA 126.196 1.798 . . . . 0.0 110.301 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -56.42 -49.44 74.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 126.42 1.888 . . . . 0.0 111.359 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' MET . 74.6 m -104.27 14.88 29.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.952 1.301 . . . . 0.0 112.257 -173.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 30.2 m-85 -113.93 142.52 46.03 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.605 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.92 31.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.2 mt -83.79 124.19 30.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.171 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.36 152.99 29.25 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -85.56 137.63 36.28 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 52.7 Cg_endo -70.59 -13.23 32.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.072 2.515 . . . . 0.0 115.81 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.41 -44.42 3.1 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.855 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.5 p -87.46 -19.13 28.44 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.561 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 63.03 21.74 13.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 110.783 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 140.89 33.95 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.892 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -100.71 143.86 30.37 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.484 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -78.65 107.63 11.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -100.58 10.49 41.11 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.801 0.81 . . . . 0.0 109.949 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.48 152.72 41.76 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.483 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.6 m -83.59 -38.18 21.96 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.203 174.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -128.61 149.51 50.61 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 45' ' ' VAL . 25.7 mt -84.41 161.64 20.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.502 0.668 . . . . 0.0 110.731 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 64.4 p -120.01 155.74 55.13 Favored Pre-proline 0 N--CA 1.401 -2.895 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.45 -32.11 95.63 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.889 1.726 . . . . 0.0 109.801 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.74 -42.48 99.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.379 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 2.6 mmp_? -64.76 -38.36 90.72 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.667 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 76.7 mt -65.77 -47.94 73.5 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.016 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.258 20.1 t -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.92 -26.95 66.23 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.534 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -43.97 52.22 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 19.0 mt-10 -54.73 -23.26 16.95 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.34 -35.19 37.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.179 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 m -144.52 -80.37 0.18 Allowed 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -163.77 -175.5 4.14 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 125.788 1.635 . . . . 0.0 108.384 -177.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 3.3 m-85 -120.96 148.59 43.89 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 169.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.6 101.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.568 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.459 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -78.86 106.45 10.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -127.23 161.42 28.59 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.469 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 42.7 mtp . . . . . 0 N--CA 1.404 -2.751 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 166.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 25.5 m . . . . . 0 N--CA 1.393 -3.277 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 58.2 mtt -106.69 139.75 40.63 Favored 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.047 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 61.8 tttt -99.97 98.36 9.13 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.59 138.3 37.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.611 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 85.4 mtt180 -68.12 133.14 48.45 Favored 'General case' 0 CA--C 1.478 -1.804 0 CA-C-O 121.029 0.442 . . . . 0.0 110.551 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.9 t -120.12 124.63 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-O 117.735 -1.126 . . . . 0.0 108.639 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' HB2' HG23 ' A' ' 96' ' ' ILE 0.259 21.8 mm-40 -84.2 153.46 23.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 170.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -126.03 130.82 51.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 176.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.319 -0.734 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.35 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.444 -1.441 0 N-CA-C 108.974 -1.202 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 1.4 p -138.78 152.46 47.93 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.44 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -147.68 149.65 15.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.3 m -96.21 108.32 20.78 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 44.5 t-80 -113.05 147.17 37.79 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 -171.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 48.4 mm -84.89 112.74 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' SER . 84.3 m-85 -113.68 146.07 40.36 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 123.039 0.535 . . . . 0.0 109.589 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.92 169.55 22.02 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 123.782 0.833 . . . . 0.0 109.243 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 26.24 24.06 Favored Glycine 0 C--N 1.298 -1.563 0 O-C-N 124.203 0.939 . . . . 0.0 112.435 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.62 -32.44 5.19 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-O 121.499 0.666 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 35.1 m -94.01 134.43 36.43 Favored 'General case' 0 N--CA 1.389 -3.523 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 148.76 15.12 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.261 0.553 . . . . 0.0 110.731 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.9 t -53.82 -52.28 36.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.114 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -57.08 -33.77 67.63 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.019 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.61 -37.06 65.55 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 122.06 -0.4 . . . . 0.0 110.712 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.8 m-70 -62.83 -39.27 93.82 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 27.2 mt -65.31 -44.13 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.67 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.4 mttt -56.93 -34.22 67.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.728 0.694 . . . . 0.0 111.18 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.56 -53.88 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.98 -48.27 70.54 Favored 'General case' 0 C--O 1.211 -0.921 0 O-C-N 123.558 0.536 . . . . 0.0 111.039 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.2 mt -56.88 -50.75 71.53 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -59.28 -37.32 77.38 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -74.07 -31.0 62.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.872 0.368 . . . . 0.0 111.644 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 37.0 m-85 -87.06 2.44 49.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? 73.81 29.23 1.49 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.107 1.363 . . . . 0.0 113.108 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -105.83 135.99 19.34 Favored Pre-proline 0 N--CA 1.411 -2.392 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -56.58 137.01 79.12 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 122.016 1.811 . . . . 0.0 110.953 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.639 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.84 -10.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.945 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.305 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.8 -14.45 63.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.358 0.599 . . . . 0.0 110.956 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.5 mptp? -87.83 -5.19 58.73 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -48.55 -31.06 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 126.269 1.828 . . . . 0.0 110.428 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.275 15.5 m -55.37 -46.39 76.48 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 126.47 1.908 . . . . 0.0 110.964 174.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -103.01 7.79 39.01 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.755 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 26.0 m-85 -106.68 142.19 36.73 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.331 0.586 . . . . 0.0 111.432 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.04 141.02 23.78 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.387 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 97' ' ' LEU . 80.1 mt -72.63 156.49 38.91 Favored 'General case' 0 N--CA 1.418 -2.051 0 O-C-N 124.82 1.325 . . . . 0.0 108.306 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 38.4 tt0 -146.12 152.0 38.58 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 21.6 t-20 -89.3 137.17 29.33 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.133 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 56.7 Cg_endo -71.7 -17.6 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.788 2.326 . . . . 0.0 115.278 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -107.75 -46.26 3.84 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.311 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.2 p -84.05 -24.09 30.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.02 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 ' HA ' HE21 ' A' ' 69' ' ' GLN . 11.2 mt 69.61 14.57 8.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.451 1.1 . . . . 0.0 111.152 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 145.75 27.15 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.515 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 8.9 m-30 -88.06 -174.57 4.74 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 122.388 1.09 . . . . 0.0 112.194 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' LEU . 93.9 t -124.57 101.84 9.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 167.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.49 14.81 29.35 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.695 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.32 158.3 33.03 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 125.483 1.513 . . . . 0.0 110.579 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.7 m -84.24 -36.38 22.75 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.735 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.78 146.74 52.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.5 mt -80.18 153.85 28.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.287 0.565 . . . . 0.0 110.999 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.7 p -108.37 154.28 41.52 Favored Pre-proline 0 N--CA 1.403 -2.795 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.79 -36.6 95.51 Favored 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 110.02 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.86 -43.35 94.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.265 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -66.32 -37.15 84.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.314 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.769 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.8 mt -63.29 -51.45 66.05 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.831 0.707 . . . . 0.0 110.568 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.95 -45.86 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.58 -24.67 67.14 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.24 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.7 -39.94 35.13 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.704 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 32.5 mt-10 -51.03 -27.37 7.76 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 118.36 0.527 . . . . 0.0 111.809 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -49.7 -37.89 30.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.664 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -147.2 -88.66 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -154.98 177.76 10.95 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.476 1.11 . . . . 0.0 109.051 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.4 m-85 -116.74 151.95 35.36 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 170.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 98' ' ' ARG . 20.5 mt -117.8 135.96 56.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -118.75 115.38 24.35 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -176.101 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -147.73 173.47 12.74 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.5 mtp . . . . . 0 N--CA 1.397 -3.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.012 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.441 -0.89 0 CA-C-O 121.664 0.745 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.676 ' SD ' ' HG3' ' A' ' 91' ' ' GLU . 46.4 mtt -117.86 138.45 52.1 Favored 'General case' 0 CA--C 1.467 -2.233 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.819 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 30.3 ttpt -97.82 99.86 11.2 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.74 140.85 24.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.015 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -69.19 129.15 39.03 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -115.2 123.18 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.736 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.016 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.04 148.43 26.86 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 117.561 -1.656 . . . . 0.0 107.396 168.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -126.11 129.22 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 176.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.402 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.307 -1.277 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.117 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--O 1.239 0.557 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.3 p -138.98 156.31 47.32 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.268 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -149.29 148.75 15.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.411 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 13.9 m -95.61 105.47 17.46 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 173.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 44.8 t-80 -112.28 144.37 41.8 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.609 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.262 40.2 mm -83.69 113.46 22.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.49 145.32 41.37 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.94 -174.15 4.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 124.265 1.026 . . . . 0.0 108.289 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.44 22.43 8.33 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -112.15 -25.91 9.08 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.179 0.592 . . . . 0.0 111.231 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.4 m -96.69 154.08 17.49 Favored 'General case' 0 N--CA 1.389 -3.492 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.67 156.26 27.66 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 82' ' ' LEU . 91.4 t -52.96 -52.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 123.7 0.625 . . . . 0.0 109.717 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -55.68 -36.5 67.2 Favored 'General case' 0 C--O 1.196 -1.726 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.31 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -74.48 -36.19 63.29 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.993 -0.442 . . . . 0.0 111.758 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.57 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.6 m-70 -61.25 -38.79 87.95 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 36.8 mt -66.16 -42.95 92.15 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.079 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.67 -37.98 71.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.647 0.658 . . . . 0.0 110.796 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.44 -53.69 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.057 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.8 mt -53.36 -49.61 66.79 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.467 0.479 . . . . 0.0 110.777 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -56.91 -47.43 80.57 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.522 0.514 . . . . 0.0 110.103 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.93 -40.52 93.53 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -70.84 -31.01 67.58 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.04 0.448 . . . . 0.0 111.51 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -86.67 1.87 50.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.341 0.591 . . . . 0.0 111.49 174.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 64.86 38.82 6.37 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 124.808 1.243 . . . . 0.0 113.18 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.0 mt -108.15 140.48 21.72 Favored Pre-proline 0 N--CA 1.41 -2.467 0 C-N-CA 124.988 1.315 . . . . 0.0 107.631 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.93 132.67 48.88 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.089 1.859 . . . . 0.0 110.925 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.609 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.9 m -63.75 -9.65 5.85 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.972 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.651 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -14.16 62.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.211 0.529 . . . . 0.0 111.544 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 64.2 mttm -85.38 -9.16 57.93 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.982 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.6 p -49.76 -30.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.906 2.082 . . . . 0.0 109.849 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.255 12.8 m -54.73 -48.91 71.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.146 1.778 . . . . 0.0 109.841 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -101.45 7.06 42.68 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.214 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 15.6 m-85 -106.55 144.38 33.3 Favored 'General case' 0 CA--C 1.477 -1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 110.751 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.57 149.25 25.19 Favored 'General case' 0 N--CA 1.41 -2.439 0 O-C-N 124.233 0.958 . . . . 0.0 109.292 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.68 132.75 35.61 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.574 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 70' ' ' ASN . 45.5 tt0 -118.92 153.58 34.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 25.1 t-20 -86.03 131.0 48.08 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 33.1 Cg_endo -66.22 -20.26 56.03 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.421 2.748 . . . . 0.0 115.836 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -107.27 -43.61 4.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 p -87.37 -24.37 24.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.052 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt 70.72 19.45 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 124.366 1.066 . . . . 0.0 111.8 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.85 138.89 33.76 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.508 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 6.3 m-85 -91.72 168.89 11.15 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.711 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.434 HG13 ' OD2' ' A' ' 79' ' ' ASP . 66.4 t -111.93 79.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.032 0.92 . . . . 0.0 111.399 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.27 -1.56 6.47 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.726 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' HG13 ' A' ' 77' ' ' VAL . 50.8 m-20 -64.06 151.26 43.54 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.282 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -79.91 -41.17 26.66 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.282 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -131.32 153.22 49.82 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 124.22 1.008 . . . . 0.0 108.553 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.4 mt -85.99 153.67 21.99 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 82.7 p -109.51 155.32 41.48 Favored Pre-proline 0 N--CA 1.402 -2.849 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.53 -33.87 93.75 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.126 1.884 . . . . 0.0 109.973 173.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.75 -45.91 90.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.919 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -64.48 -37.92 89.23 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.179 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.545 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.0 mt -64.03 -47.52 79.91 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.612 0.57 . . . . 0.0 109.934 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.259 35.6 t -62.13 -46.29 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -67.2 -25.53 66.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.36 -43.12 28.51 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.676 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 4.2 mt-10 -53.72 -19.27 3.94 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -53.08 -39.81 63.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.84 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 m -144.88 -82.14 0.16 Allowed 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -161.91 -178.73 6.65 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.513 1.125 . . . . 0.0 109.114 -178.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.99 147.02 46.05 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 169.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -113.43 101.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.458 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.52 105.06 9.54 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -126.75 159.21 34.42 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.683 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 46.0 mtp . . . . . 0 N--CA 1.393 -3.309 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 167.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.415 -2.198 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 10.7 mmt -122.91 137.29 54.98 Favored 'General case' 0 CA--C 1.477 -1.865 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.838 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 27.3 ttpt -96.22 98.95 10.71 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.28 139.32 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.721 -172.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 92.0 mtt180 -71.35 131.54 43.56 Favored 'General case' 0 CA--C 1.471 -2.088 0 O-C-N 123.456 0.473 . . . . 0.0 110.429 173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' SER . 40.5 t -117.95 124.8 73.6 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.484 0 CA-C-O 117.911 -1.043 . . . . 0.0 109.011 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -80.0 149.55 30.72 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 168.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 ' CD1' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -126.4 125.6 42.45 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 120.467 0.175 . . . . 0.0 111.08 175.354 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.438 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 N--CA 1.442 -0.869 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.032 167.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.467 -0.07 0 N-CA-C 110.558 -0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -134.1 156.31 48.51 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.05 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.3 p -149.22 148.41 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 m -97.41 106.96 19.38 Favored 'General case' 0 N--CA 1.391 -3.389 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 41.8 t-80 -114.68 146.21 41.15 Favored 'General case' 0 N--CA 1.416 -2.157 0 C-N-CA 123.791 0.836 . . . . 0.0 110.529 -169.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.25 44.8 mm -83.13 112.92 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.664 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -113.12 145.87 40.18 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.23 169.63 18.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.38 17.85 42.79 Favored Glycine 0 C--N 1.292 -1.871 0 O-C-N 124.299 0.999 . . . . 0.0 113.008 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -108.08 -25.16 11.26 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-O 122.131 0.967 . . . . 0.0 110.998 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.1 m -103.6 137.84 41.1 Favored 'General case' 0 N--CA 1.391 -3.403 0 C-N-CA 125.059 1.344 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.91 150.01 17.47 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 121.44 0.638 . . . . 0.0 111.237 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' A' ' 82' ' ' LEU . 83.8 t -52.8 -51.18 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.227 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -53.37 -42.18 66.62 Favored 'General case' 0 C--O 1.198 -1.619 0 O-C-N 125.003 1.439 . . . . 0.0 110.61 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.29 -39.07 85.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -62.51 -37.83 87.56 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 mt -66.52 -43.82 90.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.015 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.1 mttt -56.22 -34.72 66.58 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.839 0.745 . . . . 0.0 111.143 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.12 -53.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.136 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.31 -47.89 68.86 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 123.274 0.359 . . . . 0.0 111.12 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 79.5 mt -57.26 -49.43 76.07 Favored 'General case' 0 C--O 1.199 -1.564 0 O-C-N 123.705 0.628 . . . . 0.0 109.613 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -58.63 -39.8 81.53 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -71.41 -32.36 68.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.8 m-85 -86.42 -2.71 58.67 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.1 0.476 . . . . 0.0 111.835 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 69.15 39.23 1.76 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.389 1.476 . . . . 0.0 112.665 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.4 mt -106.42 136.85 19.32 Favored Pre-proline 0 N--CA 1.408 -2.538 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.28 134.91 62.06 Favored 'Trans proline' 0 CA--C 1.501 -1.16 0 C-N-CA 121.738 1.625 . . . . 0.0 111.515 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.1 m -64.38 -11.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.63 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.843 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.6 -20.61 64.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.257 0.551 . . . . 0.0 109.66 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 65.9 mttm -83.17 -2.46 55.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.265 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -49.0 -30.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 126.942 2.097 . . . . 0.0 110.618 176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -54.99 -58.12 8.92 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.915 173.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.1 m -87.85 10.96 16.84 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.422 -174.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 25.1 m-85 -109.22 143.51 38.57 Favored 'General case' 0 C--N 1.277 -2.567 0 O-C-N 121.277 -0.89 . . . . 0.0 111.34 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB3' HH22 ' A' ' 98' ' ' ARG . . . -147.96 154.35 40.22 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.037 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 97' ' ' LEU . 81.5 mt -89.29 160.48 16.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 41.5 tt0 -150.0 150.53 31.93 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 122.521 0.328 . . . . 0.0 110.207 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.83 137.98 31.5 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 124.459 1.103 . . . . 0.0 108.642 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.58 -21.16 30.06 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.814 2.342 . . . . 0.0 115.38 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -105.76 -42.49 5.15 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.747 -0.781 . . . . 0.0 113.001 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.5 p -90.43 -20.77 22.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.474 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt 66.58 17.96 10.7 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.491 1.117 . . . . 0.0 111.375 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.92 140.0 33.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 5.8 m-30 -86.03 -174.75 5.25 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.977 0.894 . . . . 0.0 110.567 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.0 101.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.97 11.95 36.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.796 1.284 . . . . 0.0 109.455 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.16 159.63 32.31 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 112.581 -2.1 . . . . 0.0 111.019 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 m -84.43 -39.44 18.97 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.317 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.06 154.92 45.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.863 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.9 mt -89.19 147.7 24.03 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.141 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 70.6 p -99.28 153.08 37.96 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.91 -34.17 97.99 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.428 2.085 . . . . 0.0 109.815 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -59.07 -47.62 84.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.142 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -60.28 -37.82 81.67 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 69.3 mt -64.35 -48.9 73.76 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.822 0.701 . . . . 0.0 110.401 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 43.7 t -63.48 -43.76 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -61.57 -29.89 70.32 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.79 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.56 -34.06 25.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.978 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.13 -24.58 55.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.644 0.735 . . . . 0.0 112.381 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 36.4 mmtm -54.09 -40.36 67.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.154 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.9 m -144.2 -88.31 0.12 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -156.64 178.96 9.73 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 108.752 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.25 152.85 34.93 Favored 'General case' 0 C--O 1.203 -1.363 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.499 HG22 ' HG3' ' A' ' 98' ' ' ARG . 2.7 mp -114.09 133.86 58.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.59 115.93 26.09 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.515 HH11 ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -146.41 177.56 8.94 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 65' ' ' SER . 49.4 mtp . . . . . 0 N--CA 1.381 -3.885 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.13 34.12 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.36 84.01 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -130.16 154.14 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.163 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.62 -88.89 0.23 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.83 -70.45 1.0 Allowed Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 m -85.34 147.48 26.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 39.6 mtt -128.19 140.1 52.1 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -170.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -97.21 94.81 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -104.11 137.29 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.76 -171.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 41.6 mtm180 -71.82 130.7 41.7 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.386 0.613 . . . . 0.0 110.196 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' SER . 45.8 t -117.99 127.91 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.346 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.28 43.4 mt-10 -90.18 143.76 26.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 116.257 -2.177 . . . . 0.0 109.358 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.2 tm? -111.7 129.67 56.03 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.77 122.62 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -150.07 76.24 1.27 Allowed 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.483 1.135 . . . . 0.0 109.215 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.81 15.24 31.63 Favored Glycine 0 C--N 1.295 -1.727 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.299 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.04 -40.32 18.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.22 137.24 33.12 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 165.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -82.96 69.98 9.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -140.9 115.96 9.84 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 24' ' ' SER . 12.7 p -137.5 -158.92 0.9 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -82.24 30.77 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 22' ' ' THR . 17.7 m 72.19 11.51 5.93 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.911 1.684 . . . . 0.0 109.747 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.5 p -99.2 173.57 3.71 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.68 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 6.0 Cg_exo -80.9 -160.22 0.12 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 49.5 mt-30 -84.76 20.41 1.79 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 26' ' ' PRO . 25.8 mp0 -108.34 95.42 15.82 Favored Pre-proline 0 C--N 1.271 -2.829 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 36.7 Cg_endo -89.69 131.16 1.94 Allowed 'Trans proline' 0 N--CA 1.426 -2.494 0 C-N-CA 122.379 2.053 . . . . 0.0 111.176 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.23 -47.34 74.13 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -135.96 158.1 45.24 Favored 'General case' 0 N--CA 1.401 -2.882 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -92.86 160.45 33.96 Favored Pre-proline 0 C--N 1.274 -2.68 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -50.81 128.43 24.27 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.247 1.965 . . . . 0.0 108.675 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.7 p -135.87 153.1 51.58 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 -173.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -146.87 145.95 19.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 m -97.8 104.98 17.05 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -111.24 144.87 39.7 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.76 113.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.45 143.84 42.91 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.1 164.51 37.11 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.397 1.079 . . . . 0.0 108.402 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.84 14.81 63.58 Favored Glycine 0 C--N 1.291 -1.967 0 O-C-N 124.239 0.962 . . . . 0.0 112.787 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -105.61 -28.34 10.81 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 121.994 0.902 . . . . 0.0 110.1 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 39.9 m -94.7 132.36 39.53 Favored 'General case' 0 N--CA 1.39 -3.466 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.362 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.94 149.55 14.97 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' A' ' 82' ' ' LEU . 88.2 t -54.9 -53.15 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.163 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 22.3 pttm -54.38 -30.72 52.91 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 124.468 1.105 . . . . 0.0 111.02 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.8 m-20 -78.1 -36.31 48.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.204 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 96.2 m-70 -64.04 -39.73 94.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 30.1 mt -66.87 -44.32 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.977 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 96.4 mttt -56.69 -34.4 67.38 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.64 0.654 . . . . 0.0 110.821 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.4 t -69.59 -54.27 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.652 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.51 -49.51 67.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.429 0.456 . . . . 0.0 111.159 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.1 mt -54.74 -50.13 69.13 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 123.622 0.576 . . . . 0.0 109.844 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.0 m -58.16 -39.87 79.96 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -71.53 -27.87 63.48 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.139 0.495 . . . . 0.0 111.712 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 46.1 m-85 -89.82 2.04 55.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.291 0.567 . . . . 0.0 111.609 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 67.77 35.47 3.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.318 1.447 . . . . 0.0 112.579 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.2 135.78 19.42 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.97 135.88 69.63 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.429 2.086 . . . . 0.0 111.156 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 32.4 m -64.37 -10.73 8.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.813 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.392 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.42 -15.99 63.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.77 0.795 . . . . 0.0 109.523 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.91 -7.53 58.11 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.964 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -46.45 -30.69 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.097 0 C-N-CA 127.226 2.211 . . . . 0.0 111.128 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.271 16.5 m -56.99 -45.09 83.21 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 126.018 1.727 . . . . 0.0 111.724 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' MET . 8.7 m -100.9 7.13 43.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.057 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 28.8 m-85 -109.91 143.56 39.66 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 122.154 -0.341 . . . . 0.0 110.92 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 147.65 28.42 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.325 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 89.0 mt -80.47 134.67 36.01 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.603 1.189 . . . . 0.0 107.944 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -125.8 147.08 49.53 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.48 135.73 68.6 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.91 -16.14 29.38 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 115.076 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -105.83 -46.76 4.05 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.687 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -90.05 -18.09 26.58 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.639 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt 65.07 22.63 12.37 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.387 1.075 . . . . 0.0 110.918 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.05 135.87 35.89 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.374 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.61 149.85 20.83 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.644 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.86 106.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.62 10.86 29.0 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 123.107 1.432 . . . . 0.0 108.83 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.49 154.03 37.19 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.165 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.2 m -83.53 -35.46 24.79 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.702 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -129.8 149.55 51.49 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.263 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 82' ' ' LEU . 18.7 mt -85.37 153.04 22.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -108.35 158.84 32.76 Favored Pre-proline 0 N--CA 1.411 -2.415 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.1 -35.9 98.36 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.176 1.917 . . . . 0.0 109.16 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.75 -41.66 95.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.814 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -63.59 -43.08 97.99 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.524 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 69.8 mt -62.99 -48.08 80.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.377 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.1 -45.8 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.18 -27.96 68.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.66 -44.09 29.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.46 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 3.7 mm-40 -52.58 -22.18 4.7 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.84 -34.42 40.54 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.2 m -146.62 -83.84 0.12 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.63 177.91 10.87 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.52 1.128 . . . . 0.0 108.587 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m-85 -116.45 151.78 35.35 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 170.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 10.6 mt -114.9 140.81 34.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -119.34 107.01 12.85 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -129.0 159.48 35.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.39 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 65' ' ' SER . 52.3 mtp -76.19 128.01 34.07 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 166.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -66.81 126.01 91.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 O-C-N 123.815 0.697 . . . . 0.0 111.528 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.84 101.4 1.18 Allowed 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 122.034 1.822 . . . . 0.0 108.863 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -170.29 150.68 3.64 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.2 45.5 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.65 118.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.092 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.52 145.46 24.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.79 78.32 8.53 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 . . . . . 0 C--N 1.276 -2.594 0 CA-C-N 113.318 -1.764 . . . . 0.0 111.455 -179.761 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.21 97.05 10.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.461 0.648 . . . . 0.0 110.838 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -129.37 91.98 3.28 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -86.02 155.64 20.76 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.763 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.26 -17.25 7.06 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.92 77.05 1.25 Allowed Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 m -71.23 140.05 50.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.326 0.584 . . . . 0.0 110.864 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.727 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 47.0 mtt -123.88 141.88 51.63 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.727 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.1 tttm -100.66 97.01 7.73 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -107.33 139.75 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.743 -172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 10.7 mtp180 -67.22 134.92 52.59 Favored 'General case' 0 CA--C 1.454 -2.72 0 CA-C-O 121.838 0.828 . . . . 0.0 111.828 170.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.3 t -120.81 122.9 69.06 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.501 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.308 0.7 OUTLIER -83.78 144.41 29.33 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 116.082 -2.247 . . . . 0.0 108.518 166.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.6 tm? -114.55 137.09 52.3 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -111.29 118.76 58.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.093 168.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.95 67.7 0.61 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.83 167.16 30.67 Favored Glycine 0 N--CA 1.428 -1.878 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.787 -174.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -129.53 21.25 5.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.967 0.889 . . . . 0.0 109.054 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.01 -162.07 0.51 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 113.941 -1.482 . . . . 0.0 110.543 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.7 m80 80.39 110.48 0.07 Allowed 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 125.801 1.641 . . . . 0.0 109.891 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -131.71 168.83 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.199 0.999 . . . . 0.0 112.931 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 p -132.85 -151.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.1 m -59.16 151.11 23.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.1 t -81.12 15.17 1.98 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.047 0.927 . . . . 0.0 111.703 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.9 p -83.58 159.57 60.9 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.502 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -87.43 22.44 0.91 Allowed 'Trans proline' 0 C--O 1.225 -0.136 0 C-N-CA 122.792 2.328 . . . . 0.0 111.296 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -97.23 21.22 10.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.602 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.95 9.82 Favored Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.19 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.24 111.26 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.686 2.257 . . . . 0.0 110.622 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -133.56 86.61 2.31 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -93.9 -176.12 3.93 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.4 155.3 93.78 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 118.343 0.519 . . . . 0.0 110.229 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.46 134.41 45.6 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 123.718 2.945 . . . . 0.0 111.081 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.8 m -140.37 159.89 41.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.149 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 8.5 p -150.36 149.45 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -98.77 104.69 16.76 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 36.5 t-80 -109.67 147.9 32.3 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.315 -170.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 113.02 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.81 147.45 38.33 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.25 -170.37 3.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.34 18.25 8.33 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.86 -28.37 8.41 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 124.03 0.932 . . . . 0.0 110.596 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.648 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 40.7 m -95.5 131.84 41.24 Favored 'General case' 0 N--CA 1.386 -3.67 0 C-N-CA 124.513 1.125 . . . . 0.0 109.096 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 148.49 14.73 Favored 'General case' 0 C--O 1.254 1.332 0 O-C-N 123.795 0.684 . . . . 0.0 110.618 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.2 -53.15 31.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.111 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -54.54 -31.92 57.31 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.344 1.028 . . . . 0.0 111.419 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 m-20 -75.88 -38.75 57.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.443 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.648 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 40.1 m80 -61.98 -39.24 91.5 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.5 mt -67.1 -43.31 88.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.1 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HG3' HG21 ' A' ' 63' ' ' VAL . 98.2 mttt -58.98 -34.3 71.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.066 0.848 . . . . 0.0 111.141 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.1 t -68.14 -52.62 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.239 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.79 -48.71 72.38 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.403 0.439 . . . . 0.0 111.089 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.66 -47.49 79.67 Favored 'General case' 0 C--O 1.2 -1.513 0 O-C-N 123.644 0.59 . . . . 0.0 109.796 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.2 m -59.42 -40.34 86.41 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -70.91 -34.04 71.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.522 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 50.3 m-85 -83.81 -2.37 56.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.37 0.605 . . . . 0.0 111.702 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 69.72 34.42 2.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.806 1.643 . . . . 0.0 111.999 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.27 137.24 19.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.68 132.47 50.41 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 121.926 1.751 . . . . 0.0 110.877 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.54 -10.14 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.166 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.99 -14.34 62.65 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.97 0.414 . . . . 0.0 111.187 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 60.8 mttm -86.33 -7.74 58.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.408 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -46.41 -32.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 C-N-CA 126.666 1.986 . . . . 0.0 110.833 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 p -54.17 -49.77 68.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 125.997 1.719 . . . . 0.0 111.219 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.0 9.21 41.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.865 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 16.4 m-85 -109.94 140.08 44.32 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.779 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.876 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 86.0 mt -85.53 125.85 33.4 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.394 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -113.82 148.62 36.3 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 120.78 0.324 . . . . 0.0 110.872 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -81.94 132.22 54.68 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.82 -18.59 52.94 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.627 2.218 . . . . 0.0 115.288 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.65 -44.44 4.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.014 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 p -89.5 -20.29 24.03 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.252 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 mt 68.48 16.53 9.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 111.654 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.69 139.37 38.5 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -98.95 147.36 25.06 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.728 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.11 106.01 14.03 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.469 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.1 10.15 41.72 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 123.983 0.913 . . . . 0.0 109.888 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.98 154.14 39.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.273 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.5 m -82.85 -38.48 22.94 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.052 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -130.67 148.74 52.5 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.351 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -80.65 157.71 25.87 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.771 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 56.5 p -110.78 153.92 43.48 Favored Pre-proline 0 N--CA 1.403 -2.816 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.63 -32.09 81.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.619 1.546 . . . . 0.0 110.119 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.66 -51.01 71.76 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.72 0.808 . . . . 0.0 110.783 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.504 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 23.9 mmm180 -60.95 -37.99 84.3 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 123.205 0.315 . . . . 0.0 110.688 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.8 mt -63.22 -49.21 75.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 123.973 0.796 . . . . 0.0 110.34 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.98 -44.2 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.63 -33.22 73.55 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.586 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.13 -42.48 46.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.65 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 25.0 mt-10 -52.34 -23.19 5.46 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -53.48 -35.59 60.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.896 0.879 . . . . 0.0 112.583 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 m -145.2 -84.82 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER -162.23 178.13 9.01 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.797 1.239 . . . . 0.0 108.612 -177.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 m-85 -111.63 146.88 36.65 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 ' CE2' ' A' ' 94' ' ' TYR . 4.9 mt -112.66 100.41 10.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.765 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.34 102.71 8.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -123.87 160.08 28.23 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.664 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 52.3 mtp -77.32 128.73 34.81 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 166.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 100' ' ' LYS . 44.9 mtpt -65.86 135.96 95.57 Favored Pre-proline 0 C--N 1.274 -2.704 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.536 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.0 109.99 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.639 2.226 . . . . 0.0 110.008 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -68.12 143.39 55.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.4 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.4 156.83 21.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.013 0.821 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -81.44 98.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.086 0 CA-C-O 121.422 0.63 . . . . 0.0 109.74 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.32 110.38 8.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -98.38 29.99 3.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.584 0.707 . . . . 0.0 111.679 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.547 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 4.4 mmp_? . . . . . 0 C--N 1.301 -1.52 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.548 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.06 -52.55 0.64 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -56.06 -32.34 64.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt 54.24 79.56 0.13 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.91 -23.2 8.78 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.76 51.79 54.74 Favored Glycine 0 CA--C 1.477 -2.286 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m -69.88 127.58 33.39 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.0 112.552 -172.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.9 mtt -113.68 138.17 50.58 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.704 -1.589 . . . . 0.0 111.782 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 77.0 tttt -96.97 90.49 5.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -100.49 137.84 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.47 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 16.3 mtm180 -73.79 131.36 41.47 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.5 t -118.39 127.65 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.294 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.767 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 34.6 mt-10 -88.23 148.37 24.39 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 116.63 -2.028 . . . . 0.0 107.866 165.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -118.66 128.97 55.03 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.055 0.222 . . . . 0.0 110.542 177.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.416 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -103.2 118.38 50.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.545 169.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -136.79 26.83 3.03 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.95 66.95 0.85 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.995 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -124.77 -9.71 7.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 124.597 1.159 . . . . 0.0 108.791 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.6 23.46 2.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.533 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.4 m80 56.84 69.08 0.78 Allowed 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.679 0.792 . . . . 0.0 111.806 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -131.67 80.22 1.91 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p 54.17 -160.29 0.15 Allowed 'General case' 0 C--O 1.256 1.436 0 C-N-CA 124.011 0.925 . . . . 0.0 110.385 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -77.14 145.41 37.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m -81.95 13.61 3.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.178 0.99 . . . . 0.0 111.124 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 p -89.5 133.57 34.3 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 9.2 Cg_endo -92.28 56.92 0.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.039 2.493 . . . . 0.0 113.264 -172.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -84.13 26.32 0.76 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.022 0.915 . . . . 0.0 110.896 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 30' ' ' GLN . 13.2 mm-40 -116.37 164.87 16.53 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.507 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.99 28.89 0.48 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.632 2.221 . . . . 0.0 110.238 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 28' ' ' GLN . 79.1 mt-30 -148.29 103.44 3.44 Favored 'General case' 0 N--CA 1.407 -2.587 0 C-N-CA 127.445 2.298 . . . . 0.0 106.359 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.5 -166.0 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 46.2 m-80 -71.82 154.34 92.84 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -41.09 126.1 2.51 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.37 2.713 . . . . 0.0 110.36 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.6 p -132.49 150.08 52.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.688 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 9.3 p -147.02 148.22 16.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 12.8 m -99.5 105.44 17.35 Favored 'General case' 1 N--CA 1.379 -4.021 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -110.05 146.32 35.56 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.922 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -83.52 111.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 7' ' ' SER . 87.8 m-85 -112.25 145.1 40.54 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -145.07 172.05 13.62 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.45 17.64 54.98 Favored Glycine 0 C--N 1.307 -1.069 0 O-C-N 124.271 0.982 . . . . 0.0 112.606 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -113.67 -22.75 10.09 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 121.618 0.723 . . . . 0.0 111.987 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 59.8 m -101.28 137.17 39.98 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.137 0.975 . . . . 0.0 109.952 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.14 147.33 16.41 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 124.025 0.828 . . . . 0.0 110.767 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.3 t -54.98 -53.97 28.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.857 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -57.6 -28.93 64.07 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.267 0.98 . . . . 0.0 111.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 m-20 -75.91 -37.29 58.94 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.228 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.483 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 39.4 m80 -62.15 -38.3 88.48 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 171.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 43.5 mt -67.11 -43.58 88.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.172 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -57.17 -34.46 68.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.836 0.744 . . . . 0.0 111.034 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' ASP . 63.4 t -70.55 -52.86 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.595 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.65 -49.62 67.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.252 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 91.7 mt -56.36 -48.29 77.11 Favored 'General case' 0 C--O 1.206 -1.231 0 O-C-N 123.48 0.487 . . . . 0.0 109.801 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.8 m -58.94 -40.18 83.89 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -71.82 -29.81 64.82 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.959 0.409 . . . . 0.0 112.023 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 41.1 m-85 -86.94 -0.97 57.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.232 0.539 . . . . 0.0 112.159 175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 69.79 30.86 3.68 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.967 1.707 . . . . 0.0 112.579 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.23 135.51 20.29 Favored Pre-proline 0 N--CA 1.404 -2.74 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.26 134.68 60.62 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.952 1.768 . . . . 0.0 111.24 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.2 m -63.26 -9.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.655 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.6 -15.46 63.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.785 0.326 . . . . 0.0 110.534 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -86.91 -5.48 59.08 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.847 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 1.6 p -48.9 -32.71 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 125.095 1.358 . . . . 0.0 110.609 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -57.14 -42.22 80.55 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.89 1.276 . . . . 0.0 110.379 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.2 m -103.52 13.7 32.87 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.243 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 15.8 m-85 -117.77 144.29 45.45 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.89 154.77 31.77 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.042 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.4 mt -83.58 130.14 34.98 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.76 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 38.5 tt0 -115.34 150.7 35.88 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -81.09 131.99 57.9 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.84 -19.82 46.32 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.914 2.409 . . . . 0.0 115.537 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.52 -45.28 4.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.355 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -92.14 -18.29 23.72 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.267 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.93 20.36 10.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.476 1.11 . . . . 0.0 112.443 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.16 137.71 35.9 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 37.5 m-85 -94.54 147.44 23.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.217 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.44 107.67 13.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -101.38 12.38 37.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.195 0.521 . . . . 0.0 111.09 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -76.44 155.77 33.65 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 122.299 1.047 . . . . 0.0 111.684 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -81.86 -38.31 25.61 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.627 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.34 151.02 51.3 Favored 'General case' 0 N--CA 1.417 -2.121 0 C-N-CA 123.901 0.881 . . . . 0.0 108.631 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.9 mt -83.33 154.53 24.03 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.352 0.596 . . . . 0.0 110.521 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -111.46 153.44 44.17 Favored Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.42 -36.38 79.09 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 0.0 109.674 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.45 -46.49 86.45 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.813 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.59 -37.12 86.46 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 75.8 mt -65.19 -49.12 70.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.922 0.763 . . . . 0.0 110.184 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.51 -44.07 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -62.16 -32.2 72.79 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.17 -43.83 23.16 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.79 -25.25 7.24 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -54.35 -36.67 64.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.672 1.189 . . . . 0.0 112.529 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.6 m -140.67 -80.79 0.26 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.05 -178.92 3.9 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 124.864 1.265 . . . . 0.0 108.443 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 2.6 m-85 -117.43 148.15 42.05 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 170.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.8 mt -115.65 101.57 12.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.019 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -78.28 103.72 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -125.97 164.3 21.11 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.514 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 65' ' ' SER . 58.4 mtp -79.41 122.97 27.06 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -61.5 155.87 56.33 Favored Pre-proline 0 C--N 1.282 -2.337 0 C-N-CA 125.019 1.327 . . . . 0.0 112.68 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.72 103.58 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.157 1.905 . . . . 0.0 108.709 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -135.26 156.02 49.67 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 131.79 51.0 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.132 0.491 . . . . 0.0 111.053 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt -86.36 136.03 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.725 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.95 96.0 5.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.011 0.434 . . . . 0.0 110.452 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -127.86 82.48 2.09 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.064 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 107' ' ' ARG 0.274 0.0 OUTLIER . . . . . 0 N--CA 1.397 -3.099 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.15 177.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.018 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.52 -8.64 54.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.114 0.457 . . . . 0.0 112.078 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -125.28 62.11 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.028 0.918 . . . . 0.0 111.334 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.1 mtp -116.48 41.64 2.61 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.553 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.65 63.6 0.31 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.99 44.72 1.04 Allowed Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.529 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 m -84.39 130.78 34.75 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.625 0.726 . . . . 0.0 109.193 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 45.0 mtt -112.95 141.24 47.01 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.71 -169.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HE2' HD11 ' A' ' 38' ' ' ILE . 22.5 ttmm -98.63 101.07 12.38 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -112.22 138.64 40.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 124.833 1.253 . . . . 0.0 109.834 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 43.4 mtt180 -71.33 134.99 47.14 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.555 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 34' ' ' SER . 58.5 t -118.88 127.69 75.75 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.79 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.019 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.77 149.46 24.84 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.52 -1.672 . . . . 0.0 107.765 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tm? -115.17 132.65 56.54 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.093 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -105.54 114.35 44.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -160.24 83.84 0.71 Allowed 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.18 48.15 0.97 Allowed Glycine 0 C--N 1.269 -3.142 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.989 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -86.84 -41.5 13.99 Favored 'General case' 0 CA--C 1.468 -2.177 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.92 96.88 8.95 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.799 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -89.94 92.85 9.18 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -106.73 167.44 9.87 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.04 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.7 p -92.33 134.5 34.85 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.867 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 p -126.76 97.12 4.87 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 120.874 0.369 . . . . 0.0 110.67 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 m -88.9 -13.09 39.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.936 0.874 . . . . 0.0 108.805 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 p -85.93 154.57 58.21 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.007 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.13 60.21 3.82 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.139 2.559 . . . . 0.0 112.264 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -117.25 45.07 1.97 Allowed 'General case' 0 N--CA 1.402 -2.831 0 C-N-CA 123.845 0.858 . . . . 0.0 109.593 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 22.8 mp0 -56.07 115.24 9.21 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.934 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 6.0 Cg_exo -80.33 95.49 1.0 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.349 2.033 . . . . 0.0 109.099 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -93.69 -53.62 3.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.645 0.736 . . . . 0.0 110.233 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -111.32 168.24 9.68 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.957 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 92.4 m-20 -81.84 143.95 51.01 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.277 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 8.5 Cg_endo -49.17 132.49 28.26 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 124.123 3.216 . . . . 0.0 109.735 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.6 p -139.37 157.25 46.19 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.011 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.4 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -97.45 99.48 10.9 Favored 'General case' 0 N--CA 1.387 -3.594 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 45.5 t-80 -106.12 144.99 32.04 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.814 -167.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.529 HD11 ' HE2' ' A' ' 9' ' ' LYS 0.253 48.4 mm -83.65 114.06 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -115.35 151.5 34.52 Favored 'General case' 0 C--N 1.272 -2.78 0 C-N-CA 123.299 0.639 . . . . 0.0 109.513 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -146.71 -167.79 2.85 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.16 21.18 5.24 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -108.98 -25.46 10.71 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.469 0.652 . . . . 0.0 110.171 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.3 m -105.79 138.08 42.59 Favored 'General case' 0 N--CA 1.412 -2.342 0 C-N-CA 124.633 1.173 . . . . 0.0 109.391 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.64 145.86 22.44 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 121.444 0.64 . . . . 0.0 110.93 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 81.4 t -48.54 -52.05 9.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.701 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -56.57 -35.35 68.07 Favored 'General case' 0 C--O 1.198 -1.617 0 O-C-N 124.565 1.166 . . . . 0.0 111.204 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.61 -34.62 65.13 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.862 -0.524 . . . . 0.0 111.703 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -63.38 -36.98 85.51 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.62 -41.65 85.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.354 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -56.26 -38.78 71.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.856 0.753 . . . . 0.0 110.622 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.75 -53.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.902 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.3 mt -53.22 -50.56 64.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.133 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.99 -49.14 76.65 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 123.677 0.611 . . . . 0.0 110.047 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -59.13 -38.76 80.44 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -73.94 -31.47 63.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 14' ' ' LEU . 29.6 m-85 -81.58 -8.45 59.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.066 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt 74.57 37.23 0.56 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.638 1.575 . . . . 0.0 111.91 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.6 mt -109.63 131.53 21.85 Favored Pre-proline 0 N--CA 1.409 -2.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.72 136.11 57.89 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 C-N-CA 122.557 2.171 . . . . 0.0 111.932 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.7 m -64.29 -9.8 6.94 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.903 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.49 -15.93 63.35 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.674 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.9 mptp? -85.32 -4.36 59.13 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.5 p -49.37 -30.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.919 1.688 . . . . 0.0 110.481 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.2 p -56.05 -50.53 70.7 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.005 173.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 19.6 m -98.44 13.16 32.69 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.256 -172.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.2 m-85 -114.25 142.43 46.29 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.942 -0.474 . . . . 0.0 111.748 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.08 146.65 24.1 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.671 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.92 138.26 38.79 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.059 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -122.14 144.97 48.62 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 24.8 t-20 -76.89 130.32 76.24 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 17.3 Cg_exo -67.42 -18.72 49.67 Favored 'Trans proline' 0 C--N 1.329 -0.453 0 C-N-CA 122.575 2.183 . . . . 0.0 114.957 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -110.52 -39.48 4.9 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.2 p -90.12 -18.07 26.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.146 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 68.86 15.56 8.92 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.0 111.943 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.72 137.72 37.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.38 156.91 17.9 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.289 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.07 77.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 122.141 0.972 . . . . 0.0 111.845 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.4 2.94 2.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 125.234 1.414 . . . . 0.0 114.174 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.84 154.73 41.48 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.582 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -82.96 -37.28 24.31 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.851 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.49 153.37 48.88 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.291 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 82' ' ' LEU . 19.5 mt -85.68 146.83 26.65 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.2 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -99.02 157.79 33.46 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.5 -34.81 98.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.071 1.848 . . . . 0.0 109.398 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.09 -45.67 93.77 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.401 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 8.7 mmt180 -61.14 -39.7 91.04 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.699 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 79.0 mt -64.86 -48.68 73.4 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 124.073 0.858 . . . . 0.0 109.778 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.77 -45.3 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -63.83 -28.71 70.04 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.131 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.06 24.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.636 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 15.6 mt-10 -53.02 -22.71 6.13 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 119.059 0.845 . . . . 0.0 113.117 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.93 -42.93 65.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.706 0.803 . . . . 0.0 110.826 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.6 m -140.91 -80.41 0.26 Allowed 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -167.36 -179.26 4.39 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 124.133 0.973 . . . . 0.0 109.04 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.61 149.49 42.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.3 99.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.02 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -78.8 105.5 10.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.018 0.913 . . . . 0.0 108.589 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -124.07 166.15 16.26 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.427 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.4 mtp -81.11 132.79 35.38 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -61.71 147.68 88.48 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 124.402 1.081 . . . . 0.0 110.006 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.23 117.2 2.11 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.434 2.756 . . . . 0.0 111.146 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -93.45 149.89 20.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.712 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.36 -158.42 0.45 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.23 130.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.187 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 132.48 48.92 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.419 0.628 . . . . 0.0 111.25 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.55 16.33 5.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.193 0.997 . . . . 0.0 110.618 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 . . . . . 0 C--N 1.282 -2.343 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.606 177.046 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.56 -171.37 0.17 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.209 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -114.55 140.73 48.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.918 -0.489 . . . . 0.0 110.383 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.6 mtp -102.35 155.52 18.19 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.23 63.12 0.19 Allowed Glycine 0 C--N 1.289 -2.077 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.9 53.68 0.63 Allowed Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.119 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 m -78.72 140.22 38.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.5 mmt -115.46 138.23 51.24 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.899 -172.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -99.04 91.98 5.27 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.61 137.27 31.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.939 -171.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 30.0 mtm105 -69.42 130.71 43.29 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 121.714 0.769 . . . . 0.0 110.225 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.0 t -117.07 122.58 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.385 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.487 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.275 33.0 mt-10 -82.38 149.36 27.73 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 116.566 -2.053 . . . . 0.0 107.037 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.52 123.09 36.97 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp -98.62 109.77 24.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 119.242 -0.983 . . . . 0.0 109.019 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -126.35 11.43 7.48 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.647 0.737 . . . . 0.0 109.058 172.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.54 63.78 0.45 Allowed Glycine 0 C--N 1.289 -2.053 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.659 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.3 -37.28 38.12 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.82 99.18 8.79 Favored 'General case' 0 N--CA 1.388 -3.559 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -65.43 108.83 2.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.886 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -115.35 142.78 46.23 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p 54.84 -165.76 0.1 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.686 1.194 . . . . 0.0 111.46 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 p -64.17 104.31 0.72 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -149.15 110.11 4.33 Favored 'General case' 0 N--CA 1.406 -2.643 0 C-N-CA 123.75 0.82 . . . . 0.0 108.787 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 p -68.2 170.66 7.17 Favored Pre-proline 0 C--N 1.275 -2.63 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.541 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -68.39 178.75 3.46 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.763 2.309 . . . . 0.0 112.373 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -80.99 30.62 0.32 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 125.318 1.447 . . . . 0.0 113.999 -174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' HB2' ' HG3' ' A' ' 31' ' ' GLN . 89.2 mt-30 -70.49 170.48 10.53 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.57 158.07 16.6 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-N 120.874 1.348 . . . . 0.0 110.749 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 60.22 27.98 17.53 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 125.25 1.42 . . . . 0.0 111.412 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 28' ' ' GLN . 83.4 mm-40 -109.33 -52.35 2.78 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 123.65 1.69 . . . . 0.0 114.022 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -63.38 155.73 73.36 Favored Pre-proline 1 C--N 1.2 -5.911 0 CA-C-N 110.148 -3.206 . . . . 0.0 112.152 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.26 135.52 11.52 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.928 3.085 . . . . 0.0 110.044 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.6 m -145.86 157.59 43.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.193 0.52 . . . . 0.0 112.008 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -147.76 148.15 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.734 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.803 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.4 m -97.05 103.86 15.82 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -107.86 147.59 30.73 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.138 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.83 111.18 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.0 146.02 38.62 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.47 -168.85 3.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.83 20.45 6.03 Favored Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.471 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.12 -26.86 9.0 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.641 0.734 . . . . 0.0 110.699 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.0 m -99.62 135.3 41.25 Favored 'General case' 0 N--CA 1.39 -3.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.942 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.31 146.12 12.76 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 123.931 0.769 . . . . 0.0 111.58 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.0 t -52.75 -54.0 18.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.643 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -56.82 -31.02 64.31 Favored 'General case' 0 C--O 1.204 -1.329 0 O-C-N 124.464 1.102 . . . . 0.0 111.977 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 -38.94 62.16 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -61.91 -37.6 85.24 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.5 mt -68.81 -42.35 82.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.127 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.7 mttt -58.58 -33.55 70.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.87 -54.82 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.6 mt -53.12 -49.34 66.74 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 123.268 0.355 . . . . 0.0 111.178 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 86.4 mt -56.65 -48.19 78.12 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 123.404 0.44 . . . . 0.0 110.224 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -59.7 -38.76 82.47 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.71 -30.32 64.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.856 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.43 1.09 55.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.362 0.601 . . . . 0.0 112.03 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 67.3 35.05 4.55 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.489 1.516 . . . . 0.0 112.497 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.54 136.76 19.13 Favored Pre-proline 0 N--CA 1.411 -2.407 0 C-N-CA 124.802 1.241 . . . . 0.0 107.8 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.13 133.0 50.24 Favored 'Trans proline' 0 CA--C 1.495 -1.445 0 C-N-CA 121.999 1.799 . . . . 0.0 110.861 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -62.05 -9.85 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.115 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.05 -19.2 64.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.277 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -82.21 -5.51 58.55 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.9 p -48.01 -29.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 125.759 1.623 . . . . 0.0 110.975 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -48.95 77.54 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.977 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.0 m -99.78 12.96 35.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.843 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.3 m-85 -115.78 140.28 49.37 Favored 'General case' 0 CA--C 1.473 -1.992 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.163 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -156.07 152.36 27.93 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.434 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.71 127.99 33.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.859 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.609 HE21 ' HE1' ' A' ' 76' ' ' TYR . 21.5 tt0 -111.04 144.53 40.01 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -73.87 125.18 90.52 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 -19.97 64.43 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.177 2.585 . . . . 0.0 114.84 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.79 -44.79 4.55 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.935 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.8 p -90.78 -15.18 30.59 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.89 18.96 11.71 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.799 1.24 . . . . 0.0 111.262 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.47 136.38 38.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.734 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.609 ' HE1' HE21 ' A' ' 69' ' ' GLN . 8.6 m-85 -92.77 147.76 22.6 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.385 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.9 105.99 17.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -107.07 13.87 26.96 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.799 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.23 163.97 27.04 Favored 'General case' 0 CA--C 1.461 -2.451 0 CA-C-O 122.719 1.247 . . . . 0.0 112.755 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.7 m -88.3 -38.92 14.79 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-N 112.6 -2.091 . . . . 0.0 109.129 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -131.85 149.21 52.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.857 0.863 . . . . 0.0 110.17 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 45' ' ' VAL . 21.5 mt -86.15 152.61 22.7 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.796 0.838 . . . . 0.0 111.786 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 62.0 p -103.05 155.92 36.0 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.73 -31.49 91.99 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.017 1.812 . . . . 0.0 109.411 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.7 -44.6 96.63 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.475 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 2.3 mmp_? -60.25 -38.8 84.59 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 58.0 mt -67.31 -47.63 69.99 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.699 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.607 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 42.9 t -62.74 -47.65 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 176.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 45.9 mt-10 -62.69 -30.8 71.67 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 111.664 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.43 58.27 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.909 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 3.0 mm-40 -59.08 -22.88 61.5 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -54.69 -38.74 67.38 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.097 172.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.4 m -144.76 -78.89 0.19 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.37 -177.27 4.4 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.699 1.2 . . . . 0.0 108.568 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.46 151.1 39.79 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.3 102.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.555 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.02 107.41 10.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -126.42 159.2 33.95 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.901 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 62.9 mtp -78.97 127.2 31.69 Favored 'General case' 0 N--CA 1.4 -2.97 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -58.31 141.9 82.15 Favored Pre-proline 0 N--CA 1.428 -1.544 0 O-C-N 124.576 1.173 . . . . 0.0 109.341 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -39.5 107.14 0.06 OUTLIER 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 124.102 3.201 . . . . 0.0 115.291 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -134.05 154.5 51.12 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.044 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.6 177.17 3.51 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.4 mt -73.48 97.93 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-O 121.541 0.686 . . . . 0.0 109.599 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.89 97.55 0.94 Allowed 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.93 68.75 8.47 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 121.625 0.726 . . . . 0.0 112.442 -174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 . . . . . 0 C--N 1.28 -2.45 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.592 174.664 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.21 -17.4 54.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.516 0.674 . . . . 0.0 109.847 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -105.52 -176.39 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.321 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 mmt -105.29 175.78 5.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.145 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.23 -96.74 2.38 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.29 75.08 0.71 Allowed Glycine 0 CA--C 1.483 -1.965 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 m -68.92 141.23 55.06 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.136 0.493 . . . . 0.0 110.728 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 13.0 mmt -123.78 140.84 52.59 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.293 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' HD13 ' A' ' 38' ' ' ILE . 28.5 ttpt -98.95 95.68 7.32 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.232 1.015 . . . . 0.0 108.953 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -105.45 139.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.243 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.8 mmt180 -65.76 131.86 47.33 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-O 121.139 0.495 . . . . 0.0 110.04 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.5 t -117.01 126.16 74.28 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.734 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.265 33.6 mt-10 -86.02 150.1 24.7 Favored 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 116.642 -2.023 . . . . 0.0 107.185 167.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -121.94 130.84 53.65 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 112.34 35.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.8 20.9 1.01 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.33 -166.79 24.5 Favored Glycine 0 N--CA 1.417 -2.603 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.089 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -124.79 48.48 1.97 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -57.99 143.31 43.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.307 -2.224 . . . . 0.0 113.184 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -114.92 119.27 35.97 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.97 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.477 ' NH1' ' HB2' ' A' ' 57' ' ' LYS . 70.6 mtt180 -110.33 -163.49 0.86 Allowed 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -60.55 102.97 0.21 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.355 0.598 . . . . 0.0 112.375 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.9 t -151.43 103.45 2.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -86.93 -5.06 59.21 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.564 0.697 . . . . 0.0 109.289 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 5.4 p -85.11 178.33 2.43 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.55 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 25' ' ' THR . 5.2 Cg_exo -38.93 158.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 124.58 3.52 . . . . 0.0 113.788 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.54 19.21 0.27 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.648 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' PRO . 48.0 mt-30 65.35 163.54 0.12 Allowed Pre-proline 0 C--N 1.309 -1.18 0 C-N-CA 125.902 1.681 . . . . 0.0 111.349 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.79 136.55 71.02 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.291 -1.465 . . . . 0.0 108.291 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -82.6 60.32 5.15 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.866 1.317 . . . . 0.0 112.274 -174.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -136.64 -169.12 2.39 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 127.639 2.376 . . . . 0.0 106.216 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 94.1 m-20 -83.55 151.28 61.66 Favored Pre-proline 0 C--N 1.282 -2.326 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.07 133.07 18.46 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.989 3.126 . . . . 0.0 110.047 171.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 25.5 p -136.08 152.43 50.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.506 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -148.35 151.43 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 m -100.93 105.95 17.24 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -113.09 140.81 47.56 Favored 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.503 -171.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.251 36.3 mm -76.84 111.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 179.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.74 145.96 39.61 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -148.42 -170.74 3.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.9 17.58 7.65 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -108.71 -28.94 8.95 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.689 0.757 . . . . 0.0 109.719 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -100.45 132.06 46.04 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.772 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.59 151.23 4.41 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.524 0.73 . . . . 0.0 111.875 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.55 -54.28 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.996 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.72 -30.46 65.55 Favored 'General case' 0 C--O 1.204 -1.301 0 O-C-N 124.221 0.951 . . . . 0.0 112.525 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -73.66 -37.05 65.42 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.079 -0.388 . . . . 0.0 110.033 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -62.77 -39.59 94.64 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 42.8 mt -68.52 -41.82 83.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.31 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -58.39 -34.66 70.98 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 119.047 0.84 . . . . 0.0 110.759 174.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.7 t -68.7 -54.13 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.3 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.85 -47.33 74.31 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.215 0.322 . . . . 0.0 111.191 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.1 mt -57.59 -46.87 83.48 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 123.377 0.423 . . . . 0.0 109.977 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -59.35 -40.69 87.19 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.16 -32.78 67.18 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 47.2 m-85 -83.94 -5.75 59.28 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.387 0.613 . . . . 0.0 111.296 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 26.1 mtpp 69.28 45.99 0.82 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 126.287 1.835 . . . . 0.0 112.983 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.99 135.88 21.26 Favored Pre-proline 0 N--CA 1.404 -2.739 0 C-N-CA 125.782 1.633 . . . . 0.0 107.286 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.36 134.64 62.13 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.142 1.895 . . . . 0.0 111.373 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.3 m -63.77 -10.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.176 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.94 -15.84 63.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.726 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.5 mptp? -85.0 -4.04 59.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.83 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.1 p -47.05 -31.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 126.08 1.752 . . . . 0.0 110.296 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.4 m -55.78 -47.02 77.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.744 1.618 . . . . 0.0 110.849 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -100.72 12.66 37.02 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.33 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.4 m-85 -113.28 143.24 44.75 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.906 -0.496 . . . . 0.0 111.654 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.35 147.54 28.43 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.838 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -83.54 125.64 31.98 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 124.26 0.975 . . . . 0.0 108.415 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -112.77 147.77 36.19 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.22 129.91 70.94 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.08 -20.63 67.75 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.82 2.347 . . . . 0.0 115.179 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -103.71 -44.89 4.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.984 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 p -89.5 -20.55 23.7 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.851 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt 67.24 17.27 10.26 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.599 1.159 . . . . 0.0 111.821 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.2 39.18 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.53 154.26 17.38 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.45 110.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -102.32 11.58 37.89 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.546 0.689 . . . . 0.0 110.424 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.17 156.85 36.89 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.934 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.6 m -81.73 -38.59 25.49 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.618 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.46 149.27 52.21 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 124.194 0.997 . . . . 0.0 108.657 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.66 155.07 28.22 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.554 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 73.0 p -109.35 153.32 42.8 Favored Pre-proline 0 N--CA 1.401 -2.899 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HG2' ' OE2' ' A' ' 85' ' ' GLU . 8.6 Cg_endo -53.94 -37.56 85.87 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.553 2.169 . . . . 0.0 110.386 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 mp0 -60.09 -44.43 94.8 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.485 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 4.0 mmp_? -61.7 -40.4 94.9 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 83' ' ' THR . 66.3 mt -66.29 -47.12 74.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.711 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.76 -46.3 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.585 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 86' ' ' ARG . 49.7 mt-10 -63.78 -31.8 73.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 111.451 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.82 61.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.622 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -57.33 -24.9 58.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.188 0.595 . . . . 0.0 111.934 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 67.0 mttm -56.17 -35.62 67.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.506 1.122 . . . . 0.0 112.534 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.1 m -146.79 -85.1 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.61 -178.82 7.38 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.297 1.039 . . . . 0.0 108.843 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.35 149.27 42.11 Favored 'General case' 0 C--O 1.209 -1.075 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 169.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 98' ' ' ARG . 9.7 mt -116.63 101.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 118.821 0.737 . . . . 0.0 110.325 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -79.39 102.99 9.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 96' ' ' ILE . 25.0 mtp180 -119.99 161.05 21.57 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 46.8 mtp -78.82 125.3 29.19 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 43.5 mtpt -59.73 130.22 88.1 Favored Pre-proline 0 C--N 1.288 -2.107 0 O-C-N 124.169 0.918 . . . . 0.0 112.311 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 53.6 Cg_exo -60.24 110.08 0.73 Allowed 'Trans proline' 0 CA--C 1.506 -0.901 0 C-N-CA 123.027 2.484 . . . . 0.0 110.791 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 63.98 100.95 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.103 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.88 -166.89 1.28 Allowed 'General case' 0 C--N 1.251 -3.712 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.211 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.66 102.01 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.99 29.9 6.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.23 17.75 4.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.703 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 . . . . . 0 N--CA 1.436 -1.132 0 C-N-CA 127.392 2.277 . . . . 0.0 114.279 173.429 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.27 111.33 17.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -136.8 141.22 42.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtm 62.42 24.62 14.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.817 0.847 . . . . 0.0 110.806 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.33 -58.86 0.64 Allowed Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.38 66.2 1.82 Allowed Glycine 0 N--CA 1.423 -2.225 0 CA-C-N 115.128 -0.536 . . . . 0.0 113.649 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 m -80.77 150.83 29.09 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 12.0 mmt -127.96 142.07 51.35 Favored 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -99.13 97.57 8.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -109.4 138.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.17 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 87.9 mtt180 -69.3 130.79 43.57 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.364 0.602 . . . . 0.0 110.683 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 48.3 t -116.83 123.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.561 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.607 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.259 35.6 mt-10 -84.69 142.4 29.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.622 -2.031 . . . . 0.0 107.711 169.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.4 tm? -115.38 130.73 56.98 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.972 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -115.44 123.79 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -122.88 3.06 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.976 1.37 . . . . 0.0 111.032 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.03 25.2 74.47 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.103 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -140.12 27.48 2.15 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.05 65.75 1.14 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.627 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.57 20.41 4.29 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 122.144 0.973 . . . . 0.0 110.598 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.48 23.68 6.83 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.435 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -80.31 80.4 6.75 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.402 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -121.86 16.39 10.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.865 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -91.28 -6.12 53.7 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.064 0.935 . . . . 0.0 109.165 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 30' ' ' GLN . 5.0 p -82.1 162.03 58.27 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.106 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -76.31 -155.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.285 2.656 . . . . 0.0 109.278 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -81.19 13.47 2.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 122.57 1.176 . . . . 0.0 111.383 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -89.15 159.99 43.88 Favored Pre-proline 0 C--N 1.278 -2.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.684 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.25 136.31 8.24 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 123.5 2.8 . . . . 0.0 112.118 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HA ' HG21 ' A' ' 25' ' ' THR . 25.2 mp0 -82.0 71.41 9.03 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 122.317 1.056 . . . . 0.0 110.426 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.33 175.87 3.1 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 113.056 -1.884 . . . . 0.0 112.552 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.413 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 87.7 m-20 -57.74 144.86 72.57 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -172.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.74 137.84 79.59 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.556 3.504 . . . . 0.0 109.422 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.6 m -143.61 159.89 41.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.792 -0.567 . . . . 0.0 109.623 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -151.69 150.39 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -97.35 106.72 19.09 Favored 'General case' 0 N--CA 1.394 -3.261 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 173.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -110.2 145.42 37.32 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.132 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.254 50.2 mm -83.28 109.89 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.85 144.51 39.76 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -152.41 169.21 23.11 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 124.235 1.014 . . . . 0.0 108.534 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.65 17.98 53.93 Favored Glycine 0 C--N 1.282 -2.465 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -104.95 -30.03 10.08 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-O 121.715 0.769 . . . . 0.0 109.963 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.681 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 31.6 m -97.75 137.39 36.7 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 124.793 1.237 . . . . 0.0 108.564 175.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.04 149.34 12.1 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-O 121.517 0.675 . . . . 0.0 110.44 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.6 t -55.74 -53.92 31.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.096 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -57.4 -31.1 65.5 Favored 'General case' 0 C--O 1.208 -1.107 0 O-C-N 124.159 0.912 . . . . 0.0 111.818 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -74.16 -36.64 64.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 122.344 -0.223 . . . . 0.0 110.813 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.681 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 91.3 m-70 -62.76 -39.06 92.99 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.7 mt -68.67 -43.12 83.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.473 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.7 mttt -58.51 -31.88 68.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.733 0.697 . . . . 0.0 110.899 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 47' ' ' ASP . 91.1 t -68.61 -54.31 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.417 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -53.14 -48.76 67.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 122.502 0.321 . . . . 0.0 111.013 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.0 mt -57.73 -49.07 77.79 Favored 'General case' 0 C--O 1.195 -1.815 0 O-C-N 123.654 0.596 . . . . 0.0 109.811 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 m -59.72 -38.51 81.87 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -72.68 -31.91 65.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 47.6 m-85 -83.09 -7.09 59.69 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.188 0.518 . . . . 0.0 111.334 173.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 72.02 38.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.62 1.568 . . . . 0.0 112.237 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' CG2' ' HD2' ' A' ' 62' ' ' LYS . 75.1 mt -105.89 134.79 19.57 Favored Pre-proline 0 N--CA 1.409 -2.517 0 C-N-CA 125.345 1.458 . . . . 0.0 107.865 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.01 131.39 46.15 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.339 2.026 . . . . 0.0 111.325 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.6 m -62.42 -11.04 5.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.553 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.43 -14.65 62.22 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HD2' ' CG2' ' A' ' 58' ' ' ILE . 66.9 mttm -81.62 -9.96 59.54 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.827 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.3 p -47.27 -31.33 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 127.257 2.223 . . . . 0.0 110.343 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 m -54.41 -46.24 73.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.564 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' MET . 14.8 t -94.41 -0.64 54.68 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.823 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 20.0 m-85 -101.14 139.05 37.36 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.714 -1.194 . . . . 0.0 112.315 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . . . -149.56 142.24 24.55 Favored 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.646 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 97' ' ' LEU . 79.2 mt -79.0 126.41 30.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.7 148.57 38.06 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.82 128.0 73.09 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.08 -17.64 40.55 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 122.553 2.169 . . . . 0.0 114.828 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.85 -43.28 5.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.209 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 p -91.25 -18.86 23.7 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.62 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 mt 69.45 17.62 8.02 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.382 1.073 . . . . 0.0 111.671 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.96 140.82 30.79 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.55 150.83 19.85 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 120.959 0.409 . . . . 0.0 110.692 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.7 t -87.9 106.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.08 16.69 23.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.403 1.097 . . . . 0.0 109.836 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.49 158.26 32.84 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.75 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.65 -38.13 20.2 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.29 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -131.58 144.82 51.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.272 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.8 mt -78.96 152.74 30.87 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.777 0.798 . . . . 0.0 110.632 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.9 p -106.32 152.21 40.47 Favored Pre-proline 0 N--CA 1.398 -3.051 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.44 -31.69 92.01 Favored 'Trans proline' 0 C--O 1.208 -0.977 0 C-N-CA 122.287 1.992 . . . . 0.0 109.865 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.24 -47.81 82.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.458 0.703 . . . . 0.0 110.644 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 3.7 mmp_? -62.54 -37.27 85.46 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.893 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 83' ' ' THR . 57.7 mt -66.92 -47.29 72.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.385 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.97 -46.06 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.126 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -64.27 -30.98 72.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.659 0.742 . . . . 0.0 111.209 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.09 -34.09 59.52 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.623 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.43 -24.39 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -53.67 -40.22 65.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.102 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m -143.05 -80.69 0.2 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.64 -179.29 6.77 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.788 1.235 . . . . 0.0 108.947 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -119.1 155.52 31.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 12.4 mt -115.83 134.59 58.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -107.78 99.8 9.23 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -176.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -121.5 162.3 20.77 Favored 'General case' 0 CA--C 1.46 -2.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.018 -172.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' SER . 54.4 mtp -82.92 137.82 34.08 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 169.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 67' ' ' ALA . 87.8 mttt -74.27 164.48 60.98 Favored Pre-proline 0 C--N 1.271 -2.812 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.24 83.17 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.036 1.824 . . . . 0.0 111.521 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 59.76 120.46 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 127.674 2.39 . . . . 0.0 112.99 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.26 170.64 11.29 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.604 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.07 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-O 122.115 0.959 . . . . 0.0 109.573 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.38 103.36 1.78 Allowed 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.1 t70 64.49 26.42 13.4 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.171 1.462 . . . . 0.0 110.122 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 . . . . . 0 N--CA 1.404 -2.731 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.617 -179.18 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.86 73.89 0.35 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.206 1.003 . . . . 0.0 112.088 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -170.1 137.47 1.56 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.407 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.2 mtt -128.56 172.16 11.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.46 1.21 Allowed Glycine 0 C--O 1.243 0.684 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.84 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.86 68.41 1.48 Allowed Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.475 -0.393 . . . . 0.0 112.68 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 m -82.57 142.21 31.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.708 0.29 . . . . 0.0 110.889 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mmt -118.26 139.72 50.89 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.583 ' HD3' ' CD1' ' A' ' 38' ' ' ILE . 36.5 tptt -100.55 100.19 10.89 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.32 136.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.287 -170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 62.6 mtm180 -69.26 135.94 51.22 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-O 121.567 0.699 . . . . 0.0 110.754 171.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' SER . 62.3 t -121.11 124.54 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.571 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.272 29.8 mt-10 -85.9 138.82 31.75 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.907 -1.917 . . . . 0.0 108.228 168.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -115.99 129.61 56.45 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 178.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.411 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp -108.43 113.33 43.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.718 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HB3' HD11 ' A' ' 14' ' ' LEU . 28.3 p-10 -112.31 17.89 19.03 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.528 1.156 . . . . 0.0 110.491 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.5 150.2 5.32 Favored Glycine 0 N--CA 1.407 -3.268 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.055 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -105.94 14.03 28.53 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.93 90.89 5.36 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -77.22 98.3 5.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.857 0.837 . . . . 0.0 112.552 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -94.34 90.23 6.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.181 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 p -77.13 111.96 13.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.5 p -173.25 176.63 2.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.7 m -89.71 75.59 7.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.878 1.323 . . . . 0.0 110.471 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.469 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 12.8 p -122.03 -175.7 0.38 Allowed Pre-proline 0 C--N 1.257 -3.414 0 CA-C-N 112.773 -2.012 . . . . 0.0 107.689 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.469 ' CD ' ' HB ' ' A' ' 25' ' ' THR . 5.0 Cg_exo -77.27 25.65 0.47 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.143 1.895 . . . . 0.0 112.043 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' A' ' 25' ' ' THR . 45.8 mt-30 -121.47 35.39 4.9 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.669 1.588 . . . . 0.0 108.757 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -49.18 117.51 6.71 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.575 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.25 40.23 0.81 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 123.391 2.727 . . . . 0.0 113.811 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -93.8 -67.54 0.85 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -125.64 -170.07 2.11 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 35.5 m-80 -90.41 146.71 35.06 Favored Pre-proline 0 N--CA 1.402 -2.83 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -37.27 132.8 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 124.683 3.589 . . . . 0.0 111.662 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 30.6 m -138.91 159.54 41.9 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.729 -0.607 . . . . 0.0 112.128 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.0 p -151.93 150.92 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -95.92 115.82 28.0 Favored 'General case' 1 N--CA 1.378 -4.055 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 171.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -115.23 142.57 46.49 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.399 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 31.1 mm -79.39 110.82 15.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.01 141.38 42.9 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' O ' ' HE1' ' A' ' 48' ' ' HIS . 7.9 p-10 -145.99 160.34 42.0 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.274 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.4 20.34 51.1 Favored Glycine 0 C--N 1.281 -2.496 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.812 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -110.19 -24.97 10.41 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 121.701 0.763 . . . . 0.0 109.815 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 91.4 m -103.23 137.19 41.71 Favored 'General case' 0 N--CA 1.401 -2.875 0 C-N-CA 124.274 1.03 . . . . 0.0 109.436 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.18 152.6 13.36 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.692 0.758 . . . . 0.0 111.69 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.4 t -56.26 -54.83 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.129 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -57.07 -30.39 64.26 Favored 'General case' 0 C--O 1.207 -1.183 0 O-C-N 124.31 1.006 . . . . 0.0 111.387 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 m-20 -75.48 -37.4 60.26 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.593 ' HE1' ' O ' ' A' ' 40' ' ' ASP . 37.6 m80 -61.36 -39.28 90.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.2 mt -67.38 -43.35 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.072 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 63' ' ' VAL . 93.1 mttt -57.28 -35.22 69.51 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.036 0.835 . . . . 0.0 110.936 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 97.1 t -69.0 -53.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.322 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -53.14 -48.86 67.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 123.357 0.411 . . . . 0.0 110.982 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.7 mt -57.65 -47.75 81.39 Favored 'General case' 0 C--O 1.202 -1.428 0 O-C-N 123.408 0.443 . . . . 0.0 110.048 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 m -58.92 -40.97 86.18 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -71.21 -35.02 71.37 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.187 0.517 . . . . 0.0 112.19 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.552 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 46.1 m-85 -79.46 -2.17 40.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.241 0.543 . . . . 0.0 111.332 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 70.54 36.43 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.205 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -107.31 138.39 19.89 Favored Pre-proline 0 N--CA 1.415 -2.201 0 C-N-CA 125.277 1.431 . . . . 0.0 107.81 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.93 133.14 56.06 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 121.805 1.67 . . . . 0.0 110.638 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.8 m -62.77 -10.04 4.99 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.512 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.09 -19.6 65.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.0 110.125 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.4 mptp? -80.61 -8.06 59.48 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.765 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.2 p -47.97 -33.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 C-N-CA 125.548 1.539 . . . . 0.0 110.052 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.256 14.4 m -54.42 -48.17 71.95 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 126.184 1.794 . . . . 0.0 109.907 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 99' ' ' MET . 25.4 m -100.49 14.47 31.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.09 -1.413 . . . . 0.0 112.179 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.0 m-85 -112.26 139.06 48.11 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.376 0.608 . . . . 0.0 112.05 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.91 141.99 24.9 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.779 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 90.0 mt -76.06 159.13 31.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.38 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 45.5 tt0 -143.25 150.5 39.37 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.16 128.96 71.6 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.18 -15.72 43.21 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.763 2.309 . . . . 0.0 115.226 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -109.37 -45.52 3.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.756 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -88.97 -17.62 29.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.465 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt 70.91 15.02 6.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.494 1.117 . . . . 0.0 112.683 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.96 137.46 38.33 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.048 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 3.9 m-85 -85.1 174.21 9.87 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.045 0.45 . . . . 0.0 111.61 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.35 107.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.51 12.34 26.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.004 0.907 . . . . 0.0 110.293 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.38 157.58 33.99 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.73 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -84.33 -40.81 17.47 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.042 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.92 152.35 49.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 123.774 0.829 . . . . 0.0 109.409 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 45' ' ' VAL . 18.0 mt -88.34 148.59 24.2 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.517 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.1 p -99.49 152.9 37.96 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.35 -35.66 92.11 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.704 2.269 . . . . 0.0 110.125 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.39 -48.96 77.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.482 0.713 . . . . 0.0 110.511 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -61.48 -37.27 83.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 123.304 0.377 . . . . 0.0 111.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 63.6 mt -64.85 -47.98 75.96 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.694 0.621 . . . . 0.0 110.578 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -63.99 -44.83 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -61.68 -27.68 68.86 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.798 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.43 -36.33 24.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -53.93 -24.56 16.73 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -50.29 -39.81 46.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.724 0.81 . . . . 0.0 111.021 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.6 m -147.74 -92.35 0.08 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.46 178.46 8.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.512 0.725 . . . . 0.0 109.424 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.65 154.41 30.59 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 14.3 mt -116.33 139.78 41.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 170.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -116.22 109.12 17.0 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -127.95 160.88 30.5 Favored 'General case' 0 CA--C 1.467 -2.248 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 54.8 mtp -80.44 136.36 36.32 Favored 'General case' 0 N--CA 1.397 -3.08 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -60.96 116.5 19.03 Favored Pre-proline 0 C--N 1.286 -2.183 0 O-C-N 124.358 1.036 . . . . 0.0 109.63 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.17 102.48 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.755 2.303 . . . . 0.0 111.774 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -89.01 99.95 12.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.441 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.51 -176.93 6.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.817 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.2 mt -95.93 133.19 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.68 82.81 0.87 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 122.093 0.949 . . . . 0.0 109.948 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -138.95 89.87 2.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.352 -178.505 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.98 -176.83 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 110.868 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -93.12 107.77 19.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.001 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.64 126.64 34.08 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.506 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.88 56.68 0.08 OUTLIER Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.05 57.31 0.67 Allowed Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 p -84.76 142.6 29.7 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.8 mmt -118.31 138.47 52.37 Favored 'General case' 0 CA--C 1.47 -2.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.909 -172.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 76.4 tttt -97.18 93.07 6.34 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.86 140.08 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.211 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 86.2 mtt180 -70.13 129.62 39.91 Favored 'General case' 0 CA--C 1.475 -1.932 0 O-C-N 123.516 0.51 . . . . 0.0 110.113 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' SER . 41.2 t -115.49 124.74 72.3 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.546 0 CA-C-O 117.675 -1.155 . . . . 0.0 108.092 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.268 47.0 mt-10 -85.54 145.39 27.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 116.829 -1.948 . . . . 0.0 107.764 168.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -116.14 131.66 56.88 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.078 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -108.36 119.61 58.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HB2' HD11 ' A' ' 14' ' ' LEU . 64.4 t30 -129.18 19.74 5.87 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.52 174.87 50.17 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 112.613 -2.085 . . . . 0.0 111.095 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -96.32 4.0 52.58 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.943 0.878 . . . . 0.0 109.914 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.42 -179.53 4.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.276 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.2 m80 74.13 83.26 0.11 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.329 1.051 . . . . 0.0 108.432 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.42 144.2 46.43 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.837 -174.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p 55.61 31.91 18.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.256 1.022 . . . . 0.0 111.036 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.6 m -150.83 -40.95 0.12 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.354 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -146.49 100.22 3.32 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 122.06 0.933 . . . . 0.0 111.966 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 p -143.25 166.1 22.02 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.38 88.17 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.807 1.672 . . . . 0.0 109.739 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -90.31 21.08 4.01 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -138.78 117.6 9.3 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.912 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.74 46.34 1.66 Allowed 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 123.091 2.527 . . . . 0.0 110.627 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -141.78 -56.31 0.47 Allowed 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 124.592 1.157 . . . . 0.0 108.791 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -140.8 -158.82 0.89 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.462 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 4.4 m-20 -72.38 -179.02 0.72 Allowed Pre-proline 0 C--O 1.257 1.458 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 32' ' ' ASN . 5.2 Cg_endo -52.38 129.44 31.67 Favored 'Trans proline' 0 C--N 1.384 2.436 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 169.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.1 p -140.56 162.16 36.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.263 -171.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -151.37 149.45 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.0 m -98.23 107.36 19.82 Favored 'General case' 0 N--CA 1.386 -3.645 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -113.93 146.59 39.87 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.469 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.73 112.02 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.96 146.04 39.73 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.3 173.95 14.93 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 123.535 0.734 . . . . 0.0 109.159 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.54 14.98 56.36 Favored Glycine 0 C--N 1.304 -1.228 0 O-C-N 124.413 1.071 . . . . 0.0 112.825 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -108.97 -32.11 7.38 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 121.209 0.528 . . . . 0.0 112.063 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.8 m -93.72 134.2 36.29 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.59 0.756 . . . . 0.0 109.317 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.77 149.1 6.53 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.041 0.936 . . . . 0.0 110.942 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.7 t -55.29 -53.14 38.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.523 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -59.36 -28.36 66.78 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.434 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 m-20 -73.35 -39.1 65.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -61.89 -38.48 88.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.3 mt -69.22 -43.99 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.13 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.2 mttt -56.91 -34.18 67.67 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 118.985 0.811 . . . . 0.0 110.603 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 47' ' ' ASP . 96.2 t -69.17 -55.51 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.445 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.1 -49.19 66.99 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 123.301 0.375 . . . . 0.0 111.55 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.46 -48.55 76.84 Favored 'General case' 0 C--O 1.201 -1.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.138 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.7 m -59.81 -36.79 77.49 Favored 'General case' 0 N--CA 1.397 -3.109 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -73.43 -32.13 64.22 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 43.9 m-85 -84.64 -3.95 58.76 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 122.883 0.473 . . . . 0.0 111.688 174.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 70.49 35.76 1.87 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.219 1.408 . . . . 0.0 112.718 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.3 mt -105.23 132.1 21.17 Favored Pre-proline 0 N--CA 1.409 -2.511 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.82 135.36 62.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.07 1.847 . . . . 0.0 111.267 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -62.32 -9.52 3.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.904 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -68.01 -16.39 64.02 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 120.874 0.368 . . . . 0.0 110.11 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.58 -5.11 58.39 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.619 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.3 p -47.6 -33.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 C-N-CA 125.933 1.693 . . . . 0.0 110.995 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.276 15.3 m -54.8 -48.56 72.58 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 126.061 1.745 . . . . 0.0 110.444 174.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.7 m -102.11 17.73 22.56 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.821 -172.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.4 m-85 -116.76 142.65 46.64 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.73 146.44 25.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.222 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 85.9 mt -79.61 126.39 30.83 Favored 'General case' 0 N--CA 1.418 -2.057 0 O-C-N 124.71 1.256 . . . . 0.0 107.846 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 98' ' ' ARG . 38.8 tt0 -114.21 147.8 38.37 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.05 125.7 84.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -8.34 22.61 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 122.655 2.237 . . . . 0.0 115.169 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.47 -40.75 3.56 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.298 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.2 p -90.44 -20.79 22.35 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.069 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt 70.59 18.91 6.33 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.797 1.239 . . . . 0.0 111.977 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.28 140.86 30.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.634 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' OH ' ' HD3' ' A' ' 98' ' ' ARG . 80.9 m-85 -98.14 144.53 27.51 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.822 0.344 . . . . 0.0 110.23 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.15 106.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -100.26 12.14 37.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.062 0.934 . . . . 0.0 110.362 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.15 152.21 34.98 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.371 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.9 m -79.12 -36.98 39.73 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.152 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.34 143.83 50.8 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.115 0.966 . . . . 0.0 108.806 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.9 mt -77.49 157.54 30.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.39 0.614 . . . . 0.0 111.257 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.0 p -111.71 153.64 44.27 Favored Pre-proline 0 N--CA 1.409 -2.477 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.28 -34.93 72.29 Favored 'Trans proline' 0 C--O 1.21 -0.91 0 C-N-CA 122.35 2.034 . . . . 0.0 110.349 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.86 -48.49 77.98 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 4.1 mmp_? -61.11 -38.85 87.8 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.369 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 52.4 mt -67.69 -48.09 67.55 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.727 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.22 -47.56 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.26 -29.66 70.46 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.253 0.549 . . . . 0.0 111.784 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.45 -37.03 60.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.78 -24.23 48.89 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -53.0 -43.79 66.74 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -137.63 -82.46 0.34 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.22 178.55 6.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.16 1.384 . . . . 0.0 108.489 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 155.07 30.4 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 11.7 mt -115.39 138.51 45.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 99.26 7.06 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 69' ' ' GLN . 44.0 mtp180 -119.67 162.63 18.69 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 41.2 mtp -78.6 125.92 30.02 Favored 'General case' 0 N--CA 1.393 -3.288 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.01 150.8 59.46 Favored Pre-proline 0 C--N 1.288 -2.103 0 O-C-N 124.454 1.096 . . . . 0.0 109.867 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -51.25 99.29 0.04 OUTLIER 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.609 2.873 . . . . 0.0 114.903 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -135.1 115.81 13.85 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 113.09 -1.868 . . . . 0.0 106.547 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.84 -165.13 0.78 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.89 113.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.17 98.68 9.06 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.44 77.65 1.53 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 172.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.236 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.577 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.178 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.16 -172.48 0.17 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.331 1.053 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -91.79 110.93 22.28 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.645 0.259 . . . . 0.0 111.191 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.45 105.49 17.64 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.21 -40.05 5.56 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.27 -44.62 1.2 Allowed Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m -82.79 133.67 35.14 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 44.6 mtt -114.13 139.41 49.35 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.566 -170.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -100.36 96.87 7.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.43 138.58 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.851 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 17.3 mtp180 -68.21 131.13 44.83 Favored 'General case' 0 CA--C 1.46 -2.503 0 CA-C-O 122.146 0.974 . . . . 0.0 111.947 170.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.5 t -118.15 123.51 71.73 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.361 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.155 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 11' ' ' ARG 0.272 0.5 OUTLIER -83.98 149.42 26.31 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.213 166.451 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -123.34 130.66 53.03 Favored 'General case' 0 C--N 1.265 -3.08 0 O-C-N 123.469 0.481 . . . . 0.0 111.084 176.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp -109.82 119.4 58.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.29 169.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -129.36 45.08 2.86 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 31.97 0.83 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 115.729 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -87.85 -14.25 39.96 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.5 6.71 16.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.422 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -137.47 92.17 2.67 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.85 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -128.55 -170.1 2.19 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p 55.08 -153.06 0.33 Allowed 'General case' 0 C--O 1.249 1.059 0 C-N-CA 122.869 0.468 . . . . 0.0 110.107 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -56.44 -32.93 65.37 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.711 0.404 . . . . 0.0 111.302 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 80.62 126.09 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.444 ' HB ' ' OE1' ' A' ' 27' ' ' GLN . 10.4 p -64.05 160.62 46.32 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.238 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.86 32.1 0.51 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.223 2.616 . . . . 0.0 114.082 -176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.444 ' OE1' ' HB ' ' A' ' 25' ' ' THR . 1.9 mp0 -94.23 42.25 1.09 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.395 1.078 . . . . 0.0 109.995 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -39.69 113.66 0.89 Allowed Pre-proline 0 C--O 1.249 1.03 0 O-C-N 125.543 1.777 . . . . 0.0 112.073 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.47 89.53 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.489 2.126 . . . . 0.0 110.799 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -71.57 -42.39 67.88 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -121.85 158.67 28.41 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -105.12 152.57 39.74 Favored Pre-proline 0 C--N 1.27 -2.867 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.74 130.4 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.378 2.719 . . . . 0.0 110.533 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.2 m -138.6 155.79 48.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.1 p -147.98 150.2 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.4 m -98.11 105.36 17.5 Favored 'General case' 0 N--CA 1.387 -3.616 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -109.59 147.79 32.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.402 -170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.9 113.84 23.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.31 146.0 40.13 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.36 -171.89 3.68 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.58 -11.44 11.6 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.559 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -83.07 -26.11 31.41 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 124.197 0.999 . . . . 0.0 111.996 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.444 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 36.7 m -96.2 131.7 42.4 Favored 'General case' 0 N--CA 1.388 -3.561 0 C-N-CA 123.793 0.837 . . . . 0.0 109.631 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 149.57 9.0 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.867 0.73 . . . . 0.0 110.844 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.6 t -55.66 -51.78 54.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.87 -31.0 64.37 Favored 'General case' 0 C--O 1.202 -1.427 0 O-C-N 124.381 1.05 . . . . 0.0 111.387 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.0 m-20 -75.42 -38.9 59.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.444 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 39.3 m80 -61.71 -40.23 94.29 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.8 mt -68.34 -42.46 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.13 -34.36 70.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.89 0.768 . . . . 0.0 110.977 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.0 t -68.97 -53.38 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.4 -48.28 68.8 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.22 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.8 mt -57.84 -48.39 79.9 Favored 'General case' 0 C--O 1.193 -1.91 0 O-C-N 123.538 0.523 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -60.14 -38.91 84.54 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -72.11 -30.4 65.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.1 -0.375 . . . . 0.0 111.52 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 41.2 m-85 -88.56 -0.24 57.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.377 0.608 . . . . 0.0 112.201 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 69.0 32.46 3.77 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.661 1.584 . . . . 0.0 112.28 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -103.16 135.6 19.37 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.86 133.02 53.32 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.96 1.773 . . . . 0.0 111.918 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.0 m -62.59 -9.27 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.795 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.98 -18.38 62.62 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.634 0.731 . . . . 0.0 109.585 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -82.4 -9.99 59.23 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.903 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.7 p -46.04 -31.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 126.902 2.081 . . . . 0.0 110.741 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 m -54.67 -45.97 73.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.903 1.681 . . . . 0.0 111.067 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.4 t -97.96 0.33 46.22 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.618 -173.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -103.59 137.23 41.94 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.405 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.25 145.45 31.28 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.567 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.54 123.93 29.65 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -111.07 148.48 32.54 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -82.37 126.71 73.38 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 18.6 Cg_endo -60.63 -23.62 76.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.419 2.746 . . . . 0.0 114.82 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -103.84 -46.17 4.57 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.47 -1.292 . . . . 0.0 112.855 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -88.01 -17.1 31.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.557 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt 66.42 18.21 10.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 111.285 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.95 138.24 35.0 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.145 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -96.16 143.99 26.79 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.3 102.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.1 13.98 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 123.037 1.398 . . . . 0.0 108.537 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.55 158.56 31.08 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.999 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.5 m -84.88 -37.82 20.17 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.824 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -129.58 155.4 45.87 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.965 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.76 147.15 23.42 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.174 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.0 p -98.99 151.06 37.23 Favored Pre-proline 0 N--CA 1.401 -2.913 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.51 -33.85 93.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.245 1.963 . . . . 0.0 109.975 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.56 -47.41 85.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -61.3 -36.01 78.9 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.689 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 68.2 mt -64.09 -50.15 69.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.697 0.623 . . . . 0.0 110.485 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.24 -43.36 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.77 -32.99 69.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.76 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.11 -42.43 23.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.681 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 11.7 mt-10 -52.2 -25.28 8.76 Favored 'General case' 0 C--N 1.369 1.441 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.52 -36.81 62.18 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 124.367 1.067 . . . . 0.0 112.258 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -143.99 -83.14 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -165.92 -178.75 4.88 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.668 0.787 . . . . 0.0 109.263 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.12 148.29 43.22 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.404 HG22 ' HG2' ' A' ' 98' ' ' ARG . 10.9 mt -114.95 100.69 11.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.621 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.79 103.24 8.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' HG2' HG22 ' A' ' 96' ' ' ILE . 30.0 mtp180 -126.34 162.48 25.41 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.685 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 45.5 mtp -78.33 133.28 37.63 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 167.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.9 153.36 88.64 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -54.25 111.68 0.78 Allowed 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.298 2.665 . . . . 0.0 112.822 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -135.05 148.63 49.94 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.249 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.86 -176.04 2.24 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.24 141.56 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 69.31 70.12 0.26 Allowed 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.196 1.398 . . . . 0.0 109.075 -171.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -101.61 80.28 2.03 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.11 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.46 ' H ' ' HD3' ' A' ' 107' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.285 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.696 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.55 -164.84 1.23 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.263 34.6 p-80 52.95 66.38 1.25 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.387 1.075 . . . . 0.0 112.499 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 71.75 76.38 0.17 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.594 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.36 79.81 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.187 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.41 72.76 1.18 Allowed Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m -73.58 131.96 42.28 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.484 0.659 . . . . 0.0 110.968 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 42.3 mtt -115.57 141.09 48.53 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.494 -172.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -99.63 95.07 6.72 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.86 138.69 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.849 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 54.9 mtm-85 -69.39 131.53 44.93 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-O 121.623 0.725 . . . . 0.0 110.841 172.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' SER . 46.7 t -119.19 124.07 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.578 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.216 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 12' ' ' VAL . 31.4 mm-40 -81.18 158.88 24.77 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -130.81 133.17 45.73 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 122.074 -0.391 . . . . 0.0 111.091 175.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -110.15 113.4 44.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -111.31 12.07 21.65 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 122.529 1.157 . . . . 0.0 109.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 146.43 -171.81 27.17 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 -175.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -125.36 -2.22 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 118.594 1.197 . . . . 0.0 109.989 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -87.69 147.92 25.01 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.424 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.2 m80 71.5 19.55 5.12 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtm-85 -127.69 66.46 1.33 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -94.98 88.37 5.24 Favored 'General case' 0 N--CA 1.409 -2.475 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.753 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.4 m -75.37 94.67 3.1 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -93.02 -2.95 55.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.044 0.926 . . . . 0.0 109.525 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.93 172.68 9.19 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.513 178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.69 51.34 1.17 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.041 2.494 . . . . 0.0 111.378 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.16 84.05 1.64 Allowed 'General case' 0 N--CA 1.383 -3.799 0 C-N-CA 128.042 2.537 . . . . 0.0 105.073 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 30' ' ' GLN . 13.3 mm100 -42.08 134.2 2.44 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.539 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.26 25.18 0.31 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 123.944 3.096 . . . . 0.0 113.879 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 28' ' ' GLN . 92.8 mt-30 -89.81 -13.53 36.4 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.937 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.34 140.1 29.94 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 52.3 m-80 -127.58 178.29 1.67 Allowed Pre-proline 0 C--N 1.253 -3.599 0 C-N-CA 124.969 1.307 . . . . 0.0 108.693 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 32' ' ' ASN . 7.4 Cg_endo -55.04 132.08 50.2 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.623 1.549 . . . . 0.0 108.139 166.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 5.5 p -140.52 161.04 38.68 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.46 149.07 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -97.69 105.28 17.4 Favored 'General case' 0 N--CA 1.389 -3.513 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -109.11 147.28 32.69 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.103 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -83.26 110.67 18.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.06 149.02 34.01 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -149.48 -169.72 3.45 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.35 15.1 8.73 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -106.59 -34.19 7.43 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.677 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -93.97 134.35 36.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 C-N-CA 124.152 0.981 . . . . 0.0 108.376 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.56 151.72 7.63 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.563 0.697 . . . . 0.0 111.589 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 82' ' ' LEU . 98.5 t -55.27 -54.58 23.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.734 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -56.89 -30.43 63.88 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.628 -177.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.7 m-20 -73.79 -37.44 64.95 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.962 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -62.43 -38.67 90.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.4 mt -67.81 -44.22 85.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 63' ' ' VAL . 95.9 mttt -57.47 -34.16 68.73 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.843 0.747 . . . . 0.0 111.129 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 47' ' ' ASP . 85.7 t -69.05 -54.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.66 -49.19 68.48 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.657 0.383 . . . . 0.0 111.471 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.1 mt -57.25 -47.41 81.46 Favored 'General case' 0 C--O 1.195 -1.806 0 O-C-N 123.38 0.425 . . . . 0.0 110.05 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.68 -38.37 84.73 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -70.61 -37.83 73.9 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.975 0.417 . . . . 0.0 111.514 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 57.0 m-85 -78.81 -9.52 59.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.389 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm 74.42 39.74 0.45 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.87 1.268 . . . . 0.0 112.584 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.73 140.92 22.3 Favored Pre-proline 0 N--CA 1.411 -2.382 0 C-N-CA 125.74 1.616 . . . . 0.0 107.622 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.97 134.47 53.36 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 122.222 1.948 . . . . 0.0 111.087 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.4 m -63.28 -9.63 5.13 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.89 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.801 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.48 -14.83 62.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.0 110.221 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 65.1 mttm -88.98 -6.46 57.22 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.844 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.1 p -49.62 -29.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 126.287 1.835 . . . . 0.0 109.773 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 p -54.08 -51.14 65.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.237 1.815 . . . . 0.0 110.977 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' MET . 5.8 m -98.03 6.91 47.1 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.881 -171.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 16.8 m-85 -107.79 143.55 36.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.342 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.31 145.04 25.92 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.29 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 83.9 mt -80.97 128.13 33.34 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -118.09 149.8 40.41 Favored 'General case' 0 C--N 1.28 -2.452 0 O-C-N 122.161 -0.337 . . . . 0.0 110.101 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -81.77 132.72 53.74 Favored Pre-proline 0 C--N 1.313 -0.982 0 O-C-N 124.385 1.053 . . . . 0.0 108.276 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.48 -19.38 48.98 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.14 2.56 . . . . 0.0 115.105 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -105.01 -40.26 5.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.735 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -95.98 -19.51 19.44 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.328 0.585 . . . . 0.0 111.239 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.89 22.62 12.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.394 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.35 140.96 33.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.716 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.76 144.52 26.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.593 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.13 102.69 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.55 13.57 31.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.824 1.297 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.75 157.04 34.02 Favored 'General case' 0 N--CA 1.405 -2.696 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.647 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.0 m -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.875 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.33 147.91 52.09 Favored 'General case' 0 N--CA 1.418 -2.069 0 C-N-CA 124.041 0.936 . . . . 0.0 108.562 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.0 mt -79.16 154.8 29.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.11 0.481 . . . . 0.0 110.208 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 p -104.71 151.59 39.33 Favored Pre-proline 0 N--CA 1.399 -2.983 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.94 -31.59 93.1 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.173 1.915 . . . . 0.0 109.727 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.66 -48.66 78.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.494 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.84 -36.39 83.06 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.4 mt -64.3 -48.79 74.29 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.496 0.498 . . . . 0.0 110.18 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.62 -46.46 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -60.85 -32.87 72.26 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 112.209 171.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.82 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.48 -27.05 35.0 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 89' ' ' GLU . 95.7 mttt -54.96 -31.38 60.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.284 1.034 . . . . 0.0 112.083 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.8 m -143.81 -86.76 0.13 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -167.38 178.79 5.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.003 1.321 . . . . 0.0 108.527 -176.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -114.89 159.71 20.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 2.9 mp -120.22 141.61 39.71 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.781 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 167.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 98.38 6.73 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -115.69 161.21 19.03 Favored 'General case' 0 CA--C 1.464 -2.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.071 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.3 mtp -78.01 134.25 37.83 Favored 'General case' 0 N--CA 1.391 -3.403 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 165.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 8.3 mtpm? -69.23 134.06 89.37 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 81.3 Cg_exo -53.92 118.2 4.71 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.52 2.813 . . . . 0.0 113.516 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -134.96 165.36 25.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.228 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 64.14 167.3 0.16 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 113.183 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.6 mt -83.62 115.0 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.04 156.22 25.97 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -80.66 66.24 6.1 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.514 1.149 . . . . 0.0 111.282 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.133 177.381 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.416 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.87 81.83 0.2 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.472 1.509 . . . . 0.0 113.933 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.74 166.24 25.28 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.4 mmm 60.83 29.68 19.17 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.383 1.087 . . . . 0.0 109.893 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.21 83.02 0.65 Allowed Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.58 -33.47 42.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m -86.1 134.3 33.83 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.495 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.6 mmt -110.08 141.43 42.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.394 -170.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 64.7 tttt -101.62 95.75 6.65 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 90' ' ' ALA . 86.2 mt -105.51 140.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.334 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -70.9 134.18 47.05 Favored 'General case' 0 CA--C 1.466 -2.283 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.867 173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.85 123.36 71.58 Favored 'Isoleucine or valine' 2 N--CA 1.37 -4.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.6 OUTLIER -84.49 148.49 26.51 Favored 'General case' 0 N--CA 1.407 -2.581 0 C-N-CA 116.25 -2.18 . . . . 0.0 107.843 167.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -115.0 134.38 55.24 Favored 'General case' 0 C--N 1.278 -2.517 0 O-C-N 123.28 0.362 . . . . 0.0 110.6 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.4 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -107.13 118.11 54.26 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -169.25 85.96 0.15 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.45 61.32 0.13 Allowed Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.684 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -79.69 -34.17 40.46 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -75.01 81.48 2.21 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 113.522 -1.672 . . . . 0.0 107.785 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.8 m80 65.57 107.75 0.04 OUTLIER 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.415 1.086 . . . . 0.0 113.394 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 29' ' ' PRO . 95.4 mtt180 -75.96 136.6 40.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p 62.46 -163.12 0.27 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 124.991 1.316 . . . . 0.0 110.507 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.8 t -113.26 19.31 17.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.4 m 66.43 80.12 0.23 Allowed 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.272 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.5 p -116.87 167.34 10.86 Favored Pre-proline 0 C--N 1.271 -2.826 0 CA-C-N 112.975 -1.921 . . . . 0.0 108.393 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.35 33.26 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.563 2.175 . . . . 0.0 112.378 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.82 -0.81 39.02 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.105 0.955 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 16.3 mp0 45.65 99.93 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 112.204 -2.271 . . . . 0.0 114.391 -176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 21' ' ' ARG . 84.8 Cg_endo -80.37 42.79 1.39 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 123.28 2.653 . . . . 0.0 112.801 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HG2' ' HB3' ' A' ' 28' ' ' GLN . 10.2 mm100 -68.29 -35.76 78.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.751 -177.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -108.81 -173.01 2.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.041 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.12 158.3 33.53 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 170.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.37 131.06 40.65 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.989 1.793 . . . . 0.0 109.614 171.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -139.12 159.8 41.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.5 p -150.37 151.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 m -99.44 107.25 19.42 Favored 'General case' 0 N--CA 1.39 -3.445 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 41.1 t-80 -112.56 146.57 38.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.916 -170.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.27 111.31 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -112.36 144.82 41.15 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 2.8 p30 -146.02 -168.52 3.01 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.13 -9.45 8.05 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.91 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 40' ' ' ASP . 2.0 mp0 -82.46 -26.86 32.27 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.81 0.814 . . . . 0.0 110.683 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.433 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 26.5 m -95.98 129.53 43.22 Favored 'General case' 0 N--CA 1.383 -3.825 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.12 149.24 9.76 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.525 0.679 . . . . 0.0 110.99 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 82' ' ' LEU . 99.0 t -53.05 -53.8 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.313 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -54.88 -32.16 60.55 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 124.612 1.195 . . . . 0.0 111.722 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 22.8 m-20 -78.79 -34.32 45.59 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.906 -0.496 . . . . 0.0 111.635 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 38.6 m80 -62.24 -39.36 92.59 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.1 mt -66.51 -42.91 90.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -56.02 -37.81 69.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.683 0.674 . . . . 0.0 110.672 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.9 t -67.07 -53.22 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.093 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -54.31 -47.75 72.11 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 123.311 0.382 . . . . 0.0 110.902 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -56.92 -49.03 76.86 Favored 'General case' 0 C--O 1.194 -1.863 0 O-C-N 123.519 0.512 . . . . 0.0 109.816 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -60.28 -37.82 81.68 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -74.06 -29.3 61.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.172 0.51 . . . . 0.0 111.867 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.55 0.98 55.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.476 0.655 . . . . 0.0 111.947 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 67.18 40.8 2.73 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.48 1.512 . . . . 0.0 113.124 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.87 136.93 20.72 Favored Pre-proline 0 N--CA 1.404 -2.766 0 C-N-CA 124.679 1.192 . . . . 0.0 108.385 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.05 134.61 63.3 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.606 2.204 . . . . 0.0 110.828 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 34.3 m -63.33 -9.85 5.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.487 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.627 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.63 -14.33 62.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.649 0.737 . . . . 0.0 110.692 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -87.26 -5.87 58.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.029 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -48.87 -31.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 126.787 2.035 . . . . 0.0 110.756 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 m -55.86 -46.11 78.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.094 1.358 . . . . 0.0 110.59 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' MET . 22.2 m -101.71 14.83 30.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.876 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.4 m-85 -115.49 144.05 44.41 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 121.789 -0.569 . . . . 0.0 111.627 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.29 156.14 31.93 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.93 133.38 33.94 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.05 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.76 149.05 42.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -81.04 131.65 58.98 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 Cg_endo -66.35 -25.73 48.96 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.611 2.207 . . . . 0.0 114.893 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.22 -44.05 5.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.402 -0.919 . . . . 0.0 113.167 -174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.03 -20.09 24.82 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.728 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 69.45 16.48 8.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.256 1.022 . . . . 0.0 111.797 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.92 37.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -92.75 152.08 19.69 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.61 103.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.86 10.62 32.46 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.144 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -76.79 159.17 30.33 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -82.92 -38.94 22.14 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.116 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.04 156.03 44.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -93.03 143.98 25.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.076 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 77.5 p -93.44 153.72 41.37 Favored Pre-proline 0 N--CA 1.409 -2.485 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.09 -32.0 94.49 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.896 1.731 . . . . 0.0 109.138 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -46.14 90.92 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.053 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.489 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 7.1 mmm180 -58.86 -39.35 81.06 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.569 0.223 . . . . 0.0 111.349 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 8' ' ' MET . 62.9 mt -64.39 -46.56 82.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 124.095 0.872 . . . . 0.0 110.359 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.2 -45.53 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -80.88 -37.14 30.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -54.33 -24.28 18.68 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -51.21 -43.98 61.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.14 0.576 . . . . 0.0 110.586 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 m -142.48 -86.75 0.15 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -157.3 -178.93 7.72 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.996 0.918 . . . . 0.0 109.427 -177.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.09 148.32 44.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -114.23 100.34 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.303 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.78 103.72 8.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -122.59 162.09 22.49 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.573 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.4 mtp -79.6 129.05 34.13 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -69.34 135.64 88.85 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.064 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.91 108.06 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.218 2.612 . . . . 0.0 110.456 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -115.78 131.42 56.94 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.689 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.07 158.77 27.77 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.595 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.3 mt -72.25 117.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.13 125.5 30.95 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.9 75.2 10.39 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.396 1.093 . . . . 0.0 110.345 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 . . . . . 0 C--N 1.29 -2.001 0 CA-C-N 111.924 -2.398 . . . . 0.0 110.143 178.466 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.874 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.55 64.24 1.82 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.087 0.955 . . . . 0.0 111.37 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -81.54 100.87 9.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.804 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.4 mmm -93.37 105.2 17.3 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.24 -110.79 0.81 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.44 85.86 1.3 Allowed Glycine 0 N--CA 1.408 -3.21 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.1 m -68.57 133.56 48.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.786 0.803 . . . . 0.0 110.26 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.521 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.2 mmt -115.55 140.43 49.17 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.143 -170.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 76.1 tttt -97.5 96.42 8.32 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.35 138.5 31.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.762 -172.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -69.74 133.69 47.77 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.293 0.568 . . . . 0.0 110.341 172.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -118.07 121.57 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.885 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.374 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 39.6 mt-10 -80.37 147.17 31.15 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.774 168.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -116.83 131.89 56.84 Favored 'General case' 0 C--N 1.272 -2.771 0 O-C-N 123.294 0.371 . . . . 0.0 110.612 175.063 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -110.96 122.77 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -133.28 66.95 1.54 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.546 1.165 . . . . 0.0 109.296 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.81 69.36 1.13 Allowed Glycine 0 C--N 1.292 -1.909 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.365 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.49 -14.93 39.05 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 121.696 0.76 . . . . 0.0 110.158 -176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.43 -15.19 60.92 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.399 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -118.03 -19.0 9.29 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.631 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 76.14 -22.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.74 1.616 . . . . 0.0 112.433 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p 55.52 69.91 0.69 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.135 1.374 . . . . 0.0 113.433 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 m 67.4 178.1 0.24 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.154 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -102.85 20.65 17.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.912 0.863 . . . . 0.0 109.148 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -63.68 149.34 92.8 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.027 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -75.67 93.41 1.0 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.275 1.983 . . . . 0.0 114.037 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.98 6.3 49.18 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.124 0.964 . . . . 0.0 110.178 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 67.85 99.04 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 C-N-CA 127.763 2.425 . . . . 0.0 112.791 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.86 87.74 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.743 2.296 . . . . 0.0 112.64 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -137.24 -58.76 0.7 Allowed 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -130.66 -165.22 1.52 Allowed 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -76.61 166.85 41.67 Favored Pre-proline 0 C--N 1.29 -1.993 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -47.03 133.32 18.26 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.213 1.942 . . . . 0.0 110.012 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.7 m -138.25 163.99 30.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.175 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -150.3 148.57 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 5.1 m -96.72 107.37 19.82 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -112.87 145.45 40.67 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.347 -170.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 49.8 mm -83.15 112.48 20.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -112.11 143.16 43.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -147.28 166.89 25.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 O-C-N 124.652 1.22 . . . . 0.0 108.693 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 18.03 56.74 Favored Glycine 0 C--N 1.279 -2.591 0 O-C-N 124.118 0.886 . . . . 0.0 112.012 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.31 -29.52 11.62 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-O 121.626 0.727 . . . . 0.0 111.278 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.533 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 83.6 m -99.67 137.74 37.73 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.897 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.38 18.97 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 123.527 0.517 . . . . 0.0 110.469 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.62 -54.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.01 -30.77 62.33 Favored 'General case' 0 C--O 1.203 -1.364 0 O-C-N 124.226 0.953 . . . . 0.0 111.501 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.97 -36.35 59.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.996 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.533 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.9 m-70 -63.1 -39.82 95.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.5 mt -66.33 -42.91 91.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.801 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.24 -34.72 68.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.619 0.645 . . . . 0.0 111.206 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.87 -54.73 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.1 mt -53.51 -47.77 69.6 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.342 0.402 . . . . 0.0 111.024 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.3 mt -56.71 -48.04 78.61 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.548 0.53 . . . . 0.0 109.806 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.1 m -59.03 -39.68 82.73 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -71.52 -29.98 65.41 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.3 m-85 -89.54 3.29 52.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.311 0.577 . . . . 0.0 112.145 175.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 57' ' ' LYS . 7.2 mmpt? 67.62 33.31 5.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.3 mt -105.28 138.29 19.5 Favored Pre-proline 0 N--CA 1.411 -2.399 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.09 136.23 63.83 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.223 1.948 . . . . 0.0 111.433 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -63.19 -9.41 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.018 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.31 -16.26 62.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.032 0.444 . . . . 0.0 110.481 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -88.5 -4.87 58.53 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -49.07 -29.21 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 127.116 2.166 . . . . 0.0 111.032 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -56.68 -47.62 79.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.533 1.533 . . . . 0.0 111.047 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB2' ' SD ' ' A' ' 99' ' ' MET . 7.3 m -98.07 1.21 47.43 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.227 -171.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -105.1 141.67 36.24 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.414 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.63 149.05 28.7 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.339 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.71 124.23 30.03 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -111.61 147.98 34.31 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.47 134.35 66.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.0 Cg_endo -65.91 -18.72 58.01 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.877 2.385 . . . . 0.0 115.667 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 -42.79 3.89 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.0 p -90.72 -18.26 25.31 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mt 62.62 22.23 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.645 1.178 . . . . 0.0 112.005 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.71 143.02 31.2 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.01 147.19 24.76 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.203 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -83.56 105.95 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -107.33 12.07 28.48 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.957 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.57 161.7 29.05 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.286 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.4 m -85.37 -39.69 17.33 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.322 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.96 152.77 50.9 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.367 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -84.58 159.64 20.61 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.885 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 38.8 p -115.47 156.54 45.8 Favored Pre-proline 0 C--N 1.276 -2.624 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.49 -35.34 92.06 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.684 2.256 . . . . 0.0 109.709 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -57.03 -49.55 75.45 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.714 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.49 -38.37 87.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 83' ' ' THR . 63.8 mt -65.75 -46.17 79.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.036 0.835 . . . . 0.0 110.54 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.98 -45.4 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -32.55 73.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.341 0.591 . . . . 0.0 112.167 172.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.43 -34.32 58.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.433 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.86 -27.51 63.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -56.05 -34.89 66.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.881 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.5 m -145.08 -78.44 0.19 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -170.73 -177.55 2.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.369 1.467 . . . . 0.0 108.743 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.51 152.23 37.29 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 168.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 98' ' ' ARG . 11.9 mt -118.81 101.78 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.066 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -78.9 104.88 9.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 96' ' ' ILE . 21.5 mtp180 -127.66 165.08 20.68 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.185 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' A' ' 65' ' ' SER . 9.1 mmm -80.88 133.01 35.5 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 167.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -63.31 119.44 52.98 Favored Pre-proline 0 C--N 1.267 -3.003 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.67 123.27 11.9 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 124.559 3.506 . . . . 0.0 113.387 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.3 6.6 p-80 40.96 74.92 0.09 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.298 1.439 . . . . 0.0 113.32 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.54 142.34 46.69 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.82 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.06 124.74 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.42 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.629 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -127.18 83.95 2.21 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.683 0.754 . . . . 0.0 112.203 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -114.48 -1.49 13.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.866 1.317 . . . . 0.0 108.651 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 . . . . . 0 C--N 1.267 -2.995 0 CA-C-N 112.631 -2.077 . . . . 0.0 107.82 -177.271 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.723 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.36 -21.65 33.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -139.3 99.33 3.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.9 mtm -90.36 107.3 19.06 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.35 -102.06 0.53 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 50.21 2.89 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.402 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m -74.63 134.4 42.05 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.4 mtt -113.11 137.18 51.83 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.991 -169.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 72.1 tttt -98.08 97.49 8.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.5 mt -109.54 138.64 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.975 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 42.5 mtm180 -69.83 129.96 40.98 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 121.213 0.53 . . . . 0.0 109.858 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.2 t -116.33 126.13 73.67 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.388 0 CA-C-O 117.806 -1.092 . . . . 0.0 108.309 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.264 50.8 mt-10 -86.85 146.98 26.0 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.225 -1.79 . . . . 0.0 107.843 167.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -121.86 126.57 49.02 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 175.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.444 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.4 mp -102.68 107.28 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.831 171.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' HB3' HD11 ' A' ' 14' ' ' LEU . 3.2 t-20 -152.94 77.21 1.15 Allowed 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 169.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.93 41.33 0.25 Allowed Glycine 0 C--N 1.276 -2.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.382 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.17 -26.73 20.0 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 1.6 mp0 -56.43 120.54 7.85 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.25 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -80.54 81.68 6.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -70.67 144.87 50.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.724 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -86.48 75.91 9.68 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.16 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.5 t -101.19 -20.34 15.33 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.853 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 m 63.16 18.68 11.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.069 . . . . 0.0 111.433 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -148.02 155.91 43.83 Favored Pre-proline 0 N--CA 1.407 -2.621 0 C-N-CA 125.847 1.659 . . . . 0.0 107.816 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.32 48.46 1.81 Allowed 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 122.907 2.405 . . . . 0.0 111.518 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -90.37 24.43 2.58 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.091 0.948 . . . . 0.0 113.214 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -83.17 160.17 60.7 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.77 111.85 0.64 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.3 2.0 . . . . 0.0 111.834 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -67.02 -49.57 64.87 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -122.63 167.02 13.94 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-20 -74.64 138.2 73.97 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 6.1 Cg_endo -45.79 132.24 13.54 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 124.519 3.479 . . . . 0.0 110.431 174.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.4 p -134.02 156.85 47.46 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.253 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -152.72 149.91 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 15.4 m -97.9 107.23 19.67 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -110.38 145.23 37.9 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.344 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.29 110.72 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.23 148.06 34.9 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.27 167.2 29.4 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 124.297 1.039 . . . . 0.0 108.351 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.43 19.71 51.53 Favored Glycine 0 C--N 1.29 -1.98 0 O-C-N 124.166 0.916 . . . . 0.0 112.64 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.64 -22.85 11.75 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.638 0.732 . . . . 0.0 110.626 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.432 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 69.4 m -105.9 139.9 39.74 Favored 'General case' 0 N--CA 1.403 -2.814 0 C-N-CA 124.59 1.156 . . . . 0.0 109.791 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 147.86 22.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.396 0.617 . . . . 0.0 110.541 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.5 t -54.17 -50.1 57.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.996 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -57.29 -31.69 65.89 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.796 -176.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 m-20 -73.66 -40.56 63.62 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 97.2 m-70 -61.24 -38.7 87.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.71 -43.7 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.222 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HG3' HG21 ' A' ' 63' ' ' VAL . 65.1 mttm -56.86 -37.11 70.85 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 119.055 0.843 . . . . 0.0 111.092 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.1 t -65.92 -53.97 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.983 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.7 -48.43 69.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.508 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -57.07 -48.51 78.41 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 123.374 0.421 . . . . 0.0 110.317 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -59.54 -39.38 83.76 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -71.82 -31.46 66.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.5 m-85 -84.35 -8.71 58.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.032 0.444 . . . . 0.0 111.303 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 mttp 71.29 46.17 0.44 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.16 1.384 . . . . 0.0 112.608 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.8 mt -113.88 136.89 22.13 Favored Pre-proline 0 N--CA 1.408 -2.544 0 C-N-CA 125.815 1.646 . . . . 0.0 107.222 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.45 131.91 48.61 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.375 2.05 . . . . 0.0 111.49 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 31.1 m -62.93 -9.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.267 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.12 -22.12 64.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.395 0.617 . . . . 0.0 109.954 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 63.4 mttm -81.41 -5.46 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.233 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p -49.72 -29.3 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 126.435 1.894 . . . . 0.0 109.776 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 p -55.15 -47.2 75.45 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.429 1.492 . . . . 0.0 110.081 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -104.64 14.92 28.98 Favored 'General case' 0 N--CA 1.4 -2.929 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.7 -171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.453 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 23.7 m-85 -114.56 145.24 42.19 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.474 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.46 35.72 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.292 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.07 154.58 17.11 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HB2' ' NH2' ' A' ' 98' ' ' ARG . 52.9 tt0 -143.18 152.78 42.16 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -87.32 131.2 44.95 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.25 -18.59 50.54 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.89 2.394 . . . . 0.0 115.3 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -105.01 -43.32 5.08 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.408 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -89.2 -21.92 23.03 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.756 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 70.27 16.44 7.28 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.766 1.226 . . . . 0.0 111.576 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.99 36.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' HE2' ' HG2' ' A' ' 100' ' ' LYS . 3.0 m-85 -83.27 168.85 16.31 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.2 t -118.43 98.82 6.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.78 14.47 28.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.369 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.75 156.2 36.84 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 126.529 1.932 . . . . 0.0 109.876 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -83.59 -38.86 21.07 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.525 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.51 154.95 45.6 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.4 mt -88.53 154.48 20.31 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.195 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.3 p -112.8 156.59 42.35 Favored Pre-proline 0 C--N 1.282 -2.326 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -56.32 -35.24 95.7 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.533 2.156 . . . . 0.0 110.281 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.03 -42.97 99.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.268 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -64.07 -38.21 90.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 123.288 0.367 . . . . 0.0 111.398 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.716 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.3 mt -65.47 -49.08 70.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.139 0.9 . . . . 0.0 110.304 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.25 -41.17 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.35 -34.14 72.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.934 172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.9 17.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.638 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 8.2 mt-10 -53.98 -23.43 13.2 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.74 -37.88 60.01 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.121 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -142.43 -82.45 0.19 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.66 178.55 8.92 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.315 1.446 . . . . 0.0 108.488 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.65 150.12 38.65 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 35.4 mt -114.76 135.69 53.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.491 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.8 OUTLIER -117.4 107.34 14.23 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -176.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.617 ' NH2' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.11 171.27 12.05 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 43.4 mtp -82.22 129.16 34.77 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 124.301 1.001 . . . . 0.0 110.179 171.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 37.7 mtmt -78.59 159.94 73.35 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 125.367 1.467 . . . . 0.0 110.999 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.72 100.18 0.58 Allowed 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.171 1.914 . . . . 0.0 109.664 168.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -149.25 144.29 26.42 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.21 -145.47 0.61 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 124.378 1.049 . . . . 0.0 108.356 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.16 91.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.71 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.58 22.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.38 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.47 80.58 8.05 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.117 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 . . . . . 0 C--N 1.28 -2.448 0 CA-C-N 112.812 -1.995 . . . . 0.0 110.115 175.793 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.764 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.4 100.14 9.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.355 0.577 . . . . 0.0 110.202 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -177.25 149.34 0.66 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -64.59 94.39 0.12 Allowed 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.722 0.639 . . . . 0.0 110.326 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 -26.08 21.0 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.0 -59.27 0.29 Allowed Glycine 0 CA--C 1.478 -2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -88.58 139.92 29.99 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 40.2 mtt -122.19 140.38 52.65 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.983 -171.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.3 tttt -100.15 93.19 5.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -102.21 141.96 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.892 -171.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 62.3 mtm-85 -72.03 131.29 42.69 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 121.365 0.602 . . . . 0.0 110.047 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 34' ' ' SER . 49.9 t -117.32 125.91 74.27 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.208 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.277 41.8 mt-10 -84.84 150.58 24.91 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 116.681 -2.008 . . . . 0.0 106.091 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -125.4 125.04 42.76 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.039 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.13 114.3 36.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.492 171.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.91 70.57 1.24 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.18 66.28 0.35 Allowed Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -94.38 -30.79 14.31 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.51 -155.47 0.55 Allowed 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 m170 80.03 167.23 0.17 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.373 1.469 . . . . 0.0 110.351 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 -137.81 177.02 8.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -89.47 95.68 10.38 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 123.818 0.699 . . . . 0.0 109.664 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m 69.07 171.53 0.3 Allowed 'General case' 0 C--O 1.253 1.25 0 C-N-CA 124.197 0.999 . . . . 0.0 111.87 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 65.39 17.47 10.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.578 1.18 . . . . 0.0 109.867 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -93.26 170.89 7.98 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.889 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.23 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.038 1.826 . . . . 0.0 113.041 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -90.59 44.42 1.2 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 125.013 1.325 . . . . 0.0 109.594 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.88 153.02 4.74 Favored Pre-proline 0 C--O 1.249 1.041 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.953 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.37 153.98 25.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.623 2.216 . . . . 0.0 111.599 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.67 -41.83 74.97 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.588 0.755 . . . . 0.0 109.016 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -92.14 -166.95 1.65 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -78.59 156.98 77.74 Favored Pre-proline 0 N--CA 1.422 -1.871 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -41.57 131.52 3.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.573 2.849 . . . . 0.0 111.02 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.5 p -133.78 154.03 51.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 120.946 0.403 . . . . 0.0 110.91 -172.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -149.53 149.47 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 7.4 m -99.6 106.03 17.96 Favored 'General case' 0 N--CA 1.391 -3.387 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -112.07 144.6 41.16 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.045 -170.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.06 112.91 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.98 151.71 33.67 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -146.28 -170.23 3.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.18 18.19 8.96 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.94 -25.38 9.02 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 123.226 0.61 . . . . 0.0 112.008 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 48' ' ' HIS . 59.9 m -98.63 136.89 38.05 Favored 'General case' 0 N--CA 1.395 -3.18 0 C-N-CA 124.553 1.141 . . . . 0.0 109.036 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 145.01 20.65 Favored 'General case' 0 C--O 1.249 1.03 0 O-C-N 123.695 0.622 . . . . 0.0 110.704 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.519 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.4 t -53.05 -53.41 22.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.879 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -58.08 -28.17 64.33 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.551 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -76.87 -37.85 54.77 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.076 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.523 ' NE2' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -62.36 -37.86 87.31 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.6 mt -68.24 -41.56 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.204 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.32 -34.41 66.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.639 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.13 -53.64 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.265 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' ILE . 17.9 mt -54.01 -46.99 71.95 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.217 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 85.5 mt -57.76 -48.71 78.87 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 123.478 0.486 . . . . 0.0 109.975 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -59.48 -37.47 78.32 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -73.32 -33.98 65.44 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 50.5 m-85 -85.4 0.24 52.79 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt 70.72 35.1 1.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 125.298 1.439 . . . . 0.0 112.665 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.7 mt -105.8 133.76 20.05 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.23 133.73 59.79 Favored 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.896 1.731 . . . . 0.0 110.821 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.6 m -61.71 -9.83 3.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.076 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.77 -20.48 65.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.558 0.218 . . . . 0.0 110.569 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.91 -4.81 58.61 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.61 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.6 p -48.91 -29.98 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 125.422 1.489 . . . . 0.0 110.622 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -55.34 -43.21 74.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.893 1.677 . . . . 0.0 110.733 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -109.4 13.59 24.06 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.66 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 16.0 m-85 -114.14 140.83 48.2 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.93 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.92 149.89 30.18 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.839 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.8 mt -82.59 122.69 28.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.234 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -109.31 149.4 29.52 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -78.6 129.61 73.66 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.86 -12.27 34.82 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.101 2.534 . . . . 0.0 115.795 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.31 -40.78 3.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.795 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.7 p -93.17 -17.55 23.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.993 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 66.27 20.08 11.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 111.748 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.42 137.28 33.98 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.559 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -95.17 137.06 34.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.73 104.58 8.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -106.2 12.85 29.65 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.979 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.53 158.24 36.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.73 -37.86 20.39 Favored 'General case' 0 N--CA 1.394 -3.252 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.077 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -128.5 147.82 50.71 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.607 0.763 . . . . 0.0 108.957 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.4 mt -81.1 152.24 27.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.584 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.9 p -108.43 154.27 41.58 Favored Pre-proline 0 N--CA 1.401 -2.9 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.38 -36.22 78.2 Favored 'Trans proline' 0 C--O 1.219 -0.452 0 C-N-CA 122.463 2.109 . . . . 0.0 110.523 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -64.09 -41.56 97.25 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 4.4 mmp_? -63.0 -36.63 84.17 Favored 'General case' 0 CA--C 1.485 -1.528 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.629 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 61.8 mt -68.42 -48.65 64.06 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 124.217 0.948 . . . . 0.0 110.62 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.591 ' O ' ' HD3' ' A' ' 92' ' ' LYS 0.311 47.8 t -61.61 -49.34 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 2.3 mp0 -64.48 -27.26 68.86 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.21 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.43 -45.26 60.42 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -54.27 -23.75 16.21 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -52.15 -46.97 65.65 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.041 0.936 . . . . 0.0 110.276 173.057 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m -135.27 -79.71 0.43 Allowed 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.92 -175.67 2.43 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.149 1.379 . . . . 0.0 108.962 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -120.1 151.32 39.23 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -116.15 101.6 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.025 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.68 109.44 12.9 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.26 163.11 26.36 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.246 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.9 mtp -79.94 131.74 35.9 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -72.52 152.8 91.83 Favored Pre-proline 0 C--N 1.277 -2.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 146.83 73.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.789 2.326 . . . . 0.0 111.261 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -139.32 -171.35 3.1 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.429 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -4.74 41.24 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 123.011 1.386 . . . . 0.0 111.809 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.03 134.77 27.21 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 CA-C-N 111.906 -2.406 . . . . 0.0 108.927 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.85 146.52 25.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 0.0 110.341 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -132.26 91.89 3.01 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 7.2 mpt_? . . . . . 0 C--N 1.292 -1.904 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.51 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.466 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.58 118.68 26.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -98.86 8.4 45.02 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.099 0.952 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 173.45 6.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.27 -53.07 4.27 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.19 -51.73 0.68 Allowed Glycine 0 CA--C 1.485 -1.839 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 m -95.86 139.83 31.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.3 mmt -115.25 138.34 51.05 Favored 'General case' 0 CA--C 1.465 -2.291 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.092 -171.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.2 tttt -100.54 93.57 5.68 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 90' ' ' ALA . 91.7 mt -103.52 140.75 20.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.732 -172.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -73.14 134.71 44.54 Favored 'General case' 0 CA--C 1.459 -2.53 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.195 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.12 122.04 69.1 Favored 'Isoleucine or valine' 2 N--CA 1.363 -4.785 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -84.14 156.74 21.97 Favored 'General case' 0 N--CA 1.406 -2.657 0 C-N-CA 115.872 -2.331 . . . . 0.0 107.063 167.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.472 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -128.81 132.44 47.83 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 177.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' N ' HD22 ' A' ' 14' ' ' LEU 0.266 1.6 mp -116.53 114.37 45.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 166.254 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -124.13 11.82 8.87 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.0 -163.73 24.79 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 -173.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -104.72 16.45 25.99 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 118.336 1.068 . . . . 0.0 108.901 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.98 137.55 57.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.963 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' THR . 31.5 m170 76.37 103.82 0.07 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.42 1.488 . . . . 0.0 111.556 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -87.35 33.14 0.69 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.063 0.935 . . . . 0.0 111.429 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.618 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 39.1 p 52.74 25.03 3.52 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.894 2.078 . . . . 0.0 114.972 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -137.31 100.66 4.31 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.562 0.696 . . . . 0.0 111.29 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 166.45 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 127.296 2.238 . . . . 0.0 105.921 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.5 p -142.74 152.68 60.0 Favored Pre-proline 0 N--CA 1.396 -3.129 0 CA-C-N 112.392 -2.186 . . . . 0.0 106.53 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -67.91 95.31 0.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.825 1.683 . . . . 0.0 110.852 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -117.89 16.22 14.3 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 67.61 88.67 0.1 Allowed Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 113.017 -1.902 . . . . 0.0 111.443 -172.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 93.8 Cg_endo -77.53 53.23 4.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 124.209 3.273 . . . . 0.0 112.602 -174.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.88 -54.65 2.02 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.767 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -128.63 -157.43 0.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.658 1.183 . . . . 0.0 108.758 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -56.34 161.39 4.08 Favored Pre-proline 0 C--O 1.251 1.173 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -47.79 127.68 14.71 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.872 1.715 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 p -142.21 158.69 43.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.346 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -151.22 149.97 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.3 m -98.14 108.29 20.96 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 47.7 t-80 -110.86 145.97 37.31 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 -170.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.01 111.62 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.56 145.72 39.82 Favored 'General case' 0 C--N 1.259 -3.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.31 -174.88 4.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.45 -13.95 13.87 Favored Glycine 0 C--N 1.304 -1.217 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.678 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -82.17 -21.82 36.35 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.814 0.816 . . . . 0.0 111.351 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 38.5 m -95.88 127.4 41.86 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.44 175.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.53 149.51 10.47 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.354 0.597 . . . . 0.0 110.471 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 ' HG ' ' A' ' 82' ' ' LEU . 97.8 t -54.13 -53.73 26.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.193 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 61.4 pttt -54.45 -31.86 56.42 Favored 'General case' 0 C--O 1.199 -1.578 0 O-C-N 124.522 1.138 . . . . 0.0 112.086 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 m-20 -77.39 -34.37 54.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.584 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 40.5 m80 -64.2 -40.16 95.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.6 mt -66.22 -43.44 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.828 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.4 mttt -57.15 -35.34 69.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.678 0.672 . . . . 0.0 111.278 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 47' ' ' ASP . 76.8 t -69.55 -53.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.482 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -54.49 -47.65 72.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.129 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 84.9 mt -55.77 -50.57 70.06 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.0 m -58.5 -39.52 80.27 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.23 -27.96 62.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 52.6 m-85 -91.74 4.24 53.26 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.386 0.612 . . . . 0.0 111.529 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 66.76 37.49 4.18 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.506 1.522 . . . . 0.0 112.556 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.64 132.66 20.84 Favored Pre-proline 0 N--CA 1.414 -2.232 0 C-N-CA 124.863 1.265 . . . . 0.0 108.259 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 134.0 58.62 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.256 1.97 . . . . 0.0 110.836 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.2 m -62.46 -10.43 5.09 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.677 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.027 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.01 -20.97 65.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.048 0.451 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -82.63 -4.36 57.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.2 p -47.78 -29.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 125.984 1.713 . . . . 0.0 110.603 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p -54.86 -46.83 74.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.56 -1.654 . . . . 0.0 111.612 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 m -105.01 10.34 34.13 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 124.312 1.045 . . . . 0.0 112.702 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 26.6 m-85 -109.19 143.34 38.74 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 121.881 -0.512 . . . . 0.0 111.391 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.77 151.88 34.33 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.1 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.36 127.85 34.86 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.033 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 45.5 tt0 -113.93 144.29 43.3 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.51 132.92 77.76 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 39.0 Cg_endo -66.99 -21.37 49.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.872 2.381 . . . . 0.0 115.416 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.73 -46.19 4.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.818 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -86.4 -20.19 28.58 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.122 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt 69.25 16.14 8.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 111.842 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.04 137.75 40.41 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.202 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -94.41 141.27 28.77 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.997 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.05 103.02 8.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -108.51 15.24 24.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.697 1.237 . . . . 0.0 109.103 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.47 155.4 38.04 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.338 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.6 m -81.27 -40.76 23.22 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.375 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.62 157.15 37.94 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.037 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -90.42 142.96 27.21 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.276 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.8 p -99.31 153.1 37.95 Favored Pre-proline 0 N--CA 1.4 -2.96 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.74 -32.58 91.72 Favored 'Trans proline' 0 C--O 1.204 -1.199 0 C-N-CA 121.882 1.721 . . . . 0.0 109.289 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.5 -46.58 88.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.191 0.596 . . . . 0.0 111.568 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -62.34 -39.44 93.09 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.692 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 55.9 mt -66.06 -48.63 70.39 Favored 'General case' 0 C--O 1.205 -1.273 0 O-C-N 123.677 0.611 . . . . 0.0 110.153 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.5 t -62.11 -46.26 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.29 -28.72 69.52 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -77.77 -35.54 51.5 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.939 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.35 -25.24 33.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.108 0.563 . . . . 0.0 111.124 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -55.39 -42.26 73.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.284 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.8 m -142.97 -82.28 0.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -160.51 -178.39 6.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.954 0.901 . . . . 0.0 109.273 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -119.49 148.41 43.3 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.7 mt -114.37 102.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.408 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -78.87 107.25 11.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -131.14 162.72 29.27 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.825 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.5 mtp -77.03 131.58 38.5 Favored 'General case' 0 N--CA 1.4 -2.944 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -60.6 152.9 64.76 Favored Pre-proline 0 C--N 1.288 -2.105 0 O-C-N 123.491 0.495 . . . . 0.0 110.647 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.38 130.17 38.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.337 2.025 . . . . 0.0 109.294 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -68.23 129.97 41.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.619 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 146.6 27.96 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.43 91.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.393 -3.302 0 CA-C-O 122.055 0.931 . . . . 0.0 110.199 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.58 137.48 32.46 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.455 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.89 79.28 9.54 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 . . . . . 0 C--N 1.287 -2.143 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.653 176.633 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.464 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.29 107.63 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 C-N-CA 125.289 1.436 . . . . 0.0 111.682 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -81.44 75.67 8.39 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -123.5 69.26 1.02 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 165.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.26 -43.34 2.24 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.87 69.47 1.39 Allowed Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m -68.63 130.2 42.15 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.252 1.025 . . . . 0.0 112.843 -167.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.8 mtt -117.26 140.07 50.01 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.956 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 38' ' ' ILE . 20.1 ttmm -96.68 98.61 10.31 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.22 137.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.4 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.55 129.11 38.95 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.125 0.488 . . . . 0.0 109.902 172.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.1 t -115.91 122.28 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.694 0 CA-C-O 117.696 -1.145 . . . . 0.0 108.272 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -83.65 153.88 24.0 Favored 'General case' 0 N--CA 1.413 -2.301 0 C-N-CA 116.456 -2.098 . . . . 0.0 108.027 167.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.75 127.96 45.89 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.197 0.31 . . . . 0.0 110.171 176.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -100.98 115.01 41.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -159.06 85.68 0.81 Allowed 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -49.29 141.75 11.34 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.642 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -74.53 -14.81 60.86 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.07 0.938 . . . . 0.0 110.102 -173.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -59.21 138.17 57.69 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.706 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -92.74 67.64 4.53 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 49.08 73.21 0.24 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 p -125.41 -151.76 0.49 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -72.96 72.23 1.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -100.34 75.06 1.77 Allowed 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 122.582 1.182 . . . . 0.0 109.44 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 p -80.0 161.05 67.22 Favored Pre-proline 0 C--N 1.254 -3.548 0 CA-C-N 113.362 -1.745 . . . . 0.0 111.158 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.19 88.89 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.394 2.063 . . . . 0.0 111.624 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -120.69 23.04 10.96 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.703 1.24 . . . . 0.0 108.861 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.13 152.78 68.7 Favored Pre-proline 0 C--N 1.286 -2.166 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.844 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.0 173.7 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.096 2.53 . . . . 0.0 113.204 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -63.9 -40.97 97.73 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.623 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -97.28 147.36 24.21 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -124.31 170.87 8.01 Favored Pre-proline 0 C--N 1.254 -3.568 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.66 133.07 10.21 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.661 2.241 . . . . 0.0 110.272 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 22.2 p -140.77 157.42 45.43 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.902 -172.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -144.98 147.59 18.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.4 m -97.37 98.8 10.27 Favored 'General case' 0 N--CA 1.386 -3.66 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -105.73 144.9 31.83 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.12 -167.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 9' ' ' LYS . 35.1 mm -84.52 112.22 21.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' SER . 83.7 m-85 -113.19 149.49 33.61 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.402 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -148.07 -170.4 3.58 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.81 15.67 8.39 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.5 -23.59 11.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.925 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.7 m -104.73 135.83 45.38 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 123.592 0.757 . . . . 0.0 109.444 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.71 148.88 9.15 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.805 0.842 . . . . 0.0 111.18 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 82' ' ' LEU . 90.2 t -54.18 -51.33 48.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.778 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 40.5 mttm -54.73 -34.14 62.06 Favored 'General case' 0 C--O 1.196 -1.714 0 O-C-N 124.685 1.241 . . . . 0.0 110.663 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 51' ' ' VAL . 12.1 m-20 -73.95 -39.18 63.93 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -62.11 -38.91 90.69 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.7 mt -67.33 -44.61 87.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.913 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.4 mttt -57.59 -33.91 68.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 118.843 0.747 . . . . 0.0 110.978 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.4 t -68.77 -54.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.189 175.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.71 -48.66 69.36 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 123.329 0.393 . . . . 0.0 111.382 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.45 -48.27 77.4 Favored 'General case' 0 C--O 1.203 -1.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -59.77 -38.31 81.46 Favored 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -74.72 -29.76 61.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.846 0.355 . . . . 0.0 111.659 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 38.5 m-85 -89.64 4.57 49.06 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.298 0.571 . . . . 0.0 112.518 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 68.97 32.38 3.85 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.642 1.577 . . . . 0.0 112.284 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -107.31 128.23 26.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -50.86 133.01 38.96 Favored 'Trans proline' 0 CA--C 1.502 -1.099 0 C-N-CA 122.52 2.147 . . . . 0.0 111.073 172.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.6 m -62.87 -9.96 5.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.682 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.88 -18.49 65.4 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.392 0.615 . . . . 0.0 110.516 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 12.1 mptt -85.14 -5.27 59.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.225 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.9 p -47.45 -27.98 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 C-N-CA 126.196 1.798 . . . . 0.0 110.301 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -56.42 -49.44 74.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 126.42 1.888 . . . . 0.0 111.359 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' MET . 74.6 m -104.27 14.88 29.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.952 1.301 . . . . 0.0 112.257 -173.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 30.2 m-85 -113.93 142.52 46.03 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.605 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.92 31.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.2 mt -83.79 124.19 30.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.171 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -113.36 152.99 29.25 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -85.56 137.63 36.28 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 52.7 Cg_endo -70.59 -13.23 32.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.072 2.515 . . . . 0.0 115.81 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.41 -44.42 3.1 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.855 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.5 p -87.46 -19.13 28.44 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.561 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 63.03 21.74 13.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 110.783 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 140.89 33.95 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.892 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -100.71 143.86 30.37 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.484 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -78.65 107.63 11.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -100.58 10.49 41.11 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.801 0.81 . . . . 0.0 109.949 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.48 152.72 41.76 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.483 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.6 m -83.59 -38.18 21.96 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.203 174.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -128.61 149.51 50.61 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 45' ' ' VAL . 25.7 mt -84.41 161.64 20.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.502 0.668 . . . . 0.0 110.731 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 64.4 p -120.01 155.74 55.13 Favored Pre-proline 0 N--CA 1.401 -2.895 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.45 -32.11 95.63 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.889 1.726 . . . . 0.0 109.801 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.74 -42.48 99.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.379 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 2.6 mmp_? -64.76 -38.36 90.72 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.667 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 76.7 mt -65.77 -47.94 73.5 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.016 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.258 20.1 t -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.92 -26.95 66.23 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.534 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -43.97 52.22 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 19.0 mt-10 -54.73 -23.26 16.95 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.34 -35.19 37.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.179 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 m -144.52 -80.37 0.18 Allowed 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -163.77 -175.5 4.14 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 125.788 1.635 . . . . 0.0 108.384 -177.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 3.3 m-85 -120.96 148.59 43.89 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 169.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.6 101.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.568 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.459 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -78.86 106.45 10.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -127.23 161.42 28.59 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.469 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 42.7 mtp -76.05 124.95 28.22 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 166.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -60.17 145.39 85.59 Favored Pre-proline 0 C--N 1.286 -2.192 0 C-N-CA 123.875 0.87 . . . . 0.0 111.306 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 148.74 86.86 Favored 'Trans proline' 0 C--O 1.256 1.406 0 C-N-CA 122.574 2.183 . . . . 0.0 110.896 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -61.44 131.09 49.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.879 0.847 . . . . 0.0 111.228 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -142.51 176.15 9.24 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.16 102.35 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.803 0 CA-C-O 121.617 0.723 . . . . 0.0 109.839 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.39 108.42 19.82 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -135.65 88.01 2.37 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.882 0.848 . . . . 0.0 110.687 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 C--N 1.284 -2.24 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.481 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.832 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.56 147.39 48.72 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -65.21 128.13 34.54 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.3 mtp -76.32 93.87 3.51 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.735 0.779 . . . . 0.0 109.622 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.5 72.8 0.47 Allowed Glycine 0 N--CA 1.412 -2.955 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.35 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.13 -45.75 7.39 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 25.5 m -109.85 123.96 50.49 Favored 'General case' 0 N--CA 1.393 -3.277 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 168.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 58.2 mtt -106.69 139.75 40.63 Favored 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.047 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 61.8 tttt -99.97 98.36 9.13 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.59 138.3 37.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.611 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 85.4 mtt180 -68.12 133.14 48.45 Favored 'General case' 0 CA--C 1.478 -1.804 0 CA-C-O 121.029 0.442 . . . . 0.0 110.551 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.9 t -120.12 124.63 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-O 117.735 -1.126 . . . . 0.0 108.639 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.259 21.8 mm-40 -84.2 153.46 23.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 170.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -126.03 130.82 51.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 176.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 17' ' ' GLY . 1.6 mp -117.92 119.72 62.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HB3' HD11 ' A' ' 14' ' ' LEU . 29.0 p-10 -110.64 13.91 22.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.341 1.067 . . . . 0.0 111.506 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 15' ' ' ILE . . . 130.9 -161.34 23.45 Favored Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.908 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -97.36 35.78 1.57 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.07 35.99 0.11 Allowed 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 125.849 1.66 . . . . 0.0 112.603 -170.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -99.51 106.7 18.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -91.21 165.85 13.25 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.609 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -78.09 84.71 4.32 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.78 0.8 . . . . 0.0 111.491 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -86.04 -49.53 7.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m 64.48 10.66 5.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.677 1.191 . . . . 0.0 112.755 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.9 p -93.97 171.72 6.64 Favored Pre-proline 0 C--N 1.28 -2.42 0 C-N-CA 124.968 1.307 . . . . 0.0 109.736 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.44 84.0 2.13 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.021 1.147 . . . . 0.0 114.511 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -86.15 2.03 48.36 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 121.538 0.685 . . . . 0.0 111.314 171.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 59.46 -179.03 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.63 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.8 105.39 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.331 1.354 . . . . 0.0 110.568 172.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -145.45 113.28 6.41 Favored 'General case' 0 N--CA 1.397 -3.098 0 C-N-CA 124.524 1.129 . . . . 0.0 108.98 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.99 -171.04 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.459 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.473 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 83.1 m-20 -68.29 156.4 90.25 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.318 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.46 124.19 10.35 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 122.554 2.169 . . . . 0.0 108.974 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 1.4 p -138.78 152.46 47.93 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.44 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -147.68 149.65 15.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.3 m -96.21 108.32 20.78 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 44.5 t-80 -113.05 147.17 37.79 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 -171.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 48.4 mm -84.89 112.74 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' SER . 84.3 m-85 -113.68 146.07 40.36 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 123.039 0.535 . . . . 0.0 109.589 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.92 169.55 22.02 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 123.782 0.833 . . . . 0.0 109.243 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 26.24 24.06 Favored Glycine 0 C--N 1.298 -1.563 0 O-C-N 124.203 0.939 . . . . 0.0 112.435 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.62 -32.44 5.19 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-O 121.499 0.666 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 35.1 m -94.01 134.43 36.43 Favored 'General case' 0 N--CA 1.389 -3.523 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 148.76 15.12 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.261 0.553 . . . . 0.0 110.731 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.9 t -53.82 -52.28 36.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.114 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -57.08 -33.77 67.63 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.019 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.61 -37.06 65.55 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 122.06 -0.4 . . . . 0.0 110.712 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.8 m-70 -62.83 -39.27 93.82 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 27.2 mt -65.31 -44.13 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.67 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.4 mttt -56.93 -34.22 67.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.728 0.694 . . . . 0.0 111.18 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.56 -53.88 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.98 -48.27 70.54 Favored 'General case' 0 C--O 1.211 -0.921 0 O-C-N 123.558 0.536 . . . . 0.0 111.039 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.2 mt -56.88 -50.75 71.53 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -59.28 -37.32 77.38 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -74.07 -31.0 62.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.872 0.368 . . . . 0.0 111.644 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 37.0 m-85 -87.06 2.44 49.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? 73.81 29.23 1.49 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.107 1.363 . . . . 0.0 113.108 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -105.83 135.99 19.34 Favored Pre-proline 0 N--CA 1.411 -2.392 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -56.58 137.01 79.12 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 122.016 1.811 . . . . 0.0 110.953 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.639 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.84 -10.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.945 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.305 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.8 -14.45 63.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.358 0.599 . . . . 0.0 110.956 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.5 mptp? -87.83 -5.19 58.73 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -48.55 -31.06 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 126.269 1.828 . . . . 0.0 110.428 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.275 15.5 m -55.37 -46.39 76.48 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 126.47 1.908 . . . . 0.0 110.964 174.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -103.01 7.79 39.01 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.755 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 26.0 m-85 -106.68 142.19 36.73 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.331 0.586 . . . . 0.0 111.432 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.04 141.02 23.78 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.387 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 97' ' ' LEU . 80.1 mt -72.63 156.49 38.91 Favored 'General case' 0 N--CA 1.418 -2.051 0 O-C-N 124.82 1.325 . . . . 0.0 108.306 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 38.4 tt0 -146.12 152.0 38.58 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 21.6 t-20 -89.3 137.17 29.33 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.133 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 56.7 Cg_endo -71.7 -17.6 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.788 2.326 . . . . 0.0 115.278 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -107.75 -46.26 3.84 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.311 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.2 p -84.05 -24.09 30.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.02 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 ' HA ' HE21 ' A' ' 69' ' ' GLN . 11.2 mt 69.61 14.57 8.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.451 1.1 . . . . 0.0 111.152 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 145.75 27.15 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.515 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 8.9 m-30 -88.06 -174.57 4.74 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 122.388 1.09 . . . . 0.0 112.194 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' LEU . 93.9 t -124.57 101.84 9.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 167.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.49 14.81 29.35 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.695 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.32 158.3 33.03 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 125.483 1.513 . . . . 0.0 110.579 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.7 m -84.24 -36.38 22.75 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.735 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.78 146.74 52.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.5 mt -80.18 153.85 28.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.287 0.565 . . . . 0.0 110.999 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.7 p -108.37 154.28 41.52 Favored Pre-proline 0 N--CA 1.403 -2.795 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.79 -36.6 95.51 Favored 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 110.02 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.86 -43.35 94.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.265 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -66.32 -37.15 84.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.314 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.769 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.8 mt -63.29 -51.45 66.05 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.831 0.707 . . . . 0.0 110.568 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.95 -45.86 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.58 -24.67 67.14 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.24 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.7 -39.94 35.13 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.704 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 32.5 mt-10 -51.03 -27.37 7.76 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 118.36 0.527 . . . . 0.0 111.809 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -49.7 -37.89 30.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.664 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -147.2 -88.66 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -154.98 177.76 10.95 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.476 1.11 . . . . 0.0 109.051 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.4 m-85 -116.74 151.95 35.36 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 170.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 98' ' ' ARG . 20.5 mt -117.8 135.96 56.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -118.75 115.38 24.35 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -176.101 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -147.73 173.47 12.74 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.5 mtp -82.12 137.64 34.94 Favored 'General case' 0 N--CA 1.397 -3.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.012 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -73.1 145.35 85.94 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.26 128.98 29.45 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.927 2.418 . . . . 0.0 111.549 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -151.66 165.9 32.92 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.29 141.53 54.31 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 104' ' ' ILE . 15.7 mm -64.54 122.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-O 121.387 0.613 . . . . 0.0 112.397 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.41 105.6 17.77 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.62 97.41 2.73 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.336 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 . . . . . 0 C--N 1.288 -2.074 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.923 177.093 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.265 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.65 -168.17 2.48 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -132.65 36.63 3.53 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 81.6 mtp 73.86 110.33 0.07 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.974 1.31 . . . . 0.0 112.546 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.66 -109.24 2.39 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.64 95.25 1.42 Allowed Glycine 0 N--CA 1.398 -3.889 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 m -68.07 134.8 51.21 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.664 0.745 . . . . 0.0 109.422 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.676 ' SD ' ' HG3' ' A' ' 91' ' ' GLU . 46.4 mtt -117.86 138.45 52.1 Favored 'General case' 0 CA--C 1.467 -2.233 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.819 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 30.3 ttpt -97.82 99.86 11.2 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.74 140.85 24.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.015 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -69.19 129.15 39.03 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -115.2 123.18 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.736 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.016 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.04 148.43 26.86 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 117.561 -1.656 . . . . 0.0 107.396 168.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -126.11 129.22 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 176.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.402 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -114.5 113.9 45.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.117 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -115.34 28.18 8.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.402 0.681 . . . . 0.0 110.854 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.08 48.34 2.39 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.787 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -133.49 -9.47 2.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.964 1.305 . . . . 0.0 110.712 174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -79.1 63.45 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.4 m80 69.89 130.98 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 124.773 1.229 . . . . 0.0 110.816 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 74.3 96.95 0.07 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 112.547 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -91.39 12.33 20.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 123.28 1.514 . . . . 0.0 110.041 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -148.98 119.92 7.65 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m 66.17 92.4 0.08 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 124.549 1.156 . . . . 0.0 109.378 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 p -70.49 169.04 15.28 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 113.465 -1.698 . . . . 0.0 113.343 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 28' ' ' GLN . 32.2 Cg_exo -64.16 -149.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.077 3.185 . . . . 0.0 114.126 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -75.61 26.79 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.932 1.293 . . . . 0.0 112.066 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 26' ' ' PRO . 32.0 mm-40 -83.81 154.0 64.45 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.619 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.02 176.19 2.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.0 2.467 . . . . 0.0 112.577 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.85 -50.61 19.51 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.12 149.68 37.34 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 90.0 m-20 -60.56 132.55 91.12 Favored Pre-proline 0 N--CA 1.427 -1.619 0 O-C-N 123.632 0.582 . . . . 0.0 110.699 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 10.0 Cg_endo -48.44 130.65 21.95 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.873 3.048 . . . . 0.0 110.103 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.3 p -138.98 156.31 47.32 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.268 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -149.29 148.75 15.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.411 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 13.9 m -95.61 105.47 17.46 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 173.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 44.8 t-80 -112.28 144.37 41.8 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.609 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.262 40.2 mm -83.69 113.46 22.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.49 145.32 41.37 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.94 -174.15 4.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 124.265 1.026 . . . . 0.0 108.289 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.44 22.43 8.33 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -112.15 -25.91 9.08 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.179 0.592 . . . . 0.0 111.231 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.4 m -96.69 154.08 17.49 Favored 'General case' 0 N--CA 1.389 -3.492 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.67 156.26 27.66 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 82' ' ' LEU . 91.4 t -52.96 -52.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 123.7 0.625 . . . . 0.0 109.717 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -55.68 -36.5 67.2 Favored 'General case' 0 C--O 1.196 -1.726 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.31 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -74.48 -36.19 63.29 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.993 -0.442 . . . . 0.0 111.758 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.57 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.6 m-70 -61.25 -38.79 87.95 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 36.8 mt -66.16 -42.95 92.15 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.079 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.67 -37.98 71.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.647 0.658 . . . . 0.0 110.796 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.44 -53.69 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.057 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.8 mt -53.36 -49.61 66.79 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.467 0.479 . . . . 0.0 110.777 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -56.91 -47.43 80.57 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.522 0.514 . . . . 0.0 110.103 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.93 -40.52 93.53 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -70.84 -31.01 67.58 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.04 0.448 . . . . 0.0 111.51 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -86.67 1.87 50.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.341 0.591 . . . . 0.0 111.49 174.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 64.86 38.82 6.37 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 124.808 1.243 . . . . 0.0 113.18 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.0 mt -108.15 140.48 21.72 Favored Pre-proline 0 N--CA 1.41 -2.467 0 C-N-CA 124.988 1.315 . . . . 0.0 107.631 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.93 132.67 48.88 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.089 1.859 . . . . 0.0 110.925 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.609 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.9 m -63.75 -9.65 5.85 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.972 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.651 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -14.16 62.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.211 0.529 . . . . 0.0 111.544 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 64.2 mttm -85.38 -9.16 57.93 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.982 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.6 p -49.76 -30.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.906 2.082 . . . . 0.0 109.849 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.255 12.8 m -54.73 -48.91 71.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.146 1.778 . . . . 0.0 109.841 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -101.45 7.06 42.68 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.214 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 15.6 m-85 -106.55 144.38 33.3 Favored 'General case' 0 CA--C 1.477 -1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 110.751 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.57 149.25 25.19 Favored 'General case' 0 N--CA 1.41 -2.439 0 O-C-N 124.233 0.958 . . . . 0.0 109.292 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.68 132.75 35.61 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.574 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 70' ' ' ASN . 45.5 tt0 -118.92 153.58 34.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 25.1 t-20 -86.03 131.0 48.08 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 33.1 Cg_endo -66.22 -20.26 56.03 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.421 2.748 . . . . 0.0 115.836 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -107.27 -43.61 4.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 p -87.37 -24.37 24.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.052 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt 70.72 19.45 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 124.366 1.066 . . . . 0.0 111.8 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.85 138.89 33.76 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.508 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 6.3 m-85 -91.72 168.89 11.15 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.711 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.434 HG13 ' OD2' ' A' ' 79' ' ' ASP . 66.4 t -111.93 79.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.032 0.92 . . . . 0.0 111.399 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.27 -1.56 6.47 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.726 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' HG13 ' A' ' 77' ' ' VAL . 50.8 m-20 -64.06 151.26 43.54 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.282 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -79.91 -41.17 26.66 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.282 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -131.32 153.22 49.82 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 124.22 1.008 . . . . 0.0 108.553 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.4 mt -85.99 153.67 21.99 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 82.7 p -109.51 155.32 41.48 Favored Pre-proline 0 N--CA 1.402 -2.849 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.53 -33.87 93.75 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.126 1.884 . . . . 0.0 109.973 173.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.75 -45.91 90.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.919 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -64.48 -37.92 89.23 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.179 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.545 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.0 mt -64.03 -47.52 79.91 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.612 0.57 . . . . 0.0 109.934 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.259 35.6 t -62.13 -46.29 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -67.2 -25.53 66.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.36 -43.12 28.51 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.676 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 4.2 mt-10 -53.72 -19.27 3.94 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -53.08 -39.81 63.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.84 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 m -144.88 -82.14 0.16 Allowed 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -161.91 -178.73 6.65 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.513 1.125 . . . . 0.0 109.114 -178.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.99 147.02 46.05 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 169.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -113.43 101.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.458 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.52 105.06 9.54 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -126.75 159.21 34.42 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.683 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 46.0 mtp -77.98 132.38 37.81 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 167.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.59 135.38 96.25 Favored Pre-proline 0 C--N 1.283 -2.3 0 O-C-N 123.905 0.753 . . . . 0.0 109.333 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -29.0 113.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.596 1 C-N-CA 125.874 4.382 . . . . 0.0 115.105 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -70.07 134.59 48.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.739 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -112.04 -160.76 0.73 Allowed 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.04 138.98 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 C-N-CA 123.242 0.617 . . . . 0.0 109.691 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.92 108.15 0.33 Allowed 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.688 0.618 . . . . 0.0 112.331 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.55 23.41 13.6 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.177 1.791 . . . . 0.0 112.275 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--N 1.3 -1.581 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.973 178.092 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.382 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.2 163.77 36.68 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -85.4 -9.65 57.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.884 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.0 mtt -64.59 109.52 2.02 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.58 38.18 6.29 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.34 20.51 30.24 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.003 -0.598 . . . . 0.0 111.97 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 146.46 23.8 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 10.7 mmt -122.91 137.29 54.98 Favored 'General case' 0 CA--C 1.477 -1.865 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.838 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 27.3 ttpt -96.22 98.95 10.71 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.28 139.32 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.721 -172.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 92.0 mtt180 -71.35 131.54 43.56 Favored 'General case' 0 CA--C 1.471 -2.088 0 O-C-N 123.456 0.473 . . . . 0.0 110.429 173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' SER . 40.5 t -117.95 124.8 73.6 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.484 0 CA-C-O 117.911 -1.043 . . . . 0.0 109.011 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' OE2' ' HB3' ' A' ' 31' ' ' GLN . 16.8 mt-10 -80.0 149.55 30.72 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 168.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 ' CD1' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -126.4 125.6 42.45 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 120.467 0.175 . . . . 0.0 111.08 175.354 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -110.44 106.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.032 167.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -114.48 7.97 16.36 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 123.955 1.836 . . . . 0.0 106.99 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.04 170.31 15.92 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 112.163 -2.289 . . . . 0.0 108.189 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.48 29.75 7.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -58.79 102.88 0.13 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.239 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.27 102.82 7.83 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.399 0.619 . . . . 0.0 110.932 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.32 130.13 42.12 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.493 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -87.47 37.47 0.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.348 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.2 m -64.53 122.43 16.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.343 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.2 m -80.14 1.62 27.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.787 0.803 . . . . 0.0 110.749 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 p -90.91 163.2 30.64 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.171 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 104.78 1.84 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.262 1.975 . . . . 0.0 109.183 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.54 -10.16 59.2 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 64.96 150.23 0.11 Allowed Pre-proline 0 C--N 1.263 -3.179 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.953 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.17 37.37 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.586 2.191 . . . . 0.0 112.192 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -85.6 42.55 0.97 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.623 0.769 . . . . 0.0 112.492 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 79.1 mt-30 48.82 -150.83 0.15 Allowed 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 125.107 1.363 . . . . 0.0 112.638 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -61.71 164.13 10.56 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -41.55 125.59 2.82 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.944 2.429 . . . . 0.0 110.558 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -134.1 156.31 48.51 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.05 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.3 p -149.22 148.41 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 m -97.41 106.96 19.38 Favored 'General case' 0 N--CA 1.391 -3.389 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 41.8 t-80 -114.68 146.21 41.15 Favored 'General case' 0 N--CA 1.416 -2.157 0 C-N-CA 123.791 0.836 . . . . 0.0 110.529 -169.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.25 44.8 mm -83.13 112.92 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.664 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -113.12 145.87 40.18 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.23 169.63 18.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.38 17.85 42.79 Favored Glycine 0 C--N 1.292 -1.871 0 O-C-N 124.299 0.999 . . . . 0.0 113.008 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -108.08 -25.16 11.26 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-O 122.131 0.967 . . . . 0.0 110.998 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.1 m -103.6 137.84 41.1 Favored 'General case' 0 N--CA 1.391 -3.403 0 C-N-CA 125.059 1.344 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.91 150.01 17.47 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 121.44 0.638 . . . . 0.0 111.237 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' A' ' 82' ' ' LEU . 83.8 t -52.8 -51.18 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.227 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -53.37 -42.18 66.62 Favored 'General case' 0 C--O 1.198 -1.619 0 O-C-N 125.003 1.439 . . . . 0.0 110.61 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.29 -39.07 85.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -62.51 -37.83 87.56 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 mt -66.52 -43.82 90.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.015 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.1 mttt -56.22 -34.72 66.58 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.839 0.745 . . . . 0.0 111.143 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.12 -53.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.136 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.31 -47.89 68.86 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 123.274 0.359 . . . . 0.0 111.12 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 79.5 mt -57.26 -49.43 76.07 Favored 'General case' 0 C--O 1.199 -1.564 0 O-C-N 123.705 0.628 . . . . 0.0 109.613 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -58.63 -39.8 81.53 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -71.41 -32.36 68.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.8 m-85 -86.42 -2.71 58.67 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.1 0.476 . . . . 0.0 111.835 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 69.15 39.23 1.76 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.389 1.476 . . . . 0.0 112.665 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.4 mt -106.42 136.85 19.32 Favored Pre-proline 0 N--CA 1.408 -2.538 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.28 134.91 62.06 Favored 'Trans proline' 0 CA--C 1.501 -1.16 0 C-N-CA 121.738 1.625 . . . . 0.0 111.515 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.1 m -64.38 -11.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.63 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.843 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.6 -20.61 64.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.257 0.551 . . . . 0.0 109.66 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 65.9 mttm -83.17 -2.46 55.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.265 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -49.0 -30.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 126.942 2.097 . . . . 0.0 110.618 176.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -54.99 -58.12 8.92 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.915 173.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.1 m -87.85 10.96 16.84 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.422 -174.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 25.1 m-85 -109.22 143.51 38.57 Favored 'General case' 0 C--N 1.277 -2.567 0 O-C-N 121.277 -0.89 . . . . 0.0 111.34 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB3' HH22 ' A' ' 98' ' ' ARG . . . -147.96 154.35 40.22 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.037 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 97' ' ' LEU . 81.5 mt -89.29 160.48 16.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 41.5 tt0 -150.0 150.53 31.93 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 122.521 0.328 . . . . 0.0 110.207 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.83 137.98 31.5 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 124.459 1.103 . . . . 0.0 108.642 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.58 -21.16 30.06 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.814 2.342 . . . . 0.0 115.38 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -105.76 -42.49 5.15 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.747 -0.781 . . . . 0.0 113.001 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.5 p -90.43 -20.77 22.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.474 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt 66.58 17.96 10.7 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.491 1.117 . . . . 0.0 111.375 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.92 140.0 33.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 5.8 m-30 -86.03 -174.75 5.25 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.977 0.894 . . . . 0.0 110.567 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.0 101.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.97 11.95 36.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.796 1.284 . . . . 0.0 109.455 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.16 159.63 32.31 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 112.581 -2.1 . . . . 0.0 111.019 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 m -84.43 -39.44 18.97 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.317 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.06 154.92 45.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.863 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.9 mt -89.19 147.7 24.03 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.141 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 70.6 p -99.28 153.08 37.96 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.91 -34.17 97.99 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.428 2.085 . . . . 0.0 109.815 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -59.07 -47.62 84.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.142 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -60.28 -37.82 81.67 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 69.3 mt -64.35 -48.9 73.76 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.822 0.701 . . . . 0.0 110.401 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 43.7 t -63.48 -43.76 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -61.57 -29.89 70.32 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.79 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.56 -34.06 25.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.978 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.13 -24.58 55.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.644 0.735 . . . . 0.0 112.381 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 36.4 mmtm -54.09 -40.36 67.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.154 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.9 m -144.2 -88.31 0.12 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -156.64 178.96 9.73 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 108.752 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.25 152.85 34.93 Favored 'General case' 0 C--O 1.203 -1.363 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.499 HG22 ' HG3' ' A' ' 98' ' ' ARG . 2.7 mp -114.09 133.86 58.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.59 115.93 26.09 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.515 HH11 ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -146.41 177.56 8.94 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 65' ' ' SER . 49.4 mtp -80.94 138.75 36.11 Favored 'General case' 0 N--CA 1.381 -3.885 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 176.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -65.37 137.62 96.76 Favored Pre-proline 0 N--CA 1.415 -2.212 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.83 105.85 0.58 Allowed 'Trans proline' 0 CA--C 1.502 -1.093 0 C-N-CA 122.576 2.184 . . . . 0.0 111.333 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -81.98 113.63 20.01 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.59 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.9 178.19 7.99 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.37 113.8 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 CA-C-O 120.911 0.386 . . . . 0.0 110.427 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.38 93.7 0.77 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.067 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.44 77.57 1.28 Allowed 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 . . . . . 0 C--N 1.301 -1.526 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.201 -175.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.411 -2.386 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 39.6 mtt -128.19 140.1 52.1 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -170.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -97.21 94.81 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -104.11 137.29 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.76 -171.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 41.6 mtm180 -71.82 130.7 41.7 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.386 0.613 . . . . 0.0 110.196 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' SER . 45.8 t -117.99 127.91 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.346 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.28 43.4 mt-10 -90.18 143.76 26.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 116.257 -2.177 . . . . 0.0 109.358 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.2 tm? -111.7 129.67 56.03 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.071 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.452 -0.914 0 N-CA-C 108.675 -1.317 . . . . 0.0 108.675 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.7 p -135.87 153.1 51.58 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 -173.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -146.87 145.95 19.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 m -97.8 104.98 17.05 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -111.24 144.87 39.7 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.76 113.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.45 143.84 42.91 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.1 164.51 37.11 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.397 1.079 . . . . 0.0 108.402 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.84 14.81 63.58 Favored Glycine 0 C--N 1.291 -1.967 0 O-C-N 124.239 0.962 . . . . 0.0 112.787 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -105.61 -28.34 10.81 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 121.994 0.902 . . . . 0.0 110.1 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 39.9 m -94.7 132.36 39.53 Favored 'General case' 0 N--CA 1.39 -3.466 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.362 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.94 149.55 14.97 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' A' ' 82' ' ' LEU . 88.2 t -54.9 -53.15 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.163 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 22.3 pttm -54.38 -30.72 52.91 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 124.468 1.105 . . . . 0.0 111.02 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.8 m-20 -78.1 -36.31 48.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.204 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 96.2 m-70 -64.04 -39.73 94.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 30.1 mt -66.87 -44.32 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.977 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 96.4 mttt -56.69 -34.4 67.38 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.64 0.654 . . . . 0.0 110.821 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.4 t -69.59 -54.27 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.652 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.51 -49.51 67.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.429 0.456 . . . . 0.0 111.159 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.1 mt -54.74 -50.13 69.13 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 123.622 0.576 . . . . 0.0 109.844 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.0 m -58.16 -39.87 79.96 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -71.53 -27.87 63.48 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.139 0.495 . . . . 0.0 111.712 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 46.1 m-85 -89.82 2.04 55.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.291 0.567 . . . . 0.0 111.609 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 67.77 35.47 3.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.318 1.447 . . . . 0.0 112.579 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.2 135.78 19.42 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.97 135.88 69.63 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.429 2.086 . . . . 0.0 111.156 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 32.4 m -64.37 -10.73 8.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.813 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.392 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.42 -15.99 63.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.77 0.795 . . . . 0.0 109.523 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.91 -7.53 58.11 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.964 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -46.45 -30.69 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.097 0 C-N-CA 127.226 2.211 . . . . 0.0 111.128 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.271 16.5 m -56.99 -45.09 83.21 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 126.018 1.727 . . . . 0.0 111.724 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' MET . 8.7 m -100.9 7.13 43.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.057 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 28.8 m-85 -109.91 143.56 39.66 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 122.154 -0.341 . . . . 0.0 110.92 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 147.65 28.42 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.325 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 89.0 mt -80.47 134.67 36.01 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.603 1.189 . . . . 0.0 107.944 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -125.8 147.08 49.53 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.48 135.73 68.6 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.91 -16.14 29.38 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 115.076 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -105.83 -46.76 4.05 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.687 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -90.05 -18.09 26.58 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.639 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt 65.07 22.63 12.37 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.387 1.075 . . . . 0.0 110.918 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.05 135.87 35.89 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.374 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.61 149.85 20.83 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.644 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.86 106.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.62 10.86 29.0 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 123.107 1.432 . . . . 0.0 108.83 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.49 154.03 37.19 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.165 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.2 m -83.53 -35.46 24.79 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.702 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -129.8 149.55 51.49 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.263 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 82' ' ' LEU . 18.7 mt -85.37 153.04 22.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -108.35 158.84 32.76 Favored Pre-proline 0 N--CA 1.411 -2.415 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.1 -35.9 98.36 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.176 1.917 . . . . 0.0 109.16 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.75 -41.66 95.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.814 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -63.59 -43.08 97.99 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.524 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 69.8 mt -62.99 -48.08 80.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.377 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.1 -45.8 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.18 -27.96 68.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.66 -44.09 29.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.46 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 3.7 mm-40 -52.58 -22.18 4.7 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.84 -34.42 40.54 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.2 m -146.62 -83.84 0.12 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.63 177.91 10.87 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.52 1.128 . . . . 0.0 108.587 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m-85 -116.45 151.78 35.35 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 170.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 10.6 mt -114.9 140.81 34.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -119.34 107.01 12.85 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -129.0 159.48 35.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.39 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 65' ' ' SER . 52.3 mtp . . . . . 0 N--CA 1.411 -2.417 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 166.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.443 -0.812 0 CA-C-O 121.326 0.584 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.727 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 47.0 mtt -123.88 141.88 51.63 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.727 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.1 tttm -100.66 97.01 7.73 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -107.33 139.75 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.743 -172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 10.7 mtp180 -67.22 134.92 52.59 Favored 'General case' 0 CA--C 1.454 -2.72 0 CA-C-O 121.838 0.828 . . . . 0.0 111.828 170.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.3 t -120.81 122.9 69.06 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.501 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.308 0.7 OUTLIER -83.78 144.41 29.33 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 116.082 -2.247 . . . . 0.0 108.518 166.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.6 tm? -114.55 137.09 52.3 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.313 -1.007 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.093 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo . . . . . 0 N--CA 1.481 0.782 0 N-CA-C 111.081 -0.392 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.8 m -140.37 159.89 41.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.149 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 8.5 p -150.36 149.45 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -98.77 104.69 16.76 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.0 t60 -109.67 147.9 32.3 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.315 -170.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 113.02 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.81 147.45 38.33 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.25 -170.37 3.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.34 18.25 8.33 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.86 -28.37 8.41 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 124.03 0.932 . . . . 0.0 110.596 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.539 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 40.7 m -95.5 131.84 41.24 Favored 'General case' 0 N--CA 1.386 -3.67 0 C-N-CA 124.513 1.125 . . . . 0.0 109.096 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 148.49 14.73 Favored 'General case' 0 C--O 1.254 1.332 0 O-C-N 123.795 0.684 . . . . 0.0 110.618 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.2 -53.15 31.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.111 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -54.54 -31.92 57.31 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.344 1.028 . . . . 0.0 111.419 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 m-20 -75.88 -38.75 57.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.443 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.539 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.0 m-70 -61.98 -39.24 91.5 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.5 mt -67.1 -43.31 88.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.1 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HG3' HG21 ' A' ' 63' ' ' VAL . 98.2 mttt -58.98 -34.3 71.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.066 0.848 . . . . 0.0 111.141 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.1 t -68.14 -52.62 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.239 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.79 -48.71 72.38 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.403 0.439 . . . . 0.0 111.089 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.66 -47.49 79.67 Favored 'General case' 0 C--O 1.2 -1.513 0 O-C-N 123.644 0.59 . . . . 0.0 109.796 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.2 m -59.42 -40.34 86.41 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -70.91 -34.04 71.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.522 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 50.3 m-85 -83.81 -2.37 56.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.37 0.605 . . . . 0.0 111.702 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 69.72 34.42 2.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.806 1.643 . . . . 0.0 111.999 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.27 137.24 19.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.68 132.47 50.41 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 121.926 1.751 . . . . 0.0 110.877 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.54 -10.14 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.166 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.99 -14.34 62.65 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.97 0.414 . . . . 0.0 111.187 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 60.8 mttm -86.33 -7.74 58.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.408 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -46.41 -32.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 C-N-CA 126.666 1.986 . . . . 0.0 110.833 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 p -54.17 -49.77 68.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 125.997 1.719 . . . . 0.0 111.219 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.0 9.21 41.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.865 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 16.4 m-85 -109.94 140.08 44.32 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.779 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.876 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 86.0 mt -85.53 125.85 33.4 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.394 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -113.82 148.62 36.3 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 120.78 0.324 . . . . 0.0 110.872 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -81.94 132.22 54.68 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.82 -18.59 52.94 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.627 2.218 . . . . 0.0 115.288 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.65 -44.44 4.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.014 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 p -89.5 -20.29 24.03 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.252 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 mt 68.48 16.53 9.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 111.654 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.69 139.37 38.5 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -98.95 147.36 25.06 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.728 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.11 106.01 14.03 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.469 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.1 10.15 41.72 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 123.983 0.913 . . . . 0.0 109.888 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.98 154.14 39.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.273 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.5 m -82.85 -38.48 22.94 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.052 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -130.67 148.74 52.5 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.351 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -80.65 157.71 25.87 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.771 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 56.5 p -110.78 153.92 43.48 Favored Pre-proline 0 N--CA 1.403 -2.816 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.63 -32.09 81.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.619 1.546 . . . . 0.0 110.119 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.66 -51.01 71.76 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.72 0.808 . . . . 0.0 110.783 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.504 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 23.9 mmm180 -60.95 -37.99 84.3 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 123.205 0.315 . . . . 0.0 110.688 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.8 mt -63.22 -49.21 75.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 123.973 0.796 . . . . 0.0 110.34 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.98 -44.2 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.63 -33.22 73.55 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.586 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.13 -42.48 46.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.65 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 25.0 mt-10 -52.34 -23.19 5.46 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -53.48 -35.59 60.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.896 0.879 . . . . 0.0 112.583 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 m -145.2 -84.82 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER -162.23 178.13 9.01 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.797 1.239 . . . . 0.0 108.612 -177.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 m-85 -111.63 146.88 36.65 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 ' CE2' ' A' ' 94' ' ' TYR . 4.9 mt -112.66 100.41 10.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.765 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.34 102.71 8.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -123.87 160.08 28.23 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.664 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 52.3 mtp . . . . . 0 N--CA 1.4 -2.959 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 166.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m . . . . . 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.0 112.552 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.9 mtt -113.68 138.17 50.58 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.704 -1.589 . . . . 0.0 111.782 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 77.0 tttt -96.97 90.49 5.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -100.49 137.84 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.47 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 16.3 mtm180 -73.79 131.36 41.47 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.5 t -118.39 127.65 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.294 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.767 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 34.6 mt-10 -88.23 148.37 24.39 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 116.63 -2.028 . . . . 0.0 107.866 165.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -118.66 128.97 55.03 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.055 0.222 . . . . 0.0 110.542 177.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.416 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.317 -0.84 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.545 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo . . . . . 0 C--O 1.238 0.488 0 N-CA-C 110.36 -0.669 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.6 p -132.49 150.08 52.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.688 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 9.3 p -147.02 148.22 16.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 12.8 m -99.5 105.44 17.35 Favored 'General case' 1 N--CA 1.379 -4.021 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -110.05 146.32 35.56 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.922 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -83.52 111.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 7' ' ' SER . 87.8 m-85 -112.25 145.1 40.54 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' H ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 p30 -145.07 172.05 13.62 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.45 17.64 54.98 Favored Glycine 0 C--N 1.307 -1.069 0 O-C-N 124.271 0.982 . . . . 0.0 112.606 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -113.67 -22.75 10.09 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 121.618 0.723 . . . . 0.0 111.987 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.563 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 59.8 m -101.28 137.17 39.98 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.137 0.975 . . . . 0.0 109.952 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.14 147.33 16.41 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 124.025 0.828 . . . . 0.0 110.767 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.3 t -54.98 -53.97 28.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.857 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -57.6 -28.93 64.07 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.267 0.98 . . . . 0.0 111.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 m-20 -75.91 -37.29 58.94 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.228 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.563 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 93.9 m-70 -62.15 -38.3 88.48 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 171.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 43.5 mt -67.11 -43.58 88.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.172 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -57.17 -34.46 68.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.836 0.744 . . . . 0.0 111.034 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' ASP . 63.4 t -70.55 -52.86 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.595 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.65 -49.62 67.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.252 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 91.7 mt -56.36 -48.29 77.11 Favored 'General case' 0 C--O 1.206 -1.231 0 O-C-N 123.48 0.487 . . . . 0.0 109.801 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.8 m -58.94 -40.18 83.89 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -71.82 -29.81 64.82 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.959 0.409 . . . . 0.0 112.023 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 41.1 m-85 -86.94 -0.97 57.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.232 0.539 . . . . 0.0 112.159 175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 69.79 30.86 3.68 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.967 1.707 . . . . 0.0 112.579 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.23 135.51 20.29 Favored Pre-proline 0 N--CA 1.404 -2.74 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.26 134.68 60.62 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.952 1.768 . . . . 0.0 111.24 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.2 m -63.26 -9.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.655 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.6 -15.46 63.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.785 0.326 . . . . 0.0 110.534 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -86.91 -5.48 59.08 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.847 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 1.6 p -48.9 -32.71 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 125.095 1.358 . . . . 0.0 110.609 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -57.14 -42.22 80.55 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.89 1.276 . . . . 0.0 110.379 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.2 m -103.52 13.7 32.87 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.243 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 15.8 m-85 -117.77 144.29 45.45 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.89 154.77 31.77 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.042 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.4 mt -83.58 130.14 34.98 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.76 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 38.5 tt0 -115.34 150.7 35.88 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -81.09 131.99 57.9 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.84 -19.82 46.32 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.914 2.409 . . . . 0.0 115.537 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.52 -45.28 4.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.355 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -92.14 -18.29 23.72 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.267 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.93 20.36 10.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.476 1.11 . . . . 0.0 112.443 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.16 137.71 35.9 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 37.5 m-85 -94.54 147.44 23.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.217 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.44 107.67 13.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -101.38 12.38 37.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.195 0.521 . . . . 0.0 111.09 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -76.44 155.77 33.65 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 122.299 1.047 . . . . 0.0 111.684 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -81.86 -38.31 25.61 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.627 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.34 151.02 51.3 Favored 'General case' 0 N--CA 1.417 -2.121 0 C-N-CA 123.901 0.881 . . . . 0.0 108.631 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.9 mt -83.33 154.53 24.03 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.352 0.596 . . . . 0.0 110.521 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -111.46 153.44 44.17 Favored Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.42 -36.38 79.09 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 0.0 109.674 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.45 -46.49 86.45 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.813 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.59 -37.12 86.46 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 75.8 mt -65.19 -49.12 70.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.922 0.763 . . . . 0.0 110.184 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.51 -44.07 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -62.16 -32.2 72.79 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.17 -43.83 23.16 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.79 -25.25 7.24 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -54.35 -36.67 64.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.672 1.189 . . . . 0.0 112.529 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.6 m -140.67 -80.79 0.26 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.05 -178.92 3.9 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 124.864 1.265 . . . . 0.0 108.443 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 2.6 m-85 -117.43 148.15 42.05 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 170.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.8 mt -115.65 101.57 12.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.019 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.422 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -78.28 103.72 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -125.97 164.3 21.11 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.514 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 65' ' ' SER . 58.4 mtp . . . . . 0 N--CA 1.405 -2.723 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.42 -1.934 0 CA-C-O 121.625 0.726 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 45.0 mtt -112.95 141.24 47.01 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.71 -169.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HE2' HD11 ' A' ' 38' ' ' ILE . 22.5 ttmm -98.63 101.07 12.38 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -112.22 138.64 40.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 124.833 1.253 . . . . 0.0 109.834 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 43.4 mtt180 -71.33 134.99 47.14 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.555 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 34' ' ' SER . 58.5 t -118.88 127.69 75.75 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.79 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.019 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.77 149.46 24.84 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.52 -1.672 . . . . 0.0 107.765 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tm? -115.17 132.65 56.54 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.093 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.306 -1.315 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.735 -0.91 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.6 p -139.37 157.25 46.19 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.011 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.4 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -97.45 99.48 10.9 Favored 'General case' 0 N--CA 1.387 -3.594 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 59.9 t60 -106.12 144.99 32.04 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.814 -167.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.529 HD11 ' HE2' ' A' ' 9' ' ' LYS 0.253 48.4 mm -83.65 114.06 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -115.35 151.5 34.52 Favored 'General case' 0 C--N 1.272 -2.78 0 C-N-CA 123.299 0.639 . . . . 0.0 109.513 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -146.71 -167.79 2.85 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.16 21.18 5.24 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -108.98 -25.46 10.71 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.469 0.652 . . . . 0.0 110.171 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.3 m -105.79 138.08 42.59 Favored 'General case' 0 N--CA 1.412 -2.342 0 C-N-CA 124.633 1.173 . . . . 0.0 109.391 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.64 145.86 22.44 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 121.444 0.64 . . . . 0.0 110.93 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 81.4 t -48.54 -52.05 9.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.701 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -56.57 -35.35 68.07 Favored 'General case' 0 C--O 1.198 -1.617 0 O-C-N 124.565 1.166 . . . . 0.0 111.204 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.61 -34.62 65.13 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.862 -0.524 . . . . 0.0 111.703 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -63.38 -36.98 85.51 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.62 -41.65 85.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.354 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -56.26 -38.78 71.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.856 0.753 . . . . 0.0 110.622 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.75 -53.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.902 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.3 mt -53.22 -50.56 64.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.133 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.99 -49.14 76.65 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 123.677 0.611 . . . . 0.0 110.047 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -59.13 -38.76 80.44 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -73.94 -31.47 63.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 14' ' ' LEU . 29.6 m-85 -81.58 -8.45 59.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.066 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt 74.57 37.23 0.56 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.638 1.575 . . . . 0.0 111.91 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.6 mt -109.63 131.53 21.85 Favored Pre-proline 0 N--CA 1.409 -2.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.72 136.11 57.89 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 C-N-CA 122.557 2.171 . . . . 0.0 111.932 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.7 m -64.29 -9.8 6.94 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.903 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.49 -15.93 63.35 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.674 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.9 mptp? -85.32 -4.36 59.13 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.5 p -49.37 -30.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.919 1.688 . . . . 0.0 110.481 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.2 p -56.05 -50.53 70.7 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.005 173.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 19.6 m -98.44 13.16 32.69 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.256 -172.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.2 m-85 -114.25 142.43 46.29 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.942 -0.474 . . . . 0.0 111.748 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.08 146.65 24.1 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.671 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.92 138.26 38.79 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.059 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -122.14 144.97 48.62 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 24.8 t-20 -76.89 130.32 76.24 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 17.3 Cg_exo -67.42 -18.72 49.67 Favored 'Trans proline' 0 C--N 1.329 -0.453 0 C-N-CA 122.575 2.183 . . . . 0.0 114.957 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -110.52 -39.48 4.9 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.2 p -90.12 -18.07 26.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.146 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 68.86 15.56 8.92 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.0 111.943 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.72 137.72 37.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.38 156.91 17.9 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.289 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.07 77.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 122.141 0.972 . . . . 0.0 111.845 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.4 2.94 2.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 125.234 1.414 . . . . 0.0 114.174 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.84 154.73 41.48 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.582 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -82.96 -37.28 24.31 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.851 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.49 153.37 48.88 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.291 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 82' ' ' LEU . 19.5 mt -85.68 146.83 26.65 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.2 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -99.02 157.79 33.46 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.5 -34.81 98.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.071 1.848 . . . . 0.0 109.398 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.09 -45.67 93.77 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.401 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 8.7 mmt180 -61.14 -39.7 91.04 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.699 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 79.0 mt -64.86 -48.68 73.4 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 124.073 0.858 . . . . 0.0 109.778 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.77 -45.3 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -63.83 -28.71 70.04 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.131 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.06 24.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.636 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 15.6 mt-10 -53.02 -22.71 6.13 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 119.059 0.845 . . . . 0.0 113.117 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.93 -42.93 65.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.706 0.803 . . . . 0.0 110.826 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.6 m -140.91 -80.41 0.26 Allowed 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -167.36 -179.26 4.39 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 124.133 0.973 . . . . 0.0 109.04 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.61 149.49 42.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.3 99.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.02 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -78.8 105.5 10.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.018 0.913 . . . . 0.0 108.589 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -124.07 166.15 16.26 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.427 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.4 mtp . . . . . 0 N--CA 1.4 -2.964 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.5 mmt -115.46 138.23 51.24 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.899 -172.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -99.04 91.98 5.27 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.61 137.27 31.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.939 -171.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 30.0 mtm105 -69.42 130.71 43.29 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 121.714 0.769 . . . . 0.0 110.225 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.0 t -117.07 122.58 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.385 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.487 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.275 33.0 mt-10 -82.38 149.36 27.73 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 116.566 -2.053 . . . . 0.0 107.037 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.52 123.09 36.97 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp . . . . . 0 C--N 1.314 -0.972 0 C-N-CA 119.242 -0.983 . . . . 0.0 109.019 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 C--O 1.242 0.696 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.6 m -145.86 157.59 43.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.193 0.52 . . . . 0.0 112.008 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -147.76 148.15 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.734 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.803 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.4 m -97.05 103.86 15.82 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -107.86 147.59 30.73 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.138 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.83 111.18 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.0 146.02 38.62 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.47 -168.85 3.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.83 20.45 6.03 Favored Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.471 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.12 -26.86 9.0 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.641 0.734 . . . . 0.0 110.699 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.0 m -99.62 135.3 41.25 Favored 'General case' 0 N--CA 1.39 -3.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.942 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.31 146.12 12.76 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 123.931 0.769 . . . . 0.0 111.58 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.469 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.0 t -52.75 -54.0 18.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.643 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -56.82 -31.02 64.31 Favored 'General case' 0 C--O 1.204 -1.329 0 O-C-N 124.464 1.102 . . . . 0.0 111.977 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 -38.94 62.16 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.91 -37.6 85.24 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.5 mt -68.81 -42.35 82.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.127 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.7 mttt -58.58 -33.55 70.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.87 -54.82 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.6 mt -53.12 -49.34 66.74 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 123.268 0.355 . . . . 0.0 111.178 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 86.4 mt -56.65 -48.19 78.12 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 123.404 0.44 . . . . 0.0 110.224 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -59.7 -38.76 82.47 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.71 -30.32 64.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.856 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.43 1.09 55.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.362 0.601 . . . . 0.0 112.03 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 67.3 35.05 4.55 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.489 1.516 . . . . 0.0 112.497 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.54 136.76 19.13 Favored Pre-proline 0 N--CA 1.411 -2.407 0 C-N-CA 124.802 1.241 . . . . 0.0 107.8 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.13 133.0 50.24 Favored 'Trans proline' 0 CA--C 1.495 -1.445 0 C-N-CA 121.999 1.799 . . . . 0.0 110.861 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.525 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -62.05 -9.85 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.115 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.05 -19.2 64.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.277 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -82.21 -5.51 58.55 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.9 p -48.01 -29.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 125.759 1.623 . . . . 0.0 110.975 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -48.95 77.54 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.977 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.0 m -99.78 12.96 35.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.843 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.3 m-85 -115.78 140.28 49.37 Favored 'General case' 0 CA--C 1.473 -1.992 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.163 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -156.07 152.36 27.93 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.434 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.71 127.99 33.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.859 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -111.04 144.53 40.01 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -73.87 125.18 90.52 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 -19.97 64.43 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.177 2.585 . . . . 0.0 114.84 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.79 -44.79 4.55 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.935 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.8 p -90.78 -15.18 30.59 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.89 18.96 11.71 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.799 1.24 . . . . 0.0 111.262 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.47 136.38 38.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.734 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 8.6 m-85 -92.77 147.76 22.6 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.385 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.9 105.99 17.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -107.07 13.87 26.96 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.799 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.23 163.97 27.04 Favored 'General case' 0 CA--C 1.461 -2.451 0 CA-C-O 122.719 1.247 . . . . 0.0 112.755 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.7 m -88.3 -38.92 14.79 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-N 112.6 -2.091 . . . . 0.0 109.129 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -131.85 149.21 52.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.857 0.863 . . . . 0.0 110.17 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 45' ' ' VAL . 21.5 mt -86.15 152.61 22.7 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.796 0.838 . . . . 0.0 111.786 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 62.0 p -103.05 155.92 36.0 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.73 -31.49 91.99 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.017 1.812 . . . . 0.0 109.411 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.7 -44.6 96.63 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.475 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.3 mmp_? -60.25 -38.8 84.59 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 58.0 mt -67.31 -47.63 69.99 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.699 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.607 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 42.9 t -62.74 -47.65 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 176.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 45.9 mt-10 -62.69 -30.8 71.67 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 111.664 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.43 58.27 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.909 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 3.0 mm-40 -59.08 -22.88 61.5 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -54.69 -38.74 67.38 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.097 172.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.4 m -144.76 -78.89 0.19 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.37 -177.27 4.4 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.699 1.2 . . . . 0.0 108.568 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.46 151.1 39.79 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.3 102.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.555 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.02 107.41 10.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -126.42 159.2 33.95 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.901 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 62.9 mtp . . . . . 0 N--CA 1.4 -2.97 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 121.136 0.493 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 13.0 mmt -123.78 140.84 52.59 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.293 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' HD13 ' A' ' 38' ' ' ILE . 28.5 ttpt -98.95 95.68 7.32 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.232 1.015 . . . . 0.0 108.953 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -105.45 139.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.243 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.8 mmt180 -65.76 131.86 47.33 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-O 121.139 0.495 . . . . 0.0 110.04 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.5 t -117.01 126.16 74.28 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.734 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.265 33.6 mt-10 -86.02 150.1 24.7 Favored 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 116.642 -2.023 . . . . 0.0 107.185 167.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -121.94 130.84 53.65 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.306 -1.318 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.071 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 CA--C 1.543 0.962 0 N-CA-C 110.047 -0.789 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 25.5 p -136.08 152.43 50.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.506 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -148.35 151.43 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 m -100.93 105.95 17.24 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -113.09 140.81 47.56 Favored 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.503 -171.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.251 36.3 mm -76.84 111.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 179.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.74 145.96 39.61 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' OD2' ' HE1' ' A' ' 48' ' ' HIS . 4.2 p30 -148.42 -170.74 3.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.9 17.58 7.65 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -108.71 -28.94 8.95 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.689 0.757 . . . . 0.0 109.719 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -100.45 132.06 46.04 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.772 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.59 151.23 4.41 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.524 0.73 . . . . 0.0 111.875 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.55 -54.28 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.996 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.72 -30.46 65.55 Favored 'General case' 0 C--O 1.204 -1.301 0 O-C-N 124.221 0.951 . . . . 0.0 112.525 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -73.66 -37.05 65.42 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.079 -0.388 . . . . 0.0 110.033 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.522 ' HE1' ' OD2' ' A' ' 40' ' ' ASP . 90.6 m-70 -62.77 -39.59 94.64 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 42.8 mt -68.52 -41.82 83.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.31 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -58.39 -34.66 70.98 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 119.047 0.84 . . . . 0.0 110.759 174.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.7 t -68.7 -54.13 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.3 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.85 -47.33 74.31 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.215 0.322 . . . . 0.0 111.191 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.1 mt -57.59 -46.87 83.48 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 123.377 0.423 . . . . 0.0 109.977 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -59.35 -40.69 87.19 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.16 -32.78 67.18 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 47.2 m-85 -83.94 -5.75 59.28 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.387 0.613 . . . . 0.0 111.296 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp 69.28 45.99 0.82 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 126.287 1.835 . . . . 0.0 112.983 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.99 135.88 21.26 Favored Pre-proline 0 N--CA 1.404 -2.739 0 C-N-CA 125.782 1.633 . . . . 0.0 107.286 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.36 134.64 62.13 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.142 1.895 . . . . 0.0 111.373 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.3 m -63.77 -10.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.176 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.94 -15.84 63.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.726 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.5 mptp? -85.0 -4.04 59.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.83 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.1 p -47.05 -31.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 126.08 1.752 . . . . 0.0 110.296 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.4 m -55.78 -47.02 77.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.744 1.618 . . . . 0.0 110.849 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -100.72 12.66 37.02 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.33 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.4 m-85 -113.28 143.24 44.75 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.906 -0.496 . . . . 0.0 111.654 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.35 147.54 28.43 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.838 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -83.54 125.64 31.98 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 124.26 0.975 . . . . 0.0 108.415 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -112.77 147.77 36.19 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.22 129.91 70.94 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.08 -20.63 67.75 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.82 2.347 . . . . 0.0 115.179 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -103.71 -44.89 4.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.984 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 p -89.5 -20.55 23.7 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.851 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt 67.24 17.27 10.26 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.599 1.159 . . . . 0.0 111.821 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.2 39.18 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.53 154.26 17.38 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.45 110.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -102.32 11.58 37.89 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.546 0.689 . . . . 0.0 110.424 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.17 156.85 36.89 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.934 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.6 m -81.73 -38.59 25.49 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.618 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.46 149.27 52.21 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 124.194 0.997 . . . . 0.0 108.657 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.66 155.07 28.22 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.554 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 73.0 p -109.35 153.32 42.8 Favored Pre-proline 0 N--CA 1.401 -2.899 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HG2' ' OE2' ' A' ' 85' ' ' GLU . 8.6 Cg_endo -53.94 -37.56 85.87 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.553 2.169 . . . . 0.0 110.386 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 mp0 -60.09 -44.43 94.8 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.0 mmp_? -61.7 -40.4 94.9 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 83' ' ' THR . 66.3 mt -66.29 -47.12 74.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.711 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.76 -46.3 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.585 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 86' ' ' ARG . 49.7 mt-10 -63.78 -31.8 73.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 111.451 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.82 61.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.622 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -57.33 -24.9 58.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.188 0.595 . . . . 0.0 111.934 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 67.0 mttm -56.17 -35.62 67.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.506 1.122 . . . . 0.0 112.534 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.1 m -146.79 -85.1 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.61 -178.82 7.38 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.297 1.039 . . . . 0.0 108.843 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.35 149.27 42.11 Favored 'General case' 0 C--O 1.209 -1.075 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 169.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 98' ' ' ARG . 9.7 mt -116.63 101.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 118.821 0.737 . . . . 0.0 110.325 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -79.39 102.99 9.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 96' ' ' ILE . 25.0 mtp180 -119.99 161.05 21.57 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 46.8 mtp . . . . . 0 N--CA 1.413 -2.284 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 168.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.424 -1.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 12.0 mmt -127.96 142.07 51.35 Favored 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -99.13 97.57 8.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -109.4 138.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.17 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 87.9 mtt180 -69.3 130.79 43.57 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.364 0.602 . . . . 0.0 110.683 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 48.3 t -116.83 123.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.561 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.607 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.259 35.6 mt-10 -84.69 142.4 29.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.622 -2.031 . . . . 0.0 107.711 169.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.4 tm? -115.38 130.73 56.98 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.972 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--O 1.246 0.895 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.48 0.721 0 N-CA-C 109.422 -1.03 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.6 m -143.61 159.89 41.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.792 -0.567 . . . . 0.0 109.623 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -151.69 150.39 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -97.35 106.72 19.09 Favored 'General case' 0 N--CA 1.394 -3.261 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 173.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -110.2 145.42 37.32 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.132 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.254 50.2 mm -83.28 109.89 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.85 144.51 39.76 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -152.41 169.21 23.11 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 124.235 1.014 . . . . 0.0 108.534 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.65 17.98 53.93 Favored Glycine 0 C--N 1.282 -2.465 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -104.95 -30.03 10.08 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-O 121.715 0.769 . . . . 0.0 109.963 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.681 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 31.6 m -97.75 137.39 36.7 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 124.793 1.237 . . . . 0.0 108.564 175.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.04 149.34 12.1 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-O 121.517 0.675 . . . . 0.0 110.44 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.6 t -55.74 -53.92 31.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.096 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -57.4 -31.1 65.5 Favored 'General case' 0 C--O 1.208 -1.107 0 O-C-N 124.159 0.912 . . . . 0.0 111.818 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -74.16 -36.64 64.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 122.344 -0.223 . . . . 0.0 110.813 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.681 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 91.3 m-70 -62.76 -39.06 92.99 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.7 mt -68.67 -43.12 83.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.473 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.7 mttt -58.51 -31.88 68.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.733 0.697 . . . . 0.0 110.899 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 47' ' ' ASP . 91.1 t -68.61 -54.31 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.417 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -53.14 -48.76 67.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 122.502 0.321 . . . . 0.0 111.013 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.0 mt -57.73 -49.07 77.79 Favored 'General case' 0 C--O 1.195 -1.815 0 O-C-N 123.654 0.596 . . . . 0.0 109.811 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 m -59.72 -38.51 81.87 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -72.68 -31.91 65.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 47.6 m-85 -83.09 -7.09 59.69 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.188 0.518 . . . . 0.0 111.334 173.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 72.02 38.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.62 1.568 . . . . 0.0 112.237 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' CG2' ' HD2' ' A' ' 62' ' ' LYS . 75.1 mt -105.89 134.79 19.57 Favored Pre-proline 0 N--CA 1.409 -2.517 0 C-N-CA 125.345 1.458 . . . . 0.0 107.865 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.01 131.39 46.15 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.339 2.026 . . . . 0.0 111.325 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.6 m -62.42 -11.04 5.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.553 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.43 -14.65 62.22 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HD2' ' CG2' ' A' ' 58' ' ' ILE . 66.9 mttm -81.62 -9.96 59.54 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.827 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.3 p -47.27 -31.33 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 127.257 2.223 . . . . 0.0 110.343 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 m -54.41 -46.24 73.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.564 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' MET . 14.8 t -94.41 -0.64 54.68 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.823 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 20.0 m-85 -101.14 139.05 37.36 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.714 -1.194 . . . . 0.0 112.315 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 142.24 24.55 Favored 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.646 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 97' ' ' LEU . 79.2 mt -79.0 126.41 30.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.7 148.57 38.06 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.82 128.0 73.09 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.08 -17.64 40.55 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 122.553 2.169 . . . . 0.0 114.828 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.85 -43.28 5.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.209 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 p -91.25 -18.86 23.7 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.62 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 mt 69.45 17.62 8.02 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.382 1.073 . . . . 0.0 111.671 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.96 140.82 30.79 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.55 150.83 19.85 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 120.959 0.409 . . . . 0.0 110.692 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.7 t -87.9 106.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.08 16.69 23.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.403 1.097 . . . . 0.0 109.836 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.49 158.26 32.84 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.75 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.65 -38.13 20.2 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.29 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -131.58 144.82 51.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.272 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.8 mt -78.96 152.74 30.87 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.777 0.798 . . . . 0.0 110.632 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.9 p -106.32 152.21 40.47 Favored Pre-proline 0 N--CA 1.398 -3.051 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.44 -31.69 92.01 Favored 'Trans proline' 0 C--O 1.208 -0.977 0 C-N-CA 122.287 1.992 . . . . 0.0 109.865 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.24 -47.81 82.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.458 0.703 . . . . 0.0 110.644 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 3.7 mmp_? -62.54 -37.27 85.46 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.893 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 83' ' ' THR . 57.7 mt -66.92 -47.29 72.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.385 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.97 -46.06 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.126 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -64.27 -30.98 72.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.659 0.742 . . . . 0.0 111.209 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.09 -34.09 59.52 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.623 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.43 -24.39 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -53.67 -40.22 65.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.102 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m -143.05 -80.69 0.2 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.64 -179.29 6.77 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.788 1.235 . . . . 0.0 108.947 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -119.1 155.52 31.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 12.4 mt -115.83 134.59 58.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -107.78 99.8 9.23 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -176.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -121.5 162.3 20.77 Favored 'General case' 0 CA--C 1.46 -2.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.018 -172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' SER . 54.4 mtp . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 169.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.708 0.29 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mmt -118.26 139.72 50.89 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.583 ' HD3' ' CD1' ' A' ' 38' ' ' ILE . 36.5 tptt -100.55 100.19 10.89 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.32 136.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.287 -170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 62.6 mtm180 -69.26 135.94 51.22 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-O 121.567 0.699 . . . . 0.0 110.754 171.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' SER . 62.3 t -121.11 124.54 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.571 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.272 29.8 mt-10 -85.9 138.82 31.75 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.907 -1.917 . . . . 0.0 108.228 168.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -115.99 129.61 56.45 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 178.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.411 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp . . . . . 0 C--O 1.248 1.001 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.718 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.493 1.494 0 N-CA-C 111.662 -0.168 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 30.6 m -138.91 159.54 41.9 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.729 -0.607 . . . . 0.0 112.128 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.0 p -151.93 150.92 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -95.92 115.82 28.0 Favored 'General case' 1 N--CA 1.378 -4.055 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 171.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -115.23 142.57 46.49 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.399 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 31.1 mm -79.39 110.82 15.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.01 141.38 42.9 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.52 ' OD1' ' HE1' ' A' ' 48' ' ' HIS . 7.9 p-10 -145.99 160.34 42.0 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.274 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.4 20.34 51.1 Favored Glycine 0 C--N 1.281 -2.496 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.812 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -110.19 -24.97 10.41 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 121.701 0.763 . . . . 0.0 109.815 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.53 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 91.4 m -103.23 137.19 41.71 Favored 'General case' 0 N--CA 1.401 -2.875 0 C-N-CA 124.274 1.03 . . . . 0.0 109.436 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.18 152.6 13.36 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.692 0.758 . . . . 0.0 111.69 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.4 t -56.26 -54.83 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.129 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -57.07 -30.39 64.26 Favored 'General case' 0 C--O 1.207 -1.183 0 O-C-N 124.31 1.006 . . . . 0.0 111.387 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 m-20 -75.48 -37.4 60.26 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.53 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 88.9 m-70 -61.36 -39.28 90.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.2 mt -67.38 -43.35 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.072 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 63' ' ' VAL . 93.1 mttt -57.28 -35.22 69.51 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.036 0.835 . . . . 0.0 110.936 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 97.1 t -69.0 -53.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.322 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -53.14 -48.86 67.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 123.357 0.411 . . . . 0.0 110.982 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.7 mt -57.65 -47.75 81.39 Favored 'General case' 0 C--O 1.202 -1.428 0 O-C-N 123.408 0.443 . . . . 0.0 110.048 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 m -58.92 -40.97 86.18 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -71.21 -35.02 71.37 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.187 0.517 . . . . 0.0 112.19 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.552 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 46.1 m-85 -79.46 -2.17 40.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.241 0.543 . . . . 0.0 111.332 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 70.54 36.43 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.205 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -107.31 138.39 19.89 Favored Pre-proline 0 N--CA 1.415 -2.201 0 C-N-CA 125.277 1.431 . . . . 0.0 107.81 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.93 133.14 56.06 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 121.805 1.67 . . . . 0.0 110.638 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.8 m -62.77 -10.04 4.99 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.512 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.09 -19.6 65.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.0 110.125 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.4 mptp? -80.61 -8.06 59.48 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.765 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.2 p -47.97 -33.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 C-N-CA 125.548 1.539 . . . . 0.0 110.052 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.256 14.4 m -54.42 -48.17 71.95 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 126.184 1.794 . . . . 0.0 109.907 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 99' ' ' MET . 25.4 m -100.49 14.47 31.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.09 -1.413 . . . . 0.0 112.179 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.0 m-85 -112.26 139.06 48.11 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.376 0.608 . . . . 0.0 112.05 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.91 141.99 24.9 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.779 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 90.0 mt -76.06 159.13 31.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.38 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 45.5 tt0 -143.25 150.5 39.37 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.16 128.96 71.6 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.18 -15.72 43.21 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.763 2.309 . . . . 0.0 115.226 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -109.37 -45.52 3.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.756 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -88.97 -17.62 29.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.465 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt 70.91 15.02 6.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.494 1.117 . . . . 0.0 112.683 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.96 137.46 38.33 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.048 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 3.9 m-85 -85.1 174.21 9.87 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.045 0.45 . . . . 0.0 111.61 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.35 107.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.51 12.34 26.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.004 0.907 . . . . 0.0 110.293 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.38 157.58 33.99 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.73 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -84.33 -40.81 17.47 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.042 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.92 152.35 49.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 123.774 0.829 . . . . 0.0 109.409 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 45' ' ' VAL . 18.0 mt -88.34 148.59 24.2 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.517 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.1 p -99.49 152.9 37.96 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.35 -35.66 92.11 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.704 2.269 . . . . 0.0 110.125 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.39 -48.96 77.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.482 0.713 . . . . 0.0 110.511 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -61.48 -37.27 83.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 123.304 0.377 . . . . 0.0 111.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 63.6 mt -64.85 -47.98 75.96 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.694 0.621 . . . . 0.0 110.578 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -63.99 -44.83 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -61.68 -27.68 68.86 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.798 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.43 -36.33 24.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -53.93 -24.56 16.73 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -50.29 -39.81 46.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.724 0.81 . . . . 0.0 111.021 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.6 m -147.74 -92.35 0.08 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.46 178.46 8.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.512 0.725 . . . . 0.0 109.424 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.65 154.41 30.59 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 14.3 mt -116.33 139.78 41.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 170.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -116.22 109.12 17.0 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -127.95 160.88 30.5 Favored 'General case' 0 CA--C 1.467 -2.248 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 54.8 mtp . . . . . 0 N--CA 1.397 -3.08 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 p . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.8 mmt -118.31 138.47 52.37 Favored 'General case' 0 CA--C 1.47 -2.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.909 -172.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 76.4 tttt -97.18 93.07 6.34 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.86 140.08 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.211 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 86.2 mtt180 -70.13 129.62 39.91 Favored 'General case' 0 CA--C 1.475 -1.932 0 O-C-N 123.516 0.51 . . . . 0.0 110.113 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' SER . 41.2 t -115.49 124.74 72.3 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.546 0 CA-C-O 117.675 -1.155 . . . . 0.0 108.092 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.268 47.0 mt-10 -85.54 145.39 27.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 116.829 -1.948 . . . . 0.0 107.764 168.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -116.14 131.66 56.88 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.314 -0.971 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 N--CA 1.447 -1.238 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.1 p -140.56 162.16 36.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.263 -171.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -151.37 149.45 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.0 m -98.23 107.36 19.82 Favored 'General case' 0 N--CA 1.386 -3.645 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -113.93 146.59 39.87 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.469 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.73 112.02 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.96 146.04 39.73 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.3 173.95 14.93 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 123.535 0.734 . . . . 0.0 109.159 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.54 14.98 56.36 Favored Glycine 0 C--N 1.304 -1.228 0 O-C-N 124.413 1.071 . . . . 0.0 112.825 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -108.97 -32.11 7.38 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 121.209 0.528 . . . . 0.0 112.063 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.8 m -93.72 134.2 36.29 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.59 0.756 . . . . 0.0 109.317 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.77 149.1 6.53 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.041 0.936 . . . . 0.0 110.942 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.7 t -55.29 -53.14 38.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.523 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -59.36 -28.36 66.78 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.434 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 m-20 -73.35 -39.1 65.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -61.89 -38.48 88.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.3 mt -69.22 -43.99 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.13 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.2 mttt -56.91 -34.18 67.67 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 118.985 0.811 . . . . 0.0 110.603 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 47' ' ' ASP . 96.2 t -69.17 -55.51 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.445 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.1 -49.19 66.99 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 123.301 0.375 . . . . 0.0 111.55 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.46 -48.55 76.84 Favored 'General case' 0 C--O 1.201 -1.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.138 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.7 m -59.81 -36.79 77.49 Favored 'General case' 0 N--CA 1.397 -3.109 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -73.43 -32.13 64.22 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 43.9 m-85 -84.64 -3.95 58.76 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 122.883 0.473 . . . . 0.0 111.688 174.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 70.49 35.76 1.87 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.219 1.408 . . . . 0.0 112.718 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.3 mt -105.23 132.1 21.17 Favored Pre-proline 0 N--CA 1.409 -2.511 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.82 135.36 62.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.07 1.847 . . . . 0.0 111.267 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -62.32 -9.52 3.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.904 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -68.01 -16.39 64.02 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 120.874 0.368 . . . . 0.0 110.11 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.58 -5.11 58.39 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.619 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.3 p -47.6 -33.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 C-N-CA 125.933 1.693 . . . . 0.0 110.995 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.276 15.3 m -54.8 -48.56 72.58 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 126.061 1.745 . . . . 0.0 110.444 174.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.7 m -102.11 17.73 22.56 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.821 -172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.4 m-85 -116.76 142.65 46.64 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.73 146.44 25.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.222 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 85.9 mt -79.61 126.39 30.83 Favored 'General case' 0 N--CA 1.418 -2.057 0 O-C-N 124.71 1.256 . . . . 0.0 107.846 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 98' ' ' ARG . 38.8 tt0 -114.21 147.8 38.37 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.05 125.7 84.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -8.34 22.61 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 122.655 2.237 . . . . 0.0 115.169 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.47 -40.75 3.56 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.298 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.2 p -90.44 -20.79 22.35 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.069 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt 70.59 18.91 6.33 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.797 1.239 . . . . 0.0 111.977 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.28 140.86 30.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.634 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' OH ' ' HD3' ' A' ' 98' ' ' ARG . 80.9 m-85 -98.14 144.53 27.51 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.822 0.344 . . . . 0.0 110.23 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.15 106.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -100.26 12.14 37.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.062 0.934 . . . . 0.0 110.362 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.15 152.21 34.98 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.371 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.9 m -79.12 -36.98 39.73 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.152 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.34 143.83 50.8 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.115 0.966 . . . . 0.0 108.806 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.9 mt -77.49 157.54 30.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.39 0.614 . . . . 0.0 111.257 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.0 p -111.71 153.64 44.27 Favored Pre-proline 0 N--CA 1.409 -2.477 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.28 -34.93 72.29 Favored 'Trans proline' 0 C--O 1.21 -0.91 0 C-N-CA 122.35 2.034 . . . . 0.0 110.349 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.86 -48.49 77.98 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.1 mmp_? -61.11 -38.85 87.8 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.369 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 52.4 mt -67.69 -48.09 67.55 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.727 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.22 -47.56 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.26 -29.66 70.46 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.253 0.549 . . . . 0.0 111.784 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.45 -37.03 60.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.78 -24.23 48.89 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -53.0 -43.79 66.74 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -137.63 -82.46 0.34 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.22 178.55 6.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.16 1.384 . . . . 0.0 108.489 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 155.07 30.4 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 11.7 mt -115.39 138.51 45.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 99.26 7.06 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 69' ' ' GLN . 44.0 mtp180 -119.67 162.63 18.69 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 41.2 mtp . . . . . 0 N--CA 1.393 -3.288 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.425 -1.691 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 44.6 mtt -114.13 139.41 49.35 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.566 -170.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -100.36 96.87 7.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.43 138.58 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.851 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 17.3 mtp180 -68.21 131.13 44.83 Favored 'General case' 0 CA--C 1.46 -2.503 0 CA-C-O 122.146 0.974 . . . . 0.0 111.947 170.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.5 t -118.15 123.51 71.73 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.361 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.155 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 11' ' ' ARG 0.272 0.5 OUTLIER -83.98 149.42 26.31 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.213 166.451 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -123.34 130.66 53.03 Favored 'General case' 0 C--N 1.265 -3.08 0 O-C-N 123.469 0.481 . . . . 0.0 111.084 176.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp . . . . . 0 C--O 1.245 0.848 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.29 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo . . . . . 0 CA--C 1.539 0.73 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.2 m -138.6 155.79 48.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.1 p -147.98 150.2 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.4 m -98.11 105.36 17.5 Favored 'General case' 0 N--CA 1.387 -3.616 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -109.59 147.79 32.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.402 -170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.9 113.84 23.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.31 146.0 40.13 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.36 -171.89 3.68 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.58 -11.44 11.6 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.559 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -83.07 -26.11 31.41 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 124.197 0.999 . . . . 0.0 111.996 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 36.7 m -96.2 131.7 42.4 Favored 'General case' 0 N--CA 1.388 -3.561 0 C-N-CA 123.793 0.837 . . . . 0.0 109.631 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 149.57 9.0 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.867 0.73 . . . . 0.0 110.844 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.6 t -55.66 -51.78 54.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.87 -31.0 64.37 Favored 'General case' 0 C--O 1.202 -1.427 0 O-C-N 124.381 1.05 . . . . 0.0 111.387 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.0 m-20 -75.42 -38.9 59.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.584 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -61.71 -40.23 94.29 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.8 mt -68.34 -42.46 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.13 -34.36 70.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.89 0.768 . . . . 0.0 110.977 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.0 t -68.97 -53.38 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.4 -48.28 68.8 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.22 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.8 mt -57.84 -48.39 79.9 Favored 'General case' 0 C--O 1.193 -1.91 0 O-C-N 123.538 0.523 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -60.14 -38.91 84.54 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -72.11 -30.4 65.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.1 -0.375 . . . . 0.0 111.52 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 41.2 m-85 -88.56 -0.24 57.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.377 0.608 . . . . 0.0 112.201 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 69.0 32.46 3.77 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.661 1.584 . . . . 0.0 112.28 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -103.16 135.6 19.37 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.86 133.02 53.32 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.96 1.773 . . . . 0.0 111.918 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.0 m -62.59 -9.27 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.795 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.98 -18.38 62.62 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.634 0.731 . . . . 0.0 109.585 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -82.4 -9.99 59.23 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.903 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.7 p -46.04 -31.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 126.902 2.081 . . . . 0.0 110.741 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 m -54.67 -45.97 73.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.903 1.681 . . . . 0.0 111.067 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.4 t -97.96 0.33 46.22 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.618 -173.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -103.59 137.23 41.94 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.405 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.25 145.45 31.28 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.567 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.54 123.93 29.65 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -111.07 148.48 32.54 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -82.37 126.71 73.38 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 18.6 Cg_endo -60.63 -23.62 76.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.419 2.746 . . . . 0.0 114.82 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -103.84 -46.17 4.57 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.47 -1.292 . . . . 0.0 112.855 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -88.01 -17.1 31.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.557 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt 66.42 18.21 10.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 111.285 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.95 138.24 35.0 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.145 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -96.16 143.99 26.79 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.3 102.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.1 13.98 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 123.037 1.398 . . . . 0.0 108.537 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.55 158.56 31.08 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.999 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.5 m -84.88 -37.82 20.17 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.824 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -129.58 155.4 45.87 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.965 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.76 147.15 23.42 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.174 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.0 p -98.99 151.06 37.23 Favored Pre-proline 0 N--CA 1.401 -2.913 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.51 -33.85 93.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.245 1.963 . . . . 0.0 109.975 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.56 -47.41 85.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -61.3 -36.01 78.9 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.689 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 68.2 mt -64.09 -50.15 69.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.697 0.623 . . . . 0.0 110.485 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.24 -43.36 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.77 -32.99 69.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.76 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.11 -42.43 23.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.681 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 11.7 mt-10 -52.2 -25.28 8.76 Favored 'General case' 0 C--N 1.369 1.441 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.52 -36.81 62.18 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 124.367 1.067 . . . . 0.0 112.258 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -143.99 -83.14 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -165.92 -178.75 4.88 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.668 0.787 . . . . 0.0 109.263 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.12 148.29 43.22 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.404 HG22 ' HG2' ' A' ' 98' ' ' ARG . 10.9 mt -114.95 100.69 11.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.621 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.79 103.24 8.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.404 ' HG2' HG22 ' A' ' 96' ' ' ILE . 30.0 mtp180 -126.34 162.48 25.41 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.685 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 45.5 mtp . . . . . 0 N--CA 1.405 -2.69 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.484 0.659 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 42.3 mtt -115.57 141.09 48.53 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.494 -172.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -99.63 95.07 6.72 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.86 138.69 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.849 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 54.9 mtm-85 -69.39 131.53 44.93 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-O 121.623 0.725 . . . . 0.0 110.841 172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' SER . 46.7 t -119.19 124.07 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.578 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.216 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 12' ' ' VAL . 31.4 mm-40 -81.18 158.88 24.77 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -130.81 133.17 45.73 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 122.074 -0.391 . . . . 0.0 111.091 175.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--O 1.243 0.745 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.457 -0.646 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 5.5 p -140.52 161.04 38.68 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.46 149.07 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -97.69 105.28 17.4 Favored 'General case' 0 N--CA 1.389 -3.513 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -109.11 147.28 32.69 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.103 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -83.26 110.67 18.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.06 149.02 34.01 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -149.48 -169.72 3.45 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.35 15.1 8.73 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -106.59 -34.19 7.43 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.677 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -93.97 134.35 36.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 C-N-CA 124.152 0.981 . . . . 0.0 108.376 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.56 151.72 7.63 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.563 0.697 . . . . 0.0 111.589 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 82' ' ' LEU . 98.5 t -55.27 -54.58 23.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.734 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -56.89 -30.43 63.88 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.628 -177.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.7 m-20 -73.79 -37.44 64.95 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.962 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -62.43 -38.67 90.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.4 mt -67.81 -44.22 85.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 63' ' ' VAL . 95.9 mttt -57.47 -34.16 68.73 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.843 0.747 . . . . 0.0 111.129 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 47' ' ' ASP . 85.7 t -69.05 -54.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.66 -49.19 68.48 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.657 0.383 . . . . 0.0 111.471 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.1 mt -57.25 -47.41 81.46 Favored 'General case' 0 C--O 1.195 -1.806 0 O-C-N 123.38 0.425 . . . . 0.0 110.05 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.68 -38.37 84.73 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -70.61 -37.83 73.9 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.975 0.417 . . . . 0.0 111.514 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 57.0 m-85 -78.81 -9.52 59.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.389 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm 74.42 39.74 0.45 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.87 1.268 . . . . 0.0 112.584 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.73 140.92 22.3 Favored Pre-proline 0 N--CA 1.411 -2.382 0 C-N-CA 125.74 1.616 . . . . 0.0 107.622 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.97 134.47 53.36 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 122.222 1.948 . . . . 0.0 111.087 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.4 m -63.28 -9.63 5.13 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.89 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.801 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.48 -14.83 62.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.0 110.221 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 65.1 mttm -88.98 -6.46 57.22 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.844 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.1 p -49.62 -29.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 126.287 1.835 . . . . 0.0 109.773 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 p -54.08 -51.14 65.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.237 1.815 . . . . 0.0 110.977 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' MET . 5.8 m -98.03 6.91 47.1 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.881 -171.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 16.8 m-85 -107.79 143.55 36.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.342 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.31 145.04 25.92 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.29 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 83.9 mt -80.97 128.13 33.34 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -118.09 149.8 40.41 Favored 'General case' 0 C--N 1.28 -2.452 0 O-C-N 122.161 -0.337 . . . . 0.0 110.101 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -81.77 132.72 53.74 Favored Pre-proline 0 C--N 1.313 -0.982 0 O-C-N 124.385 1.053 . . . . 0.0 108.276 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.48 -19.38 48.98 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.14 2.56 . . . . 0.0 115.105 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -105.01 -40.26 5.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.735 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -95.98 -19.51 19.44 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.328 0.585 . . . . 0.0 111.239 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.89 22.62 12.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.394 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.35 140.96 33.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.716 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.76 144.52 26.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.593 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.13 102.69 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.55 13.57 31.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.824 1.297 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.75 157.04 34.02 Favored 'General case' 0 N--CA 1.405 -2.696 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.647 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.0 m -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.875 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.33 147.91 52.09 Favored 'General case' 0 N--CA 1.418 -2.069 0 C-N-CA 124.041 0.936 . . . . 0.0 108.562 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.0 mt -79.16 154.8 29.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.11 0.481 . . . . 0.0 110.208 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 p -104.71 151.59 39.33 Favored Pre-proline 0 N--CA 1.399 -2.983 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.94 -31.59 93.1 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.173 1.915 . . . . 0.0 109.727 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.66 -48.66 78.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.494 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.84 -36.39 83.06 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.4 mt -64.3 -48.79 74.29 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.496 0.498 . . . . 0.0 110.18 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.62 -46.46 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -60.85 -32.87 72.26 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 112.209 171.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.82 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.48 -27.05 35.0 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 89' ' ' GLU . 95.7 mttt -54.96 -31.38 60.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.284 1.034 . . . . 0.0 112.083 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.8 m -143.81 -86.76 0.13 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -167.38 178.79 5.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.003 1.321 . . . . 0.0 108.527 -176.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -114.89 159.71 20.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 2.9 mp -120.22 141.61 39.71 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.781 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 167.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 98.38 6.73 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -115.69 161.21 19.03 Favored 'General case' 0 CA--C 1.464 -2.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.071 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.3 mtp . . . . . 0 N--CA 1.391 -3.403 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 165.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.41 -2.466 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.495 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.6 mmt -110.08 141.43 42.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.394 -170.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 64.7 tttt -101.62 95.75 6.65 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 90' ' ' ALA . 86.2 mt -105.51 140.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.334 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -70.9 134.18 47.05 Favored 'General case' 0 CA--C 1.466 -2.283 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.867 173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.85 123.36 71.58 Favored 'Isoleucine or valine' 2 N--CA 1.37 -4.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.6 OUTLIER -84.49 148.49 26.51 Favored 'General case' 0 N--CA 1.407 -2.581 0 C-N-CA 116.25 -2.18 . . . . 0.0 107.843 167.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -115.0 134.38 55.24 Favored 'General case' 0 C--N 1.278 -2.517 0 O-C-N 123.28 0.362 . . . . 0.0 110.6 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.4 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--O 1.251 1.165 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--O 1.239 0.534 0 N-CA-C 109.614 -0.956 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -139.12 159.8 41.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.5 p -150.37 151.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 m -99.44 107.25 19.42 Favored 'General case' 0 N--CA 1.39 -3.445 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.0 t60 -112.56 146.57 38.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.916 -170.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.27 111.31 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -112.36 144.82 41.15 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 2.8 p30 -146.02 -168.52 3.01 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.13 -9.45 8.05 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.91 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 40' ' ' ASP . 2.0 mp0 -82.46 -26.86 32.27 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.81 0.814 . . . . 0.0 110.683 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.601 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 26.5 m -95.98 129.53 43.22 Favored 'General case' 0 N--CA 1.383 -3.825 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.12 149.24 9.76 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.525 0.679 . . . . 0.0 110.99 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 82' ' ' LEU . 99.0 t -53.05 -53.8 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.313 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -54.88 -32.16 60.55 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 124.612 1.195 . . . . 0.0 111.722 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 22.8 m-20 -78.79 -34.32 45.59 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.906 -0.496 . . . . 0.0 111.635 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.601 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.7 m-70 -62.24 -39.36 92.59 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.1 mt -66.51 -42.91 90.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -56.02 -37.81 69.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.683 0.674 . . . . 0.0 110.672 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.9 t -67.07 -53.22 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.093 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -54.31 -47.75 72.11 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 123.311 0.382 . . . . 0.0 110.902 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -56.92 -49.03 76.86 Favored 'General case' 0 C--O 1.194 -1.863 0 O-C-N 123.519 0.512 . . . . 0.0 109.816 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -60.28 -37.82 81.68 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -74.06 -29.3 61.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.172 0.51 . . . . 0.0 111.867 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.55 0.98 55.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.476 0.655 . . . . 0.0 111.947 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 67.18 40.8 2.73 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.48 1.512 . . . . 0.0 113.124 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.87 136.93 20.72 Favored Pre-proline 0 N--CA 1.404 -2.766 0 C-N-CA 124.679 1.192 . . . . 0.0 108.385 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.05 134.61 63.3 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.606 2.204 . . . . 0.0 110.828 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 34.3 m -63.33 -9.85 5.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.487 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.627 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.63 -14.33 62.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.649 0.737 . . . . 0.0 110.692 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -87.26 -5.87 58.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.029 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -48.87 -31.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 126.787 2.035 . . . . 0.0 110.756 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 m -55.86 -46.11 78.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.094 1.358 . . . . 0.0 110.59 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' MET . 22.2 m -101.71 14.83 30.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.876 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.4 m-85 -115.49 144.05 44.41 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 121.789 -0.569 . . . . 0.0 111.627 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.29 156.14 31.93 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.93 133.38 33.94 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.05 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.76 149.05 42.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -81.04 131.65 58.98 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 Cg_endo -66.35 -25.73 48.96 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.611 2.207 . . . . 0.0 114.893 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.22 -44.05 5.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.402 -0.919 . . . . 0.0 113.167 -174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.03 -20.09 24.82 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.728 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 69.45 16.48 8.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.256 1.022 . . . . 0.0 111.797 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.92 37.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -92.75 152.08 19.69 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.61 103.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.86 10.62 32.46 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.144 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -76.79 159.17 30.33 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -82.92 -38.94 22.14 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.116 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.04 156.03 44.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -93.03 143.98 25.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.076 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 77.5 p -93.44 153.72 41.37 Favored Pre-proline 0 N--CA 1.409 -2.485 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.09 -32.0 94.49 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.896 1.731 . . . . 0.0 109.138 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -46.14 90.92 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.053 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.489 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 7.1 mmm180 -58.86 -39.35 81.06 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.569 0.223 . . . . 0.0 111.349 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 8' ' ' MET . 62.9 mt -64.39 -46.56 82.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 124.095 0.872 . . . . 0.0 110.359 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.2 -45.53 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -80.88 -37.14 30.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -54.33 -24.28 18.68 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -51.21 -43.98 61.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.14 0.576 . . . . 0.0 110.586 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 m -142.48 -86.75 0.15 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -157.3 -178.93 7.72 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.996 0.918 . . . . 0.0 109.427 -177.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.09 148.32 44.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -114.23 100.34 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.303 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.78 103.72 8.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -122.59 162.09 22.49 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.573 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.4 mtp . . . . . 0 N--CA 1.398 -3.048 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.434 -1.226 0 CA-C-O 121.786 0.803 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.521 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.2 mmt -115.55 140.43 49.17 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.143 -170.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 76.1 tttt -97.5 96.42 8.32 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.35 138.5 31.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.762 -172.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -69.74 133.69 47.77 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.293 0.568 . . . . 0.0 110.341 172.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -118.07 121.57 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.885 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.374 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 39.6 mt-10 -80.37 147.17 31.15 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.774 168.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -116.83 131.89 56.84 Favored 'General case' 0 C--N 1.272 -2.771 0 O-C-N 123.294 0.371 . . . . 0.0 110.612 175.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.453 0 N-CA-C 110.012 -0.803 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.7 m -138.25 163.99 30.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.175 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -150.3 148.57 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 5.1 m -96.72 107.37 19.82 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -112.87 145.45 40.67 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.347 -170.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 49.8 mm -83.15 112.48 20.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -112.11 143.16 43.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -147.28 166.89 25.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 O-C-N 124.652 1.22 . . . . 0.0 108.693 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 18.03 56.74 Favored Glycine 0 C--N 1.279 -2.591 0 O-C-N 124.118 0.886 . . . . 0.0 112.012 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.31 -29.52 11.62 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-O 121.626 0.727 . . . . 0.0 111.278 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.533 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 83.6 m -99.67 137.74 37.73 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.897 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.38 18.97 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 123.527 0.517 . . . . 0.0 110.469 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.62 -54.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.01 -30.77 62.33 Favored 'General case' 0 C--O 1.203 -1.364 0 O-C-N 124.226 0.953 . . . . 0.0 111.501 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.97 -36.35 59.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.996 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.533 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.9 m-70 -63.1 -39.82 95.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.5 mt -66.33 -42.91 91.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.801 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.24 -34.72 68.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.619 0.645 . . . . 0.0 111.206 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.87 -54.73 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.1 mt -53.51 -47.77 69.6 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.342 0.402 . . . . 0.0 111.024 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.3 mt -56.71 -48.04 78.61 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.548 0.53 . . . . 0.0 109.806 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.1 m -59.03 -39.68 82.73 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -71.52 -29.98 65.41 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.3 m-85 -89.54 3.29 52.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.311 0.577 . . . . 0.0 112.145 175.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 7.2 mmpt? 67.62 33.31 5.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.3 mt -105.28 138.29 19.5 Favored Pre-proline 0 N--CA 1.411 -2.399 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.09 136.23 63.83 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.223 1.948 . . . . 0.0 111.433 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -63.19 -9.41 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.018 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.31 -16.26 62.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.032 0.444 . . . . 0.0 110.481 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -88.5 -4.87 58.53 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -49.07 -29.21 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 127.116 2.166 . . . . 0.0 111.032 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -56.68 -47.62 79.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.533 1.533 . . . . 0.0 111.047 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB2' ' SD ' ' A' ' 99' ' ' MET . 7.3 m -98.07 1.21 47.43 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.227 -171.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -105.1 141.67 36.24 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.414 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.63 149.05 28.7 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.339 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.71 124.23 30.03 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' HD22 ' A' ' 74' ' ' LEU . 20.5 tt0 -111.61 147.98 34.31 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.47 134.35 66.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.0 Cg_endo -65.91 -18.72 58.01 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.877 2.385 . . . . 0.0 115.667 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 -42.79 3.89 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.0 p -90.72 -18.26 25.31 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.431 HD22 ' NE2' ' A' ' 69' ' ' GLN . 7.6 mt 62.62 22.23 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.645 1.178 . . . . 0.0 112.005 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.71 143.02 31.2 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.01 147.19 24.76 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.203 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -83.56 105.95 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -107.33 12.07 28.48 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.957 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.57 161.7 29.05 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.286 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.4 m -85.37 -39.69 17.33 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.322 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.96 152.77 50.9 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.367 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -84.58 159.64 20.61 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.885 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 38.8 p -115.47 156.54 45.8 Favored Pre-proline 0 C--N 1.276 -2.624 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.49 -35.34 92.06 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.684 2.256 . . . . 0.0 109.709 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -57.03 -49.55 75.45 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.714 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.49 -38.37 87.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 83' ' ' THR . 63.8 mt -65.75 -46.17 79.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.036 0.835 . . . . 0.0 110.54 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.98 -45.4 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -32.55 73.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.341 0.591 . . . . 0.0 112.167 172.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.43 -34.32 58.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.433 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.86 -27.51 63.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -56.05 -34.89 66.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.881 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.5 m -145.08 -78.44 0.19 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -170.73 -177.55 2.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.369 1.467 . . . . 0.0 108.743 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.51 152.23 37.29 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 168.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 98' ' ' ARG . 11.9 mt -118.81 101.78 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.066 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -78.9 104.88 9.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 96' ' ' ILE . 21.5 mtp180 -127.66 165.08 20.68 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.185 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' A' ' 65' ' ' SER . 9.1 mmm . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.4 mtt -113.11 137.18 51.83 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.991 -169.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 72.1 tttt -98.08 97.49 8.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.5 mt -109.54 138.64 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.975 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 42.5 mtm180 -69.83 129.96 40.98 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 121.213 0.53 . . . . 0.0 109.858 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.2 t -116.33 126.13 73.67 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.388 0 CA-C-O 117.806 -1.092 . . . . 0.0 108.309 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.264 50.8 mt-10 -86.85 146.98 26.0 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.225 -1.79 . . . . 0.0 107.843 167.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -121.86 126.57 49.02 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 175.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.444 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.424 -1.755 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.831 171.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 C--O 1.236 0.397 0 N-CA-C 110.431 -0.642 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.4 p -134.02 156.85 47.46 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.253 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -152.72 149.91 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 15.4 m -97.9 107.23 19.67 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -110.38 145.23 37.9 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.344 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.29 110.72 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.23 148.06 34.9 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.27 167.2 29.4 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 124.297 1.039 . . . . 0.0 108.351 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.43 19.71 51.53 Favored Glycine 0 C--N 1.29 -1.98 0 O-C-N 124.166 0.916 . . . . 0.0 112.64 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.64 -22.85 11.75 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.638 0.732 . . . . 0.0 110.626 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.432 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 69.4 m -105.9 139.9 39.74 Favored 'General case' 0 N--CA 1.403 -2.814 0 C-N-CA 124.59 1.156 . . . . 0.0 109.791 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 147.86 22.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.396 0.617 . . . . 0.0 110.541 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.5 t -54.17 -50.1 57.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.996 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -57.29 -31.69 65.89 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.796 -176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 m-20 -73.66 -40.56 63.62 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 97.2 m-70 -61.24 -38.7 87.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.71 -43.7 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.222 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HG3' HG21 ' A' ' 63' ' ' VAL . 65.1 mttm -56.86 -37.11 70.85 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 119.055 0.843 . . . . 0.0 111.092 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.1 t -65.92 -53.97 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.983 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.7 -48.43 69.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.508 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -57.07 -48.51 78.41 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 123.374 0.421 . . . . 0.0 110.317 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -59.54 -39.38 83.76 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -71.82 -31.46 66.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.5 m-85 -84.35 -8.71 58.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.032 0.444 . . . . 0.0 111.303 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 mttp 71.29 46.17 0.44 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.16 1.384 . . . . 0.0 112.608 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.8 mt -113.88 136.89 22.13 Favored Pre-proline 0 N--CA 1.408 -2.544 0 C-N-CA 125.815 1.646 . . . . 0.0 107.222 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.45 131.91 48.61 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.375 2.05 . . . . 0.0 111.49 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 31.1 m -62.93 -9.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.267 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.12 -22.12 64.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.395 0.617 . . . . 0.0 109.954 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 63.4 mttm -81.41 -5.46 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.233 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p -49.72 -29.3 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 126.435 1.894 . . . . 0.0 109.776 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 p -55.15 -47.2 75.45 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.429 1.492 . . . . 0.0 110.081 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -104.64 14.92 28.98 Favored 'General case' 0 N--CA 1.4 -2.929 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.7 -171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.453 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 23.7 m-85 -114.56 145.24 42.19 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.474 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.46 35.72 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.292 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.07 154.58 17.11 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HB2' ' NH2' ' A' ' 98' ' ' ARG . 52.9 tt0 -143.18 152.78 42.16 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -87.32 131.2 44.95 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.25 -18.59 50.54 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.89 2.394 . . . . 0.0 115.3 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -105.01 -43.32 5.08 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.408 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -89.2 -21.92 23.03 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.756 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 70.27 16.44 7.28 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.766 1.226 . . . . 0.0 111.576 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.99 36.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -83.27 168.85 16.31 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.2 t -118.43 98.82 6.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.78 14.47 28.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.369 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.75 156.2 36.84 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 126.529 1.932 . . . . 0.0 109.876 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -83.59 -38.86 21.07 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.525 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.51 154.95 45.6 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.4 mt -88.53 154.48 20.31 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.195 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.3 p -112.8 156.59 42.35 Favored Pre-proline 0 C--N 1.282 -2.326 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -56.32 -35.24 95.7 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.533 2.156 . . . . 0.0 110.281 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.03 -42.97 99.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.268 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -64.07 -38.21 90.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 123.288 0.367 . . . . 0.0 111.398 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.716 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.3 mt -65.47 -49.08 70.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.139 0.9 . . . . 0.0 110.304 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.25 -41.17 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.35 -34.14 72.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.934 172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.9 17.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.638 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 8.2 mt-10 -53.98 -23.43 13.2 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.74 -37.88 60.01 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.121 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -142.43 -82.45 0.19 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.66 178.55 8.92 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.315 1.446 . . . . 0.0 108.488 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.65 150.12 38.65 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 35.4 mt -114.76 135.69 53.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.491 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.8 OUTLIER -117.4 107.34 14.23 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -176.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.617 ' NH2' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.11 171.27 12.05 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 43.4 mtp . . . . . 0 N--CA 1.411 -2.388 0 O-C-N 124.301 1.001 . . . . 0.0 110.179 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.414 -2.236 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 40.2 mtt -122.19 140.38 52.65 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.983 -171.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.3 tttt -100.15 93.19 5.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -102.21 141.96 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.892 -171.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 62.3 mtm-85 -72.03 131.29 42.69 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 121.365 0.602 . . . . 0.0 110.047 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 34' ' ' SER . 49.9 t -117.32 125.91 74.27 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.208 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.277 41.8 mt-10 -84.84 150.58 24.91 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 116.681 -2.008 . . . . 0.0 106.091 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -125.4 125.04 42.76 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.306 -1.31 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.492 171.275 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 N-CA-C 111.02 -0.415 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.5 p -133.78 154.03 51.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 120.946 0.403 . . . . 0.0 110.91 -172.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -149.53 149.47 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 7.4 m -99.6 106.03 17.96 Favored 'General case' 0 N--CA 1.391 -3.387 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -112.07 144.6 41.16 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.045 -170.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.06 112.91 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.98 151.71 33.67 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -146.28 -170.23 3.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.18 18.19 8.96 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.94 -25.38 9.02 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 123.226 0.61 . . . . 0.0 112.008 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 48' ' ' HIS . 59.9 m -98.63 136.89 38.05 Favored 'General case' 0 N--CA 1.395 -3.18 0 C-N-CA 124.553 1.141 . . . . 0.0 109.036 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 145.01 20.65 Favored 'General case' 0 C--O 1.249 1.03 0 O-C-N 123.695 0.622 . . . . 0.0 110.704 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.519 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.4 t -53.05 -53.41 22.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.879 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -58.08 -28.17 64.33 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.551 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -76.87 -37.85 54.77 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.076 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.523 ' NE2' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -62.36 -37.86 87.31 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.6 mt -68.24 -41.56 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.204 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.32 -34.41 66.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.639 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.13 -53.64 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.265 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' ILE . 17.9 mt -54.01 -46.99 71.95 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.217 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 85.5 mt -57.76 -48.71 78.87 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 123.478 0.486 . . . . 0.0 109.975 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -59.48 -37.47 78.32 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -73.32 -33.98 65.44 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 50.5 m-85 -85.4 0.24 52.79 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt 70.72 35.1 1.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 125.298 1.439 . . . . 0.0 112.665 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.7 mt -105.8 133.76 20.05 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.23 133.73 59.79 Favored 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.896 1.731 . . . . 0.0 110.821 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.6 m -61.71 -9.83 3.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.076 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.77 -20.48 65.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.558 0.218 . . . . 0.0 110.569 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.91 -4.81 58.61 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.61 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.6 p -48.91 -29.98 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 125.422 1.489 . . . . 0.0 110.622 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -55.34 -43.21 74.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.893 1.677 . . . . 0.0 110.733 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -109.4 13.59 24.06 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.66 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 16.0 m-85 -114.14 140.83 48.2 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.93 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.92 149.89 30.18 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.839 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.8 mt -82.59 122.69 28.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.234 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -109.31 149.4 29.52 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -78.6 129.61 73.66 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.86 -12.27 34.82 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.101 2.534 . . . . 0.0 115.795 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.31 -40.78 3.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.795 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.7 p -93.17 -17.55 23.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.993 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 66.27 20.08 11.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 111.748 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.42 137.28 33.98 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.559 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -95.17 137.06 34.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.73 104.58 8.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -106.2 12.85 29.65 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.979 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.53 158.24 36.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.73 -37.86 20.39 Favored 'General case' 0 N--CA 1.394 -3.252 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.077 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -128.5 147.82 50.71 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.607 0.763 . . . . 0.0 108.957 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.4 mt -81.1 152.24 27.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.584 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.9 p -108.43 154.27 41.58 Favored Pre-proline 0 N--CA 1.401 -2.9 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.38 -36.22 78.2 Favored 'Trans proline' 0 C--O 1.219 -0.452 0 C-N-CA 122.463 2.109 . . . . 0.0 110.523 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -64.09 -41.56 97.25 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.644 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.4 mmp_? -63.0 -36.63 84.17 Favored 'General case' 0 CA--C 1.485 -1.528 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.629 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 61.8 mt -68.42 -48.65 64.06 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 124.217 0.948 . . . . 0.0 110.62 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.591 ' O ' ' HD3' ' A' ' 92' ' ' LYS 0.311 47.8 t -61.61 -49.34 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 2.3 mp0 -64.48 -27.26 68.86 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.21 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.43 -45.26 60.42 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -54.27 -23.75 16.21 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -52.15 -46.97 65.65 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.041 0.936 . . . . 0.0 110.276 173.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m -135.27 -79.71 0.43 Allowed 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.92 -175.67 2.43 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.149 1.379 . . . . 0.0 108.962 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -120.1 151.32 39.23 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -116.15 101.6 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.025 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.68 109.44 12.9 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.26 163.11 26.36 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.246 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.9 mtp . . . . . 0 N--CA 1.399 -2.995 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.415 -2.19 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.3 mmt -115.25 138.34 51.05 Favored 'General case' 0 CA--C 1.465 -2.291 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.092 -171.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.2 tttt -100.54 93.57 5.68 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 90' ' ' ALA . 91.7 mt -103.52 140.75 20.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.732 -172.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -73.14 134.71 44.54 Favored 'General case' 0 CA--C 1.459 -2.53 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.195 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.12 122.04 69.1 Favored 'Isoleucine or valine' 2 N--CA 1.363 -4.785 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -84.14 156.74 21.97 Favored 'General case' 0 N--CA 1.406 -2.657 0 C-N-CA 115.872 -2.331 . . . . 0.0 107.063 167.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.472 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -128.81 132.44 47.83 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 177.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' N ' HD22 ' A' ' 14' ' ' LEU 0.266 1.6 mp . . . . . 0 C--N 1.316 -0.876 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 166.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 CA-C-O 120.943 0.31 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 p -142.21 158.69 43.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.346 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -151.22 149.97 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.3 m -98.14 108.29 20.96 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 43.4 t60 -110.86 145.97 37.31 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 -170.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.01 111.62 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.56 145.72 39.82 Favored 'General case' 0 C--N 1.259 -3.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.31 -174.88 4.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.45 -13.95 13.87 Favored Glycine 0 C--N 1.304 -1.217 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.678 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -82.17 -21.82 36.35 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.814 0.816 . . . . 0.0 111.351 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.508 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 38.5 m -95.88 127.4 41.86 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.44 175.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.53 149.51 10.47 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.354 0.597 . . . . 0.0 110.471 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 ' HG ' ' A' ' 82' ' ' LEU . 97.8 t -54.13 -53.73 26.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.193 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 61.4 pttt -54.45 -31.86 56.42 Favored 'General case' 0 C--O 1.199 -1.578 0 O-C-N 124.522 1.138 . . . . 0.0 112.086 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 m-20 -77.39 -34.37 54.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.508 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.2 m-70 -64.2 -40.16 95.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.6 mt -66.22 -43.44 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.828 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.4 mttt -57.15 -35.34 69.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.678 0.672 . . . . 0.0 111.278 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 47' ' ' ASP . 76.8 t -69.55 -53.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.482 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -54.49 -47.65 72.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.129 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 84.9 mt -55.77 -50.57 70.06 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.0 m -58.5 -39.52 80.27 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.23 -27.96 62.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 52.6 m-85 -91.74 4.24 53.26 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.386 0.612 . . . . 0.0 111.529 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 66.76 37.49 4.18 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.506 1.522 . . . . 0.0 112.556 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.64 132.66 20.84 Favored Pre-proline 0 N--CA 1.414 -2.232 0 C-N-CA 124.863 1.265 . . . . 0.0 108.259 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 134.0 58.62 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.256 1.97 . . . . 0.0 110.836 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.2 m -62.46 -10.43 5.09 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.677 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.027 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.01 -20.97 65.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.048 0.451 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -82.63 -4.36 57.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.2 p -47.78 -29.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 125.984 1.713 . . . . 0.0 110.603 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p -54.86 -46.83 74.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.56 -1.654 . . . . 0.0 111.612 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 m -105.01 10.34 34.13 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 124.312 1.045 . . . . 0.0 112.702 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 26.6 m-85 -109.19 143.34 38.74 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 121.881 -0.512 . . . . 0.0 111.391 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.77 151.88 34.33 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.1 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.36 127.85 34.86 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.033 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 45.5 tt0 -113.93 144.29 43.3 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.51 132.92 77.76 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 39.0 Cg_endo -66.99 -21.37 49.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.872 2.381 . . . . 0.0 115.416 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.73 -46.19 4.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.818 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -86.4 -20.19 28.58 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.122 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt 69.25 16.14 8.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 111.842 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.04 137.75 40.41 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.202 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -94.41 141.27 28.77 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.997 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.05 103.02 8.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -108.51 15.24 24.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.697 1.237 . . . . 0.0 109.103 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.47 155.4 38.04 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.338 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.6 m -81.27 -40.76 23.22 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.375 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.62 157.15 37.94 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.037 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -90.42 142.96 27.21 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.276 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.8 p -99.31 153.1 37.95 Favored Pre-proline 0 N--CA 1.4 -2.96 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.74 -32.58 91.72 Favored 'Trans proline' 0 C--O 1.204 -1.199 0 C-N-CA 121.882 1.721 . . . . 0.0 109.289 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.5 -46.58 88.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.191 0.596 . . . . 0.0 111.568 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -62.34 -39.44 93.09 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.692 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 55.9 mt -66.06 -48.63 70.39 Favored 'General case' 0 C--O 1.205 -1.273 0 O-C-N 123.677 0.611 . . . . 0.0 110.153 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.5 t -62.11 -46.26 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.29 -28.72 69.52 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -77.77 -35.54 51.5 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.939 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.35 -25.24 33.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.108 0.563 . . . . 0.0 111.124 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -55.39 -42.26 73.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.284 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.8 m -142.97 -82.28 0.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -160.51 -178.39 6.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.954 0.901 . . . . 0.0 109.273 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -119.49 148.41 43.3 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.7 mt -114.37 102.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.408 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -78.87 107.25 11.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -131.14 162.72 29.27 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.825 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.5 mtp . . . . . 0 N--CA 1.4 -2.944 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m . . . . . 0 N--CA 1.432 -1.364 0 CA-C-O 122.252 1.025 . . . . 0.0 112.843 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.8 mtt -117.26 140.07 50.01 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.956 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 38' ' ' ILE . 20.1 ttmm -96.68 98.61 10.31 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.22 137.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.4 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.55 129.11 38.95 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.125 0.488 . . . . 0.0 109.902 172.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.1 t -115.91 122.28 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.694 0 CA-C-O 117.696 -1.145 . . . . 0.0 108.272 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -83.65 153.88 24.0 Favored 'General case' 0 N--CA 1.413 -2.301 0 C-N-CA 116.456 -2.098 . . . . 0.0 108.027 167.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.75 127.96 45.89 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.197 0.31 . . . . 0.0 110.171 176.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp . . . . . 0 C--N 1.31 -1.13 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.457 -0.638 0 N-CA-C 110.272 -0.703 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 22.2 p -140.77 157.42 45.43 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.902 -172.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -144.98 147.59 18.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.4 m -97.37 98.8 10.27 Favored 'General case' 0 N--CA 1.386 -3.66 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -105.73 144.9 31.83 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.12 -167.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 9' ' ' LYS . 35.1 mm -84.52 112.22 21.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' SER . 83.7 m-85 -113.19 149.49 33.61 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.402 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -148.07 -170.4 3.58 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.81 15.67 8.39 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.5 -23.59 11.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.925 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.7 m -104.73 135.83 45.38 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 123.592 0.757 . . . . 0.0 109.444 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.71 148.88 9.15 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.805 0.842 . . . . 0.0 111.18 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 82' ' ' LEU . 90.2 t -54.18 -51.33 48.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.778 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 40.5 mttm -54.73 -34.14 62.06 Favored 'General case' 0 C--O 1.196 -1.714 0 O-C-N 124.685 1.241 . . . . 0.0 110.663 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 51' ' ' VAL . 12.1 m-20 -73.95 -39.18 63.93 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -62.11 -38.91 90.69 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.7 mt -67.33 -44.61 87.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.913 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.4 mttt -57.59 -33.91 68.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 118.843 0.747 . . . . 0.0 110.978 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.4 t -68.77 -54.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.189 175.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.71 -48.66 69.36 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 123.329 0.393 . . . . 0.0 111.382 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.45 -48.27 77.4 Favored 'General case' 0 C--O 1.203 -1.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -59.77 -38.31 81.46 Favored 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -74.72 -29.76 61.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.846 0.355 . . . . 0.0 111.659 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 38.5 m-85 -89.64 4.57 49.06 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.298 0.571 . . . . 0.0 112.518 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 68.97 32.38 3.85 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.642 1.577 . . . . 0.0 112.284 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -107.31 128.23 26.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -50.86 133.01 38.96 Favored 'Trans proline' 0 CA--C 1.502 -1.099 0 C-N-CA 122.52 2.147 . . . . 0.0 111.073 172.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.6 m -62.87 -9.96 5.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.682 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.88 -18.49 65.4 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.392 0.615 . . . . 0.0 110.516 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 12.1 mptt -85.14 -5.27 59.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.225 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.9 p -47.45 -27.98 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 C-N-CA 126.196 1.798 . . . . 0.0 110.301 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -56.42 -49.44 74.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 126.42 1.888 . . . . 0.0 111.359 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' MET . 74.6 m -104.27 14.88 29.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.952 1.301 . . . . 0.0 112.257 -173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 30.2 m-85 -113.93 142.52 46.03 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.605 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.92 31.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.2 mt -83.79 124.19 30.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.171 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -113.36 152.99 29.25 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -85.56 137.63 36.28 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 52.7 Cg_endo -70.59 -13.23 32.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.072 2.515 . . . . 0.0 115.81 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.41 -44.42 3.1 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.855 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.5 p -87.46 -19.13 28.44 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.561 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 63.03 21.74 13.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 110.783 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 140.89 33.95 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.892 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -100.71 143.86 30.37 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.484 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -78.65 107.63 11.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -100.58 10.49 41.11 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.801 0.81 . . . . 0.0 109.949 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.48 152.72 41.76 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.483 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.6 m -83.59 -38.18 21.96 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.203 174.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -128.61 149.51 50.61 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 45' ' ' VAL . 25.7 mt -84.41 161.64 20.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.502 0.668 . . . . 0.0 110.731 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 64.4 p -120.01 155.74 55.13 Favored Pre-proline 0 N--CA 1.401 -2.895 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.45 -32.11 95.63 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.889 1.726 . . . . 0.0 109.801 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.74 -42.48 99.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.379 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.6 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.6 mmp_? -64.76 -38.36 90.72 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.667 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 76.7 mt -65.77 -47.94 73.5 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.016 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.258 20.1 t -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.92 -26.95 66.23 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.534 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -43.97 52.22 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 19.0 mt-10 -54.73 -23.26 16.95 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.34 -35.19 37.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.179 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 m -144.52 -80.37 0.18 Allowed 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -163.77 -175.5 4.14 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 125.788 1.635 . . . . 0.0 108.384 -177.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 3.3 m-85 -120.96 148.59 43.89 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 169.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.6 101.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.568 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.459 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -78.86 106.45 10.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -127.23 161.42 28.59 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.469 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 42.7 mtp . . . . . 0 N--CA 1.404 -2.751 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 166.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 25.5 m . . . . . 0 N--CA 1.393 -3.277 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 58.2 mtt -106.69 139.75 40.63 Favored 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.047 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 61.8 tttt -99.97 98.36 9.13 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.59 138.3 37.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.611 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 85.4 mtt180 -68.12 133.14 48.45 Favored 'General case' 0 CA--C 1.478 -1.804 0 CA-C-O 121.029 0.442 . . . . 0.0 110.551 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.9 t -120.12 124.63 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-O 117.735 -1.126 . . . . 0.0 108.639 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' HB2' HG23 ' A' ' 96' ' ' ILE 0.259 21.8 mm-40 -84.2 153.46 23.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 170.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -126.03 130.82 51.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 176.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--N 1.319 -0.734 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.35 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.444 -1.441 0 N-CA-C 108.974 -1.202 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 1.4 p -138.78 152.46 47.93 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.44 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -147.68 149.65 15.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.3 m -96.21 108.32 20.78 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.5 t60 -113.05 147.17 37.79 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 -171.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 48.4 mm -84.89 112.74 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' SER . 84.3 m-85 -113.68 146.07 40.36 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 123.039 0.535 . . . . 0.0 109.589 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.92 169.55 22.02 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 123.782 0.833 . . . . 0.0 109.243 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 26.24 24.06 Favored Glycine 0 C--N 1.298 -1.563 0 O-C-N 124.203 0.939 . . . . 0.0 112.435 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.62 -32.44 5.19 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-O 121.499 0.666 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 35.1 m -94.01 134.43 36.43 Favored 'General case' 0 N--CA 1.389 -3.523 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 148.76 15.12 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.261 0.553 . . . . 0.0 110.731 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.9 t -53.82 -52.28 36.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.114 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -57.08 -33.77 67.63 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.019 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.61 -37.06 65.55 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 122.06 -0.4 . . . . 0.0 110.712 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.8 m-70 -62.83 -39.27 93.82 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 27.2 mt -65.31 -44.13 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.67 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.4 mttt -56.93 -34.22 67.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.728 0.694 . . . . 0.0 111.18 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.56 -53.88 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.98 -48.27 70.54 Favored 'General case' 0 C--O 1.211 -0.921 0 O-C-N 123.558 0.536 . . . . 0.0 111.039 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.2 mt -56.88 -50.75 71.53 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -59.28 -37.32 77.38 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -74.07 -31.0 62.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.872 0.368 . . . . 0.0 111.644 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 37.0 m-85 -87.06 2.44 49.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? 73.81 29.23 1.49 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.107 1.363 . . . . 0.0 113.108 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -105.83 135.99 19.34 Favored Pre-proline 0 N--CA 1.411 -2.392 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -56.58 137.01 79.12 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 122.016 1.811 . . . . 0.0 110.953 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.639 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.84 -10.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.945 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.305 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.8 -14.45 63.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.358 0.599 . . . . 0.0 110.956 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 3.5 mptp? -87.83 -5.19 58.73 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -48.55 -31.06 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 126.269 1.828 . . . . 0.0 110.428 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.275 15.5 m -55.37 -46.39 76.48 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 126.47 1.908 . . . . 0.0 110.964 174.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -103.01 7.79 39.01 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.755 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 26.0 m-85 -106.68 142.19 36.73 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.331 0.586 . . . . 0.0 111.432 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.04 141.02 23.78 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.387 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 97' ' ' LEU . 80.1 mt -72.63 156.49 38.91 Favored 'General case' 0 N--CA 1.418 -2.051 0 O-C-N 124.82 1.325 . . . . 0.0 108.306 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 38.4 tt0 -146.12 152.0 38.58 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 21.6 t-20 -89.3 137.17 29.33 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.133 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 56.7 Cg_endo -71.7 -17.6 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.788 2.326 . . . . 0.0 115.278 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -107.75 -46.26 3.84 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.311 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.2 p -84.05 -24.09 30.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.02 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.45 ' HA ' HE21 ' A' ' 69' ' ' GLN . 11.2 mt 69.61 14.57 8.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.451 1.1 . . . . 0.0 111.152 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 145.75 27.15 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.515 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 8.9 m-30 -88.06 -174.57 4.74 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 122.388 1.09 . . . . 0.0 112.194 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' LEU . 93.9 t -124.57 101.84 9.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 167.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.49 14.81 29.35 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.695 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.32 158.3 33.03 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 125.483 1.513 . . . . 0.0 110.579 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.7 m -84.24 -36.38 22.75 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.735 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.78 146.74 52.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.5 mt -80.18 153.85 28.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.287 0.565 . . . . 0.0 110.999 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.7 p -108.37 154.28 41.52 Favored Pre-proline 0 N--CA 1.403 -2.795 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.79 -36.6 95.51 Favored 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 110.02 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.86 -43.35 94.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.265 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -66.32 -37.15 84.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.314 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.769 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.8 mt -63.29 -51.45 66.05 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.831 0.707 . . . . 0.0 110.568 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.95 -45.86 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.58 -24.67 67.14 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.24 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.7 -39.94 35.13 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.704 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 32.5 mt-10 -51.03 -27.37 7.76 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 118.36 0.527 . . . . 0.0 111.809 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -49.7 -37.89 30.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.664 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -147.2 -88.66 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -154.98 177.76 10.95 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.476 1.11 . . . . 0.0 109.051 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.4 m-85 -116.74 151.95 35.36 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 170.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 98' ' ' ARG . 20.5 mt -117.8 135.96 56.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -118.75 115.38 24.35 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -176.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -147.73 173.47 12.74 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.5 mtp . . . . . 0 N--CA 1.397 -3.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.012 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.441 -0.89 0 CA-C-O 121.664 0.745 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.676 ' SD ' ' HG3' ' A' ' 91' ' ' GLU . 46.4 mtt -117.86 138.45 52.1 Favored 'General case' 0 CA--C 1.467 -2.233 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.819 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 30.3 ttpt -97.82 99.86 11.2 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.74 140.85 24.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.015 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -69.19 129.15 39.03 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -115.2 123.18 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.736 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.016 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.04 148.43 26.86 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 117.561 -1.656 . . . . 0.0 107.396 168.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -126.11 129.22 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 176.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.402 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 C--N 1.307 -1.277 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.117 168.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--O 1.239 0.557 0 N-CA-C 110.103 -0.768 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.3 p -138.98 156.31 47.32 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.268 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -149.29 148.75 15.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.411 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 13.9 m -95.61 105.47 17.46 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 173.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.1 t60 -112.28 144.37 41.8 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.609 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.262 40.2 mm -83.69 113.46 22.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.49 145.32 41.37 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.94 -174.15 4.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 124.265 1.026 . . . . 0.0 108.289 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.44 22.43 8.33 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -112.15 -25.91 9.08 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.179 0.592 . . . . 0.0 111.231 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.4 m -96.69 154.08 17.49 Favored 'General case' 0 N--CA 1.389 -3.492 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.67 156.26 27.66 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 82' ' ' LEU . 91.4 t -52.96 -52.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 123.7 0.625 . . . . 0.0 109.717 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -55.68 -36.5 67.2 Favored 'General case' 0 C--O 1.196 -1.726 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.31 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -74.48 -36.19 63.29 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.993 -0.442 . . . . 0.0 111.758 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.57 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.6 m-70 -61.25 -38.79 87.95 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 36.8 mt -66.16 -42.95 92.15 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.079 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.67 -37.98 71.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.647 0.658 . . . . 0.0 110.796 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.44 -53.69 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.057 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.8 mt -53.36 -49.61 66.79 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.467 0.479 . . . . 0.0 110.777 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -56.91 -47.43 80.57 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.522 0.514 . . . . 0.0 110.103 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.93 -40.52 93.53 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -70.84 -31.01 67.58 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.04 0.448 . . . . 0.0 111.51 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -86.67 1.87 50.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.341 0.591 . . . . 0.0 111.49 174.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 64.86 38.82 6.37 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 124.808 1.243 . . . . 0.0 113.18 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.0 mt -108.15 140.48 21.72 Favored Pre-proline 0 N--CA 1.41 -2.467 0 C-N-CA 124.988 1.315 . . . . 0.0 107.631 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.93 132.67 48.88 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.089 1.859 . . . . 0.0 110.925 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.609 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.9 m -63.75 -9.65 5.85 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.972 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.651 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -14.16 62.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.211 0.529 . . . . 0.0 111.544 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 64.2 mttm -85.38 -9.16 57.93 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.982 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.6 p -49.76 -30.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.906 2.082 . . . . 0.0 109.849 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.255 12.8 m -54.73 -48.91 71.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.146 1.778 . . . . 0.0 109.841 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -101.45 7.06 42.68 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.214 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 15.6 m-85 -106.55 144.38 33.3 Favored 'General case' 0 CA--C 1.477 -1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 110.751 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.57 149.25 25.19 Favored 'General case' 0 N--CA 1.41 -2.439 0 O-C-N 124.233 0.958 . . . . 0.0 109.292 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.68 132.75 35.61 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.574 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 70' ' ' ASN . 45.5 tt0 -118.92 153.58 34.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 25.1 t-20 -86.03 131.0 48.08 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 33.1 Cg_endo -66.22 -20.26 56.03 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.421 2.748 . . . . 0.0 115.836 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -107.27 -43.61 4.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 p -87.37 -24.37 24.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.052 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt 70.72 19.45 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 124.366 1.066 . . . . 0.0 111.8 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.85 138.89 33.76 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.508 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 6.3 m-85 -91.72 168.89 11.15 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.711 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.434 HG13 ' OD2' ' A' ' 79' ' ' ASP . 66.4 t -111.93 79.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.032 0.92 . . . . 0.0 111.399 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.27 -1.56 6.47 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.726 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' HG13 ' A' ' 77' ' ' VAL . 50.8 m-20 -64.06 151.26 43.54 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.282 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -79.91 -41.17 26.66 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.282 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -131.32 153.22 49.82 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 124.22 1.008 . . . . 0.0 108.553 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.4 mt -85.99 153.67 21.99 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 82.7 p -109.51 155.32 41.48 Favored Pre-proline 0 N--CA 1.402 -2.849 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.53 -33.87 93.75 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.126 1.884 . . . . 0.0 109.973 173.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.75 -45.91 90.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.919 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -64.48 -37.92 89.23 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.179 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.545 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.0 mt -64.03 -47.52 79.91 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.612 0.57 . . . . 0.0 109.934 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.259 35.6 t -62.13 -46.29 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -67.2 -25.53 66.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.36 -43.12 28.51 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.676 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 4.2 mt-10 -53.72 -19.27 3.94 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -53.08 -39.81 63.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.84 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 m -144.88 -82.14 0.16 Allowed 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -161.91 -178.73 6.65 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.513 1.125 . . . . 0.0 109.114 -178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.99 147.02 46.05 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 169.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -113.43 101.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.458 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.52 105.06 9.54 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -126.75 159.21 34.42 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.683 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 46.0 mtp . . . . . 0 N--CA 1.393 -3.309 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 167.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.415 -2.198 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 10.7 mmt -122.91 137.29 54.98 Favored 'General case' 0 CA--C 1.477 -1.865 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.838 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 27.3 ttpt -96.22 98.95 10.71 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.28 139.32 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.721 -172.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 92.0 mtt180 -71.35 131.54 43.56 Favored 'General case' 0 CA--C 1.471 -2.088 0 O-C-N 123.456 0.473 . . . . 0.0 110.429 173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' SER . 40.5 t -117.95 124.8 73.6 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.484 0 CA-C-O 117.911 -1.043 . . . . 0.0 109.011 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -80.0 149.55 30.72 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 168.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 ' CD1' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -126.4 125.6 42.45 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 120.467 0.175 . . . . 0.0 111.08 175.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.438 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp . . . . . 0 N--CA 1.442 -0.869 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.032 167.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.467 -0.07 0 N-CA-C 110.558 -0.593 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -134.1 156.31 48.51 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.05 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.3 p -149.22 148.41 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 m -97.41 106.96 19.38 Favored 'General case' 0 N--CA 1.391 -3.389 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t60 -114.68 146.21 41.15 Favored 'General case' 0 N--CA 1.416 -2.157 0 C-N-CA 123.791 0.836 . . . . 0.0 110.529 -169.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.25 44.8 mm -83.13 112.92 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.664 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -113.12 145.87 40.18 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.23 169.63 18.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.38 17.85 42.79 Favored Glycine 0 C--N 1.292 -1.871 0 O-C-N 124.299 0.999 . . . . 0.0 113.008 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -108.08 -25.16 11.26 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-O 122.131 0.967 . . . . 0.0 110.998 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.1 m -103.6 137.84 41.1 Favored 'General case' 0 N--CA 1.391 -3.403 0 C-N-CA 125.059 1.344 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.91 150.01 17.47 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 121.44 0.638 . . . . 0.0 111.237 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' A' ' 82' ' ' LEU . 83.8 t -52.8 -51.18 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.227 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -53.37 -42.18 66.62 Favored 'General case' 0 C--O 1.198 -1.619 0 O-C-N 125.003 1.439 . . . . 0.0 110.61 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.29 -39.07 85.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -62.51 -37.83 87.56 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 mt -66.52 -43.82 90.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.015 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.1 mttt -56.22 -34.72 66.58 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.839 0.745 . . . . 0.0 111.143 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.12 -53.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.136 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.31 -47.89 68.86 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 123.274 0.359 . . . . 0.0 111.12 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 79.5 mt -57.26 -49.43 76.07 Favored 'General case' 0 C--O 1.199 -1.564 0 O-C-N 123.705 0.628 . . . . 0.0 109.613 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -58.63 -39.8 81.53 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -71.41 -32.36 68.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.8 m-85 -86.42 -2.71 58.67 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.1 0.476 . . . . 0.0 111.835 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 69.15 39.23 1.76 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.389 1.476 . . . . 0.0 112.665 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.4 mt -106.42 136.85 19.32 Favored Pre-proline 0 N--CA 1.408 -2.538 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.28 134.91 62.06 Favored 'Trans proline' 0 CA--C 1.501 -1.16 0 C-N-CA 121.738 1.625 . . . . 0.0 111.515 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.1 m -64.38 -11.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.63 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.843 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.6 -20.61 64.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.257 0.551 . . . . 0.0 109.66 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 65.9 mttm -83.17 -2.46 55.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.265 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -49.0 -30.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 126.942 2.097 . . . . 0.0 110.618 176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -54.99 -58.12 8.92 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.915 173.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.1 m -87.85 10.96 16.84 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.422 -174.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 25.1 m-85 -109.22 143.51 38.57 Favored 'General case' 0 C--N 1.277 -2.567 0 O-C-N 121.277 -0.89 . . . . 0.0 111.34 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB3' HH22 ' A' ' 98' ' ' ARG . . . -147.96 154.35 40.22 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.037 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 97' ' ' LEU . 81.5 mt -89.29 160.48 16.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 41.5 tt0 -150.0 150.53 31.93 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 122.521 0.328 . . . . 0.0 110.207 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.83 137.98 31.5 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 124.459 1.103 . . . . 0.0 108.642 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.58 -21.16 30.06 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.814 2.342 . . . . 0.0 115.38 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -105.76 -42.49 5.15 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.747 -0.781 . . . . 0.0 113.001 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.5 p -90.43 -20.77 22.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.474 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt 66.58 17.96 10.7 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.491 1.117 . . . . 0.0 111.375 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.92 140.0 33.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 5.8 m-30 -86.03 -174.75 5.25 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.977 0.894 . . . . 0.0 110.567 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.0 101.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.97 11.95 36.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.796 1.284 . . . . 0.0 109.455 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.16 159.63 32.31 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 112.581 -2.1 . . . . 0.0 111.019 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 m -84.43 -39.44 18.97 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.317 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.06 154.92 45.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.863 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.9 mt -89.19 147.7 24.03 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.141 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 70.6 p -99.28 153.08 37.96 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.91 -34.17 97.99 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.428 2.085 . . . . 0.0 109.815 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -59.07 -47.62 84.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.142 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -60.28 -37.82 81.67 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 69.3 mt -64.35 -48.9 73.76 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.822 0.701 . . . . 0.0 110.401 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 43.7 t -63.48 -43.76 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -61.57 -29.89 70.32 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.79 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.56 -34.06 25.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.978 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.13 -24.58 55.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.644 0.735 . . . . 0.0 112.381 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 36.4 mmtm -54.09 -40.36 67.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.154 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.9 m -144.2 -88.31 0.12 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -156.64 178.96 9.73 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 108.752 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.25 152.85 34.93 Favored 'General case' 0 C--O 1.203 -1.363 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.499 HG22 ' HG3' ' A' ' 98' ' ' ARG . 2.7 mp -114.09 133.86 58.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.59 115.93 26.09 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.515 HH11 ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -146.41 177.56 8.94 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 65' ' ' SER . 49.4 mtp . . . . . 0 N--CA 1.381 -3.885 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.13 34.12 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.36 84.01 3.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.7 mtt -130.16 154.14 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.163 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.62 -88.89 0.23 Allowed Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.83 -70.45 1.0 Allowed Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 m -85.34 147.48 26.5 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.524 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 39.6 mtt -128.19 140.1 52.1 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -170.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -97.21 94.81 7.32 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -104.11 137.29 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.846 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.76 -171.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 41.6 mtm180 -71.82 130.7 41.7 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-O 121.386 0.613 . . . . 0.0 110.196 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 34' ' ' SER . 45.8 t -117.99 127.91 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.16 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.346 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.28 43.4 mt-10 -90.18 143.76 26.47 Favored 'General case' 0 N--CA 1.419 -1.987 0 C-N-CA 116.257 -2.177 . . . . 0.0 109.358 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 56' ' ' PHE . 1.2 tm? -111.7 129.67 56.03 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.77 122.62 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 169.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -150.07 76.24 1.27 Allowed 'General case' 0 N--CA 1.421 -1.881 0 CA-C-O 122.483 1.135 . . . . 0.0 109.215 170.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.81 15.24 31.63 Favored Glycine 0 C--N 1.295 -1.727 0 CA-C-N 112.265 -2.243 . . . . 0.0 109.299 173.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -84.04 -40.32 18.51 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -85.22 137.24 33.12 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 165.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -82.96 69.98 9.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -140.9 115.96 9.84 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 24' ' ' SER . 12.7 p -137.5 -158.92 0.9 Allowed 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -82.24 30.77 0.39 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 22' ' ' THR . 17.7 m 72.19 11.51 5.93 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.911 1.684 . . . . 0.0 109.747 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.5 p -99.2 173.57 3.71 Favored Pre-proline 0 C--N 1.297 -1.711 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.68 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HB2' ' OE1' ' A' ' 28' ' ' GLN . 6.0 Cg_exo -80.9 -160.22 0.12 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.714 2.276 . . . . 0.0 110.756 175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 49.5 mt-30 -84.76 20.41 1.79 Allowed 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -175.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 26' ' ' PRO . 25.8 mp0 -108.34 95.42 15.82 Favored Pre-proline 0 C--N 1.271 -2.829 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 36.7 Cg_endo -89.69 131.16 1.94 Allowed 'Trans proline' 0 N--CA 1.426 -2.494 0 C-N-CA 122.379 2.053 . . . . 0.0 111.176 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -66.23 -47.34 74.13 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -135.96 158.1 45.24 Favored 'General case' 0 N--CA 1.401 -2.882 0 N-CA-C 104.534 -2.395 . . . . 0.0 104.534 168.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -92.86 160.45 33.96 Favored Pre-proline 0 C--N 1.274 -2.68 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 172.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -50.81 128.43 24.27 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.247 1.965 . . . . 0.0 108.675 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.7 p -135.87 153.1 51.58 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 -173.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.5 p -146.87 145.95 19.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.0 m -97.8 104.98 17.05 Favored 'General case' 0 N--CA 1.388 -3.574 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -111.24 144.87 39.7 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.133 -169.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.76 113.09 19.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.45 143.84 42.91 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -152.1 164.51 37.11 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 124.397 1.079 . . . . 0.0 108.402 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.84 14.81 63.58 Favored Glycine 0 C--N 1.291 -1.967 0 O-C-N 124.239 0.962 . . . . 0.0 112.787 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -105.61 -28.34 10.81 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 121.994 0.902 . . . . 0.0 110.1 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.516 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 39.9 m -94.7 132.36 39.53 Favored 'General case' 0 N--CA 1.39 -3.466 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.362 176.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.94 149.55 14.97 Favored 'General case' 0 C--O 1.248 0.979 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' A' ' 82' ' ' LEU . 88.2 t -54.9 -53.15 36.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.163 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 22.3 pttm -54.38 -30.72 52.91 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 124.468 1.105 . . . . 0.0 111.02 -176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.478 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.8 m-20 -78.1 -36.31 48.25 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.204 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 96.2 m-70 -64.04 -39.73 94.73 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 30.1 mt -66.87 -44.32 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.977 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 96.4 mttt -56.69 -34.4 67.38 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.64 0.654 . . . . 0.0 110.821 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.4 t -69.59 -54.27 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.652 177.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 mt -53.51 -49.51 67.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 O-C-N 123.429 0.456 . . . . 0.0 111.159 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.1 mt -54.74 -50.13 69.13 Favored 'General case' 0 C--O 1.203 -1.39 0 O-C-N 123.622 0.576 . . . . 0.0 109.844 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.0 m -58.16 -39.87 79.96 Favored 'General case' 0 N--CA 1.397 -3.118 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -71.53 -27.87 63.48 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.139 0.495 . . . . 0.0 111.712 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 14' ' ' LEU . 46.1 m-85 -89.82 2.04 55.43 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.291 0.567 . . . . 0.0 111.609 174.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 67.77 35.47 3.94 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.318 1.447 . . . . 0.0 112.579 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.7 mt -106.2 135.78 19.42 Favored Pre-proline 0 N--CA 1.41 -2.466 0 N-CA-C 107.618 -1.252 . . . . 0.0 107.618 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.97 135.88 69.63 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.429 2.086 . . . . 0.0 111.156 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 32.4 m -64.37 -10.73 8.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.813 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.392 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -69.42 -15.99 63.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.77 0.795 . . . . 0.0 109.523 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -86.91 -7.53 58.11 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.964 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -46.45 -30.69 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.097 0 C-N-CA 127.226 2.211 . . . . 0.0 111.128 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.271 16.5 m -56.99 -45.09 83.21 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 126.018 1.727 . . . . 0.0 111.724 175.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 99' ' ' MET . 8.7 m -100.9 7.13 43.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.057 -172.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 28.8 m-85 -109.91 143.56 39.66 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 122.154 -0.341 . . . . 0.0 110.92 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.56 147.65 28.42 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.325 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 89.0 mt -80.47 134.67 36.01 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.603 1.189 . . . . 0.0 107.944 173.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -125.8 147.08 49.53 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -76.48 135.73 68.6 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.91 -16.14 29.38 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.493 2.128 . . . . 0.0 115.076 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -105.83 -46.76 4.05 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.687 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 63.5 p -90.05 -18.09 26.58 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.639 -173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mt 65.07 22.63 12.37 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.387 1.075 . . . . 0.0 110.918 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.05 135.87 35.89 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.374 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -94.61 149.85 20.83 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.644 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.86 106.29 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.62 10.86 29.0 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 123.107 1.432 . . . . 0.0 108.83 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.49 154.03 37.19 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.165 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.2 m -83.53 -35.46 24.79 Favored 'General case' 0 C--N 1.262 -3.219 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.702 176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -129.8 149.55 51.49 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.263 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 82' ' ' LEU . 18.7 mt -85.37 153.04 22.8 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.212 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.2 p -108.35 158.84 32.76 Favored Pre-proline 0 N--CA 1.411 -2.415 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -58.1 -35.9 98.36 Favored 'Trans proline' 0 C--O 1.216 -0.585 0 C-N-CA 122.176 1.917 . . . . 0.0 109.16 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.75 -41.66 95.87 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.814 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -63.59 -43.08 97.99 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.524 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 69.8 mt -62.99 -48.08 80.36 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.377 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.1 -45.8 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.509 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -66.18 -27.96 68.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.66 -44.09 29.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.46 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 3.7 mm-40 -52.58 -22.18 4.7 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.84 -34.42 40.54 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.2 m -146.62 -83.84 0.12 Allowed 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -157.63 177.91 10.87 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 124.52 1.128 . . . . 0.0 108.587 -176.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 1.5 m-85 -116.45 151.78 35.35 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 170.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 10.6 mt -114.9 140.81 34.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -119.34 107.01 12.85 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.8 mtp180 -129.0 159.48 35.79 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.39 -172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 65' ' ' SER . 52.3 mtp -76.19 128.01 34.07 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 166.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -66.81 126.01 91.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 O-C-N 123.815 0.697 . . . . 0.0 111.528 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.84 101.4 1.18 Allowed 'Trans proline' 0 C--O 1.254 1.313 0 C-N-CA 122.034 1.822 . . . . 0.0 108.863 174.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -170.29 150.68 3.64 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.2 45.5 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.65 118.66 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.092 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.52 145.46 24.79 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -81.79 78.32 8.53 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.5 ptt-85 . . . . . 0 C--N 1.276 -2.594 0 CA-C-N 113.318 -1.764 . . . . 0.0 111.455 -179.761 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.21 97.05 10.14 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.461 0.648 . . . . 0.0 110.838 -177.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -129.37 91.98 3.28 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.2 mmt -86.02 155.64 20.76 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.763 -177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.26 -17.25 7.06 Favored Glycine 0 N--CA 1.436 -1.338 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 100.92 77.05 1.25 Allowed Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 m -71.23 140.05 50.29 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.326 0.584 . . . . 0.0 110.864 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.727 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 47.0 mtt -123.88 141.88 51.63 Favored 'General case' 0 CA--C 1.479 -1.756 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.727 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 47.1 tttm -100.66 97.01 7.73 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 174.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -107.33 139.75 27.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.743 -172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 10.7 mtp180 -67.22 134.92 52.59 Favored 'General case' 0 CA--C 1.454 -2.72 0 CA-C-O 121.838 0.828 . . . . 0.0 111.828 170.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.3 t -120.81 122.9 69.06 Favored 'Isoleucine or valine' 1 N--CA 1.369 -4.501 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.308 0.7 OUTLIER -83.78 144.41 29.33 Favored 'General case' 0 N--CA 1.408 -2.565 0 C-N-CA 116.082 -2.247 . . . . 0.0 108.518 166.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.6 tm? -114.55 137.09 52.3 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.751 176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -111.29 118.76 58.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.093 168.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -155.95 67.7 0.61 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.034 -2.21 . . . . 0.0 105.034 170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.83 167.16 30.67 Favored Glycine 0 N--CA 1.428 -1.878 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.787 -174.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -129.53 21.25 5.59 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.967 0.889 . . . . 0.0 109.054 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -82.01 -162.07 0.51 Allowed 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 113.941 -1.482 . . . . 0.0 110.543 -176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.7 m80 80.39 110.48 0.07 Allowed 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 125.801 1.641 . . . . 0.0 109.891 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.7 mtt180 -131.71 168.83 17.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.199 0.999 . . . . 0.0 112.931 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 p -132.85 -151.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.1 m -59.16 151.11 23.51 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.1 t -81.12 15.17 1.98 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 122.047 0.927 . . . . 0.0 111.703 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.9 p -83.58 159.57 60.9 Favored Pre-proline 0 C--N 1.281 -2.383 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.502 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -87.43 22.44 0.91 Allowed 'Trans proline' 0 C--O 1.225 -0.136 0 C-N-CA 122.792 2.328 . . . . 0.0 111.296 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -97.23 21.22 10.25 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.602 -175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.46 122.95 9.82 Favored Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.19 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.24 111.26 3.02 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.686 2.257 . . . . 0.0 110.622 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -133.56 86.61 2.31 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -93.9 -176.12 3.93 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 169.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.4 155.3 93.78 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 118.343 0.519 . . . . 0.0 110.229 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.46 134.41 45.6 Favored 'Trans proline' 0 N--CA 1.481 0.782 0 C-N-CA 123.718 2.945 . . . . 0.0 111.081 175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.8 m -140.37 159.89 41.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.149 -177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 8.5 p -150.36 149.45 14.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.7 m -98.77 104.69 16.76 Favored 'General case' 0 N--CA 1.392 -3.369 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.0 t60 -109.67 147.9 32.3 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.315 -170.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.4 mm -83.53 113.02 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.696 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -113.81 147.45 38.33 Favored 'General case' 0 C--N 1.271 -2.81 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -147.25 -170.37 3.53 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.34 18.25 8.33 Favored Glycine 0 C--O 1.241 0.571 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.86 -28.37 8.41 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 124.03 0.932 . . . . 0.0 110.596 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 40.7 m -95.5 131.84 41.24 Favored 'General case' 0 N--CA 1.386 -3.67 0 C-N-CA 124.513 1.125 . . . . 0.0 109.096 176.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 148.49 14.73 Favored 'General case' 0 C--O 1.254 1.332 0 O-C-N 123.795 0.684 . . . . 0.0 110.618 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.2 -53.15 31.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.111 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -54.54 -31.92 57.31 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.344 1.028 . . . . 0.0 111.419 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 51' ' ' VAL . 7.6 m-20 -75.88 -38.75 57.53 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.443 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.539 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.0 m-70 -61.98 -39.24 91.5 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.5 mt -67.1 -43.31 88.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.564 -1.198 . . . . 0.0 112.1 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.433 ' HG3' HG21 ' A' ' 63' ' ' VAL . 98.2 mttt -58.98 -34.3 71.66 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.066 0.848 . . . . 0.0 111.141 175.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.1 t -68.14 -52.62 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.239 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.9 mt -54.79 -48.71 72.38 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.403 0.439 . . . . 0.0 111.089 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.66 -47.49 79.67 Favored 'General case' 0 C--O 1.2 -1.513 0 O-C-N 123.644 0.59 . . . . 0.0 109.796 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.2 m -59.42 -40.34 86.41 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -70.91 -34.04 71.15 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.522 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 50.3 m-85 -83.81 -2.37 56.23 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.37 0.605 . . . . 0.0 111.702 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 69.72 34.42 2.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.806 1.643 . . . . 0.0 111.999 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.3 mt -102.27 137.24 19.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.68 132.47 50.41 Favored 'Trans proline' 0 C--O 1.244 0.817 0 C-N-CA 121.926 1.751 . . . . 0.0 110.877 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.549 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.54 -10.14 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-N 114.888 -1.051 . . . . 0.0 113.166 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.99 -14.34 62.65 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.97 0.414 . . . . 0.0 111.187 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 60.8 mttm -86.33 -7.74 58.25 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.408 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -46.41 -32.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 C-N-CA 126.666 1.986 . . . . 0.0 110.833 177.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 p -54.17 -49.77 68.55 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 125.997 1.719 . . . . 0.0 111.219 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.2 t -96.0 9.21 41.49 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.865 -175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 16.4 m-85 -109.94 140.08 44.32 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.779 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -147.87 149.1 31.64 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.876 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 86.0 mt -85.53 125.85 33.4 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.394 175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -113.82 148.62 36.3 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 120.78 0.324 . . . . 0.0 110.872 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -81.94 132.22 54.68 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.82 -18.59 52.94 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.627 2.218 . . . . 0.0 115.288 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.65 -44.44 4.87 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.014 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.8 p -89.5 -20.29 24.03 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.252 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 mt 68.48 16.53 9.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 124.168 0.987 . . . . 0.0 111.654 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.69 139.37 38.5 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.128 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -98.95 147.36 25.06 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.728 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -84.11 106.01 14.03 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.469 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.1 10.15 41.72 Favored 'General case' 0 CA--C 1.497 -1.064 0 C-N-CA 123.983 0.913 . . . . 0.0 109.888 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.98 154.14 39.44 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.273 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.5 m -82.85 -38.48 22.94 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.052 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -130.67 148.74 52.5 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.351 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.3 mt -80.65 157.71 25.87 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.771 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.504 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 56.5 p -110.78 153.92 43.48 Favored Pre-proline 0 N--CA 1.403 -2.816 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 175.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.63 -32.09 81.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.619 1.546 . . . . 0.0 110.119 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.66 -51.01 71.76 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 123.72 0.808 . . . . 0.0 110.783 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.504 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 23.9 mmm180 -60.95 -37.99 84.3 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 123.205 0.315 . . . . 0.0 110.688 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.727 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.8 mt -63.22 -49.21 75.09 Favored 'General case' 0 N--CA 1.433 -1.305 0 O-C-N 123.973 0.796 . . . . 0.0 110.34 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.0 t -62.98 -44.2 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -61.63 -33.22 73.55 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.586 173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.13 -42.48 46.77 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.65 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 25.0 mt-10 -52.34 -23.19 5.46 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -53.48 -35.59 60.73 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 123.896 0.879 . . . . 0.0 112.583 173.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 m -145.2 -84.82 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER -162.23 178.13 9.01 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 124.797 1.239 . . . . 0.0 108.612 -177.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 m-85 -111.63 146.88 36.65 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 168.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.55 HG12 ' CE2' ' A' ' 94' ' ' TYR . 4.9 mt -112.66 100.41 10.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.765 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.34 102.71 8.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -123.87 160.08 28.23 Favored 'General case' 0 CA--C 1.479 -1.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.664 -174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.478 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 52.3 mtp -77.32 128.73 34.81 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 166.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 100' ' ' LYS . 44.9 mtpt -65.86 135.96 95.57 Favored Pre-proline 0 C--N 1.274 -2.704 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.536 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -57.0 109.99 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.639 2.226 . . . . 0.0 110.008 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -68.12 143.39 55.45 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.4 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.4 156.83 21.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 124.013 0.821 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.6 mt -81.44 98.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.086 0 CA-C-O 121.422 0.63 . . . . 0.0 109.74 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -136.32 110.38 8.3 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -98.38 29.99 3.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.584 0.707 . . . . 0.0 111.679 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.547 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 4.4 mmp_? . . . . . 0 C--N 1.301 -1.52 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.548 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.06 -52.55 0.64 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -56.06 -32.34 64.01 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt 54.24 79.56 0.13 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.91 -23.2 8.78 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.76 51.79 54.74 Favored Glycine 0 CA--C 1.477 -2.286 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m -69.88 127.58 33.39 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.0 112.552 -172.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.9 mtt -113.68 138.17 50.58 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 113.704 -1.589 . . . . 0.0 111.782 -172.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 77.0 tttt -96.97 90.49 5.21 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.0 mt -100.49 137.84 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.017 0 CA-C-N 113.998 -1.456 . . . . 0.0 110.47 -171.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 16.3 mtm180 -73.79 131.36 41.47 Favored 'General case' 0 N--CA 1.415 -2.212 0 CA-C-O 121.617 0.722 . . . . 0.0 110.563 173.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.5 t -118.39 127.65 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.294 0 CA-C-O 117.997 -1.002 . . . . 0.0 108.767 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 34.6 mt-10 -88.23 148.37 24.39 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 116.63 -2.028 . . . . 0.0 107.866 165.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -118.66 128.97 55.03 Favored 'General case' 0 C--N 1.273 -2.719 0 O-C-N 123.055 0.222 . . . . 0.0 110.542 177.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.416 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -103.2 118.38 50.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.545 169.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -136.79 26.83 3.03 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.95 66.95 0.85 Allowed Glycine 0 C--N 1.335 0.483 0 CA-C-N 113.933 -1.485 . . . . 0.0 112.995 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -124.77 -9.71 7.28 Favored 'General case' 0 N--CA 1.426 -1.655 0 C-N-CA 124.597 1.159 . . . . 0.0 108.791 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -89.6 23.46 2.62 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.533 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.4 m80 56.84 69.08 0.78 Allowed 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.679 0.792 . . . . 0.0 111.806 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -131.67 80.22 1.91 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p 54.17 -160.29 0.15 Allowed 'General case' 0 C--O 1.256 1.436 0 C-N-CA 124.011 0.925 . . . . 0.0 110.385 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.6 p -77.14 145.41 37.77 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 m -81.95 13.61 3.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.178 0.99 . . . . 0.0 111.124 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.7 p -89.5 133.57 34.3 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.311 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 25' ' ' THR . 9.2 Cg_endo -92.28 56.92 0.69 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 123.039 2.493 . . . . 0.0 113.264 -172.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -84.13 26.32 0.76 Allowed 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 122.022 0.915 . . . . 0.0 110.896 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.528 ' C ' ' H ' ' A' ' 30' ' ' GLN . 13.2 mm-40 -116.37 164.87 16.53 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.507 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -78.99 28.89 0.48 Allowed 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.632 2.221 . . . . 0.0 110.238 173.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 28' ' ' GLN . 79.1 mt-30 -148.29 103.44 3.44 Favored 'General case' 0 N--CA 1.407 -2.587 0 C-N-CA 127.445 2.298 . . . . 0.0 106.359 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -67.5 -166.0 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.914 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 46.2 m-80 -71.82 154.34 92.84 Favored Pre-proline 0 N--CA 1.426 -1.647 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -41.09 126.1 2.51 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.37 2.713 . . . . 0.0 110.36 173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.6 p -132.49 150.08 52.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.688 -172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 9.3 p -147.02 148.22 16.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 12.8 m -99.5 105.44 17.35 Favored 'General case' 1 N--CA 1.379 -4.021 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -110.05 146.32 35.56 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.922 -170.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.6 mm -83.52 111.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 -177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 7' ' ' SER . 87.8 m-85 -112.25 145.1 40.54 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' H ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 p30 -145.07 172.05 13.62 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.45 17.64 54.98 Favored Glycine 0 C--N 1.307 -1.069 0 O-C-N 124.271 0.982 . . . . 0.0 112.606 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -113.67 -22.75 10.09 Favored 'General case' 0 N--CA 1.406 -2.63 0 CA-C-O 121.618 0.723 . . . . 0.0 111.987 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.563 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 59.8 m -101.28 137.17 39.98 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.137 0.975 . . . . 0.0 109.952 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.14 147.33 16.41 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 124.025 0.828 . . . . 0.0 110.767 174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.3 t -54.98 -53.97 28.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.857 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -57.6 -28.93 64.07 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.267 0.98 . . . . 0.0 111.695 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 m-20 -75.91 -37.29 58.94 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.228 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.563 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 93.9 m-70 -62.15 -38.3 88.48 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 171.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 43.5 mt -67.11 -43.58 88.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 114.628 -1.169 . . . . 0.0 112.172 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -57.17 -34.46 68.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.836 0.744 . . . . 0.0 111.034 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 47' ' ' ASP . 63.4 t -70.55 -52.86 25.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.595 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.65 -49.62 67.53 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 119.367 -0.349 . . . . 0.0 111.252 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 91.7 mt -56.36 -48.29 77.11 Favored 'General case' 0 C--O 1.206 -1.231 0 O-C-N 123.48 0.487 . . . . 0.0 109.801 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.8 m -58.94 -40.18 83.89 Favored 'General case' 0 N--CA 1.395 -3.181 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -71.82 -29.81 64.82 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 120.959 0.409 . . . . 0.0 112.023 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.461 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 41.1 m-85 -86.94 -0.97 57.46 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.232 0.539 . . . . 0.0 112.159 175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 69.79 30.86 3.68 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 125.967 1.707 . . . . 0.0 112.579 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.8 mt -100.23 135.51 20.29 Favored Pre-proline 0 N--CA 1.404 -2.74 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.26 134.68 60.62 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.952 1.768 . . . . 0.0 111.24 174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.2 m -63.26 -9.14 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.655 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -69.6 -15.46 63.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.785 0.326 . . . . 0.0 110.534 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -86.91 -5.48 59.08 Favored 'General case' 0 C--O 1.199 -1.595 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.847 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 1.6 p -48.9 -32.71 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 125.095 1.358 . . . . 0.0 110.609 177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.3 t -57.14 -42.22 80.55 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 124.89 1.276 . . . . 0.0 110.379 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.2 m -103.52 13.7 32.87 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 115.239 -0.892 . . . . 0.0 112.243 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 15.8 m-85 -117.77 144.29 45.45 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.89 154.77 31.77 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.042 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.4 mt -83.58 130.14 34.98 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.76 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 38.5 tt0 -115.34 150.7 35.88 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -81.09 131.99 57.9 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.84 -19.82 46.32 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.914 2.409 . . . . 0.0 115.537 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -103.52 -45.28 4.89 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.355 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.8 p -92.14 -18.29 23.72 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.267 -172.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 66.93 20.36 10.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.476 1.11 . . . . 0.0 112.443 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.16 137.71 35.9 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.417 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 37.5 m-85 -94.54 147.44 23.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.217 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 62.0 t -80.44 107.67 13.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -101.38 12.38 37.49 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.195 0.521 . . . . 0.0 111.09 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -76.44 155.77 33.65 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-O 122.299 1.047 . . . . 0.0 111.684 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.5 m -81.86 -38.31 25.61 Favored 'General case' 0 N--CA 1.4 -2.952 0 CA-C-N 113.874 -1.512 . . . . 0.0 110.627 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.34 151.02 51.3 Favored 'General case' 0 N--CA 1.417 -2.121 0 C-N-CA 123.901 0.881 . . . . 0.0 108.631 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.9 mt -83.33 154.53 24.03 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.352 0.596 . . . . 0.0 110.521 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -111.46 153.44 44.17 Favored Pre-proline 0 N--CA 1.403 -2.813 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -53.42 -36.38 79.09 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.36 2.04 . . . . 0.0 109.674 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.45 -46.49 86.45 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.813 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.59 -37.12 86.46 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 75.8 mt -65.19 -49.12 70.98 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.922 0.763 . . . . 0.0 110.184 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.51 -44.07 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.048 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -62.16 -32.2 72.79 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.228 173.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.17 -43.83 23.16 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.79 -25.25 7.24 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -54.35 -36.67 64.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 124.672 1.189 . . . . 0.0 112.529 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.6 m -140.67 -80.79 0.26 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.05 -178.92 3.9 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 124.864 1.265 . . . . 0.0 108.443 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 2.6 m-85 -117.43 148.15 42.05 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 170.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.8 mt -115.65 101.57 12.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.019 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.422 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -78.28 103.72 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -125.97 164.3 21.11 Favored 'General case' 0 CA--C 1.476 -1.889 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.514 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' ' 65' ' ' SER . 58.4 mtp -79.41 122.97 27.06 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -61.5 155.87 56.33 Favored Pre-proline 0 C--N 1.282 -2.337 0 C-N-CA 125.019 1.327 . . . . 0.0 112.68 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.72 103.58 0.59 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.157 1.905 . . . . 0.0 108.709 171.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -135.26 156.02 49.67 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 131.79 51.0 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.132 0.491 . . . . 0.0 111.053 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt -86.36 136.03 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.586 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.725 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -109.95 96.0 5.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.011 0.434 . . . . 0.0 110.452 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -127.86 82.48 2.09 Favored 'General case' 0 CA--C 1.48 -1.717 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.064 176.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 107' ' ' ARG 0.274 0.0 OUTLIER . . . . . 0 N--CA 1.397 -3.099 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.15 177.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.018 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.52 -8.64 54.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.114 0.457 . . . . 0.0 112.078 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -125.28 62.11 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.028 0.918 . . . . 0.0 111.334 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.1 mtp -116.48 41.64 2.61 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.553 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.65 63.6 0.31 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.99 44.72 1.04 Allowed Glycine 0 N--CA 1.428 -1.853 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.529 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 m -84.39 130.78 34.75 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.625 0.726 . . . . 0.0 109.193 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.699 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 45.0 mtt -112.95 141.24 47.01 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.539 -1.21 . . . . 0.0 113.71 -169.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HE2' HD11 ' A' ' 38' ' ' ILE . 22.5 ttmm -98.63 101.07 12.38 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.5 mt -112.22 138.64 40.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 124.833 1.253 . . . . 0.0 109.834 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 43.4 mtt180 -71.33 134.99 47.14 Favored 'General case' 0 N--CA 1.421 -1.892 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.555 175.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 34' ' ' SER . 58.5 t -118.88 127.69 75.75 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.79 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.019 178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -86.77 149.46 24.84 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.52 -1.672 . . . . 0.0 107.765 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tm? -115.17 132.65 56.54 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 120.866 0.365 . . . . 0.0 110.093 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -105.54 114.35 44.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -160.24 83.84 0.71 Allowed 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -112.18 48.15 0.97 Allowed Glycine 0 C--N 1.269 -3.142 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.989 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -86.84 -41.5 13.99 Favored 'General case' 0 CA--C 1.468 -2.177 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -83.92 96.88 8.95 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.799 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -89.94 92.85 9.18 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -106.73 167.44 9.87 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.04 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.7 p -92.33 134.5 34.85 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.867 177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.8 p -126.76 97.12 4.87 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-O 120.874 0.369 . . . . 0.0 110.67 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 m -88.9 -13.09 39.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.936 0.874 . . . . 0.0 108.805 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 p -85.93 154.57 58.21 Favored Pre-proline 0 N--CA 1.419 -2.012 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.007 175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.13 60.21 3.82 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.139 2.559 . . . . 0.0 112.264 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -117.25 45.07 1.97 Allowed 'General case' 0 N--CA 1.402 -2.831 0 C-N-CA 123.845 0.858 . . . . 0.0 109.593 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 30' ' ' GLN . 22.8 mp0 -56.07 115.24 9.21 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.934 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 6.0 Cg_exo -80.33 95.49 1.0 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.349 2.033 . . . . 0.0 109.099 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 28' ' ' GLN . 26.8 mm-40 -93.69 -53.62 3.96 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.645 0.736 . . . . 0.0 110.233 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -111.32 168.24 9.68 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.957 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 92.4 m-20 -81.84 143.95 51.01 Favored Pre-proline 0 C--N 1.294 -1.844 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.277 -177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 8.5 Cg_endo -49.17 132.49 28.26 Favored 'Trans proline' 0 C--O 1.244 0.814 0 C-N-CA 124.123 3.216 . . . . 0.0 109.735 170.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.6 p -139.37 157.25 46.19 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.011 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.4 p -151.05 148.79 14.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 m -97.45 99.48 10.9 Favored 'General case' 0 N--CA 1.387 -3.594 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 59.9 t60 -106.12 144.99 32.04 Favored 'General case' 0 N--CA 1.406 -2.643 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.814 -167.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.529 HD11 ' HE2' ' A' ' 9' ' ' LYS 0.253 48.4 mm -83.65 114.06 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -115.35 151.5 34.52 Favored 'General case' 0 C--N 1.272 -2.78 0 C-N-CA 123.299 0.639 . . . . 0.0 109.513 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -146.71 -167.79 2.85 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -129.16 21.18 5.24 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -108.98 -25.46 10.71 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-O 121.469 0.652 . . . . 0.0 110.171 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.3 m -105.79 138.08 42.59 Favored 'General case' 0 N--CA 1.412 -2.342 0 C-N-CA 124.633 1.173 . . . . 0.0 109.391 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.64 145.86 22.44 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 121.444 0.64 . . . . 0.0 110.93 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 81.4 t -48.54 -52.05 9.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.701 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -56.57 -35.35 68.07 Favored 'General case' 0 C--O 1.198 -1.617 0 O-C-N 124.565 1.166 . . . . 0.0 111.204 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.61 -34.62 65.13 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.862 -0.524 . . . . 0.0 111.703 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -63.38 -36.98 85.51 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.62 -41.65 85.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-N 114.343 -1.299 . . . . 0.0 112.354 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -56.26 -38.78 71.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.856 0.753 . . . . 0.0 110.622 173.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.75 -53.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.814 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.902 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.3 mt -53.22 -50.56 64.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.133 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.99 -49.14 76.65 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 123.677 0.611 . . . . 0.0 110.047 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.9 m -59.13 -38.76 80.44 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -73.94 -31.47 63.06 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.69 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 14' ' ' LEU . 29.6 m-85 -81.58 -8.45 59.71 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.066 174.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt 74.57 37.23 0.56 Allowed 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 125.638 1.575 . . . . 0.0 111.91 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.6 mt -109.63 131.53 21.85 Favored Pre-proline 0 N--CA 1.409 -2.482 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.72 136.11 57.89 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 C-N-CA 122.557 2.171 . . . . 0.0 111.932 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.625 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.7 m -64.29 -9.8 6.94 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.903 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -69.49 -15.93 63.35 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 120.104 -0.638 . . . . 0.0 110.674 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.9 mptp? -85.32 -4.36 59.13 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.5 p -49.37 -30.23 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 125.919 1.688 . . . . 0.0 110.481 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.2 p -56.05 -50.53 70.7 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.005 173.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 19.6 m -98.44 13.16 32.69 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.256 -172.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.2 m-85 -114.25 142.43 46.29 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.942 -0.474 . . . . 0.0 111.748 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -154.08 146.65 24.1 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.671 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 77.8 mt -77.92 138.26 38.79 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 114.623 -1.172 . . . . 0.0 108.059 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -122.14 144.97 48.62 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 24.8 t-20 -76.89 130.32 76.24 Favored Pre-proline 0 N--CA 1.438 -1.061 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 17.3 Cg_exo -67.42 -18.72 49.67 Favored 'Trans proline' 0 C--N 1.329 -0.453 0 C-N-CA 122.575 2.183 . . . . 0.0 114.957 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -110.52 -39.48 4.9 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 48.2 p -90.12 -18.07 26.5 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.146 -178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 68.86 15.56 8.92 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.571 1.148 . . . . 0.0 111.943 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.72 137.72 37.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.104 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.38 156.91 17.9 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.289 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.07 77.54 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-O 122.141 0.972 . . . . 0.0 111.845 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -69.4 2.94 2.6 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 125.234 1.414 . . . . 0.0 114.174 171.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.84 154.73 41.48 Favored 'General case' 0 N--CA 1.401 -2.877 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.582 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 m -82.96 -37.28 24.31 Favored 'General case' 0 C--N 1.266 -3.03 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.851 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -130.49 153.37 48.88 Favored 'General case' 0 N--CA 1.408 -2.556 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.291 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 82' ' ' LEU . 19.5 mt -85.68 146.83 26.65 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.2 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.2 p -99.02 157.79 33.46 Favored Pre-proline 0 N--CA 1.403 -2.792 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -57.5 -34.81 98.61 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.071 1.848 . . . . 0.0 109.398 174.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -61.09 -45.67 93.77 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.401 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 86' ' ' ARG . 8.7 mmt180 -61.14 -39.7 91.04 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.699 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 79.0 mt -64.86 -48.68 73.4 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 124.073 0.858 . . . . 0.0 109.778 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.77 -45.3 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.715 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -63.83 -28.71 70.04 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.131 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.06 24.59 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.636 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 15.6 mt-10 -53.02 -22.71 6.13 Favored 'General case' 0 C--N 1.374 1.656 0 CA-C-N 119.059 0.845 . . . . 0.0 113.117 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -52.93 -42.93 65.89 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 123.706 0.803 . . . . 0.0 110.826 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.6 m -140.91 -80.41 0.26 Allowed 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER -167.36 -179.26 4.39 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 124.133 0.973 . . . . 0.0 109.04 -177.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.61 149.49 42.38 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.3 99.85 9.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.02 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -78.8 105.5 10.16 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.018 0.913 . . . . 0.0 108.589 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -124.07 166.15 16.26 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.427 -173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.442 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.4 mtp -81.11 132.79 35.38 Favored 'General case' 0 N--CA 1.4 -2.964 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 170.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -61.71 147.68 88.48 Favored Pre-proline 0 C--N 1.288 -2.09 0 C-N-CA 124.402 1.081 . . . . 0.0 110.006 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -47.23 117.2 2.11 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.434 2.756 . . . . 0.0 111.146 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -93.45 149.89 20.88 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.712 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.36 -158.42 0.45 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 mm -61.23 130.26 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.187 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.66 132.48 48.92 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 121.419 0.628 . . . . 0.0 111.25 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.55 16.33 5.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.193 0.997 . . . . 0.0 110.618 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 . . . . . 0 C--N 1.282 -2.343 0 CA-C-N 114.161 -1.382 . . . . 0.0 107.606 177.046 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.027 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.56 -171.37 0.17 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.298 1.039 . . . . 0.0 111.209 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -114.55 140.73 48.53 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.918 -0.489 . . . . 0.0 110.383 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.6 mtp -102.35 155.52 18.19 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.23 63.12 0.19 Allowed Glycine 0 C--N 1.289 -2.077 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.9 53.68 0.63 Allowed Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 120.169 -1.015 . . . . 0.0 112.119 -177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 m -78.72 140.22 38.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.5 mmt -115.46 138.23 51.24 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.899 -172.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -99.04 91.98 5.27 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -102.61 137.27 31.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.939 -171.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 30.0 mtm105 -69.42 130.71 43.29 Favored 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 121.714 0.769 . . . . 0.0 110.225 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.0 t -117.07 122.58 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.385 0 CA-C-O 117.402 -1.285 . . . . 0.0 108.487 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.275 33.0 mt-10 -82.38 149.36 27.73 Favored 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 116.566 -2.053 . . . . 0.0 107.037 167.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.52 123.09 36.97 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 120.99 0.424 . . . . 0.0 111.156 176.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp -98.62 109.77 24.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 C-N-CA 119.242 -0.983 . . . . 0.0 109.019 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -126.35 11.43 7.48 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 121.647 0.737 . . . . 0.0 109.058 172.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -102.54 63.78 0.45 Allowed Glycine 0 C--N 1.289 -2.053 0 CA-C-N 114.187 -1.37 . . . . 0.0 112.659 -174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -79.3 -37.28 38.12 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -105.82 99.18 8.79 Favored 'General case' 0 N--CA 1.388 -3.559 0 N-CA-C 105.445 -2.058 . . . . 0.0 105.445 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -65.43 108.83 2.1 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.886 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -115.35 142.78 46.23 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.96 -176.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.5 p 54.84 -165.76 0.1 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.686 1.194 . . . . 0.0 111.46 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 p -64.17 104.31 0.72 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -149.15 110.11 4.33 Favored 'General case' 0 N--CA 1.406 -2.643 0 C-N-CA 123.75 0.82 . . . . 0.0 108.787 -174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.1 p -68.2 170.66 7.17 Favored Pre-proline 0 C--N 1.275 -2.63 0 CA-C-N 114.11 -1.405 . . . . 0.0 110.541 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -68.39 178.75 3.46 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.763 2.309 . . . . 0.0 112.373 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.4 mp0 -80.99 30.62 0.32 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 125.318 1.447 . . . . 0.0 113.999 -174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' HB2' ' HG3' ' A' ' 31' ' ' GLN . 89.2 mt-30 -70.49 170.48 10.53 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.57 158.07 16.6 Favored 'Trans proline' 0 N--CA 1.433 -2.07 0 CA-C-N 120.874 1.348 . . . . 0.0 110.749 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 60.22 27.98 17.53 Favored 'General case' 0 N--CA 1.426 -1.642 0 C-N-CA 125.25 1.42 . . . . 0.0 111.412 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 28' ' ' GLN . 83.4 mm-40 -109.33 -52.35 2.78 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-O 123.65 1.69 . . . . 0.0 114.022 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -63.38 155.73 73.36 Favored Pre-proline 1 C--N 1.2 -5.911 0 CA-C-N 110.148 -3.206 . . . . 0.0 112.152 -174.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -45.26 135.52 11.52 Favored 'Trans proline' 0 C--N 1.356 0.934 0 C-N-CA 123.928 3.085 . . . . 0.0 110.044 171.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 53.6 m -145.86 157.59 43.9 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.193 0.52 . . . . 0.0 112.008 -175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -147.76 148.15 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.734 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.803 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.4 m -97.05 103.86 15.82 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -107.86 147.59 30.73 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.138 -169.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.83 111.18 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -112.0 146.02 38.62 Favored 'General case' 0 C--N 1.27 -2.875 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -145.47 -168.85 3.07 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -126.83 20.45 6.03 Favored Glycine 0 N--CA 1.435 -1.386 0 C-N-CA 120.886 -0.674 . . . . 0.0 111.471 -176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -111.12 -26.86 9.0 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.641 0.734 . . . . 0.0 110.699 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.0 m -99.62 135.3 41.25 Favored 'General case' 0 N--CA 1.39 -3.472 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.942 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.31 146.12 12.76 Favored 'General case' 0 N--CA 1.437 -1.075 0 O-C-N 123.931 0.769 . . . . 0.0 111.58 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.0 t -52.75 -54.0 18.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.643 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 0.3 OUTLIER -56.82 -31.02 64.31 Favored 'General case' 0 C--O 1.204 -1.329 0 O-C-N 124.464 1.102 . . . . 0.0 111.977 -177.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.72 -38.94 62.16 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 120.74 0.305 . . . . 0.0 110.492 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -61.91 -37.6 85.24 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.5 mt -68.81 -42.35 82.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.127 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.7 mttt -58.58 -33.55 70.09 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.943 0.792 . . . . 0.0 111.183 174.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.87 -54.82 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.6 mt -53.12 -49.34 66.74 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 123.268 0.355 . . . . 0.0 111.178 177.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 86.4 mt -56.65 -48.19 78.12 Favored 'General case' 0 C--O 1.203 -1.352 0 O-C-N 123.404 0.44 . . . . 0.0 110.224 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -59.7 -38.76 82.47 Favored 'General case' 0 N--CA 1.404 -2.745 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -72.71 -30.32 64.11 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 120.87 0.367 . . . . 0.0 111.856 176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.43 1.09 55.46 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.362 0.601 . . . . 0.0 112.03 176.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt 67.3 35.05 4.55 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.489 1.516 . . . . 0.0 112.497 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.54 136.76 19.13 Favored Pre-proline 0 N--CA 1.411 -2.407 0 C-N-CA 124.802 1.241 . . . . 0.0 107.8 176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.13 133.0 50.24 Favored 'Trans proline' 0 CA--C 1.495 -1.445 0 C-N-CA 121.999 1.799 . . . . 0.0 110.861 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.525 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.0 m -62.05 -9.85 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.115 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.05 -19.2 64.87 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.277 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -82.21 -5.51 58.55 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.9 p -48.01 -29.22 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 C-N-CA 125.759 1.623 . . . . 0.0 110.975 176.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -57.24 -48.95 77.54 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.977 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.0 m -99.78 12.96 35.33 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.843 -173.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.3 m-85 -115.78 140.28 49.37 Favored 'General case' 0 CA--C 1.473 -1.992 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.163 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -156.07 152.36 27.93 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.434 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.71 127.99 33.94 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.859 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -111.04 144.53 40.01 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -73.87 125.18 90.52 Favored Pre-proline 0 C--N 1.314 -0.962 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.86 -19.97 64.43 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.177 2.585 . . . . 0.0 114.84 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.79 -44.79 4.55 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.935 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.8 p -90.78 -15.18 30.59 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.604 -173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.1 mt 64.89 18.96 11.71 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.799 1.24 . . . . 0.0 111.262 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.47 136.38 38.35 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.734 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 8.6 m-85 -92.77 147.76 22.6 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.385 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 77.3 t -92.9 105.99 17.41 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -107.07 13.87 26.96 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.799 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.23 163.97 27.04 Favored 'General case' 0 CA--C 1.461 -2.451 0 CA-C-O 122.719 1.247 . . . . 0.0 112.755 178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.7 m -88.3 -38.92 14.79 Favored 'General case' 0 N--CA 1.379 -3.987 0 CA-C-N 112.6 -2.091 . . . . 0.0 109.129 173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -131.85 149.21 52.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 123.857 0.863 . . . . 0.0 110.17 179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HG ' HG22 ' A' ' 45' ' ' VAL . 21.5 mt -86.15 152.61 22.7 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 123.796 0.838 . . . . 0.0 111.786 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 62.0 p -103.05 155.92 36.0 Favored Pre-proline 0 N--CA 1.42 -1.956 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.73 -31.49 91.99 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.017 1.812 . . . . 0.0 109.411 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -61.7 -44.6 96.63 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.475 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.515 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.3 mmp_? -60.25 -38.8 84.59 Favored 'General case' 0 CA--C 1.498 -1.028 0 CA-C-O 120.74 0.305 . . . . 0.0 110.938 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 58.0 mt -67.31 -47.63 69.99 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.699 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.607 ' O ' ' HD3' ' A' ' 92' ' ' LYS . 42.9 t -62.74 -47.65 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 176.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 45.9 mt-10 -62.69 -30.8 71.67 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 111.664 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.54 -35.43 58.27 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.909 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 91' ' ' GLU . 3.0 mm-40 -59.08 -22.88 61.5 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.607 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -54.69 -38.74 67.38 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.097 172.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.4 m -144.76 -78.89 0.19 Allowed 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.37 -177.27 4.4 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.699 1.2 . . . . 0.0 108.568 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -120.46 151.1 39.79 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 168.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -117.3 102.44 13.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.555 175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.473 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.02 107.41 10.56 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.5 mtp85 -126.42 159.2 33.95 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.901 -173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' SER . 62.9 mtp -78.97 127.2 31.69 Favored 'General case' 0 N--CA 1.4 -2.97 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -58.31 141.9 82.15 Favored Pre-proline 0 N--CA 1.428 -1.544 0 O-C-N 124.576 1.173 . . . . 0.0 109.341 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -39.5 107.14 0.06 OUTLIER 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 124.102 3.201 . . . . 0.0 115.291 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -134.05 154.5 51.12 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.919 -1.491 . . . . 0.0 109.044 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.6 177.17 3.51 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.4 mt -73.48 97.93 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-O 121.541 0.686 . . . . 0.0 109.599 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.89 97.55 0.94 Allowed 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.93 68.75 8.47 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-O 121.625 0.726 . . . . 0.0 112.442 -174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 . . . . . 0 C--N 1.28 -2.45 0 CA-C-N 114.403 -1.272 . . . . 0.0 108.592 174.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.21 -17.4 54.9 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.516 0.674 . . . . 0.0 109.847 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -105.52 -176.39 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.321 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.8 mmt -105.29 175.78 5.38 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.145 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.23 -96.74 2.38 Favored Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.29 75.08 0.71 Allowed Glycine 0 CA--C 1.483 -1.965 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 m -68.92 141.23 55.06 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.136 0.493 . . . . 0.0 110.728 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.532 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 13.0 mmt -123.78 140.84 52.59 Favored 'General case' 0 CA--C 1.488 -1.426 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.293 -171.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' HD13 ' A' ' 38' ' ' ILE . 28.5 ttpt -98.95 95.68 7.32 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.232 1.015 . . . . 0.0 108.953 174.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.1 mt -105.45 139.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.243 -171.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.8 mmt180 -65.76 131.86 47.33 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-O 121.139 0.495 . . . . 0.0 110.04 169.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.5 t -117.01 126.16 74.28 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.734 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.453 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.265 33.6 mt-10 -86.02 150.1 24.7 Favored 'General case' 0 N--CA 1.411 -2.411 0 C-N-CA 116.642 -2.023 . . . . 0.0 107.185 167.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.563 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -121.94 130.84 53.65 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 112.34 35.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 171.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -148.8 20.9 1.01 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.33 -166.79 24.5 Favored Glycine 0 N--CA 1.417 -2.603 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.089 -173.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.79 48.48 1.97 Allowed 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -57.99 143.31 43.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.307 -2.224 . . . . 0.0 113.184 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 31.9 m170 -114.92 119.27 35.97 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.97 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.477 ' NH1' ' HB2' ' A' ' 57' ' ' LYS . 70.6 mtt180 -110.33 -163.49 0.86 Allowed 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -60.55 102.97 0.21 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.355 0.598 . . . . 0.0 112.375 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.9 t -151.43 103.45 2.99 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -86.93 -5.06 59.21 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.564 0.697 . . . . 0.0 109.289 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 26' ' ' PRO . 5.4 p -85.11 178.33 2.43 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.55 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 25' ' ' THR . 5.2 Cg_exo -38.93 158.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 124.58 3.52 . . . . 0.0 113.788 172.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.54 19.21 0.27 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.4 -1.273 . . . . 0.0 113.648 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' PRO . 48.0 mt-30 65.35 163.54 0.12 Allowed Pre-proline 0 C--N 1.309 -1.18 0 C-N-CA 125.902 1.681 . . . . 0.0 111.349 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.79 136.55 71.02 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.291 -1.465 . . . . 0.0 108.291 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.563 ' H ' HE21 ' A' ' 30' ' ' GLN . 0.0 OUTLIER -82.6 60.32 5.15 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.866 1.317 . . . . 0.0 112.274 -174.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -136.64 -169.12 2.39 Favored 'General case' 0 N--CA 1.401 -2.903 0 C-N-CA 127.639 2.376 . . . . 0.0 106.216 177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 94.1 m-20 -83.55 151.28 61.66 Favored Pre-proline 0 C--N 1.282 -2.326 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.027 177.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -47.07 133.07 18.46 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.989 3.126 . . . . 0.0 110.047 171.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 25.5 p -136.08 152.43 50.86 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.506 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -148.35 151.43 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 m -100.93 105.95 17.24 Favored 'General case' 0 C--N 1.263 -3.186 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 173.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -113.09 140.81 47.56 Favored 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.503 -171.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.251 36.3 mm -76.84 111.44 13.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 179.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.74 145.96 39.61 Favored 'General case' 0 C--N 1.269 -2.925 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' OD2' ' HE1' ' A' ' 48' ' ' HIS . 4.2 p30 -148.42 -170.74 3.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.9 17.58 7.65 Favored Glycine 0 C--N 1.308 -1.008 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -108.71 -28.94 8.95 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.689 0.757 . . . . 0.0 109.719 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -100.45 132.06 46.04 Favored 'General case' 0 N--CA 1.4 -2.938 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.772 173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.59 151.23 4.41 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 123.524 0.73 . . . . 0.0 111.875 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.55 -54.28 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.996 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -57.72 -30.46 65.55 Favored 'General case' 0 C--O 1.204 -1.301 0 O-C-N 124.221 0.951 . . . . 0.0 112.525 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.5 m-20 -73.66 -37.05 65.42 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 122.079 -0.388 . . . . 0.0 110.033 177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.522 ' HE1' ' OD2' ' A' ' 40' ' ' ASP . 90.6 m-70 -62.77 -39.59 94.64 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 42.8 mt -68.52 -41.82 83.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.31 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.8 mttt -58.39 -34.66 70.98 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 119.047 0.84 . . . . 0.0 110.759 174.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.7 t -68.7 -54.13 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.3 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.8 mt -54.85 -47.33 74.31 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.215 0.322 . . . . 0.0 111.191 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.1 mt -57.59 -46.87 83.48 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 123.377 0.423 . . . . 0.0 109.977 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -59.35 -40.69 87.19 Favored 'General case' 0 N--CA 1.4 -2.925 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -72.16 -32.78 67.18 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.563 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 47.2 m-85 -83.94 -5.75 59.28 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.387 0.613 . . . . 0.0 111.296 175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 26.1 mtpp 69.28 45.99 0.82 Allowed 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 126.287 1.835 . . . . 0.0 112.983 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.9 mt -111.99 135.88 21.26 Favored Pre-proline 0 N--CA 1.404 -2.739 0 C-N-CA 125.782 1.633 . . . . 0.0 107.286 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.36 134.64 62.13 Favored 'Trans proline' 0 CA--C 1.502 -1.12 0 C-N-CA 122.142 1.895 . . . . 0.0 111.373 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.564 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.3 m -63.77 -10.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.604 0 CA-C-N 114.91 -1.041 . . . . 0.0 113.176 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.94 -15.84 63.11 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.726 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 2.5 mptp? -85.0 -4.04 59.0 Favored 'General case' 0 N--CA 1.433 -1.31 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.83 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.1 p -47.05 -31.88 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 C-N-CA 126.08 1.752 . . . . 0.0 110.296 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.4 m -55.78 -47.02 77.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 C-N-CA 125.744 1.618 . . . . 0.0 110.849 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.7 m -100.72 12.66 37.02 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.33 -173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 19.4 m-85 -113.28 143.24 44.75 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.906 -0.496 . . . . 0.0 111.654 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.35 147.54 28.43 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.838 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.1 mt -83.54 125.64 31.98 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 124.26 0.975 . . . . 0.0 108.415 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -112.77 147.77 36.19 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -79.22 129.91 70.94 Favored Pre-proline 0 C--N 1.309 -1.169 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.08 -20.63 67.75 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.82 2.347 . . . . 0.0 115.179 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -103.71 -44.89 4.96 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 119.198 -1.001 . . . . 0.0 111.984 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.3 p -89.5 -20.55 23.7 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.851 -173.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt 67.24 17.27 10.26 Favored 'General case' 0 CA--C 1.51 -0.59 0 C-N-CA 124.599 1.159 . . . . 0.0 111.821 -177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.94 139.2 39.18 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.53 154.26 17.38 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.45 110.3 22.33 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.8 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -102.32 11.58 37.89 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.546 0.689 . . . . 0.0 110.424 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.17 156.85 36.89 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.934 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.6 m -81.73 -38.59 25.49 Favored 'General case' 0 N--CA 1.403 -2.78 0 CA-C-N 114.189 -1.369 . . . . 0.0 109.618 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -130.46 149.27 52.21 Favored 'General case' 0 N--CA 1.417 -2.101 0 C-N-CA 124.194 0.997 . . . . 0.0 108.657 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.66 155.07 28.22 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.554 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 73.0 p -109.35 153.32 42.8 Favored Pre-proline 0 N--CA 1.401 -2.899 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HG2' ' OE2' ' A' ' 85' ' ' GLU . 8.6 Cg_endo -53.94 -37.56 85.87 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.553 2.169 . . . . 0.0 110.386 173.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' OE2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 mp0 -60.09 -44.43 94.8 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.979 177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.0 mmp_? -61.7 -40.4 94.9 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 83' ' ' THR . 66.3 mt -66.29 -47.12 74.65 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.711 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.76 -46.3 96.7 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.585 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 86' ' ' ARG . 49.7 mt-10 -63.78 -31.8 73.1 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.412 0.625 . . . . 0.0 111.451 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.82 61.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.622 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -57.33 -24.9 58.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.188 0.595 . . . . 0.0 111.934 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 67.0 mttm -56.17 -35.62 67.42 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.506 1.122 . . . . 0.0 112.534 173.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.1 m -146.79 -85.1 0.11 Allowed 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -159.61 -178.82 7.38 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.297 1.039 . . . . 0.0 108.843 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -119.35 149.27 42.11 Favored 'General case' 0 C--O 1.209 -1.075 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 169.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 98' ' ' ARG . 9.7 mt -116.63 101.73 12.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 118.821 0.737 . . . . 0.0 110.325 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -79.39 102.99 9.0 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 96' ' ' ILE . 25.0 mtp180 -119.99 161.05 21.57 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.493 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 46.8 mtp -78.82 125.3 29.19 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 43.5 mtpt -59.73 130.22 88.1 Favored Pre-proline 0 C--N 1.288 -2.107 0 O-C-N 124.169 0.918 . . . . 0.0 112.311 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 53.6 Cg_exo -60.24 110.08 0.73 Allowed 'Trans proline' 0 CA--C 1.506 -0.901 0 C-N-CA 123.027 2.484 . . . . 0.0 110.791 175.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 63.98 100.95 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.103 -175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -104.88 -166.89 1.28 Allowed 'General case' 0 C--N 1.251 -3.712 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.211 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.2 mt -73.66 102.01 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -121.99 29.9 6.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.23 17.75 4.14 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.703 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 . . . . . 0 N--CA 1.436 -1.132 0 C-N-CA 127.392 2.277 . . . . 0.0 114.279 173.429 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.754 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.27 111.33 17.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -136.8 141.22 42.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtm 62.42 24.62 14.66 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.817 0.847 . . . . 0.0 110.806 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 124.33 -58.86 0.64 Allowed Glycine 0 C--N 1.29 -1.985 0 N-CA-C 108.094 -2.002 . . . . 0.0 108.094 -174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.38 66.2 1.82 Allowed Glycine 0 N--CA 1.423 -2.225 0 CA-C-N 115.128 -0.536 . . . . 0.0 113.649 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.9 m -80.77 150.83 29.09 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.457 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 12.0 mmt -127.96 142.07 51.35 Favored 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -99.13 97.57 8.67 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -109.4 138.97 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.525 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.17 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 87.9 mtt180 -69.3 130.79 43.57 Favored 'General case' 0 CA--C 1.473 -2.007 0 CA-C-O 121.364 0.602 . . . . 0.0 110.683 172.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.482 ' CG1' ' HB2' ' A' ' 97' ' ' LEU . 48.3 t -116.83 123.87 72.24 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.561 0 CA-C-O 117.826 -1.083 . . . . 0.0 108.607 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.259 35.6 mt-10 -84.69 142.4 29.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.622 -2.031 . . . . 0.0 107.711 169.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.4 tm? -115.38 130.73 56.98 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.972 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -115.44 123.79 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 167.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -122.88 3.06 9.44 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.976 1.37 . . . . 0.0 111.032 176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.03 25.2 74.47 Favored Glycine 0 C--N 1.294 -1.781 0 CA-C-N 113.479 -1.691 . . . . 0.0 111.103 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -140.12 27.48 2.15 Favored 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.05 65.75 1.14 Allowed 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.627 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.57 20.41 4.29 Favored 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 122.144 0.973 . . . . 0.0 110.598 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.48 23.68 6.83 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.435 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -80.31 80.4 6.75 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 114.682 -1.144 . . . . 0.0 110.402 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -121.86 16.39 10.96 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.865 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 m -91.28 -6.12 53.7 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.064 0.935 . . . . 0.0 109.165 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 30' ' ' GLN . 5.0 p -82.1 162.03 58.27 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.106 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -76.31 -155.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.285 2.656 . . . . 0.0 109.278 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -81.19 13.47 2.83 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 122.57 1.176 . . . . 0.0 111.383 176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -89.15 159.99 43.88 Favored Pre-proline 0 C--N 1.278 -2.532 0 CA-C-N 113.566 -1.652 . . . . 0.0 107.684 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -44.25 136.31 8.24 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 123.5 2.8 . . . . 0.0 112.118 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.439 ' HA ' HG21 ' A' ' 25' ' ' THR . 25.2 mp0 -82.0 71.41 9.03 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-O 122.317 1.056 . . . . 0.0 110.426 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -68.33 175.87 3.1 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 113.056 -1.884 . . . . 0.0 112.552 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.413 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 87.7 m-20 -57.74 144.86 72.57 Favored Pre-proline 0 C--O 1.247 0.936 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.119 -172.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -55.74 137.84 79.59 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 124.556 3.504 . . . . 0.0 109.422 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.6 m -143.61 159.89 41.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.792 -0.567 . . . . 0.0 109.623 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -151.69 150.39 13.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -97.35 106.72 19.09 Favored 'General case' 0 N--CA 1.394 -3.261 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 173.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -110.2 145.42 37.32 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.132 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.254 50.2 mm -83.28 109.89 17.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.85 144.51 39.76 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -152.41 169.21 23.11 Favored 'General case' 0 C--N 1.283 -2.286 0 C-N-CA 124.235 1.014 . . . . 0.0 108.534 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.65 17.98 53.93 Favored Glycine 0 C--N 1.282 -2.465 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.655 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -104.95 -30.03 10.08 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-O 121.715 0.769 . . . . 0.0 109.963 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.681 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 31.6 m -97.75 137.39 36.7 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 124.793 1.237 . . . . 0.0 108.564 175.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.04 149.34 12.1 Favored 'General case' 0 C--O 1.255 1.38 0 CA-C-O 121.517 0.675 . . . . 0.0 110.44 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.6 t -55.74 -53.92 31.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.096 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -57.4 -31.1 65.5 Favored 'General case' 0 C--O 1.208 -1.107 0 O-C-N 124.159 0.912 . . . . 0.0 111.818 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -74.16 -36.64 64.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 122.344 -0.223 . . . . 0.0 110.813 177.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.681 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 91.3 m-70 -62.76 -39.06 92.99 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 172.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.7 mt -68.67 -43.12 83.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.722 -1.126 . . . . 0.0 112.473 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.7 mttt -58.51 -31.88 68.3 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.733 0.697 . . . . 0.0 110.899 174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 47' ' ' ASP . 91.1 t -68.61 -54.31 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.417 175.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -53.14 -48.76 67.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 122.502 0.321 . . . . 0.0 111.013 177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.0 mt -57.73 -49.07 77.79 Favored 'General case' 0 C--O 1.195 -1.815 0 O-C-N 123.654 0.596 . . . . 0.0 109.811 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.9 m -59.72 -38.51 81.87 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -72.68 -31.91 65.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.47 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 47.6 m-85 -83.09 -7.09 59.69 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.188 0.518 . . . . 0.0 111.334 173.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 72.02 38.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.62 1.568 . . . . 0.0 112.237 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' CG2' ' HD2' ' A' ' 62' ' ' LYS . 75.1 mt -105.89 134.79 19.57 Favored Pre-proline 0 N--CA 1.409 -2.517 0 C-N-CA 125.345 1.458 . . . . 0.0 107.865 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.01 131.39 46.15 Favored 'Trans proline' 0 CA--C 1.502 -1.076 0 C-N-CA 122.339 2.026 . . . . 0.0 111.325 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.6 m -62.42 -11.04 5.81 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.591 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.553 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.43 -14.65 62.22 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 111.357 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HD2' ' CG2' ' A' ' 58' ' ' ILE . 66.9 mttm -81.62 -9.96 59.54 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.827 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.3 p -47.27 -31.33 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 C-N-CA 127.257 2.223 . . . . 0.0 110.343 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 m -54.41 -46.24 73.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.564 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 99' ' ' MET . 14.8 t -94.41 -0.64 54.68 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.823 -174.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 20.0 m-85 -101.14 139.05 37.36 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 118.714 -1.194 . . . . 0.0 112.315 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB2' ' HE3' ' A' ' 100' ' ' LYS . . . -149.56 142.24 24.55 Favored 'General case' 0 N--CA 1.398 -3.036 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.646 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 97' ' ' LEU . 79.2 mt -79.0 126.41 30.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.7 148.57 38.06 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.82 128.0 73.09 Favored Pre-proline 0 C--N 1.3 -1.586 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.08 -17.64 40.55 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 C-N-CA 122.553 2.169 . . . . 0.0 114.828 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -104.85 -43.28 5.13 Favored 'General case' 0 N--CA 1.426 -1.664 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.209 -175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.6 p -91.25 -18.86 23.7 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.62 -175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 mt 69.45 17.62 8.02 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.382 1.073 . . . . 0.0 111.671 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.96 140.82 30.79 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -94.55 150.83 19.85 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 120.959 0.409 . . . . 0.0 110.692 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 91.7 t -87.9 106.05 16.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.08 16.69 23.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.403 1.097 . . . . 0.0 109.836 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.49 158.26 32.84 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.75 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.65 -38.13 20.2 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.29 173.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -131.58 144.82 51.36 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.272 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.434 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.8 mt -78.96 152.74 30.87 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.777 0.798 . . . . 0.0 110.632 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 28.9 p -106.32 152.21 40.47 Favored Pre-proline 0 N--CA 1.398 -3.051 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -57.44 -31.69 92.01 Favored 'Trans proline' 0 C--O 1.208 -0.977 0 C-N-CA 122.287 1.992 . . . . 0.0 109.865 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -58.24 -47.81 82.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.458 0.703 . . . . 0.0 110.644 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 86' ' ' ARG . 3.7 mmp_? -62.54 -37.27 85.46 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.893 178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 83' ' ' THR . 57.7 mt -66.92 -47.29 72.19 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.385 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.97 -46.06 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.126 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -64.27 -30.98 72.01 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.659 0.742 . . . . 0.0 111.209 173.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.09 -34.09 59.52 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.623 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -59.43 -24.39 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -53.67 -40.22 65.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.102 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.1 m -143.05 -80.69 0.2 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.64 -179.29 6.77 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.788 1.235 . . . . 0.0 108.947 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -119.1 155.52 31.39 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 167.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 12.4 mt -115.83 134.59 58.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 170.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD23 HD23 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -107.78 99.8 9.23 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -176.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -121.5 162.3 20.77 Favored 'General case' 0 CA--C 1.46 -2.508 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.018 -172.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 65' ' ' SER . 54.4 mtp -82.92 137.82 34.08 Favored 'General case' 0 N--CA 1.398 -3.067 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 169.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 67' ' ' ALA . 87.8 mttt -74.27 164.48 60.98 Favored Pre-proline 0 C--N 1.271 -2.812 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.24 83.17 0.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.036 1.824 . . . . 0.0 111.521 172.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 59.76 120.46 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 127.674 2.39 . . . . 0.0 112.99 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.26 170.64 11.29 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.604 -176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.4 mt -76.07 83.89 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-O 122.115 0.959 . . . . 0.0 109.573 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.38 103.36 1.78 Allowed 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.1 t70 64.49 26.42 13.4 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.171 1.462 . . . . 0.0 110.122 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 . . . . . 0 N--CA 1.404 -2.731 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.617 -179.18 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.86 73.89 0.35 Allowed 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.206 1.003 . . . . 0.0 112.088 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -170.1 137.47 1.56 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.407 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.2 mtt -128.56 172.16 11.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.46 1.21 Allowed Glycine 0 C--O 1.243 0.684 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.84 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.86 68.41 1.48 Allowed Glycine 0 C--O 1.224 -0.501 0 C-N-CA 121.475 -0.393 . . . . 0.0 112.68 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.1 m -82.57 142.21 31.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 120.708 0.29 . . . . 0.0 110.889 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 8.9 mmt -118.26 139.72 50.89 Favored 'General case' 0 C--O 1.203 -1.374 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -172.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.583 ' HD3' ' CD1' ' A' ' 38' ' ' ILE . 36.5 tptt -100.55 100.19 10.89 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.6 mt -117.32 136.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 114.413 -1.267 . . . . 0.0 111.287 -170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 62.6 mtm180 -69.26 135.94 51.22 Favored 'General case' 0 CA--C 1.481 -1.675 0 CA-C-O 121.567 0.699 . . . . 0.0 110.754 171.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' SER . 62.3 t -121.11 124.54 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.263 0 CA-C-O 117.433 -1.27 . . . . 0.0 108.571 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.272 29.8 mt-10 -85.9 138.82 31.75 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 116.907 -1.917 . . . . 0.0 108.228 168.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -115.99 129.61 56.45 Favored 'General case' 0 C--N 1.26 -3.323 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 178.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.411 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp -108.43 113.33 43.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.001 0 C-N-CA 119.5 -0.88 . . . . 0.0 108.718 169.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' HB3' HD11 ' A' ' 14' ' ' LEU . 28.3 p-10 -112.31 17.89 19.03 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.528 1.156 . . . . 0.0 110.491 176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.5 150.2 5.32 Favored Glycine 0 N--CA 1.407 -3.268 0 CA-C-N 113.513 -1.676 . . . . 0.0 111.055 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -105.94 14.03 28.53 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -79.93 90.89 5.36 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -77.22 98.3 5.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.857 0.837 . . . . 0.0 112.552 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -94.34 90.23 6.2 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.181 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 p -77.13 111.96 13.28 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.5 p -173.25 176.63 2.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.7 m -89.71 75.59 7.37 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 122.878 1.323 . . . . 0.0 110.471 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.469 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 12.8 p -122.03 -175.7 0.38 Allowed Pre-proline 0 C--N 1.257 -3.414 0 CA-C-N 112.773 -2.012 . . . . 0.0 107.689 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.469 ' CD ' ' HB ' ' A' ' 25' ' ' THR . 5.0 Cg_exo -77.27 25.65 0.47 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.143 1.895 . . . . 0.0 112.043 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' A' ' 25' ' ' THR . 45.8 mt-30 -121.47 35.39 4.9 Favored 'General case' 0 N--CA 1.409 -2.508 0 C-N-CA 125.669 1.588 . . . . 0.0 108.757 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -49.18 117.51 6.71 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.575 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.25 40.23 0.81 Allowed 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 123.391 2.727 . . . . 0.0 113.811 -175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -93.8 -67.54 0.85 Allowed 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -125.64 -170.07 2.11 Favored 'General case' 0 N--CA 1.409 -2.492 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 35.5 m-80 -90.41 146.71 35.06 Favored Pre-proline 0 N--CA 1.402 -2.83 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -37.27 132.8 0.52 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 124.683 3.589 . . . . 0.0 111.662 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 30.6 m -138.91 159.54 41.9 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.729 -0.607 . . . . 0.0 112.128 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.0 p -151.93 150.92 12.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.5 m -95.92 115.82 28.0 Favored 'General case' 1 N--CA 1.378 -4.055 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 171.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -115.23 142.57 46.49 Favored 'General case' 0 N--CA 1.389 -3.51 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.399 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.583 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 31.1 mm -79.39 110.82 15.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -110.01 141.38 42.9 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.52 ' OD1' ' HE1' ' A' ' 48' ' ' HIS . 7.9 p-10 -145.99 160.34 42.0 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.274 -179.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.4 20.34 51.1 Favored Glycine 0 C--N 1.281 -2.496 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.812 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -110.19 -24.97 10.41 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 121.701 0.763 . . . . 0.0 109.815 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.53 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 91.4 m -103.23 137.19 41.71 Favored 'General case' 0 N--CA 1.401 -2.875 0 C-N-CA 124.274 1.03 . . . . 0.0 109.436 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.18 152.6 13.36 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-O 121.692 0.758 . . . . 0.0 111.69 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.4 t -56.26 -54.83 23.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.129 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -57.07 -30.39 64.26 Favored 'General case' 0 C--O 1.207 -1.183 0 O-C-N 124.31 1.006 . . . . 0.0 111.387 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.1 m-20 -75.48 -37.4 60.26 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.53 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 88.9 m-70 -61.36 -39.28 90.03 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.2 mt -67.38 -43.35 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.072 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 63' ' ' VAL . 93.1 mttt -57.28 -35.22 69.51 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.036 0.835 . . . . 0.0 110.936 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 97.1 t -69.0 -53.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.322 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.9 mt -53.14 -48.86 67.6 Favored 'General case' 0 CA--C 1.503 -0.856 0 O-C-N 123.357 0.411 . . . . 0.0 110.982 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 87.7 mt -57.65 -47.75 81.39 Favored 'General case' 0 C--O 1.202 -1.428 0 O-C-N 123.408 0.443 . . . . 0.0 110.048 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.9 m -58.92 -40.97 86.18 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -71.21 -35.02 71.37 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.187 0.517 . . . . 0.0 112.19 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.552 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 46.1 m-85 -79.46 -2.17 40.77 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.241 0.543 . . . . 0.0 111.332 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm 70.54 36.43 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.205 174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.6 mt -107.31 138.39 19.89 Favored Pre-proline 0 N--CA 1.415 -2.201 0 C-N-CA 125.277 1.431 . . . . 0.0 107.81 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -56.93 133.14 56.06 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 121.805 1.67 . . . . 0.0 110.638 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.629 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 30.8 m -62.77 -10.04 4.99 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.643 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.512 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.09 -19.6 65.67 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.096 0.474 . . . . 0.0 110.125 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 3.4 mptp? -80.61 -8.06 59.48 Favored 'General case' 0 C--O 1.202 -1.398 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.765 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.629 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.2 p -47.97 -33.59 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 C-N-CA 125.548 1.539 . . . . 0.0 110.052 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.256 14.4 m -54.42 -48.17 71.95 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 126.184 1.794 . . . . 0.0 109.907 176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 99' ' ' MET . 25.4 m -100.49 14.47 31.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-N 114.09 -1.413 . . . . 0.0 112.179 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.0 m-85 -112.26 139.06 48.11 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.376 0.608 . . . . 0.0 112.05 178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.91 141.99 24.9 Favored 'General case' 0 N--CA 1.402 -2.849 0 CA-C-N 114.283 -1.326 . . . . 0.0 108.779 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 90.0 mt -76.06 159.13 31.09 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.38 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 45.5 tt0 -143.25 150.5 39.37 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -80.16 128.96 71.6 Favored Pre-proline 0 N--CA 1.438 -1.06 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.18 -15.72 43.21 Favored 'Trans proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.763 2.309 . . . . 0.0 115.226 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -109.37 -45.52 3.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 119.255 -0.978 . . . . 0.0 112.756 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -88.97 -17.62 29.1 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.465 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.3 mt 70.91 15.02 6.84 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.494 1.117 . . . . 0.0 112.683 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.96 137.46 38.33 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.048 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 3.9 m-85 -85.1 174.21 9.87 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.045 0.45 . . . . 0.0 111.61 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -117.35 107.57 22.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -108.51 12.34 26.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.004 0.907 . . . . 0.0 110.293 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.38 157.58 33.99 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.537 -1.665 . . . . 0.0 110.73 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -84.33 -40.81 17.47 Favored 'General case' 0 N--CA 1.405 -2.71 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.042 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -129.92 152.35 49.49 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 123.774 0.829 . . . . 0.0 109.409 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' HG ' HG22 ' A' ' 45' ' ' VAL . 18.0 mt -88.34 148.59 24.2 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.517 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.1 p -99.49 152.9 37.96 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.35 -35.66 92.11 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.704 2.269 . . . . 0.0 110.125 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.39 -48.96 77.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.482 0.713 . . . . 0.0 110.511 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -61.48 -37.27 83.01 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 123.304 0.377 . . . . 0.0 111.626 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 63.6 mt -64.85 -47.98 75.96 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.694 0.621 . . . . 0.0 110.578 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 52.1 t -63.99 -44.83 97.95 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -61.68 -27.68 68.86 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.798 173.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.43 -36.33 24.3 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -53.93 -24.56 16.73 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -50.29 -39.81 46.59 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.724 0.81 . . . . 0.0 111.021 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.6 m -147.74 -92.35 0.08 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -146.46 178.46 8.25 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.512 0.725 . . . . 0.0 109.424 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -116.65 154.41 30.59 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 14.3 mt -116.33 139.78 41.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 170.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -116.22 109.12 17.0 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -127.95 160.88 30.5 Favored 'General case' 0 CA--C 1.467 -2.248 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.696 -171.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 54.8 mtp -80.44 136.36 36.32 Favored 'General case' 0 N--CA 1.397 -3.08 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -60.96 116.5 19.03 Favored Pre-proline 0 C--N 1.286 -2.183 0 O-C-N 124.358 1.036 . . . . 0.0 109.63 173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.17 102.48 0.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.755 2.303 . . . . 0.0 111.774 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -89.01 99.95 12.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.441 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -153.51 -176.93 6.03 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.817 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.2 mt -95.93 133.19 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.68 82.81 0.87 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 122.093 0.949 . . . . 0.0 109.948 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -138.95 89.87 2.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.352 -178.505 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.152 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.98 -176.83 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.526 1.13 . . . . 0.0 110.868 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -93.12 107.77 19.5 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.001 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.3 mmm -85.64 126.64 34.08 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.506 176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.88 56.68 0.08 OUTLIER Glycine 0 C--N 1.293 -1.848 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.05 57.31 0.67 Allowed Glycine 0 N--CA 1.418 -2.513 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 p -84.76 142.6 29.7 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.525 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.8 mmt -118.31 138.47 52.37 Favored 'General case' 0 CA--C 1.47 -2.113 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.909 -172.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 76.4 tttt -97.18 93.07 6.34 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -102.86 140.08 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.211 -171.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 86.2 mtt180 -70.13 129.62 39.91 Favored 'General case' 0 CA--C 1.475 -1.932 0 O-C-N 123.516 0.51 . . . . 0.0 110.113 172.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 34' ' ' SER . 41.2 t -115.49 124.74 72.3 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.546 0 CA-C-O 117.675 -1.155 . . . . 0.0 108.092 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.268 47.0 mt-10 -85.54 145.39 27.41 Favored 'General case' 0 N--CA 1.428 -1.538 0 C-N-CA 116.829 -1.948 . . . . 0.0 107.764 168.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -116.14 131.66 56.88 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.078 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.42 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -108.36 119.61 58.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 169.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' HB2' HD11 ' A' ' 14' ' ' LEU . 64.4 t30 -129.18 19.74 5.87 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 172.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.52 174.87 50.17 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 112.613 -2.085 . . . . 0.0 111.095 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -96.32 4.0 52.58 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.943 0.878 . . . . 0.0 109.914 176.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.42 -179.53 4.66 Favored 'General case' 0 N--CA 1.407 -2.58 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.276 176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.2 m80 74.13 83.26 0.11 Allowed 'General case' 0 CA--C 1.508 -0.649 0 C-N-CA 124.329 1.051 . . . . 0.0 108.432 -172.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -73.42 144.2 46.43 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.837 -174.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p 55.61 31.91 18.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.256 1.022 . . . . 0.0 111.036 -175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.6 m -150.83 -40.95 0.12 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.354 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -146.49 100.22 3.32 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 122.06 0.933 . . . . 0.0 111.966 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 p -143.25 166.1 22.02 Favored Pre-proline 0 C--N 1.275 -2.655 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.38 88.17 0.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.807 1.672 . . . . 0.0 109.739 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -90.31 21.08 4.01 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -138.78 117.6 9.3 Favored Pre-proline 0 C--N 1.274 -2.697 0 CA-C-N 113.774 -1.557 . . . . 0.0 106.912 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.74 46.34 1.66 Allowed 'Trans proline' 0 N--CA 1.485 1.021 0 C-N-CA 123.091 2.527 . . . . 0.0 110.627 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -141.78 -56.31 0.47 Allowed 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 124.592 1.157 . . . . 0.0 108.791 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -140.8 -158.82 0.89 Allowed 'General case' 0 N--CA 1.427 -1.581 0 C-N-CA 124.615 1.166 . . . . 0.0 109.197 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.462 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 4.4 m-20 -72.38 -179.02 0.72 Allowed Pre-proline 0 C--O 1.257 1.458 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 169.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 32' ' ' ASN . 5.2 Cg_endo -52.38 129.44 31.67 Favored 'Trans proline' 0 C--N 1.384 2.436 0 N-CA-C 108.134 -1.525 . . . . 0.0 108.134 169.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.1 p -140.56 162.16 36.02 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.263 -171.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -151.37 149.45 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.456 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.0 m -98.23 107.36 19.82 Favored 'General case' 0 N--CA 1.386 -3.645 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -113.93 146.59 39.87 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.469 -170.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.0 mm -81.73 112.02 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.426 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -112.96 146.04 39.73 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.3 173.95 14.93 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 123.535 0.734 . . . . 0.0 109.159 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.54 14.98 56.36 Favored Glycine 0 C--N 1.304 -1.228 0 O-C-N 124.413 1.071 . . . . 0.0 112.825 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -108.97 -32.11 7.38 Favored 'General case' 0 N--CA 1.403 -2.785 0 CA-C-O 121.209 0.528 . . . . 0.0 112.063 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.8 m -93.72 134.2 36.29 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.59 0.756 . . . . 0.0 109.317 175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.77 149.1 6.53 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 124.041 0.936 . . . . 0.0 110.942 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG22 ' HG ' ' A' ' 82' ' ' LEU . 96.7 t -55.29 -53.14 38.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.523 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -59.36 -28.36 66.78 Favored 'General case' 0 C--O 1.204 -1.313 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.434 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.525 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.1 m-20 -73.35 -39.1 65.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -61.89 -38.48 88.49 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 39.3 mt -69.22 -43.99 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.13 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.2 mttt -56.91 -34.18 67.67 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 118.985 0.811 . . . . 0.0 110.603 174.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 47' ' ' ASP . 96.2 t -69.17 -55.51 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.445 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -53.1 -49.19 66.99 Favored 'General case' 0 C--N 1.315 -0.909 0 O-C-N 123.301 0.375 . . . . 0.0 111.55 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.5 mt -56.46 -48.55 76.84 Favored 'General case' 0 C--O 1.201 -1.465 0 O-C-N 123.646 0.591 . . . . 0.0 110.138 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.7 m -59.81 -36.79 77.49 Favored 'General case' 0 N--CA 1.397 -3.109 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -73.43 -32.13 64.22 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 43.9 m-85 -84.64 -3.95 58.76 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 122.883 0.473 . . . . 0.0 111.688 174.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm 70.49 35.76 1.87 Allowed 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.219 1.408 . . . . 0.0 112.718 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 87.3 mt -105.23 132.1 21.17 Favored Pre-proline 0 N--CA 1.409 -2.511 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -53.82 135.36 62.61 Favored 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 122.07 1.847 . . . . 0.0 111.267 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.537 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -62.32 -9.52 3.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.519 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.904 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -68.01 -16.39 64.02 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 120.874 0.368 . . . . 0.0 110.11 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -88.58 -5.11 58.39 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.619 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.3 p -47.6 -33.4 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 C-N-CA 125.933 1.693 . . . . 0.0 110.995 177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.276 15.3 m -54.8 -48.56 72.58 Favored 'General case' 0 N--CA 1.427 -1.621 0 C-N-CA 126.061 1.745 . . . . 0.0 110.444 174.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.7 m -102.11 17.73 22.56 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 114.317 -1.31 . . . . 0.0 111.821 -172.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 18.4 m-85 -116.76 142.65 46.64 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 120.948 0.404 . . . . 0.0 110.613 175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.73 146.44 25.75 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.222 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 85.9 mt -79.61 126.39 30.83 Favored 'General case' 0 N--CA 1.418 -2.057 0 O-C-N 124.71 1.256 . . . . 0.0 107.846 174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.507 ' OE1' ' HD2' ' A' ' 98' ' ' ARG . 38.8 tt0 -114.21 147.8 38.37 Favored 'General case' 0 C--N 1.279 -2.497 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.05 125.7 84.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.25 -8.34 22.61 Favored 'Trans proline' 0 C--N 1.322 -0.861 0 C-N-CA 122.655 2.237 . . . . 0.0 115.169 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.47 -40.75 3.56 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.298 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 73.2 p -90.44 -20.79 22.35 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.069 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mt 70.59 18.91 6.33 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.797 1.239 . . . . 0.0 111.977 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.28 140.86 30.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.634 178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' OH ' ' HD3' ' A' ' 98' ' ' ARG . 80.9 m-85 -98.14 144.53 27.51 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.822 0.344 . . . . 0.0 110.23 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 95.4 t -77.15 106.53 7.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -100.26 12.14 37.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.062 0.934 . . . . 0.0 110.362 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -77.15 152.21 34.98 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.371 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.9 m -79.12 -36.98 39.73 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.152 173.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -131.34 143.83 50.8 Favored 'General case' 0 N--CA 1.417 -2.125 0 C-N-CA 124.115 0.966 . . . . 0.0 108.806 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.9 mt -77.49 157.54 30.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.39 0.614 . . . . 0.0 111.257 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.511 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.0 p -111.71 153.64 44.27 Favored Pre-proline 0 N--CA 1.409 -2.477 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.28 -34.93 72.29 Favored 'Trans proline' 0 C--O 1.21 -0.91 0 C-N-CA 122.35 2.034 . . . . 0.0 110.349 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -56.86 -48.49 77.98 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.336 0.654 . . . . 0.0 110.858 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.437 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.1 mmp_? -61.11 -38.85 87.8 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.369 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 52.4 mt -67.69 -48.09 67.55 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.727 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.22 -47.56 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.26 -29.66 70.46 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.253 0.549 . . . . 0.0 111.784 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.45 -37.03 60.58 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.78 -24.23 48.89 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -53.0 -43.79 66.74 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.3 m -137.63 -82.46 0.34 Allowed 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -165.22 178.55 6.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.16 1.384 . . . . 0.0 108.489 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -117.53 155.07 30.4 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 11.7 mt -115.39 138.51 45.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 172.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.39 99.26 7.06 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.507 ' HD2' ' OE1' ' A' ' 69' ' ' GLN . 44.0 mtp180 -119.67 162.63 18.69 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -172.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 41.2 mtp -78.6 125.92 30.02 Favored 'General case' 0 N--CA 1.393 -3.288 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -59.01 150.8 59.46 Favored Pre-proline 0 C--N 1.288 -2.103 0 O-C-N 124.454 1.096 . . . . 0.0 109.867 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -51.25 99.29 0.04 OUTLIER 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 123.609 2.873 . . . . 0.0 114.903 -173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -135.1 115.81 13.85 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 113.09 -1.868 . . . . 0.0 106.547 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.84 -165.13 0.78 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.2 mt -60.89 113.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.467 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.17 98.68 9.06 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -171.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -103.44 77.65 1.53 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 172.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.236 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.577 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.178 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.16 -172.48 0.17 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.331 1.053 . . . . 0.0 111.819 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -91.79 110.93 22.28 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.645 0.259 . . . . 0.0 111.191 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.45 105.49 17.64 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.21 -40.05 5.56 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.27 -44.62 1.2 Allowed Glycine 0 CA--C 1.484 -1.849 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m -82.79 133.67 35.14 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.689 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 44.6 mtt -114.13 139.41 49.35 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.566 -170.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -100.36 96.87 7.72 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.6 mt -107.43 138.58 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.851 -172.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 17.3 mtp180 -68.21 131.13 44.83 Favored 'General case' 0 CA--C 1.46 -2.503 0 CA-C-O 122.146 0.974 . . . . 0.0 111.947 170.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' SER . 61.5 t -118.15 123.51 71.73 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.361 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.155 178.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 11' ' ' ARG 0.272 0.5 OUTLIER -83.98 149.42 26.31 Favored 'General case' 0 N--CA 1.414 -2.258 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.213 166.451 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -123.34 130.66 53.03 Favored 'General case' 0 C--N 1.265 -3.08 0 O-C-N 123.469 0.481 . . . . 0.0 111.084 176.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.6 mp -109.82 119.4 58.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.29 169.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -129.36 45.08 2.86 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.44 31.97 0.83 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 114.865 -1.061 . . . . 0.0 115.729 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -87.85 -14.25 39.96 Favored 'General case' 0 CA--C 1.494 -1.193 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.5 6.71 16.54 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.422 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.8 m80 -137.47 92.17 2.67 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.85 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -128.55 -170.1 2.19 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p 55.08 -153.06 0.33 Allowed 'General case' 0 C--O 1.249 1.059 0 C-N-CA 122.869 0.468 . . . . 0.0 110.107 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.3 m -56.44 -32.93 65.37 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 122.711 0.404 . . . . 0.0 111.302 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m 80.62 126.09 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.042 1.337 . . . . 0.0 113.056 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.584 ' HB ' ' NE2' ' A' ' 27' ' ' GLN . 10.4 p -64.05 160.62 46.32 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 113.166 -1.834 . . . . 0.0 112.238 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.86 32.1 0.51 Allowed 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 123.223 2.616 . . . . 0.0 114.082 -176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.584 ' NE2' ' HB ' ' A' ' 25' ' ' THR . 2.4 mp0 -94.23 42.25 1.09 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.395 1.078 . . . . 0.0 109.995 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -39.69 113.66 0.89 Allowed Pre-proline 0 C--O 1.249 1.03 0 O-C-N 125.543 1.777 . . . . 0.0 112.073 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -74.47 89.53 1.08 Allowed 'Trans proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.489 2.126 . . . . 0.0 110.799 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -71.57 -42.39 67.88 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -121.85 158.67 28.41 Favored 'General case' 0 N--CA 1.403 -2.817 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 170.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -105.12 152.57 39.74 Favored Pre-proline 0 C--N 1.27 -2.867 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -48.74 130.4 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.378 2.719 . . . . 0.0 110.533 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 6.2 m -138.6 155.79 48.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.1 p -147.98 150.2 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.497 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.4 m -98.11 105.36 17.5 Favored 'General case' 0 N--CA 1.387 -3.616 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -109.59 147.79 32.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.402 -170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.9 113.84 23.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.31 146.0 40.13 Favored 'General case' 0 C--N 1.269 -2.929 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 176.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -144.36 -171.89 3.68 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.58 -11.44 11.6 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 120.56 -0.828 . . . . 0.0 111.559 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -83.07 -26.11 31.41 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 124.197 0.999 . . . . 0.0 111.996 -176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.584 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 36.7 m -96.2 131.7 42.4 Favored 'General case' 0 N--CA 1.388 -3.561 0 C-N-CA 123.793 0.837 . . . . 0.0 109.631 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.0 149.57 9.0 Favored 'General case' 0 C--O 1.252 1.198 0 O-C-N 123.867 0.73 . . . . 0.0 110.844 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.6 t -55.66 -51.78 54.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.87 -31.0 64.37 Favored 'General case' 0 C--O 1.202 -1.427 0 O-C-N 124.381 1.05 . . . . 0.0 111.387 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.0 m-20 -75.42 -38.9 59.56 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.584 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -61.71 -40.23 94.29 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.8 mt -68.34 -42.46 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.394 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -58.13 -34.36 70.16 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.89 0.768 . . . . 0.0 110.977 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.0 t -68.97 -53.38 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.4 -48.28 68.8 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.22 177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.8 mt -57.84 -48.39 79.9 Favored 'General case' 0 C--O 1.193 -1.91 0 O-C-N 123.538 0.523 . . . . 0.0 109.988 178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.7 m -60.14 -38.91 84.54 Favored 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -72.11 -30.4 65.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 122.1 -0.375 . . . . 0.0 111.52 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 41.2 m-85 -88.56 -0.24 57.04 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.377 0.608 . . . . 0.0 112.201 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt 69.0 32.46 3.77 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 125.661 1.584 . . . . 0.0 112.28 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.5 mt -103.16 135.6 19.37 Favored Pre-proline 0 N--CA 1.406 -2.649 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.86 133.02 53.32 Favored 'Trans proline' 0 CA--C 1.5 -1.189 0 C-N-CA 121.96 1.773 . . . . 0.0 111.918 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 28.0 m -62.59 -9.27 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 CA-C-N 114.535 -1.211 . . . . 0.0 113.795 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -70.98 -18.38 62.62 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.634 0.731 . . . . 0.0 109.585 178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -82.4 -9.99 59.23 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.903 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.7 p -46.04 -31.6 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 C-N-CA 126.902 2.081 . . . . 0.0 110.741 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 m -54.67 -45.97 73.97 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.903 1.681 . . . . 0.0 111.067 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 99' ' ' MET . 15.4 t -97.96 0.33 46.22 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.618 -173.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -103.59 137.23 41.94 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.405 -175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.25 145.45 31.28 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.567 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.2 mt -82.54 123.93 29.65 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -111.07 148.48 32.54 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 -82.37 126.71 73.38 Favored Pre-proline 0 C--N 1.308 -1.222 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 18.6 Cg_endo -60.63 -23.62 76.31 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.419 2.746 . . . . 0.0 114.82 -178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -103.84 -46.17 4.57 Favored 'General case' 0 N--CA 1.428 -1.56 0 C-N-CA 118.47 -1.292 . . . . 0.0 112.855 -174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -88.01 -17.1 31.95 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.557 -174.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt 66.42 18.21 10.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 111.285 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.95 138.24 35.0 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.145 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -96.16 143.99 26.79 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.3 102.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.322 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.1 13.98 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 123.037 1.398 . . . . 0.0 108.537 -176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.55 158.56 31.08 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 112.729 -2.032 . . . . 0.0 109.999 177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 61.5 m -84.88 -37.82 20.17 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.824 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -129.58 155.4 45.87 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.965 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.76 147.15 23.42 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.174 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.0 p -98.99 151.06 37.23 Favored Pre-proline 0 N--CA 1.401 -2.913 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.51 -33.85 93.56 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.245 1.963 . . . . 0.0 109.975 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.56 -47.41 85.68 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.022 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -61.3 -36.01 78.9 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.689 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 68.2 mt -64.09 -50.15 69.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 O-C-N 123.697 0.623 . . . . 0.0 110.485 176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.24 -43.36 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -58.77 -32.99 69.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.76 172.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -80.11 -42.43 23.6 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.681 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 11.7 mt-10 -52.2 -25.28 8.76 Favored 'General case' 0 C--N 1.369 1.441 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -53.52 -36.81 62.18 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 124.367 1.067 . . . . 0.0 112.258 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -143.99 -83.14 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -165.92 -178.75 4.88 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 123.668 0.787 . . . . 0.0 109.263 -177.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.12 148.29 43.22 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 168.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.404 HG22 ' HG2' ' A' ' 98' ' ' ARG . 10.9 mt -114.95 100.69 11.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.621 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.79 103.24 8.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.404 ' HG2' HG22 ' A' ' 96' ' ' ILE . 30.0 mtp180 -126.34 162.48 25.41 Favored 'General case' 0 CA--C 1.485 -1.558 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.685 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.458 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 45.5 mtp -78.33 133.28 37.63 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 167.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.9 153.36 88.64 Favored Pre-proline 0 C--N 1.288 -2.074 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -54.25 111.68 0.78 Allowed 'Trans proline' 0 C--O 1.249 1.026 0 C-N-CA 123.298 2.665 . . . . 0.0 112.822 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -135.05 148.63 49.94 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.249 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.86 -176.04 2.24 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 78.2 mt -71.24 141.56 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.689 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 69.31 70.12 0.26 Allowed 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 125.196 1.398 . . . . 0.0 109.075 -171.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -101.61 80.28 2.03 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.109 -1.859 . . . . 0.0 111.11 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.46 ' HD3' ' H ' ' A' ' 107' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.268 -2.948 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.285 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.696 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.55 -164.84 1.23 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 0.263 34.6 p-80 52.95 66.38 1.25 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.387 1.075 . . . . 0.0 112.499 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 71.75 76.38 0.17 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.594 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.2 6.36 79.81 Favored Glycine 0 C--N 1.314 -0.649 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.187 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.41 72.76 1.18 Allowed Glycine 0 CA--C 1.493 -1.29 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.5 m -73.58 131.96 42.28 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 121.484 0.659 . . . . 0.0 110.968 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 42.3 mtt -115.57 141.09 48.53 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.494 -172.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -99.63 95.07 6.72 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.9 mt -106.86 138.69 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.585 -1.188 . . . . 0.0 110.849 -172.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 54.9 mtm-85 -69.39 131.53 44.93 Favored 'General case' 0 CA--C 1.481 -1.683 0 CA-C-O 121.623 0.725 . . . . 0.0 110.841 172.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' SER . 46.7 t -119.19 124.07 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.578 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.216 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' O ' HG12 ' A' ' 12' ' ' VAL . 31.4 mm-40 -81.18 158.88 24.77 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 170.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -130.81 133.17 45.73 Favored 'General case' 0 C--N 1.281 -2.41 0 O-C-N 122.074 -0.391 . . . . 0.0 111.091 175.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.45 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -110.15 113.4 44.12 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -111.31 12.07 21.65 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 122.529 1.157 . . . . 0.0 109.284 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 15' ' ' ILE . . . 146.43 -171.81 27.17 Favored Glycine 0 C--N 1.275 -2.809 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 -175.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -125.36 -2.22 7.51 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 118.594 1.197 . . . . 0.0 109.989 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -87.69 147.92 25.01 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.424 -170.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.2 m80 71.5 19.55 5.12 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 71.8 mtm-85 -127.69 66.46 1.33 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 p -94.98 88.37 5.24 Favored 'General case' 0 N--CA 1.409 -2.475 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.753 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.4 m -75.37 94.67 3.1 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.2 t -93.02 -2.95 55.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.044 0.926 . . . . 0.0 109.525 -177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.93 172.68 9.19 Favored Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.513 178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.69 51.34 1.17 Allowed 'Trans proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.041 2.494 . . . . 0.0 111.378 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.16 84.05 1.64 Allowed 'General case' 0 N--CA 1.383 -3.799 0 C-N-CA 128.042 2.537 . . . . 0.0 105.073 -174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 30' ' ' GLN . 13.3 mm100 -42.08 134.2 2.44 Favored Pre-proline 0 C--N 1.289 -2.052 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.539 179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.26 25.18 0.31 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 123.944 3.096 . . . . 0.0 113.879 -176.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 28' ' ' GLN . 92.8 mt-30 -89.81 -13.53 36.4 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.937 176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.34 140.1 29.94 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 33' ' ' PRO . 52.3 m-80 -127.58 178.29 1.67 Allowed Pre-proline 0 C--N 1.253 -3.599 0 C-N-CA 124.969 1.307 . . . . 0.0 108.693 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 32' ' ' ASN . 7.4 Cg_endo -55.04 132.08 50.2 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.623 1.549 . . . . 0.0 108.139 166.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 5.5 p -140.52 161.04 38.68 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.1 p -151.46 149.07 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -97.69 105.28 17.4 Favored 'General case' 0 N--CA 1.389 -3.513 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -109.11 147.28 32.69 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.103 -170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.1 mm -83.26 110.67 18.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -113.06 149.02 34.01 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -149.48 -169.72 3.45 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.35 15.1 8.73 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -106.59 -34.19 7.43 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.677 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -93.97 134.35 36.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 C-N-CA 124.152 0.981 . . . . 0.0 108.376 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.56 151.72 7.63 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.563 0.697 . . . . 0.0 111.589 177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.405 HG22 ' HG ' ' A' ' 82' ' ' LEU . 98.5 t -55.27 -54.58 23.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.734 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -56.89 -30.43 63.88 Favored 'General case' 0 C--O 1.206 -1.236 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.628 -177.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' HG23 ' A' ' 51' ' ' VAL . 8.7 m-20 -73.79 -37.44 64.95 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.962 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -62.43 -38.67 90.63 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.4 mt -67.81 -44.22 85.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.415 ' HG3' HG21 ' A' ' 63' ' ' VAL . 95.9 mttt -57.47 -34.16 68.73 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.843 0.747 . . . . 0.0 111.129 175.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 47' ' ' ASP . 85.7 t -69.05 -54.75 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.296 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -53.66 -49.19 68.48 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.657 0.383 . . . . 0.0 111.471 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 90.1 mt -57.25 -47.41 81.46 Favored 'General case' 0 C--O 1.195 -1.806 0 O-C-N 123.38 0.425 . . . . 0.0 110.05 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.68 -38.37 84.73 Favored 'General case' 0 N--CA 1.394 -3.272 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -70.61 -37.83 73.9 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.975 0.417 . . . . 0.0 111.514 176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 57.0 m-85 -78.81 -9.52 59.48 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.389 175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtmm 74.42 39.74 0.45 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.87 1.268 . . . . 0.0 112.584 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.8 mt -108.73 140.92 22.3 Favored Pre-proline 0 N--CA 1.411 -2.382 0 C-N-CA 125.74 1.616 . . . . 0.0 107.622 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.97 134.47 53.36 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 122.222 1.948 . . . . 0.0 111.087 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.591 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.4 m -63.28 -9.63 5.13 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.89 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.801 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.48 -14.83 62.69 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.669 0.747 . . . . 0.0 110.221 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 65.1 mttm -88.98 -6.46 57.22 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.844 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.1 p -49.62 -29.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 C-N-CA 126.287 1.835 . . . . 0.0 109.773 175.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.5 p -54.08 -51.14 65.09 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 126.237 1.815 . . . . 0.0 110.977 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 99' ' ' MET . 5.8 m -98.03 6.91 47.1 Favored 'General case' 0 N--CA 1.402 -2.838 0 CA-C-N 114.164 -1.38 . . . . 0.0 111.881 -171.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 16.8 m-85 -107.79 143.55 36.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.147 0.499 . . . . 0.0 111.342 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.31 145.04 25.92 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.29 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 83.9 mt -80.97 128.13 33.34 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -118.09 149.8 40.41 Favored 'General case' 0 C--N 1.28 -2.452 0 O-C-N 122.161 -0.337 . . . . 0.0 110.101 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -81.77 132.72 53.74 Favored Pre-proline 0 C--N 1.313 -0.982 0 O-C-N 124.385 1.053 . . . . 0.0 108.276 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.48 -19.38 48.98 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.14 2.56 . . . . 0.0 115.105 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -105.01 -40.26 5.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.735 -177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -95.98 -19.51 19.44 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.328 0.585 . . . . 0.0 111.239 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mt 64.89 22.62 12.52 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.394 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.35 140.96 33.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.716 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -95.76 144.52 26.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.593 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.13 102.69 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.55 13.57 31.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 122.824 1.297 . . . . 0.0 108.752 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.75 157.04 34.02 Favored 'General case' 0 N--CA 1.405 -2.696 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.647 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 51.0 m -82.99 -38.45 22.64 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.875 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -130.33 147.91 52.09 Favored 'General case' 0 N--CA 1.418 -2.069 0 C-N-CA 124.041 0.936 . . . . 0.0 108.562 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.0 mt -79.16 154.8 29.01 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.11 0.481 . . . . 0.0 110.208 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 p -104.71 151.59 39.33 Favored Pre-proline 0 N--CA 1.399 -2.983 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.94 -31.59 93.1 Favored 'Trans proline' 0 C--O 1.211 -0.829 0 C-N-CA 122.173 1.915 . . . . 0.0 109.727 174.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -57.66 -48.66 78.87 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.494 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -62.84 -36.39 83.06 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.664 177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 72.4 mt -64.3 -48.79 74.29 Favored 'General case' 0 C--N 1.316 -0.862 0 O-C-N 123.496 0.498 . . . . 0.0 110.18 176.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.62 -46.46 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.512 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.501 ' HA ' ' HD2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -60.85 -32.87 72.26 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 112.209 171.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.82 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.48 -27.05 35.0 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 176.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 89' ' ' GLU . 95.7 mttt -54.96 -31.38 60.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.284 1.034 . . . . 0.0 112.083 174.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.8 m -143.81 -86.76 0.13 Allowed 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.426 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.5 OUTLIER -167.38 178.79 5.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.003 1.321 . . . . 0.0 108.527 -176.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -114.89 159.71 20.36 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 168.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 2.9 mp -120.22 141.61 39.71 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.781 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 167.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.28 98.38 6.73 Favored 'General case' 0 C--N 1.268 -2.966 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 -178.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -115.69 161.21 19.03 Favored 'General case' 0 CA--C 1.464 -2.363 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.071 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.3 mtp -78.01 134.25 37.83 Favored 'General case' 0 N--CA 1.391 -3.403 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 165.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 8.3 mtpm? -69.23 134.06 89.37 Favored Pre-proline 0 C--N 1.276 -2.593 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 100' ' ' LYS . 81.3 Cg_exo -53.92 118.2 4.71 Favored 'Trans proline' 0 C--O 1.24 0.58 0 C-N-CA 123.52 2.813 . . . . 0.0 113.516 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -134.96 165.36 25.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.228 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 64.14 167.3 0.16 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 113.183 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.6 mt -83.62 115.0 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.04 156.22 25.97 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -80.66 66.24 6.1 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 122.514 1.149 . . . . 0.0 111.282 -177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.133 177.381 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.416 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.87 81.83 0.2 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.472 1.509 . . . . 0.0 113.933 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.74 166.24 25.28 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.4 mmm 60.83 29.68 19.17 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 122.383 1.087 . . . . 0.0 109.893 -178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.21 83.02 0.65 Allowed Glycine 0 N--CA 1.416 -2.651 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.58 -33.47 42.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m -86.1 134.3 33.83 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.495 ' CG ' ' HB3' ' A' ' 87' ' ' LEU . 10.6 mmt -110.08 141.43 42.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.394 -170.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 64.7 tttt -101.62 95.75 6.65 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 90' ' ' ALA . 86.2 mt -105.51 140.33 23.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.334 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.3 mtp180 -70.9 134.18 47.05 Favored 'General case' 0 CA--C 1.466 -2.283 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.867 173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.85 123.36 71.58 Favored 'Isoleucine or valine' 2 N--CA 1.37 -4.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.6 OUTLIER -84.49 148.49 26.51 Favored 'General case' 0 N--CA 1.407 -2.581 0 C-N-CA 116.25 -2.18 . . . . 0.0 107.843 167.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.533 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 1.5 tm? -115.0 134.38 55.24 Favored 'General case' 0 C--N 1.278 -2.517 0 O-C-N 123.28 0.362 . . . . 0.0 110.6 176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.4 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -107.13 118.11 54.26 Favored 'Isoleucine or valine' 0 C--O 1.251 1.165 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 169.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -169.25 85.96 0.15 Allowed 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.45 61.32 0.13 Allowed Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.684 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -79.69 -34.17 40.46 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.7 mp0 -75.01 81.48 2.21 Favored 'General case' 0 N--CA 1.415 -2.198 0 CA-C-N 113.522 -1.672 . . . . 0.0 107.785 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.8 m80 65.57 107.75 0.04 OUTLIER 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.415 1.086 . . . . 0.0 113.394 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 29' ' ' PRO . 95.4 mtt180 -75.96 136.6 40.03 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p 62.46 -163.12 0.27 Allowed 'General case' 0 C--O 1.255 1.383 0 C-N-CA 124.991 1.316 . . . . 0.0 110.507 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.8 t -113.26 19.31 17.18 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.4 m 66.43 80.12 0.23 Allowed 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.272 -175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.5 p -116.87 167.34 10.86 Favored Pre-proline 0 C--N 1.271 -2.826 0 CA-C-N 112.975 -1.921 . . . . 0.0 108.393 -178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.35 33.26 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.563 2.175 . . . . 0.0 112.378 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -99.82 -0.81 39.02 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 122.105 0.955 . . . . 0.0 110.162 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' HB3' ' HG2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER 45.65 99.93 0.03 OUTLIER Pre-proline 0 C--N 1.287 -2.144 0 CA-C-N 112.204 -2.271 . . . . 0.0 114.391 -176.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' A' ' 21' ' ' ARG . 84.8 Cg_endo -80.37 42.79 1.39 Allowed 'Trans proline' 0 CA--C 1.553 1.425 0 C-N-CA 123.28 2.653 . . . . 0.0 112.801 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HG2' ' HB3' ' A' ' 28' ' ' GLN . 10.2 mm100 -68.29 -35.76 78.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.751 -177.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -108.81 -173.01 2.17 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.041 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -97.12 158.3 33.53 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 170.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -58.37 131.06 40.65 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 C-N-CA 121.989 1.793 . . . . 0.0 109.614 171.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -139.12 159.8 41.3 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 10.5 p -150.37 151.08 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.4 m -99.44 107.25 19.42 Favored 'General case' 0 N--CA 1.39 -3.445 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.0 t60 -112.56 146.57 38.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.916 -170.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.6 mm -83.27 111.31 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.97 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -112.36 144.82 41.15 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HB2' ' OE2' ' A' ' 42' ' ' GLU . 2.8 p30 -146.02 -168.52 3.01 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.13 -9.45 8.05 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.91 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.411 ' OE2' ' HB2' ' A' ' 40' ' ' ASP . 2.0 mp0 -82.46 -26.86 32.27 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 121.81 0.814 . . . . 0.0 110.683 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.601 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 26.5 m -95.98 129.53 43.22 Favored 'General case' 0 N--CA 1.383 -3.825 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.12 149.24 9.76 Favored 'General case' 0 C--O 1.25 1.093 0 CA-C-O 121.525 0.679 . . . . 0.0 110.99 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG22 ' HG ' ' A' ' 82' ' ' LEU . 99.0 t -53.05 -53.8 20.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.313 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -54.88 -32.16 60.55 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 124.612 1.195 . . . . 0.0 111.722 -177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.403 ' O ' HG23 ' A' ' 51' ' ' VAL . 22.8 m-20 -78.79 -34.32 45.59 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.906 -0.496 . . . . 0.0 111.635 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.601 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.7 m-70 -62.24 -39.36 92.59 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 169.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.577 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 37.1 mt -66.51 -42.91 90.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.396 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -56.02 -37.81 69.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.683 0.674 . . . . 0.0 110.672 174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 47' ' ' ASP . 87.9 t -67.07 -53.22 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.093 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 49' ' ' ILE . 18.7 mt -54.31 -47.75 72.11 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 123.311 0.382 . . . . 0.0 110.902 176.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -56.92 -49.03 76.86 Favored 'General case' 0 C--O 1.194 -1.863 0 O-C-N 123.519 0.512 . . . . 0.0 109.816 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -60.28 -37.82 81.68 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -74.06 -29.3 61.82 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.172 0.51 . . . . 0.0 111.867 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.533 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -88.55 0.98 55.77 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.476 0.655 . . . . 0.0 111.947 174.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? 67.18 40.8 2.73 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.48 1.512 . . . . 0.0 113.124 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.5 mt -110.87 136.93 20.72 Favored Pre-proline 0 N--CA 1.404 -2.766 0 C-N-CA 124.679 1.192 . . . . 0.0 108.385 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.05 134.61 63.3 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 122.606 2.204 . . . . 0.0 110.828 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.615 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 34.3 m -63.33 -9.85 5.54 Favored 'Isoleucine or valine' 0 C--O 1.182 -2.487 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.627 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -70.63 -14.33 62.44 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.649 0.737 . . . . 0.0 110.692 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -87.26 -5.87 58.77 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.029 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -48.87 -31.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 126.787 2.035 . . . . 0.0 110.756 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 m -55.86 -46.11 78.32 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 125.094 1.358 . . . . 0.0 110.59 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 99' ' ' MET . 22.2 m -101.71 14.83 30.8 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-N 114.585 -1.189 . . . . 0.0 111.876 -173.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.495 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 14.4 m-85 -115.49 144.05 44.41 Favored 'General case' 0 C--N 1.289 -2.044 0 O-C-N 121.789 -0.569 . . . . 0.0 111.627 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.29 156.14 31.93 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.006 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.93 133.38 33.94 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.05 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.76 149.05 42.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -81.04 131.65 58.98 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.1 Cg_endo -66.35 -25.73 48.96 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.611 2.207 . . . . 0.0 114.893 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.22 -44.05 5.79 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 119.402 -0.919 . . . . 0.0 113.167 -174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.03 -20.09 24.82 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.728 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 mt 69.45 16.48 8.21 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 124.256 1.022 . . . . 0.0 111.797 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.54 137.92 37.33 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.049 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -92.75 152.08 19.69 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.264 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -92.61 103.56 14.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -105.86 10.62 32.46 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.144 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -76.79 159.17 30.33 Favored 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.076 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -82.92 -38.94 22.14 Favored 'General case' 0 N--CA 1.407 -2.618 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.116 176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -129.04 156.03 44.48 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.834 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -93.03 143.98 25.7 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.076 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.489 ' OG1' ' HG2' ' A' ' 86' ' ' ARG . 77.5 p -93.44 153.72 41.37 Favored Pre-proline 0 N--CA 1.409 -2.485 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.09 -32.0 94.49 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.896 1.731 . . . . 0.0 109.138 174.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -60.31 -46.14 90.92 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.053 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.489 ' HG2' ' OG1' ' A' ' 83' ' ' THR . 7.1 mmm180 -58.86 -39.35 81.06 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-O 120.569 0.223 . . . . 0.0 111.349 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 8' ' ' MET . 62.9 mt -64.39 -46.56 82.77 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 124.095 0.872 . . . . 0.0 110.359 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.2 -45.53 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.06 -30.55 69.28 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -80.88 -37.14 30.32 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.981 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -54.33 -24.28 18.68 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -51.21 -43.98 61.5 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.14 0.576 . . . . 0.0 110.586 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 m -142.48 -86.75 0.15 Allowed 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -157.3 -178.93 7.72 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 123.996 0.918 . . . . 0.0 109.427 -177.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.09 148.32 44.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 169.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -114.23 100.34 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.303 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.78 103.72 8.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -122.59 162.09 22.49 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.573 -173.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.495 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 51.4 mtp -79.6 129.05 34.13 Favored 'General case' 0 N--CA 1.398 -3.048 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -69.34 135.64 88.85 Favored Pre-proline 0 C--N 1.281 -2.402 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.064 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -48.91 108.06 0.17 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 123.218 2.612 . . . . 0.0 110.456 175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -115.78 131.42 56.94 Favored 'General case' 0 N--CA 1.411 -2.382 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.689 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.07 158.77 27.77 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.595 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.3 mt -72.25 117.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.823 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.13 125.5 30.95 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -84.9 75.2 10.39 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.396 1.093 . . . . 0.0 110.345 -178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 . . . . . 0 C--N 1.29 -2.001 0 CA-C-N 111.924 -2.398 . . . . 0.0 110.143 178.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.874 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.55 64.24 1.82 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.087 0.955 . . . . 0.0 111.37 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -81.54 100.87 9.6 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.804 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.4 mmm -93.37 105.2 17.3 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -142.24 -110.79 0.81 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.44 85.86 1.3 Allowed Glycine 0 N--CA 1.408 -3.21 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.1 m -68.57 133.56 48.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.786 0.803 . . . . 0.0 110.26 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.521 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.2 mmt -115.55 140.43 49.17 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.143 -170.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 76.1 tttt -97.5 96.42 8.32 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 174.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.1 mt -106.35 138.5 31.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.298 -1.319 . . . . 0.0 110.762 -172.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -69.74 133.69 47.77 Favored 'General case' 0 CA--C 1.47 -2.127 0 CA-C-O 121.293 0.568 . . . . 0.0 110.341 172.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -118.07 121.57 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.885 0 CA-C-O 117.639 -1.172 . . . . 0.0 108.374 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 39.6 mt-10 -80.37 147.17 31.15 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 116.673 -2.011 . . . . 0.0 106.774 168.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -116.83 131.89 56.84 Favored 'General case' 0 C--N 1.272 -2.771 0 O-C-N 123.294 0.371 . . . . 0.0 110.612 175.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -110.96 122.77 66.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 167.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -133.28 66.95 1.54 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.546 1.165 . . . . 0.0 109.296 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.81 69.36 1.13 Allowed Glycine 0 C--N 1.292 -1.909 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.365 176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.49 -14.93 39.05 Favored 'General case' 0 CA--C 1.483 -1.615 0 CA-C-O 121.696 0.76 . . . . 0.0 110.158 -176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.43 -15.19 60.92 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.399 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -118.03 -19.0 9.29 Favored 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.631 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 76.14 -22.53 0.27 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.74 1.616 . . . . 0.0 112.433 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p 55.52 69.91 0.69 Allowed 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 125.135 1.374 . . . . 0.0 113.433 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.5 m 67.4 178.1 0.24 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.154 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.5 m -102.85 20.65 17.01 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.912 0.863 . . . . 0.0 109.148 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -63.68 149.34 92.8 Favored Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.027 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -75.67 93.41 1.0 Allowed 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.275 1.983 . . . . 0.0 114.037 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.98 6.3 49.18 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.124 0.964 . . . . 0.0 110.178 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 67.85 99.04 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 C-N-CA 127.763 2.425 . . . . 0.0 112.791 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.86 87.74 1.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.743 2.296 . . . . 0.0 112.64 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -137.24 -58.76 0.7 Allowed 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -130.66 -165.22 1.52 Allowed 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -76.61 166.85 41.67 Favored Pre-proline 0 C--N 1.29 -1.993 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -47.03 133.32 18.26 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.213 1.942 . . . . 0.0 110.012 174.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 14.7 m -138.25 163.99 30.36 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.175 -174.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -150.3 148.57 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 9' ' ' LYS . 5.1 m -96.72 107.37 19.82 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -112.87 145.45 40.67 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.347 -170.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 49.8 mm -83.15 112.48 20.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -112.11 143.16 43.6 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -147.28 166.89 25.69 Favored 'General case' 0 N--CA 1.424 -1.767 0 O-C-N 124.652 1.22 . . . . 0.0 108.693 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.6 18.03 56.74 Favored Glycine 0 C--N 1.279 -2.591 0 O-C-N 124.118 0.886 . . . . 0.0 112.012 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.31 -29.52 11.62 Favored 'General case' 0 N--CA 1.407 -2.576 0 CA-C-O 121.626 0.727 . . . . 0.0 111.278 -176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.533 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 83.6 m -99.67 137.74 37.73 Favored 'General case' 0 N--CA 1.387 -3.581 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.897 174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.77 147.38 18.97 Favored 'General case' 0 C--O 1.25 1.106 0 O-C-N 123.527 0.517 . . . . 0.0 110.469 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 98.0 t -53.62 -54.12 21.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.038 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -56.01 -30.77 62.33 Favored 'General case' 0 C--O 1.203 -1.364 0 O-C-N 124.226 0.953 . . . . 0.0 111.501 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.97 -36.35 59.29 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.996 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.533 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.9 m-70 -63.1 -39.82 95.81 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 171.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 35.5 mt -66.33 -42.91 91.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.801 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -57.24 -34.72 68.88 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 118.619 0.645 . . . . 0.0 111.206 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.87 -54.73 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.394 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.1 mt -53.51 -47.77 69.6 Favored 'General case' 0 C--N 1.314 -0.957 0 O-C-N 123.342 0.402 . . . . 0.0 111.024 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.3 mt -56.71 -48.04 78.61 Favored 'General case' 0 C--O 1.203 -1.379 0 O-C-N 123.548 0.53 . . . . 0.0 109.806 178.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.1 m -59.03 -39.68 82.73 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -71.52 -29.98 65.41 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.538 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 40.3 m-85 -89.54 3.29 52.94 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.311 0.577 . . . . 0.0 112.145 175.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.609 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 7.2 mmpt? 67.62 33.31 5.09 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.3 mt -105.28 138.29 19.5 Favored Pre-proline 0 N--CA 1.411 -2.399 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.09 136.23 63.83 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.223 1.948 . . . . 0.0 111.433 175.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.4 m -63.19 -9.41 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 114.839 -1.073 . . . . 0.0 113.018 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.31 -16.26 62.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.032 0.444 . . . . 0.0 110.481 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -88.5 -4.87 58.53 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.4 p -49.07 -29.21 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 127.116 2.166 . . . . 0.0 111.032 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -56.68 -47.62 79.45 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.533 1.533 . . . . 0.0 111.047 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.468 ' HB2' ' SD ' ' A' ' 99' ' ' MET . 7.3 m -98.07 1.21 47.43 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.634 -1.166 . . . . 0.0 112.227 -171.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 17.5 m-85 -105.1 141.67 36.24 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-O 120.843 0.354 . . . . 0.0 110.414 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.63 149.05 28.7 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.339 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.9 mt -82.71 124.23 30.03 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' HD22 ' A' ' 74' ' ' LEU . 20.5 tt0 -111.61 147.98 34.31 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -77.47 134.35 66.31 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 174.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 35.0 Cg_endo -65.91 -18.72 58.01 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 122.877 2.385 . . . . 0.0 115.667 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.97 -42.79 3.89 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -175.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 52.0 p -90.72 -18.26 25.31 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.048 -175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.431 HD22 ' NE2' ' A' ' 69' ' ' GLN . 7.6 mt 62.62 22.23 13.19 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.645 1.178 . . . . 0.0 112.005 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.71 143.02 31.2 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.891 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -98.01 147.19 24.76 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.203 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -83.56 105.95 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.054 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -107.33 12.07 28.48 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.957 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.57 161.7 29.05 Favored 'General case' 0 N--CA 1.428 -1.555 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.286 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.4 m -85.37 -39.69 17.33 Favored 'General case' 0 N--CA 1.407 -2.577 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.322 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -131.96 152.77 50.9 Favored 'General case' 0 N--CA 1.411 -2.4 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.367 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.2 mt -84.58 159.64 20.61 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.885 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 38.8 p -115.47 156.54 45.8 Favored Pre-proline 0 C--N 1.276 -2.624 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.49 -35.34 92.06 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.684 2.256 . . . . 0.0 109.709 174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -57.03 -49.55 75.45 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.714 176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.49 -38.37 87.07 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.106 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 83' ' ' THR . 63.8 mt -65.75 -46.17 79.83 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.036 0.835 . . . . 0.0 110.54 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.98 -45.4 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -32.55 73.4 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.341 0.591 . . . . 0.0 112.167 172.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.43 -34.32 58.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.433 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.86 -27.51 63.3 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -56.05 -34.89 66.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.881 174.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.5 m -145.08 -78.44 0.19 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -170.73 -177.55 2.34 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.369 1.467 . . . . 0.0 108.743 -178.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -119.51 152.23 37.29 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 168.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 98' ' ' ARG . 11.9 mt -118.81 101.78 12.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.066 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.433 HD12 HD23 ' A' ' 14' ' ' LEU . 0.7 OUTLIER -78.9 104.88 9.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 96' ' ' ILE . 21.5 mtp180 -127.66 165.08 20.68 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.185 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' A' ' 65' ' ' SER . 9.1 mmm -80.88 133.01 35.5 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 167.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -63.31 119.44 52.98 Favored Pre-proline 0 C--N 1.267 -3.003 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -51.67 123.27 11.9 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 124.559 3.506 . . . . 0.0 113.387 -170.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . 0.3 6.6 p-80 40.96 74.92 0.09 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 125.298 1.439 . . . . 0.0 113.32 -175.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.54 142.34 46.69 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 113.866 -1.515 . . . . 0.0 111.82 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 71.4 mt -68.06 124.74 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.42 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.629 177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -127.18 83.95 2.21 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-O 121.683 0.754 . . . . 0.0 112.203 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -114.48 -1.49 13.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.866 1.317 . . . . 0.0 108.651 173.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 . . . . . 0 C--N 1.267 -2.995 0 CA-C-N 112.631 -2.077 . . . . 0.0 107.82 -177.271 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.723 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.36 -21.65 33.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 110.167 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -139.3 99.33 3.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.9 mtm -90.36 107.3 19.06 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.35 -102.06 0.53 Allowed Glycine 0 N--CA 1.432 -1.588 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.07 50.21 2.89 Favored Glycine 0 N--CA 1.42 -2.43 0 C-N-CA 120.768 -0.73 . . . . 0.0 111.402 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.4 m -74.63 134.4 42.05 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.4 mtt -113.11 137.18 51.83 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.991 -169.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 72.1 tttt -98.08 97.49 8.94 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.5 mt -109.54 138.64 36.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.975 -172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 42.5 mtm180 -69.83 129.96 40.98 Favored 'General case' 0 CA--C 1.479 -1.754 0 CA-C-O 121.213 0.53 . . . . 0.0 109.858 173.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' SER . 43.2 t -116.33 126.13 73.67 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.388 0 CA-C-O 117.806 -1.092 . . . . 0.0 108.309 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.264 50.8 mt-10 -86.85 146.98 26.0 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 117.225 -1.79 . . . . 0.0 107.843 167.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.491 HD23 ' CD1' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -121.86 126.57 49.02 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 175.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.444 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.4 mp -102.68 107.28 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 C-N-CA 118.587 -1.245 . . . . 0.0 107.831 171.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.417 ' HB3' HD11 ' A' ' 14' ' ' LEU . 3.2 t-20 -152.94 77.21 1.15 Allowed 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 169.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.93 41.33 0.25 Allowed Glycine 0 C--N 1.276 -2.78 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.382 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -90.17 -26.73 20.0 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 1.6 mp0 -56.43 120.54 7.85 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.25 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -80.54 81.68 6.74 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -70.67 144.87 50.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.724 -172.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.0 p -86.48 75.91 9.68 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.16 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.5 t -101.19 -20.34 15.33 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.853 -177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 m 63.16 18.68 11.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.069 . . . . 0.0 111.433 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 p -148.02 155.91 43.83 Favored Pre-proline 0 N--CA 1.407 -2.621 0 C-N-CA 125.847 1.659 . . . . 0.0 107.816 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.32 48.46 1.81 Allowed 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 122.907 2.405 . . . . 0.0 111.518 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -90.37 24.43 2.58 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 122.091 0.948 . . . . 0.0 113.214 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -83.17 160.17 60.7 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -50.77 111.85 0.64 Allowed 'Trans proline' 0 C--O 1.242 0.723 0 C-N-CA 122.3 2.0 . . . . 0.0 111.834 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -67.02 -49.57 64.87 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -122.63 167.02 13.94 Favored 'General case' 0 N--CA 1.391 -3.376 0 N-CA-C 102.483 -3.154 . . . . 0.0 102.483 170.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 89.8 m-20 -74.64 138.2 73.97 Favored Pre-proline 0 C--N 1.281 -2.377 0 C-N-CA 118.243 -1.383 . . . . 0.0 109.677 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 6.1 Cg_endo -45.79 132.24 13.54 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 124.519 3.479 . . . . 0.0 110.431 174.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 19.4 p -134.02 156.85 47.46 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.253 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.488 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -152.72 149.91 13.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 15.4 m -97.9 107.23 19.67 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 52.4 t60 -110.38 145.23 37.9 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.344 -170.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.29 110.72 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -112.23 148.06 34.9 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -152.27 167.2 29.4 Favored 'General case' 0 C--N 1.292 -1.897 0 C-N-CA 124.297 1.039 . . . . 0.0 108.351 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.43 19.71 51.53 Favored Glycine 0 C--N 1.29 -1.98 0 O-C-N 124.166 0.916 . . . . 0.0 112.64 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -109.64 -22.85 11.75 Favored 'General case' 0 N--CA 1.405 -2.709 0 CA-C-O 121.638 0.732 . . . . 0.0 110.626 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.432 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 69.4 m -105.9 139.9 39.74 Favored 'General case' 0 N--CA 1.403 -2.814 0 C-N-CA 124.59 1.156 . . . . 0.0 109.791 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.02 147.86 22.99 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-O 121.396 0.617 . . . . 0.0 110.541 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' HG ' ' A' ' 82' ' ' LEU . 94.5 t -54.17 -50.1 57.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.996 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -57.29 -31.69 65.89 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.796 -176.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 51' ' ' VAL . 5.7 m-20 -73.66 -40.56 63.62 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 97.2 m-70 -61.24 -38.7 87.6 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.52 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.5 mt -67.71 -43.7 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.222 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HG3' HG21 ' A' ' 63' ' ' VAL . 65.1 mttm -56.86 -37.11 70.85 Favored 'General case' 0 C--N 1.347 0.463 0 CA-C-N 119.055 0.843 . . . . 0.0 111.092 174.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 47' ' ' ASP . 84.1 t -65.92 -53.97 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.983 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.7 -48.43 69.57 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 119.271 -0.395 . . . . 0.0 111.508 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.7 mt -57.07 -48.51 78.41 Favored 'General case' 0 C--O 1.203 -1.387 0 O-C-N 123.374 0.421 . . . . 0.0 110.317 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -59.54 -39.38 83.76 Favored 'General case' 0 N--CA 1.412 -2.338 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -71.82 -31.46 66.57 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.488 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.5 m-85 -84.35 -8.71 58.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.032 0.444 . . . . 0.0 111.303 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.1 mttp 71.29 46.17 0.44 Allowed 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 125.16 1.384 . . . . 0.0 112.608 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 76.8 mt -113.88 136.89 22.13 Favored Pre-proline 0 N--CA 1.408 -2.544 0 C-N-CA 125.815 1.646 . . . . 0.0 107.222 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.45 131.91 48.61 Favored 'Trans proline' 0 C--O 1.246 0.918 0 C-N-CA 122.375 2.05 . . . . 0.0 111.49 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 31.1 m -62.93 -9.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.267 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -68.12 -22.12 64.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.395 0.617 . . . . 0.0 109.954 178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 63.4 mttm -81.41 -5.46 57.91 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.233 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.7 p -49.72 -29.3 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 126.435 1.894 . . . . 0.0 109.776 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.4 p -55.15 -47.2 75.45 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 125.429 1.492 . . . . 0.0 110.081 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.8 m -104.64 14.92 28.98 Favored 'General case' 0 N--CA 1.4 -2.929 0 CA-C-N 114.185 -1.37 . . . . 0.0 111.7 -171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.453 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 23.7 m-85 -114.56 145.24 42.19 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.474 177.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.46 35.72 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.292 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.2 mt -95.07 154.58 17.11 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.617 ' HB2' ' NH2' ' A' ' 98' ' ' ARG . 52.9 tt0 -143.18 152.78 42.16 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -87.32 131.2 44.95 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.25 -18.59 50.54 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.89 2.394 . . . . 0.0 115.3 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -105.01 -43.32 5.08 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.408 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.3 p -89.2 -21.92 23.03 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.756 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mt 70.27 16.44 7.28 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.766 1.226 . . . . 0.0 111.576 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.91 136.99 36.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.569 ' HE2' ' HG2' ' A' ' 100' ' ' LYS . 3.0 m-85 -83.27 168.85 16.31 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.2 t -118.43 98.82 6.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.78 14.47 28.17 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.369 -174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.75 156.2 36.84 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 126.529 1.932 . . . . 0.0 109.876 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -83.59 -38.86 21.07 Favored 'General case' 0 C--N 1.275 -2.64 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.525 176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -128.51 154.95 45.6 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 45' ' ' VAL . 20.4 mt -88.53 154.48 20.31 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.195 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.3 p -112.8 156.59 42.35 Favored Pre-proline 0 C--N 1.282 -2.326 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -56.32 -35.24 95.7 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.533 2.156 . . . . 0.0 110.281 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.03 -42.97 99.47 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.268 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -64.07 -38.21 90.25 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 123.288 0.367 . . . . 0.0 111.398 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.716 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.3 mt -65.47 -49.08 70.41 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.139 0.9 . . . . 0.0 110.304 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 t -59.25 -41.17 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -59.35 -34.14 72.02 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.934 172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.67 -41.9 17.23 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.638 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 8.2 mt-10 -53.98 -23.43 13.2 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -52.74 -37.88 60.01 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 123.929 0.892 . . . . 0.0 112.121 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 m -142.43 -82.45 0.19 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -161.66 178.55 8.92 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 125.315 1.446 . . . . 0.0 108.488 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.65 150.12 38.65 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 170.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 35.4 mt -114.76 135.69 53.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.491 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.8 OUTLIER -117.4 107.34 14.23 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -176.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.617 ' NH2' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -128.11 171.27 12.05 Favored 'General case' 0 C--O 1.256 1.441 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -175.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 43.4 mtp -82.22 129.16 34.77 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 124.301 1.001 . . . . 0.0 110.179 171.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 37.7 mtmt -78.59 159.94 73.35 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 125.367 1.467 . . . . 0.0 110.999 178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.72 100.18 0.58 Allowed 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.171 1.914 . . . . 0.0 109.664 168.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -149.25 144.29 26.42 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.21 -145.47 0.61 Allowed 'General case' 0 CA--C 1.501 -0.94 0 O-C-N 124.378 1.049 . . . . 0.0 108.356 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.7 mt -65.16 91.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.405 -2.71 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 171.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.23 120.58 22.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.38 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.47 80.58 8.05 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.117 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 . . . . . 0 C--N 1.28 -2.448 0 CA-C-N 112.812 -1.995 . . . . 0.0 110.115 175.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.764 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.4 100.14 9.1 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 117.355 0.577 . . . . 0.0 110.202 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -177.25 149.34 0.66 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -64.59 94.39 0.12 Allowed 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.722 0.639 . . . . 0.0 110.326 177.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.71 -26.08 21.0 Favored Glycine 0 CA--C 1.496 -1.098 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.0 -59.27 0.29 Allowed Glycine 0 CA--C 1.478 -2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 p -88.58 139.92 29.99 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 173.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 40.2 mtt -122.19 140.38 52.65 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.983 -171.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.3 tttt -100.15 93.19 5.58 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 95.5 mt -102.21 141.96 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.892 -171.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 62.3 mtm-85 -72.03 131.29 42.69 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-O 121.365 0.602 . . . . 0.0 110.047 173.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 34' ' ' SER . 49.9 t -117.32 125.91 74.27 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-O 117.789 -1.101 . . . . 0.0 108.208 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.277 41.8 mt-10 -84.84 150.58 24.91 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 116.681 -2.008 . . . . 0.0 106.091 166.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.7 OUTLIER -125.4 125.04 42.76 Favored 'General case' 0 C--N 1.269 -2.901 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.13 114.3 36.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 118.476 -1.29 . . . . 0.0 108.492 171.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.91 70.57 1.24 Allowed 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.18 66.28 0.35 Allowed Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -94.38 -30.79 14.31 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.51 -155.47 0.55 Allowed 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 m170 80.03 167.23 0.17 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.373 1.469 . . . . 0.0 110.351 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 80.4 mtm-85 -137.81 177.02 8.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -89.47 95.68 10.38 Favored 'General case' 0 N--CA 1.417 -2.122 0 O-C-N 123.818 0.699 . . . . 0.0 109.664 177.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.1 m 69.07 171.53 0.3 Allowed 'General case' 0 C--O 1.253 1.25 0 C-N-CA 124.197 0.999 . . . . 0.0 111.87 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.9 m 65.39 17.47 10.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.578 1.18 . . . . 0.0 109.867 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.6 p -93.26 170.89 7.98 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 114.284 -1.325 . . . . 0.0 109.889 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -65.23 -165.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.038 1.826 . . . . 0.0 113.041 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -90.59 44.42 1.2 Allowed 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 125.013 1.325 . . . . 0.0 109.594 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -51.88 153.02 4.74 Favored Pre-proline 0 C--O 1.249 1.041 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.953 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.37 153.98 25.87 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.623 2.216 . . . . 0.0 111.599 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -69.67 -41.83 74.97 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.588 0.755 . . . . 0.0 109.016 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -92.14 -166.95 1.65 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 174.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -78.59 156.98 77.74 Favored Pre-proline 0 N--CA 1.422 -1.871 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 174.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -41.57 131.52 3.77 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 123.573 2.849 . . . . 0.0 111.02 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 13.5 p -133.78 154.03 51.29 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 120.946 0.403 . . . . 0.0 110.91 -172.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -149.53 149.47 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.404 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 7.4 m -99.6 106.03 17.96 Favored 'General case' 0 N--CA 1.391 -3.387 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -112.07 144.6 41.16 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.045 -170.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.2 mm -81.06 112.91 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -114.98 151.71 33.67 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -146.28 -170.23 3.45 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.18 18.19 8.96 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.94 -25.38 9.02 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 123.226 0.61 . . . . 0.0 112.008 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' NE2' ' A' ' 48' ' ' HIS . 59.9 m -98.63 136.89 38.05 Favored 'General case' 0 N--CA 1.395 -3.18 0 C-N-CA 124.553 1.141 . . . . 0.0 109.036 177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 145.01 20.65 Favored 'General case' 0 C--O 1.249 1.03 0 O-C-N 123.695 0.622 . . . . 0.0 110.704 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.519 HG22 ' HG ' ' A' ' 82' ' ' LEU . 89.4 t -53.05 -53.41 22.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.879 178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -58.08 -28.17 64.33 Favored 'General case' 0 C--O 1.21 -1.016 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.551 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -76.87 -37.85 54.77 Favored 'General case' 0 C--N 1.282 -2.351 0 O-C-N 121.737 -0.602 . . . . 0.0 111.076 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.523 ' NE2' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-70 -62.36 -37.86 87.31 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.543 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 38.6 mt -68.24 -41.56 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.204 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -56.32 -34.41 66.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.639 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.13 -53.64 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.265 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 49' ' ' ILE . 17.9 mt -54.01 -46.99 71.95 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.217 177.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 85.5 mt -57.76 -48.71 78.87 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 123.478 0.486 . . . . 0.0 109.975 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.7 m -59.48 -37.47 78.32 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -73.32 -33.98 65.44 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 50.5 m-85 -85.4 0.24 52.79 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt 70.72 35.1 1.89 Allowed 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 125.298 1.439 . . . . 0.0 112.665 175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 81.7 mt -105.8 133.76 20.05 Favored Pre-proline 0 N--CA 1.403 -2.799 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -55.23 133.73 59.79 Favored 'Trans proline' 0 CA--C 1.5 -1.183 0 C-N-CA 121.896 1.731 . . . . 0.0 110.821 173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.576 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.6 m -61.71 -9.83 3.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.076 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -67.77 -20.48 65.22 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.558 0.218 . . . . 0.0 110.569 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -82.91 -4.81 58.61 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.61 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.6 p -48.91 -29.98 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 125.422 1.489 . . . . 0.0 110.622 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -55.34 -43.21 74.76 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.893 1.677 . . . . 0.0 110.733 174.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -109.4 13.59 24.06 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 114.119 -1.4 . . . . 0.0 112.66 -171.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 16.0 m-85 -114.14 140.83 48.2 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.93 177.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -150.92 149.89 30.18 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.839 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.8 mt -82.59 122.69 28.42 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.234 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -109.31 149.4 29.52 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -78.6 129.61 73.66 Favored Pre-proline 0 C--N 1.307 -1.259 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.86 -12.27 34.82 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.101 2.534 . . . . 0.0 115.795 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -113.31 -40.78 3.81 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.715 -0.794 . . . . 0.0 112.795 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.7 p -93.17 -17.55 23.6 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.993 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 66.27 20.08 11.05 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.188 0.995 . . . . 0.0 111.748 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.42 137.28 33.98 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.559 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -95.17 137.06 34.74 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.73 104.58 8.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -106.2 12.85 29.65 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.979 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.53 158.24 36.59 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.703 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -84.73 -37.86 20.39 Favored 'General case' 0 N--CA 1.394 -3.252 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.077 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -128.5 147.82 50.71 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 123.607 0.763 . . . . 0.0 108.957 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' HG ' HG22 ' A' ' 45' ' ' VAL . 19.4 mt -81.1 152.24 27.92 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.584 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.9 p -108.43 154.27 41.58 Favored Pre-proline 0 N--CA 1.401 -2.9 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.38 -36.22 78.2 Favored 'Trans proline' 0 C--O 1.219 -0.452 0 C-N-CA 122.463 2.109 . . . . 0.0 110.523 172.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -64.09 -41.56 97.25 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.644 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 4.4 mmp_? -63.0 -36.63 84.17 Favored 'General case' 0 CA--C 1.485 -1.528 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.629 178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.588 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 61.8 mt -68.42 -48.65 64.06 Favored 'General case' 0 N--CA 1.425 -1.712 0 O-C-N 124.217 0.948 . . . . 0.0 110.62 177.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.591 ' O ' ' HD3' ' A' ' 92' ' ' LYS 0.311 47.8 t -61.61 -49.34 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.383 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 2.3 mp0 -64.48 -27.26 68.86 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.434 -0.906 . . . . 0.0 112.21 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.43 -45.26 60.42 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -54.27 -23.75 16.21 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -52.15 -46.97 65.65 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.041 0.936 . . . . 0.0 110.276 173.057 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.1 m -135.27 -79.71 0.43 Allowed 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.92 -175.67 2.43 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 125.149 1.379 . . . . 0.0 108.962 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -120.1 151.32 39.23 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 168.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -116.15 101.6 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.025 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.68 109.44 12.9 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.7 mtp180 -129.26 163.11 26.36 Favored 'General case' 0 CA--C 1.475 -1.911 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.246 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.9 mtp -79.94 131.74 35.9 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -72.52 152.8 91.83 Favored Pre-proline 0 C--N 1.277 -2.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.55 146.83 73.21 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.789 2.326 . . . . 0.0 111.261 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -139.32 -171.35 3.1 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.429 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -4.74 41.24 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 123.011 1.386 . . . . 0.0 111.809 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.03 134.77 27.21 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.097 0 CA-C-N 111.906 -2.406 . . . . 0.0 108.927 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.85 146.52 25.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 0.0 110.341 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -132.26 91.89 3.01 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' HD2' ' H ' ' A' ' 107' ' ' ARG . 7.2 mpt_? . . . . . 0 C--N 1.292 -1.904 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.51 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.466 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.58 118.68 26.24 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -98.86 8.4 45.02 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 122.099 0.952 . . . . 0.0 109.314 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.63 173.45 6.32 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.27 -53.07 4.27 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.19 -51.73 0.68 Allowed Glycine 0 CA--C 1.485 -1.839 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 m -95.86 139.83 31.5 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 11.3 mmt -115.25 138.34 51.05 Favored 'General case' 0 CA--C 1.465 -2.291 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.092 -171.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 36' ' ' SER . 73.2 tttt -100.54 93.57 5.68 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 175.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 90' ' ' ALA . 91.7 mt -103.52 140.75 20.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.732 -172.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -73.14 134.71 44.54 Favored 'General case' 0 CA--C 1.459 -2.53 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.195 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.9 t -117.12 122.04 69.1 Favored 'Isoleucine or valine' 2 N--CA 1.363 -4.785 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.282 0.5 OUTLIER -84.14 156.74 21.97 Favored 'General case' 0 N--CA 1.406 -2.657 0 C-N-CA 115.872 -2.331 . . . . 0.0 107.063 167.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.472 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -128.81 132.44 47.83 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 177.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' N ' HD22 ' A' ' 14' ' ' LEU 0.266 1.6 mp -116.53 114.37 45.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 166.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -124.13 11.82 8.87 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 135.0 -163.73 24.79 Favored Glycine 0 N--CA 1.412 -2.956 0 N-CA-C 105.453 -3.059 . . . . 0.0 105.453 -173.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -104.72 16.45 25.99 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 118.336 1.068 . . . . 0.0 108.901 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.98 137.55 57.2 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.963 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 22' ' ' THR . 31.5 m170 76.37 103.82 0.07 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 125.42 1.488 . . . . 0.0 111.556 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -87.35 33.14 0.69 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.063 0.935 . . . . 0.0 111.429 176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.618 ' OG1' ' HA ' ' A' ' 29' ' ' PRO . 39.1 p 52.74 25.03 3.52 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.894 2.078 . . . . 0.0 114.972 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.7 m -137.31 100.66 4.31 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-O 121.562 0.696 . . . . 0.0 111.29 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 166.45 -33.71 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 127.296 2.238 . . . . 0.0 105.921 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.5 p -142.74 152.68 60.0 Favored Pre-proline 0 N--CA 1.396 -3.129 0 CA-C-N 112.392 -2.186 . . . . 0.0 106.53 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -67.91 95.31 0.41 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.825 1.683 . . . . 0.0 110.852 176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -117.89 16.22 14.3 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 67.61 88.67 0.1 Allowed Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 113.017 -1.902 . . . . 0.0 111.443 -172.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.618 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 93.8 Cg_endo -77.53 53.23 4.23 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 124.209 3.273 . . . . 0.0 112.602 -174.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.88 -54.65 2.02 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.767 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -128.63 -157.43 0.82 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.658 1.183 . . . . 0.0 108.758 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -56.34 161.39 4.08 Favored Pre-proline 0 C--O 1.251 1.173 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -47.79 127.68 14.71 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.872 1.715 . . . . 0.0 112.361 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.2 p -142.21 158.69 43.45 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.346 -175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.3 p -151.22 149.97 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.488 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.3 m -98.14 108.29 20.96 Favored 'General case' 0 N--CA 1.387 -3.621 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 43.4 t60 -110.86 145.97 37.31 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 -170.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -84.01 111.62 20.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 -177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.56 145.72 39.82 Favored 'General case' 0 C--N 1.259 -3.326 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.31 -174.88 4.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -110.45 -13.95 13.87 Favored Glycine 0 C--N 1.304 -1.217 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.678 -173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -82.17 -21.82 36.35 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.814 0.816 . . . . 0.0 111.351 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.508 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 38.5 m -95.88 127.4 41.86 Favored 'General case' 0 N--CA 1.389 -3.518 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.44 175.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.53 149.51 10.47 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-O 121.354 0.597 . . . . 0.0 110.471 174.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.465 HG22 ' HG ' ' A' ' 82' ' ' LEU . 97.8 t -54.13 -53.73 26.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.193 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 61.4 pttt -54.45 -31.86 56.42 Favored 'General case' 0 C--O 1.199 -1.578 0 O-C-N 124.522 1.138 . . . . 0.0 112.086 -177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.2 m-20 -77.39 -34.37 54.92 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.508 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 95.2 m-70 -64.2 -40.16 95.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 34.6 mt -66.22 -43.44 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.828 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 46' ' ' LYS . 99.4 mttt -57.15 -35.34 69.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.678 0.672 . . . . 0.0 111.278 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 47' ' ' ASP . 76.8 t -69.55 -53.49 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.482 176.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.1 mt -54.49 -47.65 72.78 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.129 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 84.9 mt -55.77 -50.57 70.06 Favored 'General case' 0 C--O 1.198 -1.623 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.0 m -58.5 -39.52 80.27 Favored 'General case' 0 N--CA 1.404 -2.727 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -72.23 -27.96 62.86 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.851 0.358 . . . . 0.0 111.657 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.472 ' CG ' ' HG ' ' A' ' 14' ' ' LEU . 52.6 m-85 -91.74 4.24 53.26 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.386 0.612 . . . . 0.0 111.529 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp 66.76 37.49 4.18 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 125.506 1.522 . . . . 0.0 112.556 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.3 mt -107.64 132.66 20.84 Favored Pre-proline 0 N--CA 1.414 -2.232 0 C-N-CA 124.863 1.265 . . . . 0.0 108.259 176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -54.26 134.0 58.62 Favored 'Trans proline' 0 CA--C 1.506 -0.889 0 C-N-CA 122.256 1.97 . . . . 0.0 110.836 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.2 m -62.46 -10.43 5.09 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.677 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.027 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -67.01 -20.97 65.96 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.048 0.451 . . . . 0.0 110.448 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -82.63 -4.36 57.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.2 p -47.78 -29.53 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 125.984 1.713 . . . . 0.0 110.603 176.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p -54.86 -46.83 74.73 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 113.56 -1.654 . . . . 0.0 111.612 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.0 m -105.01 10.34 34.13 Favored 'General case' 0 N--CA 1.42 -1.929 0 C-N-CA 124.312 1.045 . . . . 0.0 112.702 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' HD1' ' O ' ' A' ' 62' ' ' LYS . 26.6 m-85 -109.19 143.34 38.74 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 121.881 -0.512 . . . . 0.0 111.391 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.77 151.88 34.33 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.1 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.36 127.85 34.86 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.033 174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 45.5 tt0 -113.93 144.29 43.3 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.51 132.92 77.76 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 39.0 Cg_endo -66.99 -21.37 49.71 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.872 2.381 . . . . 0.0 115.416 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.73 -46.19 4.03 Favored 'General case' 0 CA--C 1.498 -1.056 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.818 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -86.4 -20.19 28.58 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.122 -174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt 69.25 16.14 8.48 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 111.842 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.04 137.75 40.41 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.202 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -94.41 141.27 28.77 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.997 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.4 t -82.05 103.02 8.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -108.51 15.24 24.02 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.697 1.237 . . . . 0.0 109.103 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -74.47 155.4 38.04 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.338 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 45.6 m -81.27 -40.76 23.22 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.375 175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.62 157.15 37.94 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.037 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.5 mt -90.42 142.96 27.21 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.276 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.492 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 56.8 p -99.31 153.1 37.95 Favored Pre-proline 0 N--CA 1.4 -2.96 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.74 -32.58 91.72 Favored 'Trans proline' 0 C--O 1.204 -1.199 0 C-N-CA 121.882 1.721 . . . . 0.0 109.289 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -59.5 -46.58 88.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.191 0.596 . . . . 0.0 111.568 175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -62.34 -39.44 93.09 Favored 'General case' 0 CA--C 1.495 -1.153 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.692 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 55.9 mt -66.06 -48.63 70.39 Favored 'General case' 0 C--O 1.205 -1.273 0 O-C-N 123.677 0.611 . . . . 0.0 110.153 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 50.5 t -62.11 -46.26 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.255 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -65.29 -28.72 69.52 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 10' ' ' ILE . . . -77.77 -35.54 51.5 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.939 175.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -55.35 -25.24 33.73 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.108 0.563 . . . . 0.0 111.124 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -55.39 -42.26 73.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.284 175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.8 m -142.97 -82.28 0.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.3 OUTLIER -160.51 -178.39 6.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 123.954 0.901 . . . . 0.0 109.273 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -119.49 148.41 43.3 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 168.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 69' ' ' GLN . 8.7 mt -114.37 102.25 13.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.408 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -78.87 107.25 11.46 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -131.14 162.72 29.27 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.825 -175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 57.5 mtp -77.03 131.58 38.5 Favored 'General case' 0 N--CA 1.4 -2.944 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 166.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -60.6 152.9 64.76 Favored Pre-proline 0 C--N 1.288 -2.105 0 O-C-N 123.491 0.495 . . . . 0.0 110.647 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.38 130.17 38.48 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.337 2.025 . . . . 0.0 109.294 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -68.23 129.97 41.52 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.619 -173.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.91 146.6 27.96 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 70.3 mt -75.43 91.15 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.393 -3.302 0 CA-C-O 122.055 0.931 . . . . 0.0 110.199 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.58 137.48 32.46 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.455 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -83.89 79.28 9.54 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 . . . . . 0 C--N 1.287 -2.143 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.653 176.633 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.464 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.29 107.63 0.04 OUTLIER 'General case' 0 C--O 1.242 0.666 0 C-N-CA 125.289 1.436 . . . . 0.0 111.682 178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -81.44 75.67 8.39 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -123.5 69.26 1.02 Allowed 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 165.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.26 -43.34 2.24 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -172.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.87 69.47 1.39 Allowed Glycine 0 CA--C 1.479 -2.218 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 5.0 m -68.63 130.2 42.15 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 122.252 1.025 . . . . 0.0 112.843 -167.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 48.8 mtt -117.26 140.07 50.01 Favored 'General case' 0 CA--C 1.472 -2.02 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.956 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HE2' HD11 ' A' ' 38' ' ' ILE . 20.1 ttmm -96.68 98.61 10.31 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 173.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 90.4 mt -108.22 137.78 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.619 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.4 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.55 129.11 38.95 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-O 121.125 0.488 . . . . 0.0 109.902 172.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' SER . 47.1 t -115.91 122.28 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.694 0 CA-C-O 117.696 -1.145 . . . . 0.0 108.272 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.267 0.4 OUTLIER -83.65 153.88 24.0 Favored 'General case' 0 N--CA 1.413 -2.301 0 C-N-CA 116.456 -2.098 . . . . 0.0 108.027 167.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' HG ' ' CG ' ' A' ' 56' ' ' PHE . 0.5 OUTLIER -126.75 127.96 45.89 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.197 0.31 . . . . 0.0 110.171 176.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.7 mp -100.98 115.01 41.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 170.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -159.06 85.68 0.81 Allowed 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -49.29 141.75 11.34 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.642 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -74.53 -14.81 60.86 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 122.07 0.938 . . . . 0.0 110.102 -173.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -59.21 138.17 57.69 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 113.191 -1.822 . . . . 0.0 110.706 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -92.74 67.64 4.53 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 49.08 73.21 0.24 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.5 p -125.41 -151.76 0.49 Allowed 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -72.96 72.23 1.11 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 168.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.7 m -100.34 75.06 1.77 Allowed 'General case' 0 N--CA 1.421 -1.877 0 CA-C-O 122.582 1.182 . . . . 0.0 109.44 -174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.8 p -80.0 161.05 67.22 Favored Pre-proline 0 C--N 1.254 -3.548 0 CA-C-N 113.362 -1.745 . . . . 0.0 111.158 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.19 88.89 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.394 2.063 . . . . 0.0 111.624 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -120.69 23.04 10.96 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.703 1.24 . . . . 0.0 108.861 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -82.13 152.78 68.7 Favored Pre-proline 0 C--N 1.286 -2.166 0 CA-C-N 113.388 -1.733 . . . . 0.0 108.844 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.0 173.7 0.26 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.096 2.53 . . . . 0.0 113.204 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -63.9 -40.97 97.73 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.623 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -97.28 147.36 24.21 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 170.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -124.31 170.87 8.01 Favored Pre-proline 0 C--N 1.254 -3.568 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -44.66 133.07 10.21 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 122.661 2.241 . . . . 0.0 110.272 173.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 22.2 p -140.77 157.42 45.43 Favored 'General case' 0 N--CA 1.421 -1.895 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.902 -172.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -144.98 147.59 18.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.428 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 18.4 m -97.37 98.8 10.27 Favored 'General case' 0 N--CA 1.386 -3.66 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 173.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -105.73 144.9 31.83 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.12 -167.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.524 HD11 ' HE2' ' A' ' 9' ' ' LYS . 35.1 mm -84.52 112.22 21.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 -177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' SER . 83.7 m-85 -113.19 149.49 33.61 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.402 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -148.07 -170.4 3.58 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -122.81 15.67 8.39 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.5 -23.59 11.78 Favored 'General case' 0 N--CA 1.408 -2.575 0 CA-C-O 121.532 0.682 . . . . 0.0 110.925 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.7 m -104.73 135.83 45.38 Favored 'General case' 0 N--CA 1.397 -3.089 0 C-N-CA 123.592 0.757 . . . . 0.0 109.444 174.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.71 148.88 9.15 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 123.805 0.842 . . . . 0.0 111.18 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 82' ' ' LEU . 90.2 t -54.18 -51.33 48.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.778 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 40.5 mttm -54.73 -34.14 62.06 Favored 'General case' 0 C--O 1.196 -1.714 0 O-C-N 124.685 1.241 . . . . 0.0 110.663 -176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 51' ' ' VAL . 12.1 m-20 -73.95 -39.18 63.93 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -62.11 -38.91 90.69 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 33.7 mt -67.33 -44.61 87.13 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.987 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.913 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HG3' HG21 ' A' ' 63' ' ' VAL . 97.4 mttt -57.59 -33.91 68.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 118.843 0.747 . . . . 0.0 110.978 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 47' ' ' ASP . 86.4 t -68.77 -54.03 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.189 175.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.71 -48.66 69.36 Favored 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 123.329 0.393 . . . . 0.0 111.382 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 89.8 mt -56.45 -48.27 77.4 Favored 'General case' 0 C--O 1.203 -1.393 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -59.77 -38.31 81.46 Favored 'General case' 0 N--CA 1.401 -2.883 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -74.72 -29.76 61.29 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 120.846 0.355 . . . . 0.0 111.659 176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 38.5 m-85 -89.64 4.57 49.06 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.298 0.571 . . . . 0.0 112.518 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 68.97 32.38 3.85 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 125.642 1.577 . . . . 0.0 112.284 175.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.0 mt -107.31 128.23 26.38 Favored Pre-proline 0 N--CA 1.407 -2.594 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -50.86 133.01 38.96 Favored 'Trans proline' 0 CA--C 1.502 -1.099 0 C-N-CA 122.52 2.147 . . . . 0.0 111.073 172.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.6 m -62.87 -9.96 5.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.682 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -66.88 -18.49 65.4 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.392 0.615 . . . . 0.0 110.516 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 12.1 mptt -85.14 -5.27 59.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.225 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.9 p -47.45 -27.98 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 C-N-CA 126.196 1.798 . . . . 0.0 110.301 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m -56.42 -49.44 74.52 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 126.42 1.888 . . . . 0.0 111.359 174.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 99' ' ' MET . 74.6 m -104.27 14.88 29.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 124.952 1.301 . . . . 0.0 112.257 -173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.472 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 30.2 m-85 -113.93 142.52 46.03 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.605 176.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -153.12 152.92 31.83 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 71.2 mt -83.79 124.19 30.66 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.445 -1.252 . . . . 0.0 108.171 177.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -113.36 152.99 29.25 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -85.56 137.63 36.28 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 52.7 Cg_endo -70.59 -13.23 32.39 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.072 2.515 . . . . 0.0 115.81 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -114.41 -44.42 3.1 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.855 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.5 p -87.46 -19.13 28.44 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.561 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.8 mt 63.03 21.74 13.07 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 110.783 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.79 140.89 33.95 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.892 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -100.71 143.86 30.37 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.484 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.9 t -78.65 107.63 11.17 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -100.58 10.49 41.11 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.801 0.81 . . . . 0.0 109.949 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.48 152.72 41.76 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.483 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.6 m -83.59 -38.18 21.96 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.203 174.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -128.61 149.51 50.61 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' HG ' HG22 ' A' ' 45' ' ' VAL . 25.7 mt -84.41 161.64 20.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.502 0.668 . . . . 0.0 110.731 -178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 64.4 p -120.01 155.74 55.13 Favored Pre-proline 0 N--CA 1.401 -2.895 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -58.45 -32.11 95.63 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.889 1.726 . . . . 0.0 109.801 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.74 -42.48 99.02 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.379 176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.6 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 2.6 mmp_? -64.76 -38.36 90.72 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.419 177.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.667 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 76.7 mt -65.77 -47.94 73.5 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.016 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.258 20.1 t -61.97 -44.39 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.117 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.92 -26.95 66.23 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.421 -0.911 . . . . 0.0 112.534 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -43.97 52.22 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 19.0 mt-10 -54.73 -23.26 16.95 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 176.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -51.34 -35.19 37.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.179 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 45.9 m -144.52 -80.37 0.18 Allowed 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -163.77 -175.5 4.14 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 125.788 1.635 . . . . 0.0 108.384 -177.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' CD1' ' HB3' ' A' ' 68' ' ' LEU . 3.3 m-85 -120.96 148.59 43.89 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 169.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.7 mt -116.6 101.09 11.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.568 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.459 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -78.86 106.45 10.88 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.557 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -127.23 161.42 28.59 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.469 -174.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 42.7 mtp -76.05 124.95 28.22 Favored 'General case' 0 N--CA 1.404 -2.751 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 166.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -60.17 145.39 85.59 Favored Pre-proline 0 C--N 1.286 -2.192 0 C-N-CA 123.875 0.87 . . . . 0.0 111.306 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.77 148.74 86.86 Favored 'Trans proline' 0 C--O 1.256 1.406 0 C-N-CA 122.574 2.183 . . . . 0.0 110.896 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -61.44 131.09 49.06 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-O 121.879 0.847 . . . . 0.0 111.228 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -142.51 176.15 9.24 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -84.16 102.35 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.383 -3.803 0 CA-C-O 121.617 0.723 . . . . 0.0 109.839 178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -104.39 108.42 19.82 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -135.65 88.01 2.37 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.882 0.848 . . . . 0.0 110.687 -177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 C--N 1.284 -2.24 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.481 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.832 0 N-CA-C 112.762 -0.135 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.56 147.39 48.72 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -65.21 128.13 34.54 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 85.3 mtp -76.32 93.87 3.51 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.735 0.779 . . . . 0.0 109.622 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -130.5 72.8 0.47 Allowed Glycine 0 N--CA 1.412 -2.955 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.35 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.13 -45.75 7.39 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' PHE . 25.5 m -109.85 123.96 50.49 Favored 'General case' 0 N--CA 1.393 -3.277 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 168.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.769 ' SD ' ' HB3' ' A' ' 87' ' ' LEU . 58.2 mtt -106.69 139.75 40.63 Favored 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.047 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 61.8 tttt -99.97 98.36 9.13 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.59 138.3 37.71 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 114.003 -1.453 . . . . 0.0 110.611 -173.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 85.4 mtt180 -68.12 133.14 48.45 Favored 'General case' 0 CA--C 1.478 -1.804 0 CA-C-O 121.029 0.442 . . . . 0.0 110.551 173.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 34' ' ' SER . 48.9 t -120.12 124.63 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-O 117.735 -1.126 . . . . 0.0 108.639 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' OE1' ' HB2' ' A' ' 32' ' ' ASN 0.259 21.8 mm-40 -84.2 153.46 23.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 170.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -126.03 130.82 51.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 176.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 17' ' ' GLY . 1.6 mp -117.92 119.72 62.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 166.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.5 ' HB3' HD11 ' A' ' 14' ' ' LEU . 29.0 p-10 -110.64 13.91 22.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 122.341 1.067 . . . . 0.0 111.506 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.413 ' H ' HG22 ' A' ' 15' ' ' ILE . . . 130.9 -161.34 23.45 Favored Glycine 0 N--CA 1.411 -3.007 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.908 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -97.36 35.78 1.57 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.07 35.99 0.11 Allowed 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 125.849 1.66 . . . . 0.0 112.603 -170.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -99.51 106.7 18.74 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.8 mtm-85 -91.21 165.85 13.25 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.609 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -78.09 84.71 4.32 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-O 121.78 0.8 . . . . 0.0 111.491 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -86.04 -49.53 7.74 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m 64.48 10.66 5.96 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.677 1.191 . . . . 0.0 112.755 174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.9 p -93.97 171.72 6.64 Favored Pre-proline 0 C--N 1.28 -2.42 0 C-N-CA 124.968 1.307 . . . . 0.0 109.736 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -79.44 84.0 2.13 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 121.021 1.147 . . . . 0.0 114.511 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -86.15 2.03 48.36 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 121.538 0.685 . . . . 0.0 111.314 171.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 59.46 -179.03 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.503 0 CA-C-N 113.262 -1.79 . . . . 0.0 111.63 176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -62.8 105.39 0.43 Allowed 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.331 1.354 . . . . 0.0 110.568 172.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -145.45 113.28 6.41 Favored 'General case' 0 N--CA 1.397 -3.098 0 C-N-CA 124.524 1.129 . . . . 0.0 108.98 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -58.99 -171.04 0.01 OUTLIER 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.459 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.473 ' HB2' ' OE1' ' A' ' 13' ' ' GLU . 83.1 m-20 -68.29 156.4 90.25 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.318 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -48.46 124.19 10.35 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 122.554 2.169 . . . . 0.0 108.974 174.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 1.4 p -138.78 152.46 47.93 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.44 -172.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.501 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.5 p -147.68 149.65 15.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.3 m -96.21 108.32 20.78 Favored 'General case' 0 N--CA 1.395 -3.221 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 173.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.407 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 46.5 t60 -113.05 147.17 37.79 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 -171.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.26 48.4 mm -84.89 112.74 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 -177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' SER . 84.3 m-85 -113.68 146.07 40.36 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 123.039 0.535 . . . . 0.0 109.589 177.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -151.92 169.55 22.02 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 123.782 0.833 . . . . 0.0 109.243 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 26.24 24.06 Favored Glycine 0 C--N 1.298 -1.563 0 O-C-N 124.203 0.939 . . . . 0.0 112.435 -177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -116.62 -32.44 5.19 Favored 'General case' 0 N--CA 1.413 -2.323 0 CA-C-O 121.499 0.666 . . . . 0.0 111.504 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.545 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 35.1 m -94.01 134.43 36.43 Favored 'General case' 0 N--CA 1.389 -3.523 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 176.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.58 148.76 15.12 Favored 'General case' 0 C--O 1.25 1.114 0 CA-C-O 121.261 0.553 . . . . 0.0 110.731 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG22 ' HG ' ' A' ' 82' ' ' LEU . 95.9 t -53.82 -52.28 36.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.114 178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -57.08 -33.77 67.63 Favored 'General case' 0 C--O 1.203 -1.358 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.019 -176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.61 -37.06 65.55 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 122.06 -0.4 . . . . 0.0 110.712 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 94.8 m-70 -62.83 -39.27 93.82 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 172.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.553 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 27.2 mt -65.31 -44.13 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.67 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HG3' HG21 ' A' ' 63' ' ' VAL . 99.4 mttt -56.93 -34.22 67.76 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 118.728 0.694 . . . . 0.0 111.18 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 84.4 t -69.56 -53.88 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.266 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.7 mt -53.98 -48.27 70.54 Favored 'General case' 0 C--O 1.211 -0.921 0 O-C-N 123.558 0.536 . . . . 0.0 111.039 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 88.2 mt -56.88 -50.75 71.53 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -59.28 -37.32 77.38 Favored 'General case' 0 N--CA 1.402 -2.86 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -74.07 -31.0 62.66 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.872 0.368 . . . . 0.0 111.644 176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 37.0 m-85 -87.06 2.44 49.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? 73.81 29.23 1.49 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 125.107 1.363 . . . . 0.0 113.108 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.5 mt -105.83 135.99 19.34 Favored Pre-proline 0 N--CA 1.411 -2.392 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -56.58 137.01 79.12 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 122.016 1.811 . . . . 0.0 110.953 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.639 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.8 m -63.84 -10.2 6.93 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.945 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.305 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -68.8 -14.45 63.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.358 0.599 . . . . 0.0 110.956 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 66' ' ' TYR . 3.5 mptp? -87.83 -5.19 58.73 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.639 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 3.1 p -48.55 -31.06 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 126.269 1.828 . . . . 0.0 110.428 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.275 15.5 m -55.37 -46.39 76.48 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 126.47 1.908 . . . . 0.0 110.964 174.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.0 m -103.01 7.79 39.01 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.755 -172.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 99' ' ' MET . 26.0 m-85 -106.68 142.19 36.73 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 121.331 0.586 . . . . 0.0 111.432 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.04 141.02 23.78 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.387 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 97' ' ' LEU . 80.1 mt -72.63 156.49 38.91 Favored 'General case' 0 N--CA 1.418 -2.051 0 O-C-N 124.82 1.325 . . . . 0.0 108.306 174.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 38.4 tt0 -146.12 152.0 38.58 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 21.6 t-20 -89.3 137.17 29.33 Favored Pre-proline 0 C--N 1.307 -1.276 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.133 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 56.7 Cg_endo -71.7 -17.6 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.788 2.326 . . . . 0.0 115.278 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -107.75 -46.26 3.84 Favored 'General case' 0 CA--C 1.495 -1.149 0 C-N-CA 118.97 -1.092 . . . . 0.0 112.311 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.2 p -84.05 -24.09 30.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.02 -174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.45 ' HA ' HE21 ' A' ' 69' ' ' GLN . 11.2 mt 69.61 14.57 8.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 124.451 1.1 . . . . 0.0 111.152 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 145.75 27.15 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.515 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 8.9 m-30 -88.06 -174.57 4.74 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 122.388 1.09 . . . . 0.0 112.194 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 68' ' ' LEU . 93.9 t -124.57 101.84 9.64 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 167.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -104.49 14.81 29.35 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.695 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.32 158.3 33.03 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 125.483 1.513 . . . . 0.0 110.579 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.7 m -84.24 -36.38 22.75 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.735 173.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -130.78 146.74 52.31 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' A' ' 45' ' ' VAL . 27.5 mt -80.18 153.85 28.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.287 0.565 . . . . 0.0 110.999 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.7 p -108.37 154.28 41.52 Favored Pre-proline 0 N--CA 1.403 -2.795 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.79 -36.6 95.51 Favored 'Trans proline' 0 C--O 1.217 -0.561 0 C-N-CA 122.271 1.981 . . . . 0.0 110.02 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -59.86 -43.35 94.75 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.265 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -66.32 -37.15 84.71 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.314 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.769 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.8 mt -63.29 -51.45 66.05 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 123.831 0.707 . . . . 0.0 110.568 177.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.8 t -60.95 -45.86 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.58 -24.67 67.14 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.24 173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.7 -39.94 35.13 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 118.686 -0.673 . . . . 0.0 112.704 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.62 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 32.5 mt-10 -51.03 -27.37 7.76 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 118.36 0.527 . . . . 0.0 111.809 175.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -49.7 -37.89 30.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.664 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.5 m -147.2 -88.66 0.09 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.8 OUTLIER -154.98 177.76 10.95 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.476 1.11 . . . . 0.0 109.051 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' VAL . 2.4 m-85 -116.74 151.95 35.36 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 170.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 98' ' ' ARG . 20.5 mt -117.8 135.96 56.53 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 173.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD23 HD23 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -118.75 115.38 24.35 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -176.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -147.73 173.47 12.74 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -174.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 66' ' ' TYR . 38.5 mtp -82.12 137.64 34.94 Favored 'General case' 0 N--CA 1.397 -3.103 0 O-C-N 124.248 0.968 . . . . 0.0 109.012 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -73.1 145.35 85.94 Favored Pre-proline 0 N--CA 1.418 -2.041 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -59.26 128.98 29.45 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 122.927 2.418 . . . . 0.0 111.549 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -151.66 165.9 32.92 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.29 141.53 54.31 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 104' ' ' ILE . 15.7 mm -64.54 122.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 CA-C-O 121.387 0.613 . . . . 0.0 112.397 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.41 105.6 17.77 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.62 97.41 2.73 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.336 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 . . . . . 0 C--N 1.288 -2.074 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.923 177.093 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.265 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.65 -168.17 2.48 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -132.65 36.63 3.53 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 81.6 mtp 73.86 110.33 0.07 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.974 1.31 . . . . 0.0 112.546 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.66 -109.24 2.39 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.64 95.25 1.42 Allowed Glycine 0 N--CA 1.398 -3.889 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 m -68.07 134.8 51.21 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.664 0.745 . . . . 0.0 109.422 177.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.676 ' SD ' ' HG3' ' A' ' 91' ' ' GLU . 46.4 mtt -117.86 138.45 52.1 Favored 'General case' 0 CA--C 1.467 -2.233 0 CA-C-N 114.702 -1.136 . . . . 0.0 112.819 -167.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 30.3 ttpt -97.82 99.86 11.2 Favored 'General case' 0 N--CA 1.396 -3.142 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.9 mt -107.74 140.85 24.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.881 -1.509 . . . . 0.0 110.015 -173.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -69.19 129.15 39.03 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 34' ' ' SER . 60.9 t -115.2 123.18 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.736 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.016 176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.04 148.43 26.86 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 117.561 -1.656 . . . . 0.0 107.396 168.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' CD2' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -126.11 129.22 48.66 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 120.96 0.41 . . . . 0.0 110.398 176.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.402 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -114.5 113.9 45.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 119.036 -1.066 . . . . 0.0 109.117 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -115.34 28.18 8.86 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 123.402 0.681 . . . . 0.0 110.854 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.08 48.34 2.39 Favored Glycine 0 C--N 1.313 -0.709 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.787 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -133.49 -9.47 2.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 124.964 1.305 . . . . 0.0 110.712 174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -79.1 63.45 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.4 m80 69.89 130.98 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 124.773 1.229 . . . . 0.0 110.816 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.9 mtp180 74.3 96.95 0.07 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.91 0.884 . . . . 0.0 112.547 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.0 p -91.39 12.33 20.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 123.28 1.514 . . . . 0.0 110.041 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.3 m -148.98 119.92 7.65 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m 66.17 92.4 0.08 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 124.549 1.156 . . . . 0.0 109.378 -171.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 p -70.49 169.04 15.28 Favored Pre-proline 0 C--N 1.297 -1.703 0 CA-C-N 113.465 -1.698 . . . . 0.0 113.343 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 28' ' ' GLN . 32.2 Cg_exo -64.16 -149.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 124.077 3.185 . . . . 0.0 114.126 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -75.61 26.79 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.932 1.293 . . . . 0.0 112.066 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 26' ' ' PRO . 32.0 mm-40 -83.81 154.0 64.45 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 114.429 -1.26 . . . . 0.0 108.619 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.02 176.19 2.04 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.0 2.467 . . . . 0.0 112.577 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -73.85 -50.61 19.51 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.781 0.324 . . . . 0.0 110.486 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.12 149.68 37.34 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 171.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' HA ' ' HD2' ' A' ' 33' ' ' PRO . 90.0 m-20 -60.56 132.55 91.12 Favored Pre-proline 0 N--CA 1.427 -1.619 0 O-C-N 123.632 0.582 . . . . 0.0 110.699 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 32' ' ' ASN . 10.0 Cg_endo -48.44 130.65 21.95 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.873 3.048 . . . . 0.0 110.103 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.3 p -138.98 156.31 47.32 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.268 -175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG12 ' CZ ' ' A' ' 56' ' ' PHE . 7.1 p -149.29 148.75 15.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.411 ' HB3' ' HG2' ' A' ' 9' ' ' LYS . 13.9 m -95.61 105.47 17.46 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 173.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 50.1 t60 -112.28 144.37 41.8 Favored 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.609 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 9' ' ' LYS 0.262 40.2 mm -83.69 113.46 22.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -177.635 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.49 145.32 41.37 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -144.94 -174.15 4.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 124.265 1.026 . . . . 0.0 108.289 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.44 22.43 8.33 Favored Glycine 0 C--N 1.309 -0.968 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -112.15 -25.91 9.08 Favored 'General case' 0 N--CA 1.42 -1.936 0 C-N-CA 123.179 0.592 . . . . 0.0 111.231 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.4 m -96.69 154.08 17.49 Favored 'General case' 0 N--CA 1.389 -3.492 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.67 156.26 27.66 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG22 ' HG ' ' A' ' 82' ' ' LEU . 91.4 t -52.96 -52.51 28.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 123.7 0.625 . . . . 0.0 109.717 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -55.68 -36.5 67.2 Favored 'General case' 0 C--O 1.196 -1.726 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.31 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -74.48 -36.19 63.29 Favored 'General case' 0 C--N 1.291 -1.939 0 O-C-N 121.993 -0.442 . . . . 0.0 111.758 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.57 ' CE1' ' HB ' ' A' ' 43' ' ' THR . 92.6 m-70 -61.25 -38.79 87.95 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 171.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.53 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 36.8 mt -66.16 -42.95 92.15 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.093 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.079 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -56.67 -37.98 71.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.647 0.658 . . . . 0.0 110.796 174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.9 t -66.44 -53.69 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.057 178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 49' ' ' ILE . 19.8 mt -53.36 -49.61 66.79 Favored 'General case' 0 C--N 1.313 -0.998 0 O-C-N 123.467 0.479 . . . . 0.0 110.777 177.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 92.0 mt -56.91 -47.43 80.57 Favored 'General case' 0 C--O 1.192 -1.959 0 O-C-N 123.522 0.514 . . . . 0.0 110.103 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.93 -40.52 93.53 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -70.84 -31.01 67.58 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.04 0.448 . . . . 0.0 111.51 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.497 ' CD2' ' HG ' ' A' ' 14' ' ' LEU . 40.9 m-85 -86.67 1.87 50.45 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.341 0.591 . . . . 0.0 111.49 174.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm 64.86 38.82 6.37 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 124.808 1.243 . . . . 0.0 113.18 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 80.0 mt -108.15 140.48 21.72 Favored Pre-proline 0 N--CA 1.41 -2.467 0 C-N-CA 124.988 1.315 . . . . 0.0 107.631 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.93 132.67 48.88 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 C-N-CA 122.089 1.859 . . . . 0.0 110.925 173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.609 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 27.9 m -63.75 -9.65 5.85 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.972 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.651 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.83 -14.16 62.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.211 0.529 . . . . 0.0 111.544 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' O ' ' HD1' ' A' ' 66' ' ' TYR . 64.2 mttm -85.38 -9.16 57.93 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.982 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 2.6 p -49.76 -30.6 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 126.906 2.082 . . . . 0.0 109.849 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . 0.255 12.8 m -54.73 -48.91 71.95 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.146 1.778 . . . . 0.0 109.841 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 m -101.45 7.06 42.68 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.214 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 99' ' ' MET . 15.6 m-85 -106.55 144.38 33.3 Favored 'General case' 0 CA--C 1.477 -1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 110.751 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB3' ' HD2' ' A' ' 76' ' ' TYR . . . -155.57 149.25 25.19 Favored 'General case' 0 N--CA 1.41 -2.439 0 O-C-N 124.233 0.958 . . . . 0.0 109.292 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 75.4 mt -80.68 132.75 35.61 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.411 -1.268 . . . . 0.0 108.574 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 70' ' ' ASN . 45.5 tt0 -118.92 153.58 34.36 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 25.1 t-20 -86.03 131.0 48.08 Favored Pre-proline 0 C--N 1.312 -1.041 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 94' ' ' TYR . 33.1 Cg_endo -66.22 -20.26 56.03 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.421 2.748 . . . . 0.0 115.836 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -107.27 -43.61 4.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 46.0 p -87.37 -24.37 24.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.052 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt 70.72 19.45 5.98 Favored 'General case' 0 CA--C 1.51 -0.579 0 C-N-CA 124.366 1.066 . . . . 0.0 111.8 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.85 138.89 33.76 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.508 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 67' ' ' ALA . 6.3 m-85 -91.72 168.89 11.15 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.711 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.434 HG13 ' OD2' ' A' ' 79' ' ' ASP . 66.4 t -111.93 79.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-O 122.032 0.92 . . . . 0.0 111.399 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -68.27 -1.56 6.47 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.972 -1.013 . . . . 0.0 113.726 171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.434 ' OD2' HG13 ' A' ' 77' ' ' VAL . 50.8 m-20 -64.06 151.26 43.54 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.282 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 68.5 m -79.91 -41.17 26.66 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.282 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -131.32 153.22 49.82 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 124.22 1.008 . . . . 0.0 108.553 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 45' ' ' VAL . 23.4 mt -85.99 153.67 21.99 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.309 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 82.7 p -109.51 155.32 41.48 Favored Pre-proline 0 N--CA 1.402 -2.849 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.53 -33.87 93.75 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.126 1.884 . . . . 0.0 109.973 173.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -59.75 -45.91 90.76 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.919 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -64.48 -37.92 89.23 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.179 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.545 ' HB3' ' SD ' ' A' ' 8' ' ' MET . 81.0 mt -64.03 -47.52 79.91 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.612 0.57 . . . . 0.0 109.934 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . 0.259 35.6 t -62.13 -46.29 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -67.2 -25.53 66.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 174.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.36 -43.12 28.51 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.676 ' HG3' ' SD ' ' A' ' 8' ' ' MET . 4.2 mt-10 -53.72 -19.27 3.94 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -53.08 -39.81 63.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.84 173.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 m -144.88 -82.14 0.16 Allowed 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 71' ' ' PRO . 0.5 OUTLIER -161.91 -178.73 6.65 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 124.513 1.125 . . . . 0.0 109.114 -178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -120.99 147.02 46.05 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 169.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -113.43 101.67 12.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.458 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD1' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -78.52 105.06 9.54 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -126.75 159.21 34.42 Favored 'General case' 0 CA--C 1.477 -1.833 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.683 -173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.445 ' HG2' ' CE1' ' A' ' 66' ' ' TYR . 46.0 mtp -77.98 132.38 37.81 Favored 'General case' 0 N--CA 1.393 -3.309 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 167.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -63.59 135.38 96.25 Favored Pre-proline 0 C--N 1.283 -2.3 0 O-C-N 123.905 0.753 . . . . 0.0 109.333 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_exo -29.0 113.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.368 1.596 1 C-N-CA 125.874 4.382 . . . . 0.0 115.105 -174.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -70.07 134.59 48.38 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.739 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -112.04 -160.76 0.73 Allowed 'General case' 0 C--N 1.276 -2.59 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.8 mt -59.04 138.98 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 C-N-CA 123.242 0.617 . . . . 0.0 109.691 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.92 108.15 0.33 Allowed 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.688 0.618 . . . . 0.0 112.331 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.4 t70 63.55 23.41 13.6 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 126.177 1.791 . . . . 0.0 112.275 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 C--N 1.3 -1.581 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.973 178.092 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.382 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.2 163.77 36.68 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -85.4 -9.65 57.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.884 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.0 mtt -64.59 109.52 2.02 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.58 38.18 6.29 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.34 20.51 30.24 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 115.003 -0.598 . . . . 0.0 111.97 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m -91.31 146.46 23.8 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.47 ' HG3' ' HB3' ' A' ' 87' ' ' LEU . 10.7 mmt -122.91 137.29 54.98 Favored 'General case' 0 CA--C 1.477 -1.865 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.838 -172.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 37' ' ' HIS . 27.3 ttpt -96.22 98.95 10.71 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 173.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -109.28 139.32 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.721 -172.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 92.0 mtt180 -71.35 131.54 43.56 Favored 'General case' 0 CA--C 1.471 -2.088 0 O-C-N 123.456 0.473 . . . . 0.0 110.429 173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' SER . 40.5 t -117.95 124.8 73.6 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.484 0 CA-C-O 117.911 -1.043 . . . . 0.0 109.011 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.463 ' OE2' ' HB3' ' A' ' 31' ' ' GLN . 16.8 mt-10 -80.0 149.55 30.72 Favored 'General case' 0 C--O 1.203 -1.343 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 168.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD23 ' CD1' ' A' ' 97' ' ' LEU . 1.0 OUTLIER -126.4 125.6 42.45 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-O 120.467 0.175 . . . . 0.0 111.08 175.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' N ' HD22 ' A' ' 14' ' ' LEU . 1.5 mp -110.44 106.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.032 167.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -114.48 7.97 16.36 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 123.955 1.836 . . . . 0.0 106.99 172.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.04 170.31 15.92 Favored Glycine 0 N--CA 1.405 -3.428 0 CA-C-N 112.163 -2.289 . . . . 0.0 108.189 -175.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.48 29.75 7.8 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -58.79 102.88 0.13 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.395 -1.73 . . . . 0.0 109.239 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.27 102.82 7.83 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.399 0.619 . . . . 0.0 110.932 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -67.32 130.13 42.12 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.493 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -87.47 37.47 0.78 Allowed 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.348 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.2 m -64.53 122.43 16.77 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.343 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.2 m -80.14 1.62 27.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.787 0.803 . . . . 0.0 110.749 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 p -90.91 163.2 30.64 Favored Pre-proline 0 N--CA 1.422 -1.831 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.171 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.1 104.78 1.84 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.262 1.975 . . . . 0.0 109.183 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -75.54 -10.16 59.2 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 64.96 150.23 0.11 Allowed Pre-proline 0 C--N 1.263 -3.179 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.953 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.17 37.37 0.68 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.586 2.191 . . . . 0.0 112.192 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -85.6 42.55 0.97 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.623 0.769 . . . . 0.0 112.492 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 27.9 mt-30 48.82 -150.83 0.15 Allowed 'General case' 0 N--CA 1.41 -2.428 0 C-N-CA 125.107 1.363 . . . . 0.0 112.638 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -61.71 164.13 10.56 Favored Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -41.55 125.59 2.82 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.944 2.429 . . . . 0.0 110.558 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 3.0 p -134.1 156.31 48.51 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.05 -171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 11' ' ' ARG . 7.3 p -149.22 148.41 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.567 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.0 m -97.41 106.96 19.38 Favored 'General case' 0 N--CA 1.391 -3.389 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 9' ' ' LYS . 53.3 t60 -114.68 146.21 41.15 Favored 'General case' 0 N--CA 1.416 -2.157 0 C-N-CA 123.791 0.836 . . . . 0.0 110.529 -169.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . 0.25 44.8 mm -83.13 112.92 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.664 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -113.12 145.87 40.18 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.23 169.63 18.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.38 17.85 42.79 Favored Glycine 0 C--N 1.292 -1.871 0 O-C-N 124.299 0.999 . . . . 0.0 113.008 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -108.08 -25.16 11.26 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-O 122.131 0.967 . . . . 0.0 110.998 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 52.1 m -103.6 137.84 41.1 Favored 'General case' 0 N--CA 1.391 -3.403 0 C-N-CA 125.059 1.344 . . . . 0.0 108.705 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.91 150.01 17.47 Favored 'General case' 0 C--O 1.247 0.963 0 CA-C-O 121.44 0.638 . . . . 0.0 111.237 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.504 HG22 ' HG ' ' A' ' 82' ' ' LEU . 83.8 t -52.8 -51.18 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.227 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -53.37 -42.18 66.62 Favored 'General case' 0 C--O 1.198 -1.619 0 O-C-N 125.003 1.439 . . . . 0.0 110.61 -176.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -67.29 -39.07 85.96 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.629 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -62.51 -37.83 87.56 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.627 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 31.0 mt -66.52 -43.82 90.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 114.363 -1.289 . . . . 0.0 112.015 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HG3' HG21 ' A' ' 63' ' ' VAL . 94.1 mttt -56.22 -34.72 66.58 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 118.839 0.745 . . . . 0.0 111.143 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.12 -53.47 23.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.136 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 49' ' ' ILE . 20.0 mt -53.31 -47.89 68.86 Favored 'General case' 0 CA--C 1.497 -1.078 0 O-C-N 123.274 0.359 . . . . 0.0 111.12 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 49' ' ' ILE . 79.5 mt -57.26 -49.43 76.07 Favored 'General case' 0 C--O 1.199 -1.564 0 O-C-N 123.705 0.628 . . . . 0.0 109.613 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.6 m -58.63 -39.8 81.53 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -71.41 -32.36 68.33 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 35' ' ' VAL . 44.8 m-85 -86.42 -2.71 58.67 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.1 0.476 . . . . 0.0 111.835 175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.1 mttp 69.15 39.23 1.76 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 125.389 1.476 . . . . 0.0 112.665 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.4 mt -106.42 136.85 19.32 Favored Pre-proline 0 N--CA 1.408 -2.538 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -59.28 134.91 62.06 Favored 'Trans proline' 0 CA--C 1.501 -1.16 0 C-N-CA 121.738 1.625 . . . . 0.0 111.515 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.635 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 29.1 m -64.38 -11.66 10.75 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.63 0 CA-C-N 114.865 -1.062 . . . . 0.0 112.843 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.6 -20.61 64.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.257 0.551 . . . . 0.0 109.66 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 65.9 mttm -83.17 -2.46 55.55 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.265 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 60' ' ' VAL . 4.0 p -49.0 -30.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 126.942 2.097 . . . . 0.0 110.618 176.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 p -54.99 -58.12 8.92 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.915 173.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.1 m -87.85 10.96 16.84 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.422 -174.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.448 ' HD2' ' O ' ' A' ' 62' ' ' LYS . 25.1 m-85 -109.22 143.51 38.57 Favored 'General case' 0 C--N 1.277 -2.567 0 O-C-N 121.277 -0.89 . . . . 0.0 111.34 177.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' HB3' HH22 ' A' ' 98' ' ' ARG . . . -147.96 154.35 40.22 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.037 -178.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 97' ' ' LEU . 81.5 mt -89.29 160.48 16.87 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 174.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 76' ' ' TYR . 41.5 tt0 -150.0 150.53 31.93 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 122.521 0.328 . . . . 0.0 110.207 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -87.83 137.98 31.5 Favored Pre-proline 0 C--N 1.318 -0.779 0 C-N-CA 124.459 1.103 . . . . 0.0 108.642 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -70.58 -21.16 30.06 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.814 2.342 . . . . 0.0 115.38 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -105.76 -42.49 5.15 Favored 'General case' 0 CA--C 1.496 -1.127 0 C-N-CA 119.747 -0.781 . . . . 0.0 113.001 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.5 p -90.43 -20.77 22.38 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.474 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt 66.58 17.96 10.7 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.491 1.117 . . . . 0.0 111.375 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.92 140.0 33.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 69' ' ' GLN . 5.8 m-30 -86.03 -174.75 5.25 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-O 121.977 0.894 . . . . 0.0 110.567 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.8 t -118.0 101.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -102.97 11.95 36.71 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 122.796 1.284 . . . . 0.0 109.455 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -74.16 159.63 32.31 Favored 'General case' 0 N--CA 1.412 -2.336 0 CA-C-N 112.581 -2.1 . . . . 0.0 111.019 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.0 m -84.43 -39.44 18.97 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.317 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -128.06 154.92 45.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.863 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.504 ' HG ' HG22 ' A' ' 45' ' ' VAL . 16.9 mt -89.19 147.7 24.03 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.141 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.447 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 70.6 p -99.28 153.08 37.96 Favored Pre-proline 0 N--CA 1.401 -2.888 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.91 -34.17 97.99 Favored 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 122.428 2.085 . . . . 0.0 109.815 174.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -59.07 -47.62 84.58 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.142 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.4 mmm180 -60.28 -37.82 81.67 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' HB3' ' HG3' ' A' ' 8' ' ' MET . 69.3 mt -64.35 -48.9 73.76 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 123.822 0.701 . . . . 0.0 110.401 178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 43.7 t -63.48 -43.76 98.52 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.373 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -61.57 -29.89 70.32 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.79 173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.56 -34.06 25.29 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.978 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -57.13 -24.58 55.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.644 0.735 . . . . 0.0 112.381 176.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 36.4 mmtm -54.09 -40.36 67.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.154 174.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 54.9 m -144.2 -88.31 0.12 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -156.64 178.96 9.73 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 124.234 1.014 . . . . 0.0 108.752 -179.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.25 152.85 34.93 Favored 'General case' 0 C--O 1.203 -1.363 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.499 HG22 ' HG3' ' A' ' 98' ' ' ARG . 2.7 mp -114.09 133.86 58.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 170.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -117.59 115.93 26.09 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -175.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.515 HH11 ' HB2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -146.41 177.56 8.94 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 -177.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 65' ' ' SER . 49.4 mtp -80.94 138.75 36.11 Favored 'General case' 0 N--CA 1.381 -3.885 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 176.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -65.37 137.62 96.76 Favored Pre-proline 0 N--CA 1.415 -2.212 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.83 105.85 0.58 Allowed 'Trans proline' 0 CA--C 1.502 -1.093 0 C-N-CA 122.576 2.184 . . . . 0.0 111.333 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -81.98 113.63 20.01 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.59 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.9 178.19 7.99 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 64.1 mt -78.37 113.8 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 CA-C-O 120.911 0.386 . . . . 0.0 110.427 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.38 93.7 0.77 Allowed 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.067 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.44 77.57 1.28 Allowed 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 . . . . . 0 C--N 1.301 -1.526 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.201 -175.957 . . . . . . . . 0 0 . 1 stop_ save_